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ABSTRACT 
The aim of this thesis is to estimate the cost-effectiveness of intermittent preventive treatment of 
pregnant women (IPTp) with sulphadoxine-pyrimethamine (SP) to prevent Low Birth Weight 
(LBW) and anaemia due to malaria in pregnancy in Gambian multigravidae, including an 
examination of indirect costs. The study was piggy-backed on a Randomised Controlled Trial 
(RCT) of the effectiveness of IPTp conducted in the rural area of the country from July 2002 to 
February 2004. 
The specific objectives are to: 
i. Examine the cost-effectiveness of introducing SP as IPTp for malaria into 
normal antenatal care for multigravidae women in rural Gambia; 
ii. Explore various methods of valuing indirect costs and assess the extent to 
which they affect the cost-effectiveness ratio; and 
iii. Make policy recommendations as to whether to introduce SP as IPTp on cost- 
effectiveness grounds. 
The rationale for the study is that both national and international policy makers need precise 
information to determine which intervention strategies are best for prevention and control of 
malaria in pregnancy, and which strategies represent good investment. They also need to know 
how the cost-effectiveness of such interventions compared to other public health interventions. 
Cost-effectiveness analysis (CEA) is a recognised tool for advising policy makers on the value 
of an intervention. However, in practice, there are few CEA studies of malaria in general and 
malaria in pregnancy in particular in developing countries. Previous CEA studies of IPTp in 
developing countries have been limited to primigravidae and secundagravidae. Moreover, most 
of them were conducted from the perspective of the provider without incorporating indirect or 
productivity costs. This could partly be due to lack of consensus on the issue of whether or not 
to include indirect costs. 
The data required for the study was collected through several methods. For IPTp intervention 
costs to the health-care provider, antenatal clinic users and their families, a sample of 884 
multigraviade were randomly selected from the main IPTp effectiveness trial sample of 2,688 
recruited multigravidae. In addition, several sub-studies such as health facility studies for the 
IPTp intervention, a hospital study for treatment of LBW and anaemia, a time-use study and 
collection of secondary data were used to estimate costs. Time-use and employment surveys 
were used to measure the time and alternative values for unpaid work. 
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The costs data were combined with the effectiveness data from the trial to estimate incremental 
costs and consequences for Base case I (trial sample) and Base case II (non-users of bednets in 
trial sample). 
The study results showed that the net costs of IPTp with SP for multigravidae with and without 
indirect costs were D1,221,771 and D1,887,607 respectively for Base case I. The inclusion of 
indirect costs led to a 68% increase in net costs in Base case I. The corresponding figures for 
Base case II were D315,933 and D453,620. The indirect costs in Base case II constituted a 44% 
increase in net costs. In terms of effectiveness, the DALYs averted in Base cases I and II were - 
125.8 and -0.13 respectively. So the intervention created resource losses. Sensitivity analysis 
conducted by varying key costs and effectiveness parameters showed the introduction of a 
haemoglobin test led to over 400% increase in net costs for both base cases; and reduction in 
number of doses led to around a 40% reduction in net costs. Except for the use of the 
opportunity cost method of valuing indirect costs in Base case I that led to a 12% decrease in 
net costs, the use of all other human capital wage rates led to a less than 10% change in net costs 
for both base cases. 
Sensitivity analysis of giving IPTp to all pregnant women (primigravidae, secundigravidae and 
multigravidae) found that IPTp dominated the control for the two base cases. The domination 
remained regardless of whether indirect costs were included or not. However, the magnitude 
depended on the wage rate used in estimating indirect costs. The inclusion of indirect costs led 
to resource savings in the range of 9%-20% for Base case I and 10%-23% for Base case II. The 
general conclusion is that giving IPTp with SP to multigravidae alone is not cost-effective. 
However, some improvements in health outcomes were observed for those women who do not 
sleep under bednets. If IPTp were to be given to all pregnant women without regard to gravidae, 
IPTp was dominant with and without indirect costs. The resource savings varied according to 
the wage rate used. However, there may be a policy dilemma associated with giving IPTp to all 
women knowing that the trial showed it conferred no benefits, and even might carry some risks. 
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CHAPTER 1: BACKGROUND OF THE RESEARCH 
1.1 STATEMENT OF THE PROBLEM AND RATIONALE FOR THE STUDY 
Rationale for Intermittent Preventive Treatment for Pregnancy (IPTp) 
Malaria is a parasitic disease spread by mosquitoes and is endemic in parts of Africa, Asia and 
South America (RBM, 2002; 2003; Orton and Garner, 2005; Desai et al 2007). The prevalence 
of symptomatic malaria is higher amongst pregnant women when compared to non-pregnant 
women regardless of the setting, and it poses a severe threat to the pregnancy of any woman 
(Kosten et al, 2004; Brabin et al, 1988; Brabin et al, 1990; Meek et al, 2001, Crawley et al 
2007). Out of approximately 50 million pregnant women worldwide who are exposed to malaria 
annually, over 30 million of them come from the African region (Crawley et al, 2007). Most 
non-pregnant women are semi-immune to Plasmodium falciparum malaria due to previously 
repeated infection, causing them to be asymptomatic even if they have parasites in their blood. 
Cases of clinical disease in non-pregnant women are often not severe (Whitty et al, 2005). 
However, immunity to malaria that is acquired before pregnancy is usually reduced in practice 
during pregnancy, particularly the first pregnancy, leading to greater risk of mortality (Anya, 
2004). Those who do not have prior immunity to malaria infection are at even higher risk during 
pregnancy of complicated malaria and foetal loss (Shulman and Dorman, 2003; Luxemburger et 
al, 2001). 
Susceptibility to malaria infection and the severity of clinical manifestations are therefore 
determined by the level of immunity before pregnancy; that in turn is affected by the intensity 
and stability of malaria transmission (Mutabingwa, 1994). Intensity of malaria transmission in 
Sub-Saharan Africa (SSA) ranges from holo-endemic to virtually zero. Those in highland areas, 
urban settings and much of South Africa may have little or no exposure to malaria before 
pregnancy and are therefore non-immune. In particular, malaria can cause maternal anaemia 
even in the absence of peripheral parasites. The level of acquired immunity also depends on the 
parity of the woman and HIV infection, which may further impair the efficacy of the immune 
response during pregnancy (Steketee et al, 1996b; van Eijk et al, 2002; van Eijk et al, 2003; 
Verhoeff et al, 1999). 
The consequences of malaria in pregnancy for both the mother and her unborn child can be very 
serious (Steketee et al, 2001). According to Bellamy (2004), malaria in pregnancy is one of 
several causes of maternal, foetal and neonatal mortality worldwide. Malaria is directly or 
indirectly one of the leading causes of maternal and perinatal morbidity and mortality in SSA 
(Whitty et al, 2005; Menendez et al, 2000; Rogerson et al, 2000; Marchant et al, 2004). 
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It causes maternal anaemia to mothers and low birth weight (LBW) of infants born to mothers 
(Shulman et al, 2001 a; 2001b) accounting for at least 5% of perinatal deaths in developing 
countries (Guyatt and Snow, 2004). Each year, there are at least 25 million pregnancies in 
malaria-endemic areas in SSA at risk of Plasmodium falciparum malaria infection during 
pregnancy (WHO, 2004). 
A LBW newborn is defined as one that is born weighing 2500 grammes or less. In areas of 
stable transmission, malaria in pregnancy contributes to approximately 8% to 14% of LBW 
(Steketee et al, 2001; Steketee et al, 1996a; RBM, 2002; 2003), 8% to 36% of prematurity and 
an additional 13% to 70% of Intrauterine Growth Retardation (IUGR), depending on the level of 
risk (Steketee et al, 2001, RBM, 2002). Maternal malaria accounts for 30% of all preventable 
LBW during pregnancy and approximately 3% to 8% of all infant mortality (Steketee et al, 
2001; Steketee et al, 1996a). Another pathway to LBW is severe maternal anaemia, which is 
also caused by malaria infection. 
Anaemia in pregnancy is generally defined as haemoglobin level less than 11g/dl and severe 
anaemia is haemoglobin level less than 7g/dl (ORC Macro, 2005; 
http: //encyclopedia. thefreedictionary. com). Malaria is a major cause of anaemia particularly in 
primigravidae, but other causes may also play a significant role particularly in secundigravidae. 
Primigravidae or gravidae one refers to a woman who is pregnant for the first time and a woman 
who has been pregnant more than once is referred to generally as multigravidae or more 
specifically as gravidae two (also secundigravida), gravida three, and so on 
(http: //en. wikipedia. org/wiki). In areas of stable transmission, malaria in pregnancy contributes 
to approximately 2% to 15% of maternal anaemia (Steketee et al, 2001; Steketee et al, 1996c; 
SARA/USAID, 2001). 
According to Guyatt and Snow (2001 a), as many as 400 000 pregnant women may have severe 
anaemia because of malaria-infection in SSA. In holo-endemic areas - with a 5% severe 
anaemia prevalence - malaria accounts for approximately 18% of severe anaemia related 
deaths in primigravidae (Brabin et al, 2001) with the rest due to nutritional deficiencies, mainly 
iron, folate vitamin A and vitamin B 12 deficiencies or HIV infection (Meek et al, 2001). 
In their pursuit to control malaria, African leaders at an Organisation of African Unity (OAU) 
meeting in Abuja in April 2000 committed themselves to halving malaria mortality in Africa by 
2010 and to also ensuring 60% coverage of pregnant women at risk of malaria by the year 2005 
(WHO 2003a). 
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The first step to achieving this was the development of a strategic framework for controlling 
malaria by the WHO Regional Office for Africa (WHO/AFRO) which recommended a three- 
pronged approach of IPTp with appropriate drugs delivered at the antenatal clinic, use of ITNs 
and proper case management (WHO, 2003b, WHO, 2004a). 
Earlier attempts to prevent malaria in pregnancy were through chemoprophylaxis using 
chloroquine. However, maintaining a high level of compliance and widespread chloroquine 
resistance made malaria-prevention difficult (Whitty et at, 2005). An attempt to overcome these 
problems brought about the concept of IPTp with Sulphadoxine-Pyrimethamine (SP). IPTp is 
based on the assumption that every pregnant woman living in an area of stable or unstable 
malaria transmission has malaria parasites in the blood or in the placenta and should therefore 
be treated to minimise the parasites' effect on the mother and her foetus (WHO, 2004). IPTp 
refers to the periodic administration of anti-malarials during pregnancy irrespective of the 
presence of parasites and/or clinical illness (Meek et at, 2001). The aim of IPTp is to clear the 
placenta of parasites and peripheral parasitaemia during the period of maximum foetal growth 
(24-36 weeks). Whether this is truly a matter of intermittent presumptive treatment as originally 
supposed, or of chemoprophylaxis with a long-acting drug (SP) or a mixture of the two, remains 
a matter for debate. SP, which is the drug of choice in many countries for IPTp, is a 
combination of two drugs with each tablet containing 500mg of sulfadoxine and 25mg of 
pyrimethamine (WHO, 2004). A single dose of SP consists of three tablets taken at once, 
preferably under direct observation by the health care provider. Fansidar is the most common 
brand of SP, but other brands such as Falcidin, Laridox and Maladox do exist. IPTp with SP is 
currently the most effective approach in the use of anti-malarial drugs during pregnancy and is 
particularly attractive for use in areas with a high level of chloroquine (CQ) resistance (WHO, 
2004). 
According to Whitty et al (2005), prescribing anti-malarial drugs, like many other drugs, is a 
balancing act. Malaria in pregnancy, which has adverse effects for both the mother and the 
foetus, should be treated with efficacious drugs, but also safe ones, so that they can clear the 
parasites without negatively affecting the health of the mother. SP as IPTp was found to be safe 
in the prevention of placental and peripheral malaria in primigravidae and secundigravidae in 
SSA. Although there have been worries about the safety of drugs in relation to the foetus, no 
compelling evidence exists to support the claim that any of the drugs currently being used as 
anti-malarial drugs have tetratogenic effects in humans, but in large part, this may be because 
there is no evidence either way (Whitty et al, 2005). SP has been used extensively in pregnancy, 
including as IPTp, but formal safety studies in pregnancy were limited (Ward et al, 2007). 
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Evidence showed that in over 2000 pregnant women treated with SP in the second and third 
trimester, the drug did not increase the risk of malformation or other adverse events in the foetus 
(Nosten et al, 2006). 
There has been limited evidence that sulpha drugs may be linked to kernicterus when given to 
premature neonates (Silverman et al, 1956) but this has not been observed in studies where SP 
as IPTp was administered to mothers (Parise et al, 1998; Verhoeff et al, 1998; Shulman et al, 
1999). Studies found no increased risk in spontaneous abortions or congenital defects because 
of in utero exposure to SP (Parise et al, 1998; Verhoeff et al, 1999). SP as weekly prophylaxis 
has been associated with rare and severe reactions (Miller et al, 1986), but there is no evidence 
that this risk is any greater in pregnancy (Newman et al, 2003). No adverse pregnancy 
consequences were found in instances where only Pyrimethamine was given alone (Morley et 
al, 1964). 
In summary, SP based on present evidence is considered safe in the second and third trimesters 
of pregnancy (Newman et al, 2003; Nosten et al, 2006). Safety of multiple doses of SP in HIV 
infected pregnant women requires further evaluation as does SP when used in combination with 
antiretroviral drugs (Okereke, 1999). The safety of other anti-malarials for pregnant women 
such as tetracycline, doxycycyline, primaquine and halofantrine is not yet definitive and so their 
use has not been recommended (WHO, 2004). It has been noted that the lack of such evidence 
on the safety of other drugs does not mean that they have a complete clean bill of health for 
pregnant women (Whitty et al, 2005). The common trend is that, the newer the drug, the more 
likely it is to be efficacious. This is so because of lack of sufficient time for resistance to 
develop. However, the short time makes it impossible to provide sufficient data to guarantee 
their safety (Whitty et al, 2005). 
An early study from Malawi (Schultz et al, 1994) showed that two doses of SP given during 
pregnancy substantially reduced the prevalence of placental malaria. Subsequent studies from 
Malawi reveal that IPTp with SP provided through routine antenatal services reduces LBW in 
primigravidae but not in multigravidae (Verhoeff et al, 1997; Rogerson et al, 2000). In Kenya, a 
controlled trial showed that IPTp with SP given two or three times during pregnancy reduced 
the prevalence of severe anaemia in primigravidae (Shulman et al, 1999). Other studies 
conducted in Kenya showed that IPTphas beneficial effects on LBW, although this is muted in 
HIV positive women (Parise et al, 1998). It has also been reported that the efficacy of two doses 
of SP is impaired in HIV infected pregnant women with three (Verhoeff et al, 1998) or more 
(Parise et al, 1998) doses needed to achieve sufficient levels of effectiveness. 
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It is on the basis of these empirical findings that WHO recommends IPTp with SP for all 
pregnant women resident in areas of medium or high malaria endemicity (WHO, 2002). 
Evidence of SP's efficacy as IPTp, demonstrated in Kenya and Malawi (Steketee, 2001; 
Shulman et at, 1999; Schultz et at, 1994; Parise et at, 1998) led to its adoption as policy in these 
countries. IPTp with two doses of SP (in the second and third trimester) has been shown to be 
effective in reducing placental parasitaemia, thereby improving birth weight (Gulmezoglu and 
Garner, 1999) and preventing severe maternal anaemia (Shulman et at, 1999) in primigravidae. 
Although one visit may not be sufficient for IPTp to be fully efficacious, the fact that 35%-95% 
of pregnant women in Africa attend antenatal clinics at least once during pregnancy presents a 
good opportunity for IPTp to reach as many pregnant women as possible (WHO, 2004). 
However, most of the studies mentioned above were with respect to primigravidae and 
secundigravidae. Other studies considered all pregnant women without conducting separate 
efficacy analyses by gravidae. Thus, although IPTp with SP is recommended for women of all 
gravidae, there has been little evidence to support its use in multigravidae. Until very recently, 
there has been no trial that has specifically addressed the effectiveness of SP as IPTp for this 
group of women. This gap in the evidence base led to a randomised controlled trial in The 
Gambia to test the efficacy of IPTp using SP in multigravidae in rural areas. There are good 
theoretical reasons to think that IPTp may become less effective as the number of pregnancies 
increases. The impact of malaria causing anaemia in pregnancy decreases with each pregnancy. 
Therefore, whilst the risk of giving potentially teratogenic drugs in pregnancy stays steady in 
each pregnancy, the potential benefit may decrease. In some settings, the majority of 
pregnancies are in women who have had more than two children to term. The potential risk- 
benefit and cost-effectiveness of IPTp in multigravidae women is therefore a significant public 
health concern. 
Malaria in The Gambia 
Malaria in The Gambia remains a major public health problem, with associated social and 
economic implications (DoSH, 2003). The health burden is greater among pregnant women and 
children under five years, particularly in the rural areas where large numbers of breeding 
grounds favour a high vector population (Koram, 1993). Malaria is one of the leading causes of 
mortality and morbidity in the Gambia especially for children under five years (Greenwood et 
al, 1987). Although accurate figures are hard to come by, it is estimated that 2% of antenatal 
consultations and 40% of under-five visits to maternal and child health (MCH) services are due 
to malaria (DoSH, 2003). More than 20% of outpatient treatment has also been attributed to 
malaria (DoSH, 2001). 
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Furthermore, malaria is believed to be one of the main causes of severe anaemia in pregnancy 
with LBW deliveries of primigravidae in rural facilities estimated to vary between 18-30% of 
all births (DoSH, 2001). 
The recently finalised Malaria Control Policy and Strategic Plan of The Gambia (DoSH, 2003a; 
DoSH, 2003b) aim to reduce the burden of malaria through well-targeted interventions with full 
community participation. The guiding principle is to ensure that the most vulnerable groups, 
pregnant women and children under five years, benefit the most. The policy specifically targets 
six programme areas, namely; case management, malaria in pregnancy, vector control, 
management and partnership, information education and communication (IEC) and advocacy, 
and surveillance and research (DoSH, 2003a). The officially recommended first line drug for 
treatment of uncomplicated malaria is chloroquine (CQ), and the second line drug is SP. 
Quinine is reserved for treatment of severe and complicated malaria. This is however likely to 
change because the government is considering a policy change on first-line malaria treatment 
from CQ to Artemisinin-Combination Therapy (ACT) with Coartem. The policy for Malaria in 
Pregnancy is to improve the outcome of pregnancy for mothers, the foetus and the newborn by 
following the WHO's approach of use of IPTp, ITNs and case management of malaria illness 
(DoSH, 2003). This should be done through provision and promotion of the cost-effective use 
of IPTp by all pregnant women, increased access to and promotion of the use of ITNs for all 
pregnant women, promotion of early antenatal clinic attendance, and prompt diagnosis and 
treatment of cases of malaria in pregnancy. Despite the high burden of malaria in pregnancy in 
The Gambia, there is no countrywide use of chemoprophylaxis as a preventive measure in 
general, or more specifically the use of SP as IPTp for pregnant women. 
Rationale for measuring the cost-effectiveness of IPTp 
Both national and international policy makers need precise information to determine which 
intervention strategies are best for prevention and control of malaria in pregnancy and which 
strategies represent good investment. They also need to know how their cost-effectiveness 
compares to other public health interventions. Economic evaluation methods, especially cost- 
effectiveness analysis (CEA), can provide vital clues to identify the interventions that represent 
the best value for money (Goodman et al, 1999a). However, in practice, there are few studies of 
CEA of malaria and only three for chemoprophylaxis or IPTp in pregnant women (Mills, 2005). 
Comparison of these studies demonstrates significant variations in cost-effectiveness depending 
on epidemiology, relative cost, existing infrastructure, scale of activity, compliance and 
coverage, managerial capacity, etc. (Goodman et al, 2001). 
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Limitations of the studies include their concentration on primigravidae and 
secundagravidae at the expense of multigravidae and their narrow perspective whereby 
only costs affecting health care providers were considered. Each of these issues limits 
the generalisability of results from one setting to another. There is need for an economic 
evaluation that builds upon the earlier work in a number of important ways. Firstly, in terms of 
the methodology, a broader definition of both costs and effects needs to be taken. Typically, 
costs have been narrowly defined as drug costs (provider perspective), rather than a societal 
perspective, i. e. wider costs borne by the health service provider, transport costs and time off 
work for patients and families of patients (i. e. time off work to accompany patients to health 
care facilities). Secondly, a societal perspective also implies that the consequences of IPTp - in 
terms of mortality and morbidity - need to be measured as well as the process of seeking care, 
such as satisfaction or otherwise of waiting times. Thirdly, most existing studies have examined 
the sensitivity of cost-effectiveness ratios to the level of compliance but studies need to go 
further to investigate other variables likely to influence cost-effectiveness such as indirect costs, 
efficacy rates and so on. 
In an attempt to fill these gaps, an economic evaluation was piggy-backed onto the randomised 
controlled trial conducted in The Gambia to test the efficacy of IPTp using SP in multigravidae 
in rural areas. As outlined above, the potential effectiveness in multigravidae women may well 
be lower than in primigravidae and secundigravidae. This is important not only for the clinical 
risk-benefit analysis, but also for cost-effectiveness. If the effectiveness of the intervention is 
reduced and the same costs maintained, the cost-effectiveness is inevitably affected. The aim of 
the economic evaluation was to compare the costs and effects of adding SP as IPTp to normal 
antenatal care for multigravidae in The Gambia. There has not been a previous economic 
evaluation of this nature in developing countries. Cost-effectiveness analysis is a recognised 
tool for advising policy makers of the value of an intervention. However, there is no agreement 
on certain aspects of the methodology of CEA, especially the issue of whether or not to include 
indirect costs. 
Rationale for investigating indirect costs 
Indirect costs or productivity losses are defined as the costs of those resources for which no 
payment is made, but for which there is an alternative use that is of value to someone (Jacobs 
and Fassbender, 1998). In order to avoid confusion caused by the use of the term indirect costs 
by accountants to describe overhead costs, Drummond et al (2005) in their new framework 
replaced the term indirect costs with the term productivity losses. 
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However, the latter are still incorporated within the CEA framework (M. Drummond, personal 
communication, email 2006). The role of indirect costs or productivity losses in economic 
evaluation, and their estimation, have been contentious and debated widely (Drummond et al, 
2005). The inclusion of indirect costs in CEA requires expanding the perspective of the 
intervention from patients or health services to societal. A societal perspective takes into 
account all the costs and consequences that occur because of an intervention and requires 
resources to be valued within the context of their societal opportunity costs. 
There is disagreement amongst scholars with regard to the treatment of indirect costs in 
economic evaluation. The first school of thought comprises those who consider indirect costs 
important to be included in economic evaluation. However, different authors give different 
reasons and emphasis for doing so with potential implications on the transferability of findings 
from one setting to another. Jamison (1993) argued that the perspective of service users must be 
taken on board; Pritchard and Sculpher (2000) saw both paid and unpaid time as scarce 
resources that should be equally valued for all patients for ethical reasons; Posnett and Jan 
(1996) considered the value of unpaid time as an important element in the indirect cost of health 
care production especially given the shifting focus of health services from centralised to 
community care through early discharge; and Koopmanschap and Rutten (1996) argued that 
productivity effects are relevant as long as the estimates reflect the real economic impact of 
diseases and ignoring them denies the reality that production losses influence scarcity of 
resources. Other authors such as Phelps and Mushin, 1991; Creese and Parker, 1994; Haddix et 
al, 1996; base their arguments on maximising the efficiency of health care spending for the 
entire population and ensuring consistency between costs and consequences. From the reasons 
given above, only those who put forward arguments based on the importance of unpaid work 
may be relevant to developing country settings where such type of work is the norm. 
The second school of thought argues that indirect costs should not be incorporated as part of 
economic evaluation and give contradictory reasons for excluding them. Gerard and Mooney 
(1993) argue that expressing health effects in health-related quality of life measures, such as the 
Quality Adjusted Life Years (QALY), removes the logic of including non-health care costs in 
the analysis because non-health care resources such as leisure and working time have a range of 
alternative uses other than health-producing activity and therefore cannot be adequately 
reflected in the CEA. This tends to support the view of the Washington Panel that indirect costs 
(productivity costs) be measured through quality of life in the denominator of the CEA ratio and 
challenges the very basis of including indirect costs in economic evaluation. 
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Furthermore, it is not clear whether the argument made for QALYs - mostly used in developed 
countries - is relevant in developing countries where the use of DALYs is common. 
Williams (1992) argued that, due to information problems about indirect costs, these could be 
ignored. He also argued that the inclusion of such costs would lead to ethical problems by 
favouring those in active service against retirees and the handicapped. The main contradiction in 
Williams is that, although he implies the inclusion of indirect costs in economic evaluation 
might change some of the rankings in the cost per QALY league tables and influence the 
conclusions of CEA, he also states they should be ignored due to information problems. Olsen 
and Richardson (1999) suggested that including indirect costs may lead to what they refer to as 
"unacceptable distributional consequences". However, they were not very clear as to what those 
consequences are. 
The position of guidelines for economic evaluation relating to the inclusion of indirect costs in 
economic evaluation varies. Whilst the Finnish, Portuguese and Dutch have been very 
unambiguous about the inclusion of indirect costs (Finnish Ministry of Social Affairs and 
Health, 1999; Hjelmgren et al, 2001; INFARMED, 1998), the National Institute for Health and 
Clinical Excellence (NICE) in the United Kingdom has limited itself to including `net service 
and other costs' (NICE, 2001). The guidelines for England and Wales call for full opportunity 
costs to be included but are not clear about what is meant by full costs (Jacobs et al, 1995; 
Hjelmgren et al, 2001). The Canadian guidelines also call for all costs to be included but are not 
clear about patients' costs (CCOHTA, 1997). The Ontario guidelines request the inclusion of all 
relevant health care costs (Ontario Ministry of Health, 1994). Publication guidelines for the 
British Medical Journal (BMJ) and the Journal of the American Medical Association (JAMA) 
request that resource use costs associated with the intervention be included (Drummond and 
Jefferson, 1996; FDA, 1995; Siegel et al, 1997). It therefore seems that the decision to include 
indirect costs depends on the objectives of the evaluation, the geographical setting of the 
intervention and the perspective chosen. 
Rutabanzibwa-Ngajza et al, (1985) have emphasised the importance of the contribution to the 
agricultural sector by rural women in developing countries, but little has been done to assess the 
effect of unpaid household work on health interventions in subsistence settings. 
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According to Anker in his editorial to Goldschmidt-Clermont (1987), due to the low labour 
productivity of household activities, women in developing countries devote long hours to back- 
breaking work each day, and there are few days, if any, which do not require these tasks to be 
performed. This leaves little or no time for other activities outside the household. Therefore, for 
women predominantly involved in subsistence work, the inclusion of indirect costs in the 
evaluation of interventions affecting them is likely to be important. Most people in developed 
economies engaged in paid work may not lose wages for short-term utilisation of health services 
(Torgerson et al, 1994; Law, 1995). Furthermore, such people may have sufficient funds to 
afford the extra-costs of getting care by foregoing work. By contrast, it is the informal sector 
that dominates the economy in developing countries, rather than the formal sector especially in 
rural areas. 
The informal sector is deemed conceptually, methodologically and theoretically difficult to 
define in terms of its nature, size and importance, leading to criticism of lack of clarity (Peattie 
1987; Bromley 1990). However, the definition that fits its use in this thesis is that it describes 
economic activity that takes place outside the formal norms of economic transactions 
established by the state and formal business practices (Cross, 1998). The informal sector 
represents a big component of economic activity, particularly in developing countries where it 
provides economic opportunities for women and the poor (Cross, 1998). The formal sector is 
the inverse of the informal sector as it mainly describes economic activity that takes place 
within the relatively structured economic transactions established by the state and formal 
business practices. Movement between formal and informal sectors, especially in remote rural 
areas, is almost non-existent, thus leaving people with no other choice but to work within the 
informal sector. Work in rural areas of developing countries is characterised by unpaid 
household chores and subsistence work (including farming and gardening). 
Furthermore, people in developing country settings use time-consuming travel modes such as 
public transport and walking, and are usually accompanied by caregivers (Torgerson et al, 
1994). Time may be so precious to these rural women that it may affect their health-seeking 
behaviour, thereby reducing the effectiveness of interventions that benefit them (Clarke et al, 
2000). The effects of these time costs tend to be more evident in the case of preventive care than 
for treatment (Kutzin, 1993). Unlike illness, which may result in pain and suffering that can 
compel the sufferers to seek treatment, prevention rarely involves such discomfort and so 
people may not see the urgency to seek care (Ratcliffe, 1993). 
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Indirect costs are especially difficult to assess in a subsistence setting such as The Gambia and 
are therefore often excluded in economic evaluation. The few studies in developing countries 
that have looked at the household costs of health care have used different methods of 
calculation. In their attempt to summarise the various methods used to value indirect costs in 
developing countries, Attanayake et al (2000) found that mean daily income (Sharman et al 
1990), average wages (Sawyer et al 1993; Jayawardane 1993; Asenso-Okyere and Dzator 1997; 
Konradsen et al 1999), daily output per adult (Shepard et al 1991; Sauerborn et al 1991) and 
average income per day (Ettling et al 1994) were the most popular methods. Attanayake et al 
used the output-related method to measure indirect costs, by relating loss of time with loss of 
output at individual and household levels, but they failed to consider household chores. The 
only time use study at household level in The Gambia that had the potential to include indirect 
costs was conducted by Aikins (1995) using the technique of Random Spot Observation. 
However, the findings were not integrated into an economic analysis. 
The multiple roles of women in rural settings, which include being utilisers of maternal and 
MCH services and traditional care, providers of informal care, child bearing, producers of food 
and also less commonly wage labour (Rutabanzibwa-Ngajza et al, 1985), make utilisation of 
antenatal care a potentially time-consuming activity for them. Domestic activities are 
exclusively performed by unpaid household members, and in the case of The Gambia, by 
women. An important component of a women's life in The Gambia is devoted to unpaid work. 
Unpaid work includes household work, farming during the rainy season, gardening during the 
dry season and petty trading all year round in rural towns. Time is of fundamental importance 
for the women particularly during the rice-planting season when rest and leisure are usually cut 
to a minimum and attendance at clinics is greatly reduced (Rutabanzibwa-Ngajza et al, 1985). 
In The Gambia, all pregnant women pay registration fees of five Gambian Dalasis (US$0.25) to 
obtain a client-held antenatal care record card. This card entitles the holder (pregnant woman) to 
free consultations and medication during pregnancy and until six weeks after delivery for all 
conditions related to the pregnancy. Despite this relatively minimal financial cost, the average 
national antenatal visit rate is just 3.4 times per woman (Cham, 2003), which falls below the 
WHO-recommended target of four (WHO, 2001). The rate is lower in rural areas where women 
are sometimes prepared to incur extra financial costs by buying medication at local drug stores 
instead of visiting designated antenatal clinics (Chaco, 2003). One of the reasons for this, 
according to Cham (2003), is to circumvent the opportunity cost of time related to receiving 
health care at the facility level. 
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A study by Francis Foord in 2000 suggested that, by following the historical pattern of 
restricting MCH services to facilities in catchment areas, the vast number of potential 
beneficiaries might not fully utilise the services. Furthermore, staff attitudes and poor 
organisation of tasks at clinics cause patients and their caregivers to spend long periods waiting 
before receiving care (DoSH, 2000). These factors are likely to elevate indirect costs and 
undermine the uptake of SP as IPTp. 
The WHO's recommendation of using antenatal clinics as centres to provide IPTp with SP 
(WHO, 2002), should not be embraced blindly but in accordance with the characteristics of the 
setting where the intervention takes place. It is likely that interventions may suffer from lack of 
subjects in areas where clinic attendance is not regular and falls short of the required number of 
times for SP to be efficacious (at least two doses). This underscores the fact that for 
interventions such as IPTp with SP to succeed in The Gambia, allowance for indirect costs is 
likely to be critical because of the time-cost involved in getting the participation of patients, 
their families and caregivers in the programme. 
1.2 OBJECTIVES AND CONTENT OF THESIS 
The above text has identified a lack of knowledge on the cost-effectiveness of IPTp for 
multigravidae, and a lack of attention paid to a potentially important element of CEA, namely 
indirect costs. This thesis therefore has three main objectives. First, to examine the cost- 
effectiveness of introducing SP as IPTp for malaria into normal antenatal care for multigravidae 
women in rural Gambia, second, to explore various methods of valuing indirect costs and assess 
the extent to which they affect the cost-effectiveness ratio; and third, to make policy 
recommendations as to whether to introduce SP as IPTp on cost-effectiveness grounds. 
The thesis is presented in 11 chapters. This chapter has presented the statement of the problem 
and rationale for the study. Chapter 2 reviews the existing literature on economic evaluation 
including the basic techniques of economic evaluation. It also reviews the approaches of 
measuring and valuing unpaid work, and the empirical literature on the measurement of indirect 
costs in economic evaluation with special emphasis on unpaid household work. Finally, gaps in 
the current literature are identified. Chapter 3 reviews the literature on malaria in pregnancy in 
developing countries. It first reviews the general literature in SSA, focussing on the prevalence 
of low birth weight (LBW) categorised as extremely low birth weight (ELBW), very low birth 
weight (VLBW) and low birth weight (LBW), and in terms of very severe anaemia, severe 
anaemia and moderate anaemia. 
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Strategies for the prevention and control of malaria in pregnancy in Sub-Saharan Africa in 
general, and specifically within the context of The Gambia, are presented in the same chapter. 
The chapter concludes with an overview of economic evaluations of malaria in pregnancy in 
SSA. Chapter 4 describes the study setting. This chapter presents information on the 
geographical, climatic, demographic and economic situation of The Gambia. This includes the 
poverty and gender situation of the country with emphasis on the effects on women and their 
health status. 
Chapter 5 describes the relationship between the cost-effectiveness study and the IPTp trial. It 
also expands on the objectives of the empirical part of the thesis. The conceptual framework 
used for the analysis of costs and consequences data, how to move from efficacy to 
effectiveness, and trial/research and protocol driven costs are presented in this chapter. This is 
followed by a description of the methods used in the study including piloting, sampling, data 
collection tools and the various methods of data collection. Next, the data analysis plan is 
presented, which includes the various methods of valuing time, health consequences, cost- 
effectiveness analysis and incremental cost-effectiveness ratio (ICER) and sensitivity analyses. 
Chapter 6 presents the background characteristics of the study subjects and their households. It 
goes on to present the results of IPTp costs to the health care provider as well as the direct costs 
to women and their relatives. The direct costs of treatment for LBW and anaemia to the 
provider, patients and their families at the Armed Forces Provisional Ruling Council Hospital 
(AFPRCH) and Royal Victoria Teaching Hospital (RVTH) are presented. 
Chapter 7 presents the results of the household time use study in terms of the main activities, 
which are used to estimate the indirect costs of IPTp intervention, LBW and anaemia 
treatments. It estimates the hourly wage rate for women for various household tasks and 
selected wage rates for men in the study setting. Four different approaches are used to value 
time. These are later used to estimate the indirect costs of the IPTp intervention as well as the 
indirect costs of LBW babies and anaemic mothers. The indirect costs of treating anaemia at 
AFPRCH and LBW and anaemia at RVTH are also presented in this chapter. 
Chapter 8 presents the effectiveness results in terms of health outcomes and resource savings to 
the provider, patients and their families. Health outcome measures include malaria cases 
averted, deaths averted, Disability Adjusted Life Years (DALYs) averted for the three 
categories of caring for LBW (i. e. LBW, VLBW and ELBW) and the three types of anaemia 
(i. e. anaemia, severe anaemia and very severe anaemia). This is done in two phases, Base cases 
IandII. 
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Base case I uses the multigravidae population in the study site and Base case II uses the 
multigravidae population in the trial site who do not sleep under bednets. Chapter 9 presents the 
results of the incremental costs and consequences of IPTp in terms of Base cases I and II. A 
detailed sensitivity analysis is also included in Chapter 9. Chapter 10 goes on to discuss the 
methodological shortcomings of the study and summarises the main findings of the research in 
relation to the study objectives. It also discusses the findings and compares them with other 
malaria control interventions conducted both nationally and internationally. Chapter 11 draws 
conclusions and discusses the policy implications with respect to the major study findings. 
Furthermore, it identifies gaps that may need to be filled by future studies. Appendices contain 
questionnaires, operation manuals and detailed calculations. 
33 
CHAPTER 2: REVIEW OF THE THEORETICAL AND EMPIRICAL LITERATURE 
2.1 INTRODUCTION 
Due to the scope of the literature, this review chapter is divided into six sections. Section 2.2 
outlines the basic forms of economic evaluation; Section 2.3 assesses approaches to valuing 
indirect costs in economic evaluation; Section 2.4 looks at the features of subsistence economies 
and the importance of indirect costs to these economies; and Section 2.5 reviews empirical 
methods used to measure and value indirect costs. In Section 2.6, the empirical literature on the 
economic evaluation of preventive health care, with particular emphasis on indirect costs 
especially unpaid work was conducted. The same section summarises the gaps in the existing 
literature. A summary of the whole chapter is given in Section 2.7. 
2.2. OUTLINE OF THE BASIC FORMS OF ECONOMIC EVALUATION 
All resources are scarce and the aim of economics is to maximise benefits from these limited 
resources through priority setting by allocating them in an efficient manner (Slothuus, 2000), 
hence the need for economic evaluation. Economic evaluation identifies and makes a set of 
criteria, which may be useful in deciding alternative uses of limited resources. According to 
Mills and Gilson (1988), the techniques of economic evaluation play a significant role in the 
methods of health service evaluation and are based on the concern economists have with 
economic efficiency and opportunity cost. Drummond et al (2005) define economic evaluation 
as "the comparative analysis of alternative courses of action in terms of both their costs and 
consequences ". The basic task of economic evaluation includes the identification, measurement, 
valuation, and comparison of costs and consequences of the competing alternatives being 
considered. 
In the definition, "alternative courses of actions" are assessed in terms of both costs and 
consequences. "Consequences" are the collective term for the results of an intervention and 
depend on the techniques of analysis used (Drummond et al, 2005). The differences in 
techniques lie in how to deal with the identification, measurement and valuation of costs and 
consequences and on the objective and perspective of the evaluation. Economic evaluation may 
be conducted from health service, third-party payer, patients and societal perspectives (Coast et 
al, 1996). Coast and colleagues went on to indicate that, the costs considered from the 
perspectives of the health services or third party payers usually focus on the direct costs of 
providing different treatments including drugs and the effects of these drugs on associated 
treatment. 
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Out-of-pocket and travel costs of patients are taken into account when the patient perspective is 
taken. Finally, societal perspective takes into account all the costs mentioned earlier and indirect 
costs associated with the time lost from work through mortality or morbidity resulting from 
treatment (Coast et al, 1996). Although there are several forms of economic evaluation, only 
those that examine both costs and consequences for two or more alternatives are regarded as full 
economic evaluations (Drummond et al, 2005). These are Cost-effectiveness analysis (CEA), 
Cost-utility analysis (CUA) and Cost-benefit analysis (CBA) (see Figure 2.1). Cost- 
minimisation analysis (CMA), used when two interventions have the same consequences and 
the decision rule is to establish the least cost alternative, is not strictly classified as full 
economic evaluation (Drummond et al, 2005). 
Figure 2.1 Distinguishing characteristics of health care evaluation 
Are both cots (inputs) and consequences (outputs) of the alternatives examined? 
No Yes 
No Examines only Examines only 
consequences costs 
Is there IA. Partial evaluation 1B 2. Partial evaluation 
Comparison 
of two of more Cost-outcome 
alternatives' Outcome description Cost description description 
4. Full economic Yes 3A. Partial evaluation 3B evaluation 
Cost-ctlcetiveness 
Efficacy or Cost analysis analysis Cost-utility analysis 
effectiveness evaluation Cost-benefit analysis 
Source: Drummond et al (2005) 
Figure 2.1 Distinguishing characteristics of health care evaluation 
No Yes 
No Examines only Examines only 
consequences costs 
IA. Partial evaluation 1B 2. Partial evaluation 
Outcome description Cost description Cost-outcome 
description 
4. Full economic Yes 3A. Partial evaluation 3B evaluation 
Cost-ctfectiveness 
Efficacy or Cost analysis analysis 
effectiveness evaluation 
Cost-utility analysis 
Cost-benefit analysis 
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2.2.1 Cost-effectiveness analysis (CEA) 
CEA compares two or more interventions, measuring costs in monetary terms and outcomes in 
common units such as the number of cases or deaths averted, Disability-Adjusted Life Years 
(DALYs) averted, which may be achieved to different degrees by the alternatiyes. The decision 
rule is to find the lowest cost per unit of consequence. CEA is used mostly in situations where a 
decision-maker operating with a given budget is considering a limited range of options within a 
given field (Drummond et al, 2005; Witter, 2000). 
The DALY is a measure of the burden of disease that reflects the total amount of healthy life 
lost to all causes, whether from premature mortality or from some degree of disability (physical 
or mental) during a period of time (WDR, 1993). DALYs allow fatal and non-fatal outcomes to 
be combined into a composite estimate (Anand and Hanson 1997), which makes it possible for 
interventions to be ranked according to their cost-effectiveness. This, as noted by DFID (2000), 
overcomes the problems of other forms of economic analysis, which are either relevant only to 
specific diseases or rely on placing monetary values on lives. According to Murray (1996), 
Murray and Lopez (1997); and Murray and Acharya, (1997), the intended use of the DALY is to 
assist in: 
1. Setting health service priorities; 
2. Setting health research priorities; 
3. Identifying disadvantaged groups and targeting of health interventions and 
4. Providing a comparable measure of output for interventions, programmes and sector 
evaluation and planning. 
Specifically, the DALY is the sum of the present value of future years of lifetime lost through 
premature mortality, and the present value of years of future lifetime adjusted for average 
severity, frequency and intensity of any mental or physical disability caused by disease or injury 
(Fox-Rushby and Hanson 2001). It is an indicator of the burden of disease, which is the sum of 
the years of life lost (YLL), and years lived with disability (YLD). The usual definition of YLL 
is the difference between age at death and life expectancy for each age, and YLD is the number 
of years lost from varying degrees of disability associated with diseases (Brenzel, 1993). 
Brenzel further argues that, as a composite indicator, using the DALY is intuitively appealing in 
that it incorporates morbidity-adjusted years of life lost, and therefore, provides a better picture 
of the total burden of diseases in a society. Furthermore, being able to disaggregate DALYs by 
gender and even by age provides additional information from which health policy and resource 
allocation decisions can be made. 
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In CEA, one assumes that the objective is desirable even though benefits cannot be evaluated in 
monetary terms (Folland et al, 2001). CEA avoids the problem of valuation of health outcomes, 
which makes it preferable to cost-benefit analysis (Warner and Hutton, 1980). CEA is a flexible 
technique as it permits comparison between interventions targeted to the same disease, or 
compares interventions targeted at different diseases depending on the chosen outcome 
measure. 
Despite these advantages, CEA has its limitations too. The first of these is that it is not designed 
to determine the value of a programme to the society, nor does it permit comparison of 
interventions with different impacts on morbidity and mortality (Evans and Hurley, 1995). 
Furthermore, cost-effectiveness ratios are specific to a particular group of patients or settings 
and are affected by prevalence of the disease, scale of operation and technological advances 
(Neumann and Johannesson, 1994). There are disagreements over some CEA methodologies 
such as the appropriate discount rate to use and whether or not to include productivity gains or 
losses. Inclusion of productivity gains or losses either as costs or consequences is contentious 
and controversial (Drummond et al, 2005; Weinstein, 1995) and was highlighted in Chapter 1. 
Health state valuations have their shortcomings. However, for the purpose of this thesis, which 
used DALYs as the outcome measure, concentration is on critique of DALYs with emphasis on 
their construction and application. The critique draws on a number of recent reviews of DALYs 
(Fox-Rushby, 2002; DFID, 2000; Anand and Hanson, 1997) but the focus is on those attributes 
likely to affect the results of this study directly. Firstly, DALY estimates are based on data that 
do not include socio-economic or environmental factors or measures of unmet health needs 
(Arnesen and Kapiriri, 2004), and the process of determining preference weights has been 
described as unrepresentative and not transparent (Paalman et al, 1998). Age-weighting means 
that life years are assigned different values at different ages (Arsene and Kapiriri, 2004) with an 
emphasis on working adults aged between 20-30 years (DFID, 2000; Anand and Hanson, 1997). 
Some age weightings are considered inappropriate. For example, the age weighting given for 
anaemia is zero (Amesen and Kapiriri, 2004). Secondly, there is no consensus on whether to use 
a discount rate and if one is to be used, then at what rate. The use of a discount rate values 
future years of life lived less than present years, which, according to Anand and Hanson (1997), 
can only be justified based on environmental degradation, which tends to benefit the present 
generation. Thirdly, the effects of illness are captured through six disability classes, which 
assign increasing disability weights associated with the extent of loss of physical functioning 
(Murray, 1994, p439), chosen by a group of experts. 
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The weights given would therefore depend on the questions posed to the experts and their 
responses based on their understanding of the use of estimates (Barker and Green, 1996; Anand 
and Hanson, 1997). Furthermore, using `experts' can lead to; 
1. Lack of unbiased judgement; 
2. Not reflecting social preferences; 
3. Not taking patients' perceptions into account; 
4. Lack of personal experience and 
5. Variation of values from expert to expert (DFID, 2000; Paalman et al 1998; Barker and 
Green, 1996; Anand and Hanson, 1997). 
Barker and Green (1996) specifically asked who the experts were and questioned their 
representativeness in terms of gender and social class. To overcome some of the shortcomings 
of CEA related to outcome measurement, Cost-utility analysis (CUA) is used. 
2.2.2 Cost-utility analysis 
CUA is a form of economic evaluation that compares two or more interventions, measuring 
inputs in monetary terms and outcomes in a measure of improved utility. The most well-known 
measure of outcome for CUA is Quality of Life Years (QALYs) (Tan-Torres Edejer et at 2003). 
According to Williams (1985), QALYs are developed to unify scale of value for life and health, 
death and disability that may be used to measure the outcome of health care. QALYs are 
estimated by adjusting the length of time affected through the health outcome by the utility 
value (on a scale of 0 to 1) of the resulting level of health state (Drummond et at, 2005). QALY 
league tables guide decisions about incremental costs and benefits by setting reference points or 
thresholds (Mooney, 1989). The optimal decision criterion involves ranking the incremental 
cost-utility ratios of competing interventions and choosing those with the lowest price per 
QALY until the budget is exhausted (Palmer et at, 1999; Rawles, 1989). Other potential 
outcome measures are Saved-Young-Life Equivalents (SAVE) (Nord, 1995), Health Years 
Equivalents (HYE) (Mehrez and Gafni, 1989), etc. 
Despite improving on some of the shortcomings of CEA, CUA has its own limitations. One of 
these relates to measurement of outcome by utility, which is relatively young and the 
methodologies are still under development (Torrance, 1987). For example, individual 
preferences for alternative health states can be collected from survey of patients, the general 
public or health care providers. It is likely that patients who are familiar with pain and suffering 
of diseases may weigh alternative health states differently than the general population. Doubts 
have also been expressed about the theoretical background of CUA. 
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According to Slothuus (2000), QALYs are measures of preferences for health status and not 
welfare and therefore concentration is on improvements of QALYs. There also exist difficulties 
in obtaining adequate information on the costs and consequences of all the competing 
interventions required for the ranking (Palmer et al, 1999). 
2.2.3 Cost-benefit analysis (CBA) 
The third form of full economic evaluation is CBA. CBA entails measuring and valuing costs 
and benefits of alternative programmes in monetary terms and comparing them in order to 
assess which ones are desirable using decision criteria (Klarman, 1967). The monetary benefits 
and costs for each time must be estimated and then discounted back to the present time. The 
fundamental rationale behind CBA reflects the need to determine an efficient allocation of 
resources when an underlying market is not readily available (Folland et al, 2001). The costs 
consist of programme expenditures and the benefits comprise averted future losses with the 
success of the programme. Klarman (1967) identifies three groups of benefit as savings in the 
use of health care, gains in economic output and satisfactions from better health. The outcome 
of CBA is expressed in monetary units with total costs compared with total benefits. 
One of the disadvantages of CBA is its valuation problems with respect to valuing benefits. The 
two well-know valuation methods are the Human Capital Approach (HCA) and Willingness To 
Pay (WTP) approaches. The HCA values the economic return (benefits) to society using 
individual's expected earnings (annual income). This invariably lowers the value of life of 
individuals outside formal employment (i. e. elderly and children) and in developing countries 
where wages are low (Creese and Henderson, 1980). The WTP approach is based on the 
potential Pareto improvements, i. e. gainers from an intervention could compensate losers and 
still be better off. This is used as a criterion to judge whether a programme is desirable (Cullis 
and West, 1979; Mills and Thomas, 1984 and Drummond et al, 1987). The decision criterion is 
that a programme will be given the go-ahead if the benefits exceed the costs. CBA techniques 
are developed from welfare economic theory making use of potential Pareto improvement 
criterion to maximise the welfare of the community. It requires that the benefits be enough for 
the beneficiaries to, - in theory, - compensate the losers. The Pareto optimal position 
implies technical and allocative efficiency in terms of consumption and production efficiency 
whereby the marginal rates of substitution in consumption and production are equal (Dinwiddy 
and Teal, 1996). 
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Efficiency and forms of Economic Evaluation 
Efficiency in economic evaluation is divided into what is referred to as Technical and 
Allocative efficiency. Technical efficiency arises when a minimum combination of inputs are 
used to produce a given level of output (Nicholson, 2000; McGuire et al, 1988). In health care, 
technical efficiency is achieved where utilisation of resources produces a level of benefit that 
cannot be exceeded by utilising the same resources in an alternative way. In that case, 
productive efficiency, which is the maximisation of health outcome for a given cost, or the 
minimisation of cost for a given outcome is applicable (Barnum, 1993; McGuire et al 1988). 
Allocative efficiency is achieved when a given quantity of goods produced over a period is 
allocated among consumers in a way that makes it impossible to make someone better off 
without making another worse-off (Clewer and Perkins, 1998). Allocative efficiency takes into 
account the production efficiency with which health care resources are used to produce health 
outcomes as well as the way in which these outcomes are allocated among individuals in 
society. In summary, technical efficiency addresses the issue of using given resources to 
maximum advantage; production efficiency addresses the issue of choosing different 
combinations of resources to achieve the maximum health benefit for a given cost; and 
allocative efficiency focuses on achieving the right mixture of health care programmes to 
maximise the health and welfare of society (Slothuus, 2000). In CEA/CUA, only productive 
efficiency is used with outcomes restricted to health benefits because it is not possible to use 
technical efficiency to compare alternative interventions where one intervention produces the 
same or better health outcome with less or more of one resource and more or less of another 
(Slothuus, 2000). According to Cam Donaldson et al (2002), CEA alone cannot handle 
questions of allocative efficiency despite the expectations that it could do so. In contrast, CBA, 
which is broader in scope is able to inform questions of allocative efficiency because it can 
assign relative values to both health and non-health related goals to determine which goals are 
worth achieving, given the alternative uses of resources and thereby determining which 
programmes are worthwhile (Drummond et al, 2005). 
2.2.4 Relevant costs and consequences in economic evaluation of health care 
programmes 
The previous section shows the different types of economic evaluation, each measuring and 
valuing the various costs and consequences to different extents. Theoretically, there are three 
main perspectives on the role of economic evaluation in health care such as the welfarist (Birch 
and Gafni, 1996); the extra-welfarist (Culyer, 1989) and the decision-maker approach (Sugden 
and Williams, 1979). 
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Drummond et al (2005) acknowledged that, due to these differences in perspectives on 
economic evaluation, it is useful to view the various costs and consequences of health care 
programmes as building blocks that can be assembled in different ways. The detailed 
breakdown of these costs and consequences are shown in Figure 2.2. 
Figure 2.2 Components of economic evaluation in health care 
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Costs 
Costs are considered both in financial and economic terms. Financial costs are the expenditure 
on goods and services including health care. Direct costs to patients consist of monetary 
expenses in terms of fares paid, out-of-pocket expenses, user fees for outpatient visits and bed 
fees for those admitted. Costs in economics are regarded as the opportunity cost of resources 
used in an intervention; defined as the value of the benefits foregone in the next best alternative 
use (Drummond et al, 2005). In efficient markets, the value of any resource (market price) 
would equal its opportunity cost. In such instances, prices are good indicators of opportunity 
cost. According to Mills and Gilson (1988), problems arise over gifts or donations; resources 
with false prices; certain activities with externalities and when money prices are distorted by 
transfer payments (taxation or subsidies do not in themselves constitute an opportunity cost). In 
such instances, it is recommended that shadow prices be used in order to arrive at the 
opportunity cost of resource use (Phillips et al, 1993). Shadow price is an imputed valuation of a 
commodity or service that has no market value (Pearce, 1992). It is also used to correct any 
distortions in prices so that they can truly represent their opportunity costs. 
According to Drummond et al (2005), resource use by health programmes can be divided into 
four components labelled Cj- C4. In each case, quantities (q) of resource use are multiplied by 
their respective prices (p) to arrive at these costs. C1 refers to the costs of resources used in an 
intervention, including resources used in dealing with any possible adverse effects. They 
include drugs, equipment, hospitalisation, physician visits etc. This also comprises the costs of 
providing the initial intervention and costs of treatment. The common method of identifying 
these resources is known as the "ingredients approach", which may include both variable and 
fixed costs. The ingredients approach is a method where the values of inputs are based on 
quantities and unit prices (WHO, 2006). 
C2 refers to the resources consumed in other sectors and depends on the nature of the health care 
interventions being evaluated. i. e. whether they rely on resources from other public sectors 
(Drummond et al, 2005). C3 is the patient and family resources, which may consist of direct 
costs such out-of-pocket expenditures accruing from fares to travel to the health facilities, user- 
fees, other payments, informal care cost at home, expenses incurred by patients or family 
members and the value of any resources that contribute to the treatment process. Furthermore, 
patients and their families use time during treatment. This could be the time spent by patients 
and their family caregivers in seeking and receiving care at health facilities and at home. The 
valuation of these times has been a subject of controversy and will be discussed in detail in 
Section 2.3. 
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C4 is the productivity loss associated with the time spent by patients and their families in 
seeking treatment. These productivity losses to patients and their families were originally 
referred to as indirect costs. Productivity gains occur when a health intervention free up time for 
patients and their families. 
Consequences 
Another requirement for a full economic evaluation is the identification of the consequences (or 
effects) that need to be measured and valued. Consequences (or effects) consist of the 
therapeutic outcomes or effects of the alternatives being compared (Drummond et al, 2005, 
Drummond et at, 1987, Drummond and Stoddart, 1985). The first category of consequences are: 
change in patients health state, which can be measured in terms of effects (E); life years gained 
or disability days reduced. This can also be valued in terms of health state preferences (U) in the 
case of CUA or in terms of WTP for CBA. 
The second value (V) can result from the health intervention but not necessarily linked to the 
improvement in health state. This is usually referred to as the process utility (Donaldson and 
Shackley, 1997). Process utility includes the value of information or reassurance about one's 
health state. The third is based on the premise that health care intervention can save resources 
and these savings range from S, to S4. The savings (S1-S4) are said to mirror C1 to C4 discussed 
earlier and are measured in a similar way. These savings are regarded as the costs not spent on 
the alternative programme. According to Mills (1989), cost-effectiveness studies do not only 
divide programme costs by health effects (consequences) but they are increasingly netting out 
savings in treatment costs and the value of indirect benefits (savings in work time) from 
programme costs. Finally, the Global Willingness-to-pay (W) for the programme may be 
ascertained. This valuation can potentially include all the consequences identified in Figure 2.2, 
depending on what the respondent(s) to the WTP perceives to be important (Drummond et at, 
2005). The different forms of economic evaluation have been expressed by Drummond et at in 
equations 1-3 below with the details in the text. 
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Cost-effectiveness analysis = (C, - S1)/E 
{(Cl + C2 + C3 + CO - 
(S1 + S2 + S3 + S4))/E Equation......... (1) 
Where: C,... C4 represent costs 
S1- S4 represent savings 
E- represents effectiveness 
Cost-utility analysis = (C1 - S1)/U 
{(C1 + C2 +C3 + C4) - (S1 + S2 + S3 + S4))/U Equation......... (2) 
Where: U represents health state preference and the Cs are as illustrated in equation (1) 
Cost-benefit analysis = W'- (C, + C2 + C3 + CO 
((W+V+S, +S2+S3+ S4)-(C, +C2+C3+C4)) Equation......... (3) 
Where: V represents process utility 
W represents Willingness To Pay and Cs are as described in equations (1) and (2). 
Drummond et al (2005) argued that the inclusion and exclusion of costs and consequences of 
the health care interventions in economic evaluation should be "judged in the larger context of 
objectives for health services in a given country". According to Drummond and colleagues, 
despite the difficulty involved, the full identification of all costs and consequences was 
necessary for researchers to make the appropriate informed decision on whether to consider 
indirect costs or not (Drummond et al, 2005, Coast et al, 1996; Drummond and Stoddart, 1985). 
They recommended that, after identifying all the likely costs and consequences of the health 
care interventions through situation analysis, those small ones - costs and consequences - not 
worth calculating should be discarded from the analysis (Coast et al 1996). According to 
Drummond et al (2005), indirect costs arising from patients or family members. taking time off 
work to receive health care may not be substantial in practice because patients may already be 
out of work due to poor health or they may be elderly persons beyond the age of any full-time 
employment. However, indirect costs could be higher in the case of certain types of health 
intervention such as screening or therapeutic interventions that enable the early return of 
patients and informal family carers to work and/or even prolong their working lives in case of 
life saving treatments (Drummond et al, 2005). 
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2.3. VALUING INDIRECT COSTS IN ECONOMIC EVALUATION 
2.3.1. Introduction 
This section critically assesses the different approaches to valuing indirect costs (productivity 
loss). Three distinct but not wholly mutually exclusive approaches of valuing indirect costs are 
the Human Capital Approach (HCA), Friction Cost Approach (FCA) and Washington Panel 
(US Panel) Approach (WPA). 
2.3.2. Human Capital Approach (HCA) 
The HCA estimates the potential value of lost production (Grossman, 1972; 1999). According to 
Grossman (1972; 1999), the term human capital was first discussed by Pigou (1928) who stated 
that there was investment in human capital as well as investment in material capital. However, 
the use of human capital in modem neo-classical literature dates back to Jacob Mincer's article 
titled: `Investment in human capital and personal income distribution' (The Journal of Political 
Economy, 1958). Gary Becker's book titled Human Capital, published in 1964, became the 
standard reference for many years. According to Becker, human capital is similar to physical 
means of production such as factors and machines. One can therefore invest in human capital 
via education, training, medical treatment and one's income depends partly on the rate of return 
on the human capital. On the other hand, Grossman's approach to the demand for health care 
(the human capital model) states that an increase in a person's stock of knowledge or human 
capital raises his/her productivity in the market sector of the economy where he/she produces 
money earnings, and in the non-market or household sector, where the person produces 
commodities that enter his/her utility function (Grossman, 1972). To realise potential gains in 
productivity, individuals have an incentive to invest in formal schooling and on-the-job training. 
The costs of these include direct outlays on market goods and the opportunity cost of the time 
that must be withdrawn from competing uses. Grossman acknowledged Mushkin (1962), 
Becker (1964), and Funch (1966) as earlier authors on the importance of health human capital. 
In 1972, Grossman constructed a model of the demand for health capital by using the household 
production model of consumer behaviour (Grossman, 1999). Grossman's approach draws on 
Becker, 1964; Lancaster, 1966 to account for the gap between health as an output and medical 
care as one of many inputs into production. Grossman argues that a person's stock of 
knowledge affects the market and non-market productivity, while the stock of health determines 
the total amount of time spent producing money earnings and commodities (Grossman, 1972). 
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The human capital approach to valuing indirect costs is defined as, `the potential gross earnings 
lost during the time a sick person is absent from work' (Johannesson, 1997; Weisbrod, 1969; 
Rice and Cooper, 1967); counting from the first day the person is absent due to illness to the 
time of retirement in the case of permanent disability or death. The HCA assesses the impact of 
health care on lost work time, whether through prevention of illness or death for the individual 
undergoing treatment (Pritchard and Sculpher, 2000). Lost productivity due to the impact of 
morbidity and mortality on paid work are the present value of lost gross wages over the period 
of illness and from time of death to retirement respectively (Pritchard and Sculpher, 2000). 
HCA also uses the gross wage rate earned by individuals undertaking similar work on a paid 
basis to value lost time from unpaid work (Liljas, 1998; Luce et al, 1996). This gives room for 
the time used by unpaid caregivers to be valued. Aggregation of those individual figures yields 
productivity costs at the national or intervention level. 
The argument for using the gross wage rate to value lost production is based on the neo- 
classical viewpoint that wage rates are the equivalent of the value of marginal productivity 
(Johannesson, 1997). Therefore, all earned income can be taken as the monetary value of 
production lost. Work time is valued according to gross wage in the sense that, in a well- 
functioning labour market, productive output and the compensation to the worker are equal, 
because they represent the same resources (Weinstein et al, 1997). According to this theory, 
assuming diminishing marginal productivity, a profit maximising firm would employ additional 
labour until the marginal product of the last unit of employment cost faced by the firm equals 
the wage. The latter is the gross wage including additional costs of employment such as 
employer's contribution to insurance (Pritchard and Sculpher, 2000). This is what forms the 
basis of using the gross wage as the value of lost production during absence from work. 
The approach values the allocation of time both in market and non-market work. The 
measurement of unpaid work requires imputing an equivalent value for those not in paid 
employment using a number of methods (Drummond et al, 2005). These include the use of 
average wages, the cost of replacing individuals, or the opportunity cost of the production they 
could have contributed were they not at home (see Section 2.5.3; especially 2.5.3.1 for details). 
By using the human capital approach, productivity benefits in earlier studies were usually 
estimated based on the additional stream of lifetime income for an individual because of a given 
health care programme (Rice and Cooper, 1967). 
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According to Mishan (1971), the main criticism of the human capital approach is its link to 
welfare economic theory and the implicit assumption that the objective of health care was to 
maximise national productivity. HCA's assumption of full employment is also said to be 
unrealistic. Although in theory wage rates reflect marginal productivity of a worker, due to 
inherent imperfections in labour markets, wage rates may reflect inequities such as 
discrimination by race and gender (Drummond et al, 2005). For studies that take societal 
perspective, consideration is given to the valuation of healthy time gained which has no market 
value, leading to use of shadow prices and all their shortcomings (Drummond et al, 2005). The 
Erasmus group comprising Koopmanschap, Brouwer and Ineveld and others also questioned the 
welfare basis of human capital theory in terms of full employment (Koopmanschap et al, 1995). 
According to them, in contrast to the assumption of the human capital theory, in reality, 
employment differs across occupation but unemployment occurs in all economies. HCA 
provides estimates of potential loss production because of disease, rather than loss that will be 
experienced in practice (Koopmanshap and van Ineveld, 1992). Koopmanschap and van Ineveld 
(1992) argued that in practice, compensating factors exist for absence from work due to 
mortality and morbidity, and organisations adjust to minimise the impact of the production 
losses. They acknowledged that production losses do occur but are usually limited to the period 
required to replace the worker. In addition, the human capital approach values benefits to 
society using the individual's potential annual income. This tends to undervalue the lives of 
people outside formal employment or where such employment opportunities and wages are low, 
as is the case in developing countries (Creese and Henderson, 1980). The Erasmus group came 
up with an alternative called the Friction Cost Approach (FCA). 
2.3.3. Friction cost approach (FCA) 
The FCA of valuing indirect costs was put forward by the Erasmus group as an alternative to the 
HCA (Brouwer and Koopmanschap, 2005). The group assumed that workforce conditions were 
such that unemployment was at levels higher than the frictional level of unemployment and that 
there was a possibility of replacing long-term absentees from work. The frictional 
unemployment period is the time taken before a position is filled. In that case, the society will 
restore initial levels of production after a period of adaptation, the duration of which depends on 
the level of unemployment (Brouwer and Koopmanschap, 2005). 
If unemployment is greater than the frictional unemployment level, it should be possible to 
replace an employee because of illness or disability after a period (Koopmanschap et al, 1995; 
Koopmanschap and van Ineveld, 1992; Koopmanschap and Rutten, 1993; Koopmanschap et al, 
1995). 
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The FCA is based on the notion that the amount of production costs depends on the time that 
organisations need to restore the initial production level (Koopmanshap and Rutten, 1996). The 
focus of the FCA was initially on valuation of lost time from paid work with unpaid work 
valued at zero. However, in a recent article by Jacob-Tacken et al (2005), the use of the patient's 
wage to measure short-term absence from work was questioned on the basis that such time is 
compensated for during normal work hours and therefore does not lead to productivity losses. 
They argued that, in such cases, the use of the wage rate tends to overestimate productivity 
costs. When they examined the productivity costs for five patient populations and one employee 
population using the classical method of identifying when extra effort was needed, the findings 
showed that productivity costs based on identifying efforts were 25-30% of the classical 
estimates. For one-day absence, productivity costs were relevant in only 17%-19% of 
individuals and 35%-39% for two days or longer. 
FCA values productivity under three scenarios. For temporal illness, lost productivity could be 
made up on return to work or by internal labour reserves with the impact limited to medium 
term macroeconomic effects. Alternatively, an increase in costs in the form of temporary 
workers or use of overtime can be approximated by the lost output of the sick person. In the 
case of short-term illness, the sick person on his or her return compensates for the lost time by 
cutting down on leisure and increasing work time, which has the same effect as if the firm had a 
pool of reserve workers who could readily replace sick employees (Brouwer et al, 1997). 
Although this still represents costs to the individual, the only cost to the firm in such a case is 
the medium term macroeconomic consequences of short-term absence. In the case of 
permanent/long term illness, workers experiencing illness or disability longer than the frictional 
period are replaced from the unemployed. For illness or disability longer than the frictional 
period, the productivity loss is valued as in the case of mortality (Brouwer et al, 1997). 
Productivity losses - and corresponding gains from health care - are limited to the frictional 
cost period and medium term macroeconomic effects. In the case of mortality, deceased workers 
are replaced from the unemployed with the same implications as for morbidity. Leisure is 
valued as the net take home wage. In the case of death, the lost productivity during the friction 
period is the time it takes to train and replace the deceased worker. However, the possibility 
exists for the deceased to be replaced within the firm, which further provokes a series of 
replacements within the firm until the last opened position is filled from outside. 
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Johannesson and Karlsson (1997) and Liljas (1998) criticise FCA insofar as it is based on strong 
assumptions not supported by neo-classical economic theory. For example, they especially 
criticised the FCA's treatment of mortality in that the absence of costs after the frictional cost 
period implied that the opportunity cost of labour was set at close to zero after the frictional cost 
period (Drummond and McGuire, 2001). They argued that a value close to zero of direct labour 
inputs would subsequently reduce the costs of health care interventions, which they considered 
unreasonable. The view that productivity loss could be compensated when the sick person 
returns to work, was countered on the basis that the output of the worker could not be equal to 
the gross wage he/she was paid. Otherwise, this theory defied an important economic principle 
of output being equal to the wage rate (Johannesson and Karlsson, 1997). Compensating lost 
productivity through overtime and reduced leisure time would also attract costs depending on 
the value people placed on their leisure. However, according to critics, FCA values leisure at 
zero. 
If the marginal utility gain from leisure is higher than the wage paid, workers are likely to reject 
work in favour of leisure (Johannesson, 1997). Compensation through internal labour reserves 
means that firms are not operating at a profit-maximising level as stated in microeconomic 
theory. Internal labour reserves can only happen in very rare cases, in a labour market where 
recruitment is difficult. Furthermore, informal rather than formal work is the norm in many 
environments, especially in developing countries where the bulk of the people work at the 
subsistence level. FCA is difficult to operationalise, although some estimates have been made in 
the Netherlands and Canada (Koopmanschap et al, 1995; Koopmanschap and Rutten, 1996; 
Goeree et al, 1999). 
It is difficult to estimate productivity losses for short-term illness or the person staying at home. 
It is hard to see why the frictional cost approach should not be applied to all resource changes. 
FCA implies a highly unrealistic scenario that unemployment could be solved if the number of 
hours worked by employed workers was reduced and the unemployed worked those hours 
instead. For periods of illness less than the frictional period, FCA estimated productivity costs at 
80% of the value of production, which is inconsistent with economic theory (Johannesson and 
Karlsson, 1997). 
2.3.4. Washington Panel Approach (WPA) 
The most recent of the three approaches of valuing productivity costs stemmed from the 
recommendations of the Washington Panel on cost-effectiveness analysis for health care by 
Gold et al (1996). The Panel's definition of productivity cost can be divided into impaired role 
functioning and income reduction. 
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The Washington Panel recommend that analysts should make the choice to include productivity 
costs in the numerator or the denominator of cost-effectiveness ratios because, according to 
them, to include both quality of life effects of decreased productivity and all costs would lead to 
double counting. The preference of the panel as a `reference case' is for productivity costs to be 
measured through quality of life in the denominator of the CEA ratio in terms of health effects, 
and any replacement costs in the numerator. The reason given is that substitute labour may not 
be as effective as what it replaces in terms of productivity. The Panel has linked quality of life 
to role functioning because of the belief that people tend to experience a higher quality of life at 
a time when they can function well in their social settings and also in their jobs, hence its 
incorporation into the denominator in the cost-effectiveness ratio (Weinstein et al, 1997). 
The time spent by patients participating in an intervention on activities such as travelling, 
waiting and the time spent receiving treatment represent a real change in the use of resources. 
Adjustments in treatment times are not a common practice in the measurement of health-related 
quality of life (Weinstein et al, 1997). They argue that failure to take those costs on board in any 
cost-effectiveness analysis would impair findings against interventions that relied on inputs or 
outputs that are purchased and in favour of those that rely on patients, family or volunteer time. 
Under the reference case approach, these costs are valued in monetary terms and added to other 
costs in the numerator (Gold et al, 1996). The Washington Panel further states that the usage of 
time in seeking treatment is not only a cost, but also an effect, especially when it has a positive 
effect on health states. Entering it in the numerator only takes it as a cost. In addition, if the time 
is trivially small or does not differ across regimens, its inclusion has little effect on the result 
and may therefore be omitted at the discretion of the analyst (Weinstein et al, 1997). 
The Panel has received a lot of criticism especially from Brouwer et al (1997), Johannesson and 
Meltzer (1998) and Sculpher and O'Brien (2000). The bulk of the criticism centres on the 
problems of health state valuation such as the QALY. The valuation of health state is not 
intended to capture the impact of non-health related events such as loss of income. When health 
state valuation exercises do not refer to the effects of changes in income, then individuals may 
or may not implicitly incorporate these effects into their health state valuation (Brouwer et al, 
1997). It is argued that the recommendation of the Washington Panel that productivity costs be 
included as part of the QALYs in the denominator will lead to inaccurate estimation of costs in 
CEA (Brouwer et al 1997). Since health state valuation usually relates to the entire period of 
illness, changes in income beyond the frictional period are already included (Pritchard and 
Sculpher, 2000). 
50 
2.4 FEATURES OF SUBSISTENCE ECONOMIES THAT REQUIRE A CLOSER 
LOOK AT INDIRECT COSTS 
The general equilibrium and perfect labour market model in the case of the labour market may 
not be readily applicable in subsistence labour markets in developing countries. This is because 
it is a fact that labour markets in developing countries are not as efficient as those in developed 
ones. Rather, they are characterised by relatively high unemployment in urban settings and self- 
employment for survival in rural areas. Therefore, the wage rate and perfect competition to 
some extent are less relevant. The features of such a subsistence economy include the household 
as the unit of production rather than an individual. Moreover, being part of the social fabric is a 
major factor in one's ability to obtain assistance in times of need from family members and 
friends. Unlike many developed economies, issues of informal and unpaid work are central to 
measuring productivity loss. 
Unpaid household work 
The starting point in understanding household production is its definition. A household is 
defined as a person living alone or two or more persons living together as a single domestic unit 
who make common provision for food and other essentials of living, and occupy the whole or 
part of one dwelling unit (AusAID, 2003). A household need not strictly be one family; it could 
be a single person living alone or a group of two or more families staying together (Ironmonger, 
1989). Unpaid work has been defined as "productive activities" for which no payment is 
received either in cash or in kind, including time spent in educational activities (AusAID, 2003). 
The New Household Economics literature (Reid, 1934) recognises the importance of the time 
and effort household members put into production activities for their survival. Reid's work gave 
prominence to household work through what she referred to as the "third party criterion". 
According to the third party criterion, any activity, household or otherwise, should be assessed 
on the basis that it can be performed by a third party for payment. Reid concluded that if it is 
theoretically possible to pay someone to perform a task, then there is a potential market for the 
goods and services. Therefore, typical household activities such as cooking, pounding grain and 
childcare fall into productive activities, while eating does not, as it may not be possible for 
someone to perform it for another person while the payer gets the satisfaction. 
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Hawrylyshyn (1977) reinforces the third party criterion by assuming that a third person could 
produce household activities without changing household utility, because they are all activities 
within the home, which have market substitutes. The value of the output is not attributable to 
the input of any particular person(s). Quah (1986) regards household work as the identification 
of production and consumption activities within the home. Gronau (1977) sees unpaid work like 
work in the market, which one would like to delegate to someone else to perform on his/her 
behalf because it is unpleasant. 
According to Ironmonger (1996a), the economic statistics of work and production are used 
extensively in framing public policy and in business decisions. Therefore, it matters great deal 
what activities we perceive, define and measure as "work" and as "leisure". It is not only 
because this shapes everyday discourse, but because also the reporting on the measured 
"variables" actually affects our lives through practical government and business decisions 
(Ironmonger, 1996b, UNIFEM East and Southeast Asia Regional office Fact sheet I on Gender 
Issues, http: //www. unifcm-seasia. org/resources/factsheets/Gendisl. htm). Therefore, the main 
challenge in the measurement and valuation of unpaid household work is that it occurs outside 
of the market and there are no direct market prices associated with it. This is one of the main 
reasons Keynesian economists do not consider unpaid household work (Ogle, 2000). 
In subsistence economies, a large proportion of women's time is spent on unpaid work (Leslie, 
1989). Although the debate on the recognition of women's household work started as far back 
as 1898, the actual recognition by the United Nations came after the 1995 Beijing Platform for 
Action where the participants called for the inclusion of the work of women and all their 
contributions in the non-market household sectors as part of Gross Domestic Product (GDP) 
(Varjonen et al, 1999). Prior to that time, household work was excluded from the System of 
National Accounts (SNA) and was considered to have no economic value. However, following 
pressure from women's' groups, the United Nations (UN) Statistical Commission recommended 
the preparation of economic activities outside the market known as `satellite' accounts 
(Ironmonger, 1996b): "Awareness of the economic importance of unpaid household work, and 
women's work in general, has led to the widespread acceptance that statistical measurements 
should be expanded to include unpaid work" (page 1). Although this may seem to be a new 
perspective, it was developed long ago as argued by Ironmonger (1996a), particularly by the 
pioneering work of Margaret Reid (1934) and Aslaksen et al (1996). 
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The system of under-reporting unpaid work does not only make developing countries seem 
poorer than they really are, but also makes their economic growth rate appear in a more 
favourable light than what it actually is (Ogle, 2000). Evidence has shown that rural women are 
active for an average of 18 hours per day and the average number of hours spent working, 
excluding eating, leisure and dressing times, ranges from six to 15, with median time in Africa 
being 10 hours and 10.8 in Asia (Leslie, 1989). Leslie went on to say that women in developing 
countries spend most of their time on agriculture, childcare and taking care of the ill. 
Despite occupying a significant proportion of women's time, household work has not been 
given the attention it deserves. Some of the reasons for its exclusion are its independence from 
market activities, lack of data, which makes it difficult to estimate its real impact on 
communities and families in developing countries, difficulty of measurement and the inability to 
make historical comparison because unpaid services were not previously included in System of 
National Accounts (SNA) (Budlender and Brathaug, 2002). Kulshrestha and Singh argue that 
including household work in household final consumption means that all persons engaged in 
these activities would become self-employed, which by definition leads to zero unemployment 
(Budlender and Brathaug, 2002). Most of the previous time use studies conducted in the 
developed and developing world have concentrated on women and development issues, with no 
emphasis on the time use problems faced by women in balancing their time between their daily 
activities, reproduction and health roles (Mueller, 1984). The obvious gap in knowledge calls 
for the consideration of the inclusion of indirect costs, especially unpaid work, in economic 
evaluation. The various methods of the measurement and valuation of such costs is the subject 
of the next section. 
2.5. REVIEW OF EMPIRICAL METHODS USED TO MEASURE AND VALUE 
INDIRECT COSTS 
2.5.1 Introduction 
This section explores the existing literature on the empirical measurement and valuation of 
unpaid household work. 
2.5.2 Methods of time measurement 
There are several methods of measuring time, each with its advantages and disadvantages. The 
most common instruments are direct questioning in surveys and time-diary methods (Kan, Man 
Yee 2006). The latter method has been referred to as the gold standard (Juster and Stafford, 
1991; Juster, 1985). 
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This might be because of the long established belief by previous researchers that diary-based 
estimates of time use are more accurate than those from direct questions (Pelwis et at, 1990; 
Robinson, 1985). Some of the direct questions include activity log, stylised activity list, stylised 
time activity matrix, time activity matrix and time diary (Harvey and Taylor, 2000). Each of 
these methods can be combined with observation and/or recall methods. 
Stylised estimates 
Activity logs require the respondent to state the time taken to perform a particular activity for a 
given period by stating the start and end times for each activity. The method requires literacy 
and an understanding of conventional time. It also relies on the respondent remembering every 
activity. Stylised activity lists allow respondents to state how they spend the day doing each 
activity on the list. The method suffers from the danger of not having an exhaustive list and the 
inability to verify the authenticity of the responses given (Kinsley and O'Donnell, 1983; 
Robinson, 1984). A stylised time activity matrix is similar to the activity list but allows the 
inclusion of all possible` activities and should add up to 24 hours (Harvey and Taylor, 2000). 
The method relies on the respondent to correctly assign activities to categories and on the good 
memory and calculation skills of the participants. A time activity matrix is a progression from 
the activity list by having both the list and time periods alongside each other which respondents 
record the activities and times. The time activity matrix has the disadvantage of relying on 
respondents to classify and categorise the activities provided (Budlender, 2004). 
All the time use measurement instruments discussed above are collectively referred to as 
`stylised estimates' for the simple reason that they ask respondents to state how they spend their 
time on certain activities (Juster and Stafford, 1985). Stylised estimates have the advantage of 
being cheaper than diaries because the information required from them can be easily obtained 
from surveys where time use is one of several variables (Kan, Man Yee, 2006). These survey 
approaches are also less demanding on respondents' time, initiative and energy than diaries, 
thereby leading to higher response rates. Some of the common disadvantages of stylised 
estimates include recall bias due to the difficulty for respondents to exactly state the time used. 
There is also a tendency to produce total time greater than 168 hours per week (Gershunny and 
Robinson, 1994) and there is less ability to verify the times recorded due to the fact that activity 
times do not add up to 24 hours (Kalfs, 1993). 
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Stylised estimates are based on responses to questions asking about the time devoted to various 
classes of activity in an average or normal or typical week (Juster and Stafford, 1985). Stylised 
estimates require respondents to recall their activities in the recent past and to carryout an 
appropriate form of averaging (Kan, Man Yee, 2007). Kan, Man Yee and colleagues went on to 
state that, based on the above requirements, the accuracy of stylised estimates depends on the 
difficulty of the task performed which might lead to substantial measurement error and the lack 
of detail which allows the respondent scope for choosing responses which correspond to the 
pre-existing and possibly inaccurate self-image (Kan, Man Yee, 2007). 
2.5.2.1 Time use Diaries 
Time use diary is the second type of data source that builds summary measures from activities 
in a time-diary and requires a respondent to keep a very detailed record of activities throughout 
each randomly selected day throughout the survey period (Kan, Man Yee, 2007). A time use 
diary is a research tool that requires participants to describe or record their daily events and 
experiences (van den Berg and Spauwen, 2006; Minichello et al 1999). In a time use diary, 
instead of providing the list of activities, respondents are expected to record for themselves the 
activities they perform in a day with their respective durations. Diaries can be in `slot' or `open' 
form. Slot diaries allow activities to be recorded alongside the given time span, say 15 minutes, 
30 minutes etc, while open diaries ask respondents to write each activity with beginning and end 
times (Kan, Man Yee, 2006; Budlender, 2004; Bowling, 2002; Marino et al, 1999). Diaries 
could also be in the form of `yesterday's' or `tomorrow's' diaries. In yesterday's diaries, 
respondents are expected to record the previous day's activities, while in tomorrow's diaries, 
they fill the activities and their times as and when they happen. Yesterday's diaries can be filled 
through interviews, which make them suitable for those who cannot read or write (Harvey and 
Taylor, 2000). The three main types of diaries are traditional pen-and-pencil approach, which 
asks open or closed-ended questions on activity participation and time use; time unconstrained 
diaries, which allow for recording of activities including concurrent activities; and interview- 
administered diaries, which record at least primary activities but generally record primary and 
secondary activities (Harvey and Taylor, 2000). 
Diaries, that are often preferred by researchers, have the advantage of chronologic reporting of 
activities (Scheuch, 1971), consistency in timing activity data by following activities through 
the day and forcing a full accounting of time. Diaries are less dependent on the respondents' 
involvement in terms of calculation of time on different activities, and hence produce more 
accurate measures (Kan, Man Yee, 2006). 
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Dairies also provide detailed information on the respondent's time use on various activities 
during the day, the sequence of these activities and the contexts of performing them i. e. with 
whom and where. Like stylised estimates, diaries are not error-free but are less likely to lead to 
systematic bias of records and distortions. 
The main source of errors from diaries may be through recording or recall error and the day 
selected for diary-keeping may, by chance, be misrepresentative of a normal day activity. 
Furthermore, most time use surveys involving diaries have problems of limited coverage of 
their questionnaire because most people often view diary keeping as burdensome and 
cumbersome exercise for most respondents (Kan, Man Yee et al 2007). 
When using time use diary, respondents could fail to fully remember the previous day's 
activities. This problem is overcome in the case of tomorrow's diary, which is the same as the 
time diary in all respects except that it is left behind for the respondent to complete as the day 
progresses and is later collected, and reviewed (Harvey and Taylor, 2000). However, the 
drawback is that it also requires an appreciable level of literacy to be able to record activities 
(Budlender, 2004; Scheuch, 1971). 
Diaries also suffer from problems of capturing events beyond the primary activity. Missing or 
unclear data may be difficult to complete or clarify, and if the researcher contacts participants to 
obtain the missing data, then the data becomes retrospective and subject to recall errors and 
biases (Roghmann and Haggerly; 1972; Verbugge, 1980). A key problem often associated with 
unconstrained diaries is that there is a tendency to end up with a day of more than 24 hours if 
one tries to add up all the time spent in any one activity. This may be difficult to reconcile at the 
analysis stage. Completing diaries for several respondents could be a difficult task leading to 
low response rates and less thorough reporting (Kan, Man Yee, 2006). This is especially so 
during prolonged periods of diary use (Verbugge, 1980; Marino et al, 1999). Diaries are 
relatively costly both in terms of the volume of data to be collected and require a lot of time 
from respondents and researchers (van den Berg and Spauwen, 2006). For the researcher, it 
could be in the form of time required to train diary keepers and maintain their support 
(Verbugge, 1980). Finally, diaries cannot be used in certain instances where they are likely to 
incriminate respondents. These include reporting illicit drug-use or recording income that has 
not been declared to tax authorities (Marino, 1999). 
56 
A recent study using pictorial diaries to collect household health consumption and expenditure 
in Tanzania and The Gambia (Wiseman et al, 2005) observed that pictorial diaries could be used 
successfully in predominantly illiterate communities to collect data on a range of patient health 
questions. Wiseman et al (2005) identified respondent fatigue as a problem of using diaries. The 
authors however acknowledge that this phenomenon does not always lead to poor quality data. 
The study recommends a number of different techniques that field teams can use to support 
diary keepers in order for them to minimise problems of fatigue. These include regular 
interviews with diary keepers as well as the use of aid-memories and other prompts. In terms of 
costs, those conducting studies involving diaries were advised to set aside enough funds to 
support these techniques and provide adequate training for fieldworkers. Finally, Wiseman et al 
(2005) attributed the success of diaries to a trusting relationship between fieldworkers and the 
diary keeper. 
2.5.2.2 Observation 
The observation method of time use data collection requires direct observation and recording of 
events by an outside observer. It requires the subject of the study be followed as he or she 
performs work for some days (Budlender, 2004). It involves directly observing the person doing 
unpaid work and recording the time it takes to perform each activity without the direct 
involvement of the one being observed, and gathering data in a systematic way (Kalfs, 1993). 
The two main types of observation methods are direct and random observations. The former 
entails direct observation and recording of activities/events by an outside observer as they take 
place. The latter creates a sample of time to be observed through what is known as fixed interval 
sampling or random interval sampling (including random spot checks) (Harvey and Taylor, 
2000). 
The main advantage of the observation method is that it allows data to be gathered in a 
systematic way and is useful where activities are not structured and several activities are 
performed simultaneously by several people (Khan et al, 1994). Furthermore, the method does 
not require the one being observed to be educated or to have an understanding of conventional 
time. 
The main disadvantage of the observation method is that it is resource-intensive in terms of time 
and staff as it requires observing one person at a time. Observing more than one person at a time 
would require visiting those being observed at regular intervals, which could compromise 
reliability (Kalfs, 1993). The fact that the respondents know that they are being observed could 
lead to changes in behaviour in the form of `play-acting'. 
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Furthermore, direct observation could be highly intrusive and disruptive to work and may 
possibly compromise the actual behaviour (Harvey and Taylor, 2000). Harvey and Taylor 
further argue that, due to its intrusive nature, periods of observation are usually limited to 
daytime, which could be a problem in measuring the work of women in developing countries, 
which extends into the night. A few other additional drawbacks from observing people directly 
include the fact that one does not know the focus of someone's attention if they are doing 
simultaneous activities and therefore may not pick up an important element of the detail of the 
activity (Kimberly Fisher, personal communication, London, 2005). For instance, food may be 
prepared for one's own household or a special meal for someone in the extended family or a 
neighbour who is ill and needs extra assistance. Generally, some time use surveys tend to 
separately code activity undertaken for one's own household and extra activity undertaken as 
unpaid help to someone from another household, but this may not necessarily be picked up from 
observation. It is almost impossible to observe everything using the observation method because 
the observer still has to undertake essential activities, among them, eating, going to the toilet 
and, resting, during the day. 
2.5.2.3 Recall 
The recall method asks participants to retrospectively recount events, tasks, reflect on the 
various work situations and then report on their reactions, feelings or actions (van den Berg and 
Spauwen, 2006; Csikszenmihalyi and Larson 1987). The method is advantageous in that it is 
less intrusive and is usually cheaper to administer in terms of both financial and human resource 
costs than observation methods (Harvey and Taylor, 2000). The recall method can be conducted 
via a questionnaire or via a diary or interview. The method is less demanding on both 
respondents and researchers (van den Berg and Spauwen, 2006). 
The main disadvantage of the recall method is that the data it generates can suffer from under- 
reporting of events, memory distortions, selective memory or reinterpretation of past 
experiences due to recall bias (van den Berg and Spauwen, 2006; Csikszenmihalyi and Larson 
1987; Tidwell, Reis and Shave, 1996). The recall method, compared to observation, is a less 
systematic way of questioning time use information (van den Berg and Spauwen, 2006). One 
other problem is that there may be no way to determine the circumstances that led to specific 
events, contextual to the event recorded, or the exact time when such events took place 
(Minichello et al 1999). 
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Verbugge (1980) argues that infrequent, major or events of high emotional importance are 
generally well reported because people usually tend to remember them, but the tendency to have 
lapses in memory or telescoping (i. e. remembering events but not their correct date) can be a 
problem under the recall method. There is also the issue of the recall period, or how recently the 
activities took place. 
The farther back one asks people to remember, the more inaccurate their memory is likely to be 
unless the activity is particularly memorable. Nonetheless, if one's activity of interest is an 
infrequent one, such as preparations for a wedding, recall may be the only option (Kimberly 
Fisher, personal communication, London, 2005). 
The decision to use recall or other methods depends on the level of detail of activity history one 
seeks. If one's interest is in a particular type of activity, such as the role a person has played 
during the harvest, some reasonably valid information can be obtained about a particular 
activity (as opposed to all activities) by using interview techniques to help people reconstruct 
their past and using prompts to help them remember certain forms of activities (Kimberly 
Fisher, personal communication, London, 2005). 
From the review, it is clear that each method of time-measurement has its advantages and 
disadvantages. For instance, the stylised estimates are generally cheaper to administer than 
diaries and observation methods. Observation combined with diaries requires a lot of resources 
to administer which may not be the case in stylised estimates. In all types of self-reporting, one 
relies on respondents to decide which activities to report and this is compounded in some cases, 
by categorisation problems. Furthermore, regardless of the methods used, there is the perennial 
problem of simultaneous activities (i. e. when more than one activity takes place at a given point 
in time). Taking simultaneous activities on board (if not done carefully) could lead to more than 
24 hours in a 24-hour day and ignoring them could lead to understating time use (Budlender, 
2004). The likely implications of all these is that, the choice of a method depends to a large 
extent on many factors, not the least of which being the resources available and the ability of the 
researchers to support and guide participants to accurately record their activities. 
2.5.3. Methods of valuing time 
Household work has been referred to as a residual value derived indirectly by deducting from 
the final market value of household production the cost of materials and imputed capital inputs 
(ironmonger, 1996a). However, since our focus is at the microeconomic level, one would have 
to look for alternative methods. 
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The work of Goldschmidt-Clermont (1987) divides time valuation methods into input and 
output. As indicated in Section 2.3.2, in each case - input and output method - the human 
capital method is used to value unpaid labour (Klarman et al 1968; Weisbrod, 1964). 
Output-related evaluation of household production is the output of household production 
expressed either in physical units (volume) or in monetary units (value). Goldschmidt-Clermont 
(1987) further divides the approaches into market cost, replacement cost, opportunity cost, 
reservation wage and the spouse paid wage approach. Any of these methods are used with HCA. 
As stated in Sections 2.3.3, FCA does not recognise unpaid work and WPA does not consider 
indirect costs let alone unpaid work as part of the denominator. However, a slight shift in this 
position of the Erasmus School that has been observed of late was discussed in Section 2.3.3. 
2.5.3.1. Input-related method - HCA 
Input-related method is divided into two. One takes into account the value of inputs and the 
other takes the volume of inputs into consideration. 
Value of inputs 
The input-based approach involves direct imputation of labour input and the valuation of the 
production costs of inputs. The amount of labour time used in household work is assessed and 
then multiplied by a wage rate to determine the `income' from the household production, which 
is referred to as the value of unpaid work (Young, 2000). The possible wage rates are: 
1. The average wage for all workers in the economy; 
2. The average wage for all female or male workers; 
3. The minimum wage; 
4. Wages paid to subsistence domestic workers; 
5. Wages for specialist workers for each task undertaken; and 
6. The wage applying in a market enterprise for performing equivalent work. 
Methods 1 to 3 are known as the `opportunity cost approach', where the value of household 
work is derived from the potential earning in the market if the person was not engaged in 
household work. Methods 4 to 6 are known as the `replacement cost approach', where the value 
of household work is obtained from what it would take to pay someone to perform the work at 
the household level. 
The opportunity cost approach is based on the economic concept of the opportunity cost 
(Section 2.3.2) of forgoing the benefit of household work for an alternative based on the 
estimated earnings from paid rather than unpaid work (Budlender, 2004). 
60 
The method uses the potential wage rate in the labour market based on education, experience, 
age, sex and location (Young, 2000). Therefore, the value of household work depends more on 
the person doing the work than the work itself. The opportunity cost approach opens the way for 
one to use any of the wage rates as stated in methods 1-3. This could be the mean wage per hour 
in the economy calculated separately for males and females or the average of the two, assigned 
according to the person performing the unpaid work or minimum wage rate. When the 
minimum wage rate is used, labour input into household work is assigned an imputed wage 
equal to the minimum market wage rate. 
The replacement cost approach is the wage paid to a polyvalent substitute such as a domestic 
servant performing all household work (generalist) or a wage paid to a specialist like a cook 
who performs only one specific task (Goldschmidt-Clermont, 1987). The generalist approach 
uses the mean wage of the worker performing similar work to the unpaid person such as wage 
rates for maids or childminders (Budlender, 2004). The specialist approach focuses on the 
activity itself rather than the person performing the work. For each activity, it uses the wage 
earned in the market by a worker whose function and circumstances match the unpaid work. For 
instance, cooking time is valued at the hourly pay for a cook, and cleaning work at the wage rate 
paid to a cleaner (Budlender, 2004). 
Disadvantages of using wages in valuing time 
Wage-based methodologies have general and specific problems worth highlighting. Using 
market wage as a proxy to estimate opportunity cost of unpaid household work is likely to 
overstate the time value of unpaid work (Ironmonger and Sonius, 1989). Budlender and 
Brathaug (2002) also argue that one of the main disadvantages of the opportunity cost method is 
the variation in wage rates when different people perform the same type of unpaid work, 
because the pay rate of a specialist may be different from that for an ordinary housewife. They 
went on to argue that, in a situation of high unemployment, it is difficult to find the opportunity 
cost for the unemployed and economically inactive, and hence it is difficult to assign suitable 
paid work to unpaid work, let alone find an appropriate wage rate. 
Moreover, it is assumed that certain household tasks, such as cooking, command a specific 
wage. However, compared to those in the household, workers in the market are in a better 
bargaining position to negotiate their wages (Skolka, 1976). Therefore the use of this value for 
the economic evaluation of unpaid work raises problems even in the context of developed 
countries, and more so in countries with different social values and economic structures 
(Oppong, 1982). 
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The theory of substituting market and non-market work is based on the marginal value of the 
market time, which is assumed to substitute the last unit of the non-market time and market 
work until equilibrium is reached (Goldschmidt-Clermont, 1982,1987). This substitution of 
work in the two sectors is questionable in settings where household work limits the freedom to 
choose how best to allocate the marginal time units. 
The generalist approach has been criticised because it may undervalue unpaid household work 
by ignoring management responsibilities attached to household work. The specialist wage rate 
approach ignores the difference in productivity and efficiency between market and non-market 
production and assigns different wages to activities regardless of who performs them. The 
approach attempts to match as closely as possible the work of paid and unpaid work, but has the 
tendency to overvalue unpaid labour (Budlender and Brathaug, 2002; Young, 2000). 
Further problems with wage-based methodologies include the tendency of females to perform 
more unpaid work than males and hence having a lower average wage. The wage-based 
methodologies, which are generally based on only the wages of the employed population, may 
not necessarily represent the average wage when unpaid work is factored in. Unpaid work could 
be done as part of leisure and as such, it can take a much longer time than usual and in the 
process exaggerates the value of time (Australian Bureau of Statistics, 1990). One other 
common problem of wage-based evaluations is how to deal with simultaneous activities in cases 
where time is spent doing two or three activities at the same time. Quah (1986) suggests only 
considering the time of "major" or "primary" activities. This issue is resolved in the output 
method below. 
Volume of inputs 
According to Goldschmidt-Clermont (1987), this type of input-based approach requires physical 
counting of the number of persons or hours and then compares the volume of work input in 
household work with the volume of work input in market work. Alternatively, the volume of 
household product for example laundry can be compared to the output of commercial laundry. 
However, there is the perennial problem of adding or subtracting the physical quantities, which 
can be difficult. This is often solved by converting physical units to monetary units. The 
conversion is done by borrowing values from the market, which consists of wages paid for work 
similar to household work. In that case, the method will also suffer from the disadvantages of 
wage-based methodologies highlighted earlier. 
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2.5.3.2. Output-related method-HCA 
This approach requires the identification and quantification of household outputs such as 
cooked meals and their market value in terms of prices at which the household will sell or the 
prices at which the household can buy an equivalent market product (Young, 2000). It corrects 
for differences in productivity levels by focusing less on the means of production and more on 
what is produced (Budlender, 2004). 
The steps in estimating the volume of household output in the various domestic activities 
include valuing the output at the market price (producer/retail price), and then deducting 
intermediate consumption (consumption expenditures for intermediate goods or market value of 
non-market production goods in the production process). For goods or services with no market 
equivalent, an input-related evaluation is used as a complementary method by estimating the 
volume of labour inputs (in labour units) and assigning their market values (Ironmonger, 1989). 
Depending on data availability, it can be the net returns to labour (exclusive of intermediate 
consumption) in market-oriented activities performed by the household 
One of the main difficulties with the output-related method is how to match household work 
with market work and use the appropriate prices, especially in developing countries 
(Goldschmidt-Clermont, 2002). There are also difficulties in whether to use producer or retailer 
prices. For the valuation of subsistence agricultural products, Blades (1975) and Fish (1975) 
stress the importance of indicating the purpose of the evaluation as a pointer to the type of 
category of prices. Retail price is used when produce cannot be sold at the farm gate. In this 
instance, the producer price is recommended. In the case of households, the choice of price 
depends on the purpose of the evaluation. 
2.6.. REVIEW OF THE EMPIRICAL LITERATURE ON ECONOMIC EVALUATION 
OF PREVENTIVE HEALTH CARE 
2.6.1. Introduction 
This section is devoted to the review of the empirical literature on economic evaluation of 
health interventions. The review focuses on how cost-effectiveness analyses of preventive 
health interventions identify, measure and value indirect costs. The detailed criteria for the 
assessment are as per the attached information extraction tool (Appendix 1). The review 
findings are presented under sub-headings: method; results; and discussion. The section ends 
with a summary of the findings and key gaps to be filled by this research. 
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2.6.2 Methods 
The review combined several search strategies to identify relevant studies. The main strategy 
was to conduct an electronic search using two computerised databases: MEDLINE and Health 
Economic Evaluation Database (HEED), for economic evaluation studies that include indirect 
costs. Since not all articles were indexed in the databases, in order to obtain those likely to be 
omitted or poorly indexed, "grey" literature of unpublished work, including those found in 
references of other PhD theses, books, pamphlets known to the candidate with materials relating 
to economic evaluation and indirect costs, were hand-searched to determine their relevance to 
the study. Other relevant sets of studies that the candidate knew were cost-effectiveness studies 
involving indirect costs but were not captured electronically were added for review. The 
reference list of economic evaluation articles found were scrutinised for additional empirical 
studies that could have been omitted using other strategies. The search terms used in all 
databases included the following: economics, costs, cost analysis, burden of illness, cost- 
effectiveness analysis, indirect cost, productivity costs, unpaid work, domestic work, household 
production, household work, informal work, subsistence work and wage labour. 
The period for the systematic review was 1996-2006, as the results of earlier studies were 
considered too old to be relevant to the current economic evaluation focussing on indirect costs. 
Studies were included from the literature search, if they were in the English language. Also 
included were full economic evaluations (CEA) that examined at least two alternative 
interventions incorporating indirect costs rather than just referring to them. This is because CEA 
and CUA are the two methods of economic evaluation methods that can use any of the three 
methods of indirect costs valuation (HCA, FCA and WPA). 
While the use of indirect costs in CEA and CUA is of interest to the researcher, for pragmatic 
reasons and given the fact that CEA is the dominant economic evaluation method in developing 
countries, it was decided to focus the review on empirical CEA that used indirect costs 
regardless of the outcome used. Those applied cost-effectiveness studies considered were on 
prevention, screening, diagnosis etc. Studies were also left out from the review if they were 
economic evaluation of treatment or therapy. Treatment or therapy studies were excluded 
because the decision to seek treatment may involve other considerations such as pain, suffering, 
discomfort, which may compel people to ignore cost considerations in seeking care (Ratcliffe, 
1993). Empirical studies applied the concept of indirect costs in preventive health care whilst 
the methodological studies looked at the method of measuring them. The review articles, as the 
name implies, review other works in the same areas. 
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Since some of the articles were repeated across the two main databases, further sorting was 
done by recording the name(s), date of publication and page numbers of the selected articles 
from HEED to eliminate repetition. Titles and abstracts were read to assess their relevance to 
this review. The studies that met the inclusion criteria were reviewed. 
Descriptive categories were used to summarise each article in terms of the method used to 
estimate indirect costs. The details of the analytical categories are presented in Appendix 2. 
After reviewing the methods used in each study, the importance of indirect costs on overall 
cost-effectiveness ratio (ICER) was assessed. The specific issues that were assessed included: 
1. The study setting and population, 
2. Type of intervention 
3. Methods of identifying and measuring all relevant costs; 
4. Methods used to measuring indirect costs; 
5. Approaches of valuation of indirect costs 
6. Consistent use of indirect costs; 
7. Costs disaggregated; and 
8. The effects of indirect costs on the overall result assessed through sensitivity analysis. 
2.6.3 Results 
After both the electronic and hand search, 210 articles were initially identified for review. 
However, a thorough reading of the abstracts showed tthat only 81 papers fulfilled the inclusion 
criteria. The geographical distribution of the 81 cost-effectiveness studies showed that 46% of 
them came from North America (USA and Canada). The single country with the largest number 
of studies was USA with 41% of all the papers reviewed. The proportion of articles reviewed 
from the USA is more than those from the whole of Europe (37%). The least represented 
geographical area is South America with only 1%. The rest of the continents, Africa, Oceanic 
fell between the range. 
In terms of study population, the picture is mixed, with 32% focusing on adults and 26% on 
women. Amongst the proportion for all women, 7% considered only pregnant women. About 
16% considered all age groups while 15% considered only children. The rest represent infants 
(9%) and men (2%) as indicated in the summary Table 2.1. In terms of the type of intervention, 
out of the 81 studies, 35% were on screening for various conditions such as Chlamydia, 20% on 
mainly childhood vaccination programmes and 40% on prevention of diseases such as HIV/Aid 
and Tuberculosis (TB). 
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The rest is a mixture of interventions. Only three studies are on malaria (Gonzalez et al, 2000; 
Aikins et al, 1998; Wiseman et al, 2003) and none on malaria in pregnancy, which is the focus 
of this research. 
In terms of separating costs, half of the studies clearly presented costs in terms of direct and 
indirect components. Among them were Marissal et al 2000; Welte et al 2000a; 2000b; and 
Johannesson et al, 1996. The valuation of paid and unpaid work, like their identification, differs 
in many ways across studies. Thirty-eight percent of all the studies used paid work to value 
indirect costs. The use of unpaid work to estimate indirect costs instead of paid work in most 
cases has not been common. Only 2% considered unpaid work alone as part of indirect costs 
(Krahn et al, 1998; Fox-Rushby et al, 1996), one study considered household work time as the 
main determinant of indirect costs (Grover et at, 2003). Various other methods were used to 
value unpaid work. These include the average wage rate (Gow, 1999); gross salary plus taxes 
(Dayan et al, 2001); proportion of gross salary (Aikins et at, 1998) and previously lost income 
(Aledort et al, 2005). Gonzalez et al (2000) combined both paid and unpaid work using 
Tanzanian minimum wage to estimate unpaid work and Welte et al (2000b) considered unpaid 
work time only in the sensitivity analysis. Others valued unpaid work time using an average 
wage, agricultural and household work times. The rest of the studies were not explicit on the 
value of unpaid household work. 
Eleven percent of the studies did not classify their forgone time in terms of paid, unpaid or 
leisure. Instead, they identified them in terms of social cost, lost productivity and average wage 
without indicating whether they are paid or unpaid. The opportunity cost of leisure was 
considered by only 1% of the studies (Brisson M and Edmunds, 2002). Most studies used paid 
wages as a proxy for unpaid work. The shortcomings of this approach have already been 
highlighted in Section 2.5 on methods of measuring unpaid work. 
Among the three approaches used to value indirect costs, the most common method was HCA 
with 63% of the studies using this technique. FCA was used in 3% of the studies (Valkengoed et 
al, 2001; Warner et at, 1996; Smith et at, 1997; ) and WPA in 5% (Karim et at, 2004; Stinnett et 
at, 1996; Bell et at, 1999; Beutels et at, 1996). Only one study combined HCA and WPA (Weite 
et at 2000b). It could not be determined from 27% of the studies as to the methods they have 
used. From the 81 studies reviewed, 74% have disaggregated their costs into the various 
components and the rest did not. Only 42% of the studies conducted sensitivity analysis to test 
the significance of indirect costs on their results. Out of that proportion, 31% found indirect 
costs to be significant to their findings. 
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Table 2.1 Summary of cost-effectiveness studies reviewed 
of the studies 
America (North) 37 46 
... from which USA alone 
33 41 
Europe 30 37 
Asia 22 
Oceanic 34 
Children 12 15 
Pregnant women 6 7 
Women 15 19 
Men 2 2 
Adults 26 32 
All age groups 13 16 
Type of intervention 
Vaccination 16 20 
Screening 28 35 
Prevention 32 40 
Others 5 6 
Foregone time 
Paid work 31 38 
Unpaid work 2 2 
Paid & unpaid work 13 16 
Leisure time I 1 
Others 25 31 
Not stated 9 11 
Approach used to measure indirect costs 
HCA 35 43 
I-ICA (interred) 16 20 
FCA I I 
FCA (Inferred) 2 2 
WPA 4 
HCA & WPA I 
Could not be determined 22 27 
Indirect cost disaggregated from other costs 
Yes 60 74 
No 21 26 
Effects of indirect costs on results assessed through 
sensitivity analysis 
Yes 34 42 
No 47 58 
... of those who assessed the effects of 
indirect costs, 
Significant 25 74 
67 
2.6.4. Discussion and gaps in the literature 
The results of the review should be viewed in the context that not all the abstracts were very 
clear as to whether they have included indirect costs or not. Therefore, the potential to exclude 
some studies that actually included indirect costs exists. In the same way, including studies 
especially those not very clear about their methodologies is also a possibility. However, this is 
not expected to change the general direction of the findings. 
There are no doubts that many studies have incorporated indirect costs in the CEA of preventive 
health services. This is demonstrated by the number of papers reviewed (81) over a 10-year 
period (1996-2006). The general finding of the review is that, the use of indirect costs varies 
between settings. Moreover, since many of the studies were conducted in developed world 
dominated by paid work, this puts into question the transferability of their findings to the 
developing country set-up. This is mainly because the level of development, the social set-ups, 
access and utilisation of health services are mostly different in the two settings. In addition to 
the general findings, the specific areas assessed include: 
(i) Disaggregating costs into direct and indirect costs 
(ii) Selection of forgone activities such as paid, unpaid or leisure 
(iii) Approach used to value indirect costs i. e. HCA, FCA, WPA or their combination 
(iv) Use of sensitivity analysis to assess the impact of indirect costs on the results 
After the publication of several guidelines on economic evaluation (Section 1.1), one would 
expect that by now, studies would have moved towards convergence in standards. However, the 
fact remains that a lot of disparity exist in the way studies incorporate, measure, value and even 
emphasise the role of indirect costs in CEA. The review revealed inconsistencies in terms of the 
way costs are apportioned, especially with respect to direct and indirect costs. Most of the 
studies indicated that they have disaggregated their costs but the method of disaggregating is not 
consistent across studies. This is in contrast to the suggestion that costs should be disaggregated 
into the various components of direct, indirect and even intangible costs so that anyone looking 
at the studies could use a component or a combination for their purposes. In the review, 26% of 
the studies did not disaggregate their costs into various components. It is therefore very unlikely 
for anybody to assess the effects of indirect costs on the results of that 26%. In valuing indirect 
costs, both the quantities and cost per unit are very important because it helps give a breakdown 
of the various parts of the aggregate term that could be used by others. However, it will be 
difficult to multiply the resource use and their respective unit costs. Another reason for 
disaggregating costs was to assess the effect of each of the components on the overall result or 
variables of interest. 
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In terms of identification of the foregone activities, the review findings showed that most of the 
studies focussed on paid work at the expense of unpaid work and leisure times. The various 
points of view concerning the inclusion of indirect costs including paid, unpaid and leisure 
times in economic evaluation have been adequately reviewed in Section 2.3. As indicated earlier 
in Section 2.6.3, the fact that only 2% of the studies actually considered unpaid work leaves a 
gap for subsistence economies. Like in developed countries, in order to improve efficiency at 
health facilities, developing countries may move towards reducing the length of hospital stay in 
favour of informal care at home. This may lead to higher demand for the time used for 
subsistence work and hence a bigger role for unpaid work in economic evaluation. Section 2.4 
devoted a lot of time on the unique features of subsistence economies that warrants a shift away 
from using only paid work in favour of unpaid work. However, the number of studies that used 
unpaid and household works is less than the number of studies conducted in subsistence 
settings. This shows that not all the studies reviewed from subsistence economies use unpaid or 
household work. 
The details of how different schools of thought value indirect costs are highlighted in Section 
2.3. Going by the various arguments, one would expect that all the 81 studies reviewed would 
have used at least one of the approaches. However, despite the arguments as to which method is 
suitable for valuing indirect costs, few directly and clearly stated the approach used to value 
indirect costs (i. e. HCA, FCA or WPA). Among those that indicated the approach taken, the 
majority used HCA, two used FCA and WPA and the rest either implied the approach they used 
or failed to indicate their approaches they used. The candidate had to infer the approach used in 
22% of the studies because the authors did not explicitly indicate them but could not infer 27%. 
The existence of the possibility to infer the approach used in some of the studies leaves a lot of 
room for subjective interpretations. 
The final point relates to the first, largely because, it is only when indirect costs are 
disaggregated from the rest can their effects be assessed on the overall results through 
sensitivity analysis. All the studies reviewed took societal perspective, which means they expect 
a role for indirect costs. The opportunity cost of different forgone activities such as subsistence 
farm work, unpaid household work, paid work and travel when disaggregated from the outset to 
enable one to assess the impact of each on the intervention. However, 58% of the studies did not 
conduct sensitivity analysis to assess the effects of indirect costs on their results. Some of the 
few exceptions are Welte et al (2000a; 200b), Aikins et al, (1998), Lindholm et al, (1996), 
Mansergh et al, (1996). Aikins et al (1998) conducted multiple sensitivity analyses on several 
parameters including transport costs. 
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Mansergh et al (1996) included loss of productivity of HIV-infected infants in the sensitivity 
analysis. The fact that 31% of the studies that assessed the effects of indirect costs on their 
results through sensitivity analysis found them useful shows that such costs have roles in CEA. 
In summary, the inclusion of indirect costs in CEA is still work in progress because very few 
studies incorporate all the main concerns of disaggregating costs, clearly stating the forgone 
activities and approaches used and conduct sensitivity analysis. One of the main omissions of 
the studies included in this review is the clear separation of costs into direct and indirect costs. 
Some of the studies tend to aggregate the cost components and in the process mask their 
individual contribution to the overall result. The distinction between paid and unpaid work, 
especially household work, is rarely made clear. Despite being one of the major activities in 
subsistence economies, the role of unpaid work, especially household work, has not been given 
the attention it deserves. Most of the studies took into consideration the formal labour market 
(paid work) and only in very few instances were subsistence labour markets considered. All the 
above are likely to have effect on the overall results of the study and unless these 
inconsistencies are tackled, there is likely to be many disparities in studies. 
2.7 SUMMARY 
This chapter reviews literature on economic evaluation methods, approaches to valuing indirect 
costs, unpaid work and empirical literature on the use of indirect costs in cost-effectiveness 
analysis. The first section gave an overview of the basic forms of economic evaluation. It was 
revealed that CEA, CUA and CBA are the three main types of economic evaluation each with 
its advantages and disadvantages. The conventional approaches to valuing indirect costs, HCA, 
FCA and WPA were critically reviewed with respect to their use in economic evaluation. The 
unique features of developing countries showed that the conventional measurement and 
valuation methods of indirect costs cannot be readily applied in such settings. In recognising 
that fact, possible ways of measuring and valuing time were reviewed through time use 
methods. The chapter ended with a review of the empirical literature on indirect costs, which 
revealed an important gap in terms of the inclusion of indirect costs in cost-effectiveness 
analysis. This exists despite 31% found indirect costs to be significant in their overall cost- 
effectiveness ratios. 
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CHAPTER 3: MALARIA IN PREGNANCY 
3.1 INTRODUCTION 
This chapter reviews the literature on malaria in pregnancy in developing countries. It first 
reviews the general literature on malaria in pregnancy in Section 3.2 before focusing on low 
birth weight (LBW) and anaemia in Sub-Saharan Africa (SSA) in Sections 3.3 and 3.4 
respectively. Emphasis is placed on morbidity, mortality and the categorisation of LBW and 
anaemia into the various types. Section 3.5 focuses on interventions in low-income countries in 
general, with emphasis on the prevention and control of malaria including malaria in pregnancy. 
Review of economic evaluations of malaria in pregnancy in SSA is covered in Section 3.6. The 
chapter ends with a brief summary (Section 3.7). 
3.2 METHODS 
Major databases such Medline, PubMed, Popline and trial register and bibliographic databases 
of malaria in pregnancy library were searched for relevant articles using a combination of the 
following keywords: malaria, pregnancy, antenatal care, intermittent, preventive, treatment, 
prophylaxis, sulphadoxine pyrimethamine, chloroquine. The focus was on articles published 
from 1980 to June 2007. However, one article published in 1964 was exceptionally included 
because of its relevance to the subject under review. The articles from the databases were 
supplemented with relevant information on malaria in pregnancy from conference articles, 
information from websites of Roll Back malaria (RBM), WHO, UNICEF, Centre for Disease 
Control (CDC), Multilateral Initiative on Malaria (MIM) etc. Full text articles were obtained 
from London School of Hygiene and Tropical Medicine Library and electronic databases, WHO 
Global Information Full-Text (GIFT) site and Google where available. GIFT is a WHO 
initiative that provides free online full-text journals. The reference lists of full text articles were 
searched for additional references. Some of the known experts in malaria in pregnancy known 
to the candidate were contacted for relevant information. WHO Headquarters were contacted for 
detailed literature on malaria in pregnancy and they provided a comprehensive list of references. 
Most of the articles selected for review were written on developing countries with emphasis on 
Sub-Saharan Africa (SSA). Excluded were articles: Written in languages other than English, on 
other strains of malaria other than Plasmodium falciparum and from malaria endemic areas 
outside SSA. The articles on distribution of LBW and anaemia were searched from the same 
sources listed earlier. However, the main criteria for inclusion were articles that showed 
distribution of LBW and anaemia with focus on SSA regardless of cause. 
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Papers showing distributions of the two conditions in other areas were excluded. In order for the 
review to be as close as possible to the situation in The Gambia, the bulk of the studies selected 
was from the West African sub-region. Articles on the cost-effectiveness of malaria 
interventions were obtained from the same sources and from references of published reviews 
such as Goodman et al (2001) and Worrall et al (2007). 
3.3 RESULTS 
Malaria in pregnancy is a serious health risk to pregnant women but is a preventable cause of 
maternal and perinatal morbidity and mortality (Brabin, 1983; Brabin, 1991; Menendez, 1995). 
It is frequent, severe and more common in pregnant women and the early postpartum period 
than in the same women before pregnancy and in non-pregnant women (McGregor, 1984; 
Diagne et al, 2000). The effect of Plasmodium falciparum ranges from increased attractiveness 
to mosquitoes to continuing morbidity postpartum (Lindsay et al, 2000, Diagne et al, 2000). 
Lindsay (2000) indicates that pregnant women are twice as attractive to malaria mosquitoes as 
non-pregnant women. 
In areas of high and moderate (stable) malaria transmission, malaria is frequently transmitted 
from person to person leaving women with a high level of acquired immunity to Plasmodium 
falciparum malaria (Desai et al, 2007). The women are often asymptomatic due to low 
peripheral parasitaemia but there is a high prevalence of placental infection (WHO, 2002). In 
most parts of Africa where Plasmodium falciparum malaria is endemic, exposure to malaria 
parasites is intense and the adult population is relatively immune. Pregnant women however, - 
particularly primigravidae, are immuno-compromised (Menendez, 1995). The immune system 
is said to be immuno-compromised when the defence mechanism for malaria infection has been 
lost through disease or treatment (Dr. M. Jawla, personal communication, Banjul 2006). In such 
areas, pregnancy leads to a reduced effective immune response and in particular, the placenta 
provides a protected site for parasite sequestration and growth. Malaria parasites are often found 
sequestrated in large numbers in the placenta, without any being found in the blood (Beeson et 
at, 2002). According to Rogerson et at (2003), a study on the sensitivity for diagnosing malaria 
found 47% for parasites in the peripheral blood, 63% for slides dabbed onto the placenta, and 
91 % for placental histology. 
This reinforces the view that a negative blood slide for malaria parasites does not necessarily 
mean there is no malaria for semi-immune pregnant women. However, for non-pregnant adults, 
a negative slide means no malaria. 
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Parasite sequestration occurs along the surface of the placental membrane whereby parasites 
impede oxygen-nutrient transfer and the consequences contribute to the complications 
experienced by both the pregnant woman and the unborn foetus (Dr. M. Jawla, personal 
communication, Banjul 2006). Research into Plasmodium falciparum in the past decade or so 
has shown that parasites bind to specific ligands in the placenta, especially chondroitin sulphate 
A (CSA) though this is not the only one (Beeson and Brown, 2004; Mahusamy et at, 2004). 
Anti-CSA antibodies inhibit binding adhesion to the placenta over time, which is believed to be 
the reason for the reduced risk of malaria in pregnancy as the number of pregnancies increases 
(Fried et al, 1998). 
The main effects of malaria in pregnancy in stable areas are associated with malaria-related 
anaemia in the mother and with the presence of parasites in the placenta (Steketee et al, 2001; 
Shulman et al, 1999; Mutabingwa et al, 1993). The resultant impairment of foetal nutrition 
contributes to LBW, which is a leading cause of poor infant survival and development in Africa 
(MacCormick, 1985; Steketee et al 1996b; Bloland et al, 1996). Placental malaria is often not 
accompanied by a patent peripheral parasitaemia, so infection cannot be reliably screened 
through antenatal clinics (Shulman et al, 2001 a; Mockenhaupt et al, 2002; Rogerson et al, 
2003). The resultant effect is that the majority of such women do not seek care for malaria 
(Steketee et al, 1996e). 
In areas of epidemic or low (unstable) malaria transmission, malaria is infrequently transmitted 
from person to person leaving adult women with a low level of acquired immunity, which 
exposes them to illness when infected with Plasmodiumfalciparum malaria (RBM, 1998). Due 
to little or no immunity to malaria, pregnant women are likely to suffer from complicated 
malaria in the form of cerebral malaria, hypoglycaemia, hyperpyrexia, severe haemolytic 
anaemia and pulmonary oedema and acute renal failure (WHO, 2000a). According to 
Luxemburger et al (1997), pregnant women in such areas are two to three times at greater risk 
of developing malaria and severe disease than non-pregnant women. The resultant effects of 
malaria are death from severe malaria or through indirect causes such as malaria related 
anaemia (Luxemburger et al, 1997; Hammerich et al, 2002). Furthermore, Plasmodium 
falciparum may increase the risk of miscarriages, pre-term births, maternal anaemia, 
spontaneous abortion, stillbirth, LBW and neonatal death (Foresu et al, 2004; Steketee et al, 
1996b). Plasmodium falciparum is said to be responsible for the death of approximately 
200,000 infants each year (Steketee et al, 2001) as well as maternal illness and death, central 
nervous system complications and adverse reproductive outcomes (Steketee et al, 1996d; 
Luxemburger et at, 1997; Meek, 1988). 
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The effect of malaria in pregnancy is parity-specific (WHO, 2002) with the risk falling with 
increased gravity (McGregor, 1984). Primigravidae and secundagravidae are generally more 
affected than women in subsequent pregnancies (Ricke et al, 2000; Staalsoe et al, 2004). During 
the first malaria-exposed pregnancy, immunity to malaria develops in the placenta, which has 
no effects in the first pregnancy but is retained in the uterus and increases cumulatively in 
subsequent pregnancies (WHO, 2002). 
This could be the reason women in the first and second pregnancies are more affected by 
malaria than women in subsequent pregnancies. Studies in eight countries in SSA showed that 
primigravidae had higher prevalence of peripheral and placental malaria infection compared to 
multigravidae (Keuter et al, 1990; Mvondo et al, 1992; Bulmer et al, 1993; Meurias et al, 1993; 
Mutabingwa et al, 1993, WHO, 2004). The difference between those infected in terms of mean 
haemoglobin levels (McGregor, 1984; Brabin et al, 1990a) and mean birth weight (McGregor et 
al, 1983) was more marked in primigravidae than multigravidae. However, a study in Senegal 
showed that the incidence of malaria attacks in pregnancy significantly increased for 
multigravidae up to their fifth pregnancy (Diagne et al, 1997). 
Human Immunodeficiency Virus (HIV) infection diminishes a pregnant woman's ability to 
control Plasmodium falciparum infection (Steketee et al, 1996b) and therefore, the prevalence 
and intensity of malaria in pregnancy is higher in HIV positive women (Steketee et al, 1996b; 
van Eijk et al, 2002; van Eijk et al, 2003; Verhoeff et al, 1999). HIV positive women are likely 
to have symptomatic infections and increased risk of malaria-related adverse birth outcomes 
(van Eijk et al, 2003; Ayisi et al, 2003). Multigravidae with HIV infection are similar to 
primigravidae without HIV infection in terms of susceptibility to and negative consequences of 
malaria infection (van Eijk et al, 2003). Therefore, in the light of HIV infection, the risk 
associated with placental malaria appears to be independent of parity (van Eijk et al, 2003). HIV 
complicates diagnosis and management of malaria as a cause of anaemia at several levels. 
HIV is itself a common cause of anaemia in pregnant adults and leads to several other causes of 
anaemia such as crytogenic tuberculosis (Lewis et al, 2005) and may make the treatment of 
malaria in pregnancy less effective. Therefore, due to the HIV pandemic, presumptive treatment 
to all women becomes necessary. 
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Evidence suggests that malaria could play a significant role in mother-to-child-transmission 
(MTCT) of HIV (Mwapasa et al, 2004; Ayisi et al, 2003), although this is by no means certain. 
Whitty et al (2005) argued that, because malaria and HIV co-infection is very common in 
Africa, even a small effect might be important. Malaria infection may lead to chronic 
inflammation of the placenta, which significantly raises HIV viral-load in both blood (Kublin et 
al, 2005) and breast milk. All three might theoretically increase the risk of HIV MTCT, 
especially if malaria occurs in the perinatal period. However, conflicting results are emerging 
from the trials conducted in this area so far. The interaction between HIV and malaria in 
pregnancy is potentially two ways; with each appearing to affect the other adversely (Whitty et 
al, 2005). HIV-infected women seem more likely to acquire malaria during pregnancy (van Eik 
et al, 2003, Ladner et al, 2003; 2002) and have relatively high parasite densities. 
3.4 MALARIA IN PREGNANCY AND LOW BIRTH WEIGHT 
LBW is a major risk factor for infant mortality in African populations affected by malaria 
(Guyatt and Snow, 2001 b; McCormick, 1985). This is due to a combination of intra-uterine 
growth-retardation and pre-term delivery with primigravidae especially at risk from parasites 
that bind to chondroitin sulphate, and probably other receptors, on the placenta (Beeson et al, 
2002). Pre-term delivery is delivery at less than 37 completed weeks of gestation. It is generally 
believed that where LBW figures are greater than 10%, the predominant cause is Intrauterine 
Growth Retardation (IUGR) and that the lower the overall LBW rate, the greater the proportion 
due to pre-term births (Villar and Belizan, 1982). The effect of LBW is devastating for both the 
foetus and the mother. Weight at birth has been considered the strongest predictor of infant 
survival and childhood health and development (WHO, 1980). 
According to Gelbrand et al (2001), "In low and middle-income countries, 10-15% of neo-natal 
deaths are directly or indirectly attributed to low birth weight and pre-term delivery" (p25). 
Although reliable data on the magnitude and distribution of LBW is hard to come by (Gelband 
et al, 2001), a compilation of information on birth outcomes (de Onis et al, 1998) by WHO put 
the number of LBW infants born worldwide in 1995 at 20.5 million (Gelband et al, 2001). The 
malaria-related reasons for LBW babies are explained by the effect of malaria parasites on the 
placenta of the pregnant woman. LBW is partly due to parasitic sequestration in the placenta. 
Given the link between LBW and infant mortality, especially in developing countries, it is likely 
that placental malaria contributes to infant and perinatal mortality even where the malaria 
episode is successfully treated (Whitty et al, 2005). 
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Mild pre-term (32-36 weeks gestation) babies are at increased risk of respiratory distress 
syndrome, infection and neonatal and post-neonatal death (Dollfus et al, 1990; Doyle et al, 
1999). Babies born earlier, before 32 weeks, are at high risk of severe morbidity and mortality 
even with specialised neonatal intensive care. They have a high risk of neonatal death and other 
complications compared with normal birth weight babies. Some of the LBW babies who are 
lucky enough to survive remain at risk of infection and impaired growth and development 
during their childhood. 
3.4.1 Distribution of LBW 
The distribution and case fatality rates of neonatal cases in general seen at the hospital level in 
developing countries vary, as indicated in Table 3.1. A study in Nigeria by Oruamabo and 
Ogunremi (1988) reveals that the case fatality rates (CFR) for ELBW, VLBW and LBW were 
90%, 51.1% and 15.4% respectively. Another study in Port Harcourt by Okoji and Oruamabo 
(1992) reveals that of 1,509 singleton neonates, the prevalence of LBW ranged from 1.9% to 
26.9% with the lowest percentage being the proportion of ELBW babies and the highest 
representing the proportion of LBW babies. The CFR ranged from 10.8% to 89.7%, with the 
lowest attributed to fatality rate of LBW cases and the highest to ELBW babies. The study 
concluded that high mean birth weight, longer gestation, and lower incidence of birth asphyxia 
were directly related to reduce fatality in infants. Van der Mei (1994) followed 567 LBW babies 
(less than or equal to 2000g) admitted during a seven year period in a hospital in the rainforest 
area of Ghana. LBW prevalence range was 5.5% to 7.3% with the lower representing the 
prevalence of LBW and the higher being ELBW. The study also reported that 26.8% of the 
babies died at the hospital (57% of them within the first 24 hours) and the average length of stay 
(ALoS) for non-fatal cases was 11.6 days. The CFR varied from 8.4% for those weighing 1751- 
2000g to 83.3% for ELBW. Van der Mei (2000) followed the growth and survival of 105 LBWS 
infants (1000-2000g), discharged during a four-year period, until they were between 4-9 years 
of age. The study found that 14% of the children did not return for age three follow-up, 10% of 
the remaining 90 died (five after the first three months); two could not be traced and another one 
died at 4-9 years follow-up. The details of LBW and their distribution are given in Table 3.1. 
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Table 3.1 Prevalence and case fatality rate (CFR) of LBW in Sub-Saharan Africa 
Author(s) Rates Birth weight 
Extremely 
low 
(<I 000 
Very low 
(1001g- 
14991, Y) 
Low 
(1500g- 
2500g) 
Normal 
(>2500g) 
Sample size 
(where stated) 
(n) 
Oruamabo and Ogunremi Pre 1. - - - - 
(1988) CFR 90 51.1 15.4 - - 
Okoji and Oruamabo (1992) Pre. 1.9 5.7 26.9 65.5 1,509 
CFR 89.7 53.5 10.8 5.3 - 
Van der Mci et al (1994) Pre. 7.3 - 5.5 (1.751- 
2kg) 
- 567 
CFR 83.3 - 8.4 - - 
Van der Mel et al (2000) Pre. - 30.4 69.5 (1.5-2kg) - 105 (1-2k g) 
CFR - - - - - 
Kambarami (2002) Pre. - - - - - 
CFR - - 39.4 (<1.8k) - 429 
Were et al (2002) 
CFR 100 32 22(1500- 
1999) 
- 163 
Simiyu (2003) Prev. - 5 33.4 - 
308 
CFR - - - - - 
3.5 MALARIA IN PREGNANCY AND ANAEMIA 
Anaemia is very common among women of reproductive age in developing countries and the 
estimated figures for Africa are that, two-thirds of all pregnant and half of non-pregnant women 
are anaemic (Winikoff, 1988). Gelband et al (2001) have described anaemia as the most 
prevalent contributor to maternal mortality and morbidity. However, information on the number 
of deaths averted through preventing anaemia is uncertain. Anaemia is more common in 
pregnant women than their non-pregnant counterparts. This is due to the increase in quantity of 
fluid in the circulatory system (plasma) during the second trimester as well as the increased 
demand on iron and folate stores (WHO, 2002). 
The diagnosis and management processes of anaemia and malaria in pregnancy for semi- 
immune women are often not clear-cut (Whitty et al, 2005). Because placental malaria can lead 
to anaemia with few other symptoms and few clues in the laboratory tests, an afebrile woman 
with parasites seen on the peripheral blood film may have placental malaria as either a major 
contributing factor or the only cause for anaemia (Whitty et al, 2005). Even where parasites are 
seen, it does not necessarily mean that malaria is the only cause of the anaemia because anaemia 
in developing countries often has other causes (van den Broek, 2003). 
Prevalence rate. 
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Maternal deaths from all causes have been put at half a million per year worldwide, but 99% are 
said to occur in developing countries (Shulman et al, 1999). Severe maternal anaemia during 
pregnancy is a risk factor for maternal mortality and is responsible for 8-20% of such deaths in 
hospitals in Sub-Saharan Africa (SSA) and 11-13% in community-based studies (MacLeod and 
Rhode, 1998; Shulman et al, 1999). However, Shulman et al (1999) questioned the link between 
maternal death and anaemia on the basis that haemoglobin tests are not normally performed in 
places where severe anaemia is prevalent and the retrospective diagnosis of anaemia as a cause 
of death is difficult. It has been estimated that malaria-related anaemia causes an estimated 
10,000 maternal deaths each year in Africa (WHO, 2002) and there is evidence that pregnant 
women with severe anaemia are several times more likely to suffer from pregnancy-related 
deaths than those without it (Gelband et al, 2001). The widespread nature of anaemia in 
developing countries leads to consequences beyond pregnancy. Evidence from Kilifi District 
Hospital in Kenya showed that 36.5% of severely anaemic women have LBW babies compared 
with 15.7% of other women (Shulman et al, 1999). 
The numerous causes of anaemia during pregnancy include, nutritional deficiencies (Dreyfuss et 
al, 2000), haemoglobinopathies, hookworm infection (common amongst those in farm work), 
low iron bioavailability, folate and vitamin B-12 deficiency, and Plasmodium falciparum 
malaria especially in primigravidae who have a higher prevalence and density of parasitaemia. 
The contribution of malaria, however, has been singled out as substantial and unchallenged 
(Fleming, 1987; WHO, 2002). Since it is almost impossible to rule out placental malaria as a 
cause of anaemia in semi-immune women, it has been recommended that anti-malarial drugs 
should be given to all cases of severe anaemia in pregnancy, even where other causes of 
anaemia can be proven (Whitty et al, 2005). 
3.5.1 Distribution of anaemia 
As indicated in Section 3.4, anaemia has several causes. This section seeks to show the 
distribution of anaemia into mild, moderate, severe, and very severe cases regardless of cause. 
This is so because it is difficult to obtain data on anaemia that is attributable to only malaria in 
pregnancy. A prospective study of the prevalence of anaemia in pregnancy amongst 279 first- 
time attendants of antenatal care in Ethiopia found an overall prevalence rate of 41.9%; 35.9% 
for urban and 56.8% for rural areas (Desalegn, 1993). Most of the women (74.3%) had 
moderate anaemia and only 2.5% had severe anaemia. Another study of 435 pregnant women 
attending an antenatal clinic at University Clinic in Benin City in Nigeria found moderate and 
severe anaemia cases at 20.7% and 2.8% respectively (Ogbeide et al, 1994). 
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Shulman et al (1996) undertook a study to determine the prevalence and aetiology of anaemia in 
pregnancy in Coastal Kenya, to establish locally important causes and enable the development 
of appropriate intervention strategies. Of 275 women attending an antenatal clinic, prevalence 
of anaemia for all parities was 75.6%. Of these, severe anaemia represented 9.8%. Anaemia by 
parity showed that severe anaemia for primigravidae and multigravidae was 15.1% and 7.9% 
respectively. 
Severe anaemia was found to be twice as common in women with peripheral malaria 
parasitaemia when compared to those without. Van der Broek et al (2000) shows that the 
prevalence of anaemia in pregnancy in Southern Malawi was 57% for urban women and 72% 
for rural women. Of these, 3.6% of urban and 4% of rural cases was severe. Primigravidae were 
found to be at slightly higher risk of overall and severe anaemia. A cross-sectional study in 
Bobo-Dioulasso, Burkina Faso revealed that 66% of the women were anaemic. Of these, 30.8% 
were mild, 33.5% moderate, and 1.7% severe (Meda et al, 1999). Prevalence amongst HIV- 
infected women was highest at 78.4% compared to 64.7% for the non-infected. The level of 
severe anaemia in Kisimu, Kenya amongst 1,455 women was 22% (Ondimu, 2000). The details 
of anaemia and their distribution are given in Table 3.2. 
Table 3.2 Prevalence of anaemia in Sub-Saharan Africa 
Author(s) Category Anaemia "/. 
Very 
Severe 
Severe Moderate Mild All 
cases 
Sample size 
(where 
stated) 
n) 
Desalegn (1993) - - 2.5 74.3 - 41.9 
279 
Urban - - - - 35.9 - 
Rural - - - 56.8 - 
Obbcide et at 
(1994) 
- 
- 2.8 20.7 - 
435 
Shulman et at 
(1996) 
Primi: and 
Multi' 
- 9.8 - - 75.6 275 
Primi 15.1 - 
Multi - 7.9 - - 
Meda et al (1999) - 1.7 33.5 30.8 66 - 
van der Brock Urban - 3.6 - - 57 - (2000) Rural 4 - 72 - 
Ondimu (2000) - - 22 1,455 
2 Primigravidae. 
Multigravidae. 
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3.6 PREVENTION AND CONTROL OF MALARIA IN PREGNANCY 
Several malaria prevention and control approaches have been advanced. These involve 
interventions during pregnancy, treatment of complications during birth (intrapartum) and after 
birth (postpartum) and early neonatal care. Among all the available measures, the two common 
approaches to the prevention of malaria in pregnancy are insecticide treated nets (ITNs) 
(Bradley et al, 1986; Alonso et al, 1991) and Intermittent Preventative Treatment (IPT). ITNs 
have been recognised as the main tool for reducing malaria in pregnancy (ter Kulie et al, 2004, 
Lengeler, 2004). According to Whitty et al (2005), ITNs are one of the cheapest, simplest and 
most effective methods of preventing morbidity and mortality from malaria in Africa. 
Although ITNs are generally believed to be good at protecting against malaria, there is no 
guarantee that women may not get malaria at some stage during pregnancy, which may not be 
detected clinically. Despite the fact that the results of initial studies of the impact of ITNs on the 
outcome of pregnancy produced mixed results, a large trial in Western Kenya has demonstrated 
convincingly that ITNs can reduce both maternal anaemia and the incidence of LBW even in an 
area of very high transmission (ter Kuile et al, 2003a; 2003b). 
IPTp is WHO recommended method of preventing malaria in pregnancy by giving at least two 
doses of SP to all pregnant women regardless of their malaria infection status (Worrall et al, 
2007). Previous studies conducted with pregnant women have shown that by preventing or 
treating malaria in pregnancy, anaemia can be reduced and birth weight improved. A study in 
The Gambia using fortnightly maloprim, conducted by Greenwood et al (1989), found improved 
birth weight and haemoglobin in primigravidae and women of at least gravidity five but not in 
other parities. The result of a trial with chemoprophylaxis conducted in women of all parities in 
Nigeria found an improvement of birth weight for women who received chemoprophylaxis with 
pyrimethamine compared with placebo, but the greatest effect on birth weight was found in 
primigravidae and women of at least gravidity four (Morley et al, 1964). 
A study in Malawi (Steketee et al, 1996c) found an improvement in birth weight in women of 
all parities who received mefloquine compared with chloroquine. The frequency of LBW due to 
placental infection in the same country from 1988-1991 was 30.5% for primigravidae, 20% for 
secundigravidae and 14% in those of at least gravidity three (Steketee, 2001). Weekly 
prophylaxis with chloroquine has been the first preventive strategy in many countries but has 
not been very acceptable due to its bitter taste and the seemingly frequent weekly dose 
(Heymann et al, 1990). 
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Studies undertaken in Kenya and Malawi to address the effectiveness of intermittent treatment 
with anti-malarials, given between 16 and 34 weeks gestation, have demonstrated that 
intermittent treatment with Sulphadoxine-Pyrimethamine (SP) given in the second and third 
trimesters can reduce placental parasitaemia in primigravidae and secundigravidae (Schultz et 
al, 1994). It can also reduce severe maternal anaemia in primigravidae (Shulman et al, 1999), 
and improve birth weight in primigravidae and secundigravidae (Parise et al. 1998). Giving SP 
as IPTp two or three times to all pregnant women in highly endemic areas - irrespective of 
whether women have malaria parasites in their blood or not - could reduce maternal anaemia 
and increase birth weight (Shulman et al, 1999; van Eik et al, 2004; Kayentao et al, 2005; 
Rogerson et al, 2000, Challis et al, 2004). 
Trials have also shown that malaria prophylaxis improves birth outcomes in pregnant women 
living in highly endemic areas (Geelhoed et al, 2001; Ndgomugyenyi et al, 2000). However, the 
main difficulty is implementing this on a wider scale (Greenwood, 2004). Evidence supports the 
fact that the effect of IPTp is greatest in the first pregnancy, possibly because primigravidae are 
comparatively more vulnerable to malaria as explained by Whitty et al (2005). Moreover, trials 
that confirmed the efficaciousness of IPTp with SP took place in settings where rates of 
resistance to SP were moderate or low. However, the effect of SP as IPTp is reduced in those 
women with HIV co-infection. 
It is now national policy in Kenya and Malawi, as well as Tanzania, to give SP as IPTp. There 
were recommendations that this could be done through existing antenatal clinics (WHO, 2002). 
The 20th Malaria Expert Committee designated using an efficacious, preferably single-dose, 
anti-malaria drug as the preferred approach to reduce the adverse consequences of malaria in 
pregnancy (WHO, 2002). Antenatal clinics have been identified as the best institutions for these 
interventions (Schultz et al; 1995; Meek and Webster, 2001; Wolfe et al, 2001; WHO, 2002). 
Although the benefits of IPTp on women of lower parity are not in doubt, evidence of the 
benefit of preventative strategies in multigravidae remains unclear. One of the reasons for this is 
most of the previous trials limited recruitment to primigravidae, secundigravidae or both, and 
there are no known large studies on IPTp for women of more than gravidity two. Pregnant 
women and children who have not yet developed immunity are at high-risk of malaria in 
endemic areas of Sub-Saharan Africa (Clarke, 2001). Therefore, protection of this group to 
reduce the risk of exposure to mosquito bites and malaria constitutes an important part of 
malaria prevention. 
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Malaria prevention depends largely on the level of individual and community awareness of the 
danger of malaria, time and income available for prevention activities and education of 
individuals (Koram, 1993). Koram (1993) mentioned other measures such as screening houses, 
building of houses away from breeding grounds, proper disposal of cans and filling of pits 
around dwellings, clearing vegetation along edges of water bodies, and clearing ditches with a 
view to reducing the suitable breeding grounds for mosquitoes. In The Gambia, both expatriate 
and the local population have used bednets for over a century (Aikins et al, 1993; Greenwood 
and Pickering, 1993). A study in rural Gambia on the measures families take against mosquito- 
bites revealed that 90% used bednets (Clarke, 2001). Other protection measures combined with 
the use of bednets include local repellent `churai' (55%) and mosquito coils (22%) (Aikins et al, 
1993). Churai is a local insence, which women use in houses to repel mosquitoes. IPTp on the 
other hand has not been a policy in The Gambia prior to 2003. 
3.7 ECONOMIC EVALUATION OF MALARIA INTERVENTIONS IN 
DEVELOPING COUNTRIES 
The objective of this section is to review the available empirical literature on economic 
evaluations of malaria in pregnancy in SSA. The studies included involve economic 
evaluations, which involve the assessment of alternative treatments and control of malaria in 
pregnant women. The results are expressed in United States Dollars (USD). Seven peer- 
reviewed studies that have examined the cost-effectiveness of chemoprophylaxis or IPTp 
include those done by Heymann et al (1990), Helitzer-Allen et al (1993), Schultz et al (1995), 
Schultz et al (1996), Goodman et al (1999b), Wolfe et al (2001) and Breman et al (2006) (see 
Table 3.3). By using a decision-analysis model to assess the cost-effectiveness of anti-malarial 
intervention on a hypothetical cohort of 10,000 women in Malawi, Schultz et al (1995) reported 
a cost-effectiveness ratio of $9.66 (1992 prices) per case averted. Other less cost-effective 
regimens were $62.01 and $113.05 per case of LBW averted. The number of cases of LBW 
prevented by two consecutive doses of Sulphadoxine-Pyrimethamine (SP/SP), a dose of 
Sulphadoxine-Pyrimethamine followed by a dose of Chloroquine (SP/CQ) and two consecutive 
doses of Chloroquine (CQ/CQ) regimens were 205,59 and 30, respectively, with a cost per 
death averted of $81, $522 and $950. Another study in the same setting reported a cost per 
LBW death averted of $75 for two treatment doses of SP, compared with $481 for an initial SP 
dose followed by weekly CQ or $542 for two doses of chloroquine (Schultz et al, 1996). 
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Table 3.3 Summary of economic evaluations of malaria in pregnancy in Sub-Saharan Africa 
Author(s) Areas studied Intervention Cost per LBW case Cost per Cost per 
averted LBW death DALY averted 
averted 
Heymann et Malawi (1986 prices) 
al (1989) - $10.87 - - 
Helitzer- Malawi 3 different CQ + OHE-$1.67 
Allen et al intervention to CQ + NHE-$1.27 - - 
(1993) increase compliance CCQ +OHE-$1.20 
to chemo ro h taxis CCQ +NHE-$1.48 
Schultz et Malawi, 1992 costs Antenatal treatment 
al (1995) from other studies and $9.66 $81 ($79-352) 
chemoprophylaxis $62 $522($212- 
SP/Sp $113 812) 
SP/CQ $950 ($317- 
C /CQ 951) 
Schultz et Malawi SP/SP, $75 
al (1996) SP/CQ - $481 - 
C /C $542 
Goodman et SSA 2 doses (SP) $14-S29 
al(1999b) 
Wolfe et al Kenya (HIV HIV prevalence 
(2001) prevalence at least <10% (2 doses) $11 - - 
10% and less than 
10% 
HIV prevalence $14 - - 
>I 0% (monthly) 
Breman JG SSA IPTp with SP - ICER= $13 per 
et al (2006) including additional DALY averted 
doses for HIV (range $9-21) 
positive women Total cost = 
$24 
per DALY 
averted (range 
16-35 
In Malawi, Heymann et at (1990) chose four antenatal sites, two in a seasonal malaria area, and 
two in an area where malaria was present throughout the year, in order to assess compliance. 
For the 802 participants enrolled, protective efficacy for parasitaemia was 23% on first visit and 
8% on return and the cost of preventing Plasmodium falciparum was $10.87 per LBW case 
averted (1986 prices). Poor compliance due to bitter taste and short frequency of taking the 
dose 
(weekly) were given as the key reason for the high cost. If compliance was raised to 80%, the 
cost would be $1.09 per case prevented. Helitzer-Allen et al (1993) evaluated the cost- 
effectiveness of three different interventions (each comprised of a health education message and 
an anti-malarial drug) designed to increase compliance to the chemoprophylaxis programme 
compared with the base case. Compliance rates were 57%, 87%, 91% for interventions 1-3, 
respectively, against the base case of only 25%. The cost per compliant woman was $2.15 with 
the original practice. 
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This subsequently dropped to $1.64 per compliant woman for the new health education 
campaign alone and to $1.55 for the new health education message with the coated tablets. The 
costs per LBW case averted are shown in Table 3.3. A study comparing three different IPTp 
regimens with febrile case management using SP, for a hypothetical cohort of 10,000 pregnant 
women in Kenya, revealed that a two-dose SP regimen in an environment where HIV 
prevalence is 10 or less is a cost-effective strategy for preventing LBW, at $11 (two doses) and 
$14 (monthly doses) per death averted (Wolfe et al, 2001). 
Each of the above four studies were summarised in a review by Goodman et al (1999a) and the 
fifth in a recent review by Worall et at (2007). The review by Goodman and her colleagues 
aggregated the available data to derive the incremental cost-effectiveness of incorporating an 
intervention (i. e. SP intermittent treatment) into an existing structure of antenatal care, estimated 
at between $4-29 per DALY averted. The average cost-effectiveness in a very low-income 
country with high transmission was estimated at $13 per DALY averted. Of particular relevance 
to this study was the finding that using intermittent treatment rather than weekly 
chemoprophylaxis improves compliance, and in turn, cost-effectiveness. The findings of 
Breman et al (2006) summarised by Worall et at (2007) is not different from those of Goodman 
and colleagues. 
Although attempts were made by these studies to shed light on issues of the cost-effectiveness 
of alternative interventions for controlling maternal malaria, the sample sizes for some studies 
were too small to reliably generalise their finding to other settings. These studies included all 
pregnant women and were not restricted to primigravidae or multigravidae. Except for 
Goodman et a] (1999a), all of the studies estimated cost per case averted and the costs 
considered were mainly incurred by the provider. In all cases, no costs were estimated for 
patients. 
3.8 VARIATIONS IN COST-EFFECTIVENESS OF INTERVENTIONS BETWEEN 
MULTIGRAVIDAE AND EARLIER PREGNANCIES 
Malaria in pregnancy is less severe as pregnancies progress, so in theory an intervention that has 
a significant effect in a first pregnancy may not have an effect in a fourth or fifth. Empirical 
evidence in eight countries in SSA showed that primigravidae had higher prevalence of 
peripheral and placental malaria infection compared to multigravidae (see Section 3.3 for 
details). The difference between those infected in terms of mean haemoglobin levels were more 
marked in primigravidae than multigravidae. 
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No reasons have been advanced for this but it is believed that immunosuppression is more 
marked in primigravidae and also the possibility that protective immunity could be acquired in 
the placenta through malaria infection during the first pregnancy thereby reducing susceptibility 
in subsequent pregnancies (see Section 3.3 for details). Studies in Malawi report that IPTp with 
SP reduces LBW in primigravidae but not in multigravidae. The result of a trial with 
chemoprophylaxis for women of all parities in The Gambia and Nigeria found an improvement 
of birth weight for those who received chemoprophylaxis with primigravidae (see Section 3.5 
for details). 
However, the greatest effect on birth weight was found in primigravidae and women of at least 
gravidity four. In light of the differences in malaria prevalence and effectiveness of IPTp 
according to the number of pregnancies, the cost-effectiveness is also likely to be different for 
primigravidae, secundagraviade and multigravidae. Given that many pregnancies in Africa are 
to multigravidae women, it may be cost-effective to have a programme for first and second 
pregnancies, which is not cost-effective for subsequent pregnancies. 
Although IPTp with SP is recommended for women of all gravidae, there is however little 
evidence to support its use in multigravidae as there is no known previous trial that has 
specifically addressed the effectiveness of SP as IPTp for this group of women. While IPTp 
with SP has been shown to be highly cost-effective for primigravidae, the effect on cost- 
effectiveness of introducing to multigravidae remains untested. 
3.9 SUMMARY 
This chapter reviews literature on malaria in pregnancy and its effects on LBW and anaemia. 
The distribution of LBW and anaemia has also been outlined. In terms of economic evaluation 
in this area, relatively few published studies are available. Many of the existing studies suffer 
from small sample sizes, which limit the generalisability of results to other settings. Almost all 
the studies took the provider perspective and omitted important costs to patients and their 
families, the inclusion of which could change the policy conclusion. Moreover, as pointed out 
by Goodman et al (2000), many of the studies narrowly defined cost as only drug costs and 
failed to take into account additional costs normally incurred by health services with respect to 
service delivery. All the studies reviewed focused on infants in terms of cases, deaths or DALYs 
averted from LBW. Since anaemia has been cited as one of the major causes of maternal 
mortality and morbidity, it will be revealing to consider the effects of interventions on the 
mothers too. 
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The chapter ended by outlining why interventions may be different in multigravidae than earlier 
pregnancies. The difference was mainly attributed to immunosuppression being more marked in 
primigravidae than multigravidae and the possibility of acquiring protective immunity through 
malaria infection in the first pregnancy, thereby reducing susceptibility in subsequent 
pregnancies. It ended by indicating that IPTp with SP was highly cost-effective for 
primigravidae, while its effect on cost-effectiveness for multigravidae was unproven. 
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CHAPTER 4: COUNTRY PROFILE: THE GAMBIA 
4.1. INTRODUCTION 
The main purpose of this chapter is to provide an overview of the study country, The Gambia, 
followed by a detailed description of the IPTp trial settings of the country's North Bank East 
(NBE) and Lower River Division (LRW). The chapter is divided into six sections. Section 4.2 
gives the physical (geographical and climatic) and demographic profiles of the country. Sections 
4.3,4.4 and 4.5 are devoted to The Gambia's general economic situation, showing trends and 
indicators with an emphasis on poverty and gender situations and their impacts on women. 
Section 4.6 looks at the health system in general, highlighting the health infrastructure including 
antenatal and obstetrics care and the health care financing system. Section 4.7 describes the 
study location of NBE and LRD and gives reasons for the selection of these study sites. The 
chapter ends with a brief summary in Section 4.8 
4.2. PROFILE 
The Gambia is a small sovereign state in West Africa with a land area of 10,689 square 
kilometres. The country varies in width between 42 kilometres near the mouth of river Gambia 
to 24 kilometres further upstream and stretching about 480 km in length. As illustrated in Figure 
4.1, The Gambia is located at the west coast of Africa between latitudes 13. ON and 13.7N and 
longitudes 13.7W and 16.0W. The country is divided into two by the River Gambia that runs the 
entire length, from the Futa Jallon highlands in the Republic of Guinea to the Atlantic Ocean. 
The river, including its swamps and creeks, covers one third of the surface area of the country 
(approximately 2075 sq. km). Its flow is low during the dry season bringing about saline 
intrusion up to 248 km upstream and the saline interface is flushed down to 150 km during the 
rainy season. The Gambia is bordered on all sides by the Republic of Senegal, except for the 
western part, which faces the Atlantic Ocean. 
The climate is typically Sudano-Sahelian with a long dry season from November to May and a 
short rainy season from June to October. During the dry season, Harmattan winds blow from the 
Sahara desert, resulting in cool but dusty weather. There has been a general decline in rainfall 
over the past two decades, but improvements have been recorded in the latter part of the 1990s. 
Average annual rainfall ranges from 800mm in the east to 1,700mm in the west. The maximum 
temperature in the coastal area during the rainy season is about 32°C with daily minimum 
temperature ranging from 18-24°C (WHO, 2003; UNDP, 1999). 
87 
0 2% 'A tm 
O P. 60 np 
SENEGAL 
MIMI 
Allar "r": 
(h: eil' Sukuta. 
" Farafenni ßeorgelawn 
BANJUL 
Serekunaa' -" 
Mansa Konko 
Basso' 
8r, kama Santa Su 
ti INfA 
uINLn-BIS, n 
Figure 4.1 Map of the Gambia depicting the study areas of NBE and LRD 
Source: Financial Sustainability plan of EPI Programmes, (DoSH, 2003). 
The daily maximum temperature varies from 10°C during the dry season to 45°C in the rainy 
season and the humidity for the two periods ranges from 40-80%. The land is mainly low lying 
and flat, varying from sea level at the coastal area to a maximum elevation of 36m in the 
interior. The country is covered with tropical forest, mangroves and savannah woodland along 
the river and the western part (WHO/DoSH, 2005). The nature of the climate makes The 
Gambia attractive to tropical diseases such as malaria. 
4.2.1. Politics and demographic profile 
The Gambia attained internal self-government in October 1963 and full independence on 18 
February 1965. Republican status was gained in 1970 with Sir Dawda Kairaba Jawara as the 
first President, a post he held until July 1994 when he was overthrown through a military coup. 
The country was later returned to civilian rule in 1996. 
There are five administrative divisions, Western, Lower River, North Bank, Central River and 
Upper River; each administered by a Divisional Commissioner now called Governor (Figure 
4.1). In addition to the five divisions, there is Kanifing municipality, which is called Kombo St. 
Mary's division and Banjul. The administrative decentralisation of the country is currently on 
the drawing board and most of the reforms that need to go with it are yet to be effected. The 
1993 health reforms resulted in the devolution of administration to six Divisional l lealth Teams 
(DHTs). However, one fundamental aspect lacking with the Dill administration is autonomy 
with respect to budgetary matters, which are still centralised. 
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The provisional results of the 2003 National Population and Housing Census of The Gambia put 
the total population at 1,350,032 (see Table 4.1), with an annual growth rate of 2.8% (CSD, 
2003). This was a reduction from the 1993 growth rate of 4.2%. The gender mix is roughly 
equal, with 49.6% of the population male. Recent figures are not available but foreign nationals 
accounted for 13.7% of the population in 1993. The high in-migration was due to instability in 
the sub-region. The population density was estimated at 127 persons per square kilometre in 
2003 (CSD, 2006). The Greater Banjul Area, which comprises the capital, Banjul, the adjoining 
Kanifing municipality and surrounding towns, has 52% of the population. The distribution of 
the 1993 population by DHT shows that 29% lived in the Western Division, 5% in the Lower 
River Division, 13% in the North Bank Division (6% in North Bank West and 7% in North 
Bank East), 14% in the Central River Division and 13% in the Upper River Division. Twenty 
six percent (26%) of the population lived in urban areas whilst the rest live in rural areas 
(UNICEF, 2004). According to the WHO (2003), the life expectancy for the total population of 
The Gambia was 57 years in 2003; 56 years for males and 59 for females. 
Table 4.1 Population and number of health facilities by health division 
Source: Adapted from 2003 Census report & Public Expenditure Review (DoSH, 2001 a) 
4.2.2. Ethnicity and religion 
The main ethnic groups in The Gambia are Mandinka (35.65%), Wolof (13.23%), Fula 
(17.02%), Jola (9.38), Serahuli (7.3%), Serere (2.26%), Manjago (1.6%), Aku (0.73%) and 
Bambara (0.44%) (CSD, 1993). Ninety-five percent of the population practise Islam as their 
religion whilst the remaining 5% comprises mainly Christians and other faiths. The typical 
African extended family system is very apparent in The Gambia and families normally live in 
neighbouring houses in close proximity of a `compound'. A compound is a congregation of 
houses often fenced off from farming and grazing areas (WHO/DOSH, 2005). 
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4.2.3. Fertility and mortality 
The total fertility rate (TFR) is at 5.1 children per woman, and has declined by around 16% 
from 6.04 in the last three decades (1993-2003) (CSD, 2004). The Crude Birth Rate has 
decreased from 46/1000 in 1995 to 36/1000 in 2003. This rate is expected to drop further due to 
the high contraceptive prevalence rate experienced recently (i. e. 12% in 1990,17.5% in 2001). 
The mortality trends show a downward movement with the crude death rate estimated at 13 per 
1000 persons in 2003, down from 19 per 1000 persons in 1993. The high fertility rate and low 
life expectancy have resulted in a very youthful population structure. From the 1993 census, 
nearly 45% of the population was below 15 years and 19% between the ages of 15-24 years 
(CSD, 1993). Those aged 0-14 constituted 44% of the total population (45% of males and 44% 
of females were under 15 years). The 0-4 year age bracket constituted 17% of the population for 
the period 1973-1993. 
4.3. THE ECONOMY 
The Gambia is one of the least developed countries in the world with a GDP per capita 
estimated at $318 (UNDP, 2004). The country experienced a serious economic downturn 
between 1975 and 1985, with the rate of real GDP growth averaging below 3% per annum. The 
performance of the economy worsened during the latter part of this period, such that by early 
1985, the underlying internal and external imbalances had assumed major proportions owing to 
a combination of adverse factors such as expansionary financial policies, inappropriate 
exchange rates and other pricing policies (WHO/DoSH, 2005). 
In order to arrest the situation, in 1985 the government adopted a comprehensive medium term 
Economic Recovery Programme (ERP). The policy measures, although effective in reversing 
the declining economic trend, also led to a significant reduction in government expenditure on 
health and education, which had serious consequences for low-income earners. Adjustments had 
to be made to ameliorate the conditions of the poor, hence the launching of Programme for 
Sustained Development (PSD), which aimed at consolidating the economic gains of the ERP as 
well as focusing on concerns of the vulnerable groups. 
The average GDP per capita growth rate from 1990-2003 averaged 0.1% and the inflation rate 
was estimated at 17.6%. The total external debt for the same period was $615 million. The 
exports for the year 2003 totalled $102 million and imports were $116 million leading to a 
Balance of Payment (BoP) deficit of $14 million. The Gambian economy is largely dependent 
on agriculture, which employed around 57% of the labour force and accounted for about 25% of 
GDP during the period 1990-2003. 
90 
Agriculture is the source of livelihood for around 80% of the rural population. Since the 1990s, 
the service sector - including tourism - has emerged as a potential source of rapid growth for 
the economy, surpassing agriculture and contributing around 64% of GDP during the period. 
The industrial sector, made up of manufacturing, construction and utilities sub-sectors, 
remained at 11 % of GDP (Personal Communication, Director of Policy Analysis, The Gambia). 
4.4. POVERTY 
According to the National Household Poverty Survey Report, 69% of the population, mainly 
women, lives below the poverty line (CSD, 1998), with 59% of the population living on less 
than $1 a day. The income per capita is four to five times higher in the urban than the rural 
population and extreme poverty more than doubled between 1992 and 1998 in all divisions 
(UNDP, 1999). More than half (51%) of Gambians lived in abject poverty in 1998 and the 
incidence of extreme poverty was highest among the groundnut farming socio-economic group. 
Lower River, Central River, and Western Divisions are the poorest and extreme poverty is 
highest in Upper River followed by Lower River and North Bank Divisions. Poverty is a 
fundamental cause of household food insecurity and consequent under-nutrition (CSD, 1998). 
An International Labour Organisation study found that 3% of urban households and 38% of the 
urban population were food poor, while in rural areas, 37% of households and 54% of the 
population were also categorised the same. The adult literacy rate (15 years and above) was 
37%, with men at 44.5% and women at 26.9% (WHO/DoSH, 2005). The enrolment ratio for 
Lower and Upper Basic Education, including Madrassa (Islamic schools), was 75% and 72% 
respectively. In rural areas, 20% of men and 6% of women were literate. The gross enrolment 
ratio at primary school for girls was 75% from 1998-2002 and the ratio for boys for the same 
period was 82% (WHO/DoSH, 2005). 
4.5. GENDER ISSUES 
Traditional roles of women are still recognised in The Gambia and gender inequality in the 
society is largely unchallenged, having been reinforced by illiteracy and cultural practices 
(WHO/DoSH, 2005). Many traditional customs have a gender element with implications for the 
health of pregnant women and teenage girls, particularly in rural areas. Early-age marriages and 
low-age at first birth are both contributing factors to high fertility levels, lower rate of girls' 
education and poor participation of women in economic activities. As a result, when compared 
to boys, girls have limited opportunities to proceed with their education or to access various 
formal and informal avenues (WHO/DoSH, 2005). 
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Apart from early marriage, traditional and religious misconceptions of family planning, food 
taboos, high illiteracy, low status of women and harmful traditional practices such as female 
genital mutilation continue to have a negative impact on women (WHO/DoSH, 2005). 
4.6. HEALTH SYSTEM 
The health policies in The Gambia since 1979 have placed emphasis on the Primary Health Care 
strategy (PHC). The current National Health Policy, entitled "Changing for Good", was 
formulated in 2001 and the vision of the policy is the attainment of accessible quality health 
care for the Gambian population (DoSH, 2001). Health services are delivered in facilities 
funded by government, non-governmental organisations (NGOs) and private practitioners. 
There are 38 public health facilities at secondary and tertiary levels and 48 private/NGO 
facilities in The Gambia. Although no data are available on the proportion of health services 
delivered by each of these groups, 30% of the public health care facilities and 73% of 
private/NGO facilities are located within the Divisional Health Team (DHT)-Westem (i. e. 
Greater Banjul area which is mainly urban, and Brikama) (DoSH, 2001). However, it must be 
emphasised that private health facilities are smaller than public facilities. In addition, a large 
number of pharmacies, drug sellers and traditional medical practitioners exist throughout the 
country. 
The public health service delivery structure in The Gambia is a three-tier system based on the 
primary health care (PHC) strategy, with emphasis on preventive rather than curative care and 
with a clear-cut referral system. There are four hospitals, 34 secondary level facilities and 447 
health posts spread throughout the country (see Table 4.1). Access to antenatal services is good 
compared to many other Sub-Saharan African countries but still remains irregular and low 
compared to developed countries (DoSH, 2001). The average travel times to and from public 
health facilities are 72 minutes on foot, 80 minutes by vehicle, 243 minutes part foot and part 
vehicle, 82 minutes by cart and 54 minutes using other modes of travel (DoSH, 2001). The 
longest time taken to reach health facilities on foot was 97 minutes in Western Division (part 
urban and part rural) which translates into an average walking time of less than 50 minutes each 
way. It takes 62 minutes to walk to and from health facilities in exclusively urban areas (Banjul 
and Kanifing Municipal Council (K. M. C)), 57 minutes in exclusively rural areas (DoSH, 2001). 
Ninety-four percent of women attend antenatal care at least once, with an average of 3.4 
attendances for the entire duration of a pregnancy (Cham, 2003). The multiple roles and time 
constraints faced by women compared to men, potentially deter them from using health services 
(DoSH, 2000). 
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The primary level or Village Health Services (VHSs) are made up of 447 PHC villages with 
health posts and form the lowest level of health care delivery. Generally, PHC villages in The 
Gambia have on average 400 inhabitants and are staffed by a trained Village Health Worker 
(VHW) and a Traditional Birth Attendant (TBA). While the VHW maintains the supply of 
essential drugs, provides outpatient care, makes home visits and carries out health education, the 
TBA conducts deliveries, and identifies and refers at-risk mothers to the nearest health facilities 
(DoSH, 2001). Both VHWs and TBAs are supervised by a Community Health Nurse (CHN). 
Each CHN supervises at least five PHC villages and the CHNs are themselves supervised by the 
head of the nearest health facility and the DHT. Between 60-80% of the population at the 
divisional level live within the catchment area of VHS and 90% live within a radius of 7.5 km 
of a health facility, while 80% live less than an hour's travel time from the facility (DoSH, 
2001). The majority of villages in the Western division are PHC villages, while only one in six 
are in North Bank settlements such as North Bank Division, northern parts of Central River 
Division (CRD), and Upper River Division (URD). These settlements have poorer access to 
health facilities, which is further exacerbated by poor transport infrastructure (DoSH, 2001). 
Establishing a settlement as a PHC village requires the village to have a population of at least 
400, identification of VHW and TBA by the villagers, setting up of a Village Development 
Committee (VDC) and provision of the initial drugs supply worth D500 by the DoSH. 
Therefore, the delay in the expansion of PHC facilities in all villages throughout the country is 
hampered by the small size of most of the villages and the complexities in managing big towns. 
Further, having more PHC villages would entail the training of more CHNs to supervise them, 
with attendant investments in motorcycles and supervisory vehicles. It may also require building 
more health facilities for referrals since PHCs are supposed to be close to such health facilities. 
One of the main problems at the community level is the inability of communities to organise 
themselves into groups. Finally, with the coming of the Cuban Technical Assistance 
Programme, the staff posting is not strictly adhered to as doctors and qualified nurses are posted 
to lower level facilities including PHC facilities. There has been a 67% increase in the number 
of doctors between 1997 and 2001, which led to a large number of these doctors being posted at 
every level in the public health system (DoSH, 2001). The same report showed that one in 10 
doctors work at the primary level in villages. 
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Secondary level services (Basic Health Services) comprise six major health centres (UNDP, 
1999), 12 minor health centres and 16 dispensaries (DoSH, 2001). Centres are classified 
according to the type of health services they provide. Amongst them, major health institutions 
provide the highest standard of care and are staffed by doctors, State Registered Nurses (SRNs) 
and State Enrolled Nurses (SENs) as well as other technical staff such as laboratory 
technologists and pharmacists. Minor health centres have a similar staff profile as major health 
centres but without medical doctors. Dispensaries are staffed by SENs and CHNs. Complicated 
illnesses are referred from dispensaries and minor health centres to the major health centres and 
eventually to hospital if need be. Although the number of secondary care facilities has remained 
stagnant over the past 15 years, many have been upgraded during the period. Four public 
hospitals currently provide tertiary services. These are; Royal Victoria Teaching Hospital 
(RVTH), Bansang Hospital, Armed Forces Provisional Ruling Council Hospital (AFPRCH) and 
Bwiam Hospital. There are also a couple of other private and NGO hospitals. The construction 
of one more hospital in Serrekunda is at an advanced stage. 
Forty percent of the Department of State for Health (DoSH) labour force, including nearly 80% 
of its doctors and the majority of qualified SRNs and SENs, are employed in tertiary facilities. 
While almost all nurses and environmental health officers in the country are Gambians, less 
than 10% of the doctors are nationals of that country (DoSH, 2001). Almost all the medical 
doctors working in The Gambia come from Nigeria, Cuba and Egypt through bilateral 
assistance programmes. In addition to government health facilities, there are many NGOs 
participating in the provision of health care in The Gambia. Some are faith based, while others 
are local branches of international NGOs which together run 15 health facilities, including 
Medical Research Council (MRC) facilities in different parts of the country. Unlike NGO 
facilities, the bulk of the private health facilities are concentrated mainly in the western area. 
In terms of public-private mix, the DoSH has outsourced the provision of transport for its 
activities to an international NGO called Riders for Health (RFH), which is paid an agreed cost- 
per-kilometre for use of health vehicles (WHO/DoSH, 2005). Traditional medicine is 
increasingly being recognised, and 4% of the people who reported ill/injured two weeks prior to 
the 1998 National Household Poverty Survey consulted traditional healers (CSD, 1998). This 
prompted health authorities to formally recognise and incorporate traditional medicine into the 
new health policy. Use of public outpatient health services were 33% hospital and 67% basic 
health services. The corresponding proportions for public inpatient (IP) services were 44.8% for 
hospitals and 55.2% for basic health facilities (DoSH, 2001). 
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Malaria is the number-one cause of morbidity and mortality in The Gambia (DoSH, 2001). 
According to a report on selected health indicators, the top seven causes of morbidity and 
mortality in under-fives are malaria, pneumonia, anaemia, malnutrition, sepsis, low birth 
weight, trauma and burns (DoSH, 2001). About 40%-60% of the total outpatient department 
(OPD) consultations in 1999 were due to malaria, while acute respiratory tract infections 
accounted for 25% (DoSH, 2001). 
The infant mortality rate was 84/1000 live births in 2001 (NaNA/MRC, 2001) and 75 in 2003 
(CSD, 2006). The under-five mortality rate was 123/1000 in 2003. The child immunisation rate 
was above 80% in 2003. The country has been certified as polio-free by the Africa Certification 
Committee. Approximately 19% of all newborns had a low birth weight (less than 2500gm) 
(DoSH, 2001) and a survey conducted by the National Nutrition Agency (NaNA) reported that 
only 3.7% of children under five were within the expected weight for height (NaNA/MRC, 
2001). 
The nationwide survey on the prevalence of Vitamin A and iron deficiency in women and 
children in The Gambia found that 73% of pregnant women showed moderate anaemia and 5% 
showed high-risk anaemia (NaNA/MRC, 2001). Iron deficiency anaemia was common among 
pregnant women and was said to be a major contributor to the high maternal mortality rate. The 
maternal mortality rate was 730/100,000 live births in 2001, a decline from the 1990 figure of 
1,050/100,000 live births (DoSH, 2001). For women pregnant or in labour, the most important 
causes of morbidity and mortality are malaria, anaemia, haemorrhage, pre-eclampsia, sepsis, 
and ectopic pregnancy. The proportion of maternal mortality was highest for women less than 
20 years and above 40 years and varies between the various regions of the country. The HIV 
prevalence rates were only 1.1% for HIV I and 0.6% for HIV 2 (DoSH Sentinel Bulletin, 2005). 
4.6.1. Antenatal and basic obstetrics care 
Antenatal care in The Gambia is part of the Maternal and Child Health (MCH) programme and 
is part of routine health activities at the primary care level. Antenatal care shares a lot of 
common resources with other basic health interventions at the health facility level. The clinics 
are run from base facilities, which range from dispensary to minor and major health centres 
located in various parts of the country. In order to complement the work of base facilities in 
MCH including ANC, outreach clinics are held every month in the remote rural villages by 
MCH teams. The team comprises one State Registered Nurse Midwife (SRNM), one State 
Enrolled Nurse (SEN) General, one Community Health Nurse Midwife (CHNM), two 
Community Nurse Attendants (CNAs), one Senior Health Superintendent (SHS) and a driver. 
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The team uses an ambulance at the base facility to travel to these outreach facilities on a 
monthly basis. In terms of roles, the SRNM is responsible for ANC and is assisted by the 
CHNM and one of the CNAs. The SEN and one of the CHNMs are responsible for the Infant 
Welfare Clinic. Outreach services are necessary because base health facilities are usually 
located at comparatively high population centres at the expense of the rural communities. 
Outreach health facilities do not have any resident health staff, but locally recruited Traditional 
Birth Attendants (TBAs), who are trained in basic health care and operate on a voluntary basis. 
They are sometimes located in key primary health care villages. TBAs are assisted by 
government employed CHNs. Due to the decentralisation of the health system, Divisional 
Health Teams (DHTs) are responsible for monitoring and supervising all basic health facilities 
and they are also expected to visit each facility, including outreach facilities, at least once every 
month. 
According to results of the Safe Motherhood Needs Assessment of The Gambia (DoSH, 1999), 
51.6% of health facilities, including all hospitals and major health centres, provided 24-hour 
maternity services including at weekends. About 36% of the facilities had a 24-hour on-call 
service for complicated deliveries, but only 6.25% had on-call services for obstetric surgery. 
Overall, 45% of health facilities provide basic obstetrics care while only 20% provide caesarean 
section and blood transfusion. Access to these services is highest in areas where the hospitals 
are located. 
A client flow study conducted for DoSH in 2000 by Frances Foord et al reported that the task- 
orientated nature of midwives work in antenatal clinics contributed to many women receiving 
inadequate level of care (DoSH, 2000). ANC is jointly organised with Infant Welfare Clinics in 
all levels of the health delivery system except for hospitals. Out of the 24 clinics, 23 provided 
antenatal services alongside infant welfare services. In most of these clinics it was reported that 
women saw between 2-4 staff members, or up to seven when they registered for the first time. 
The average total contact time with an individual woman, excluding vaccinations and laboratory 
tests, was 6.66 minutes and the range time spent at the clinic was 4-261 minutes (DoSH, 2000). 
Women receiving holistic care had more time with the lead midwife and spent less time in the 
clinics; 69.7 minutes compared to 119.8 minutes for those receiving fragmented care. Where 
haemoglobin estimations took place, it took between 24 and 50 minutes at major health centres. 
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4.6.2. Health care financing 
The sources of health expenditure are mainly government, donors and to a limited extent, 
households. Total government expenditure for health was US$6 million for the recurrent 
expenditure in 2003, and US$4.86 million for the development budget. Total public expenditure 
on health as a percentage of GDP was 7.9% in 2003 and 8.1% in 2004 (WHO, 2006) and per 
capita total health expenditures (average 2003 and 2004 US Dollar exchange rate) was $21 each 
for 2003 and 2004. In addition, the health sector received a total of US$1.33 million from the 
Highly-Indebted Poor Countries (HIPC) resources in 2003. General government expenditure on 
health as a percentage of total health expenditure was 40% in 2003 and 2004 (WHO, 2006). 
External resource as a percentage of total health expenditure was 22% (WHO, 2006). The 
proportion of the public health budget (both recurrent and development) spent at PHC level was 
22.3%, with 28.6% at secondary level, 28% at central level including subvention to the tertiary 
hospitals, 6% on pharmaceuticals and 42% on the development budget (WHO/DoSH, 2005). 
The rest of the budget was divided between the national laboratories, health training schools and 
maintenance of the physical infrastructure. The recurrent public health expenditure as a share of 
the total government expenditure excluding debt servicing ranged from 10.8 -13.4% in 2003. 
The details of the rest of the financial indicators are in Table 4.2. 
Table 4.2 Health Financing Indicators 2003 - 2004 
Indicator 2003 2004 
GDP 10,026 12,036 
THE 809 953 
GHE 324 383 
GHE. % THE 40 40.2 
P\t lIE 485 570 
PvtHE % THE 60 59.8 
of Pvt FIE net out-of-pocket 325 380 
Out-of-pocket % THE 40 40 
External funding 176 210 
External Funding % THE 22 22 
'F[ IF per capita (at exchange rate) 21 21 
GHE per capita (at exchange rate) 8 9 
"I HE'% GDP 8.1 7.9 
Source: Compiled from WHO website and AFRO Health Report (2006) 
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Cost recovery was introduced in 1988 with the establishment of a drug revolving fund and the 
introduction of user fees. The Bamako Initiative (BI) was introduced in 1993 as a further 
development of the cost recovery programme (Bamako Initiative Strategy, DoSH, 1993). As 
part of the programme, Gambian patients pay D5 ($0.174) for each outpatient visit, registration 
at the antenatal clinic or a registration of a child at the MCH clinic. Non-Gambians pay between 
D20 ($0.70) to D50 ($1.74) for the same services. Admission per week in a public ward costs 
D25 ($0.87) in rural hospitals and D50 ($1.74) in urban hospitals for Gambians and D200 
($6.96) for non-Gambians in 2003. Admission to a private ward of a public hospital cost D750 
($26.10) per week at the RVTH. According to the household income and expenditure survey of 
1998, Gambians were willing to pay an average. of D35 ($1.22) per private health consultation, 
D54 ($1.88) per private clinic visit, D168 ($5.85) per private hospital visit and D70 ($2.44) per 
traditional healer consultation (CSD, 1998). 
4.7. THE STUDY LOCATION 
The study took place in the two trial sites, Lower River Division (LRD) and North Bank East 
(NBE) Divisional Health Teams (DHTs) and involved 14 antenatal clinics. The two Health 
Districts (NBE and LRD) chosen for the trial are on the opposite banks of the River Gambia 
(see Figure 4.1). 
4.7.1 North Bank East 
The North Bank is located in the northern part of the River Gambia. It stretches from the 
Atlantic Ocean in the West and is bordered by Senegal in the North and Central River Division 
in the East. NBE comprises the three chieftaincy districts of Lower, Central and Upper Badibu. 
A Chieftaincy District is an area administered by a traditional ruler called a chief. The length of 
the whole division is estimated to be around 130 kilometres whilst the width varies from 7.5 
kilometres to 28 kilometres (DoSH, 2001a). It is divided into two administrative health 
divisions, with headquarters in Essau (DHT-West) and Farafenni (DHT-East). The Divisional 
Health Teams supervise health services within each health division. Primary and secondary 
health services are delivered mainly through PHC posts, and health facilities funded by the 
government, private organisations and NGOs. 
The population of North Bank East (NBE) is estimated at 85,525 according to the provisional 
results of the 2003 population census as in Table 4.1 (CSD, 2003). 
° The USD equivalent was calculated using the average end of year (2003) money exchange rate of D28,7344 to $1.00 The USD 
equivalent of other amounts are in parenthesis 
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This represents an increase of 42% over the decade (1983-1993). The annual growth rate is 
estimated to be around 3.2%, i. e. 1% less than the national figure of 4.2% (CSD, 1993). Among 
the five provincial divisions in the country, the North Bank as a whole is the second most 
densely-populated, reaching a level of 68 persons per sq. km (1993 census). Commercial 
activities are more pronounced in Farafenni in Upper Badibu. The main ethnic groups are 
Mandinka (49%), Wolof (24%), Fula (20%), Jola (2.8%) and Serer (2.0%). About 14% of the 
population are non-Gambians, mainly from Senegal, Guinea Conakry, Guinea Bissau, 
Mauritania, etc. The main economic activities of NBE include subsistence farming, gardening, 
livestock rearing, fishing, tourism and petty trading. 
4.7.2. Lower River Division 
The LRD stretches from Burumang Bridge to Pakaliba, with Western Division to the West and 
the Central River Division to the East. It is bound on both the north and south by one of the 
regions of Senegal, Cassamance. LRD comprises the six chieftaincy districts of Kiang East, 
Central and West; and Jarra East, Central and West. It has one administrative health division, 
with headquarters in Mansakonko. The Divisional Health Teams supervise health services 
within each health district. Primary and secondary health services are delivered mainly through 
PHC posts, and health facilities funded by the government, private organisations and NGOs. 
The population of LRD is estimated at 72,546 according to the provisional results of the 2003 
population census as in Table 4.1 (CSD, 2003). The annual growth rate is estimated to be 
around 1.67% (CSD, 1993). Commercial activities are more pronounced in Soma but a weekly 
Lumo is held in Bureng and Kwinella. Lumo is a weekly local market where rural people meet 
to buy and sell goods. The main ethnic groups are Mandinka (70.3%), Wolof (2.5%), Fula 
(20.9%), Jola (1.3%), Sarahuleh (3%), Serer (0.4%) and the rest represent other minor ethic 
groups. The main economic activities of LRD include subsistence farming, gardening, livestock 
rearing, fishing, tourism and petty trading (CSD, 1993). 
4.7.3. Appropriateness of study area 
The study area is an appropriate representation of a typical rural setting in The Gambia where 
formal employment for women is almost non-existent. The women in these areas are mainly 
involved in subsistence farming and household work. The results of the nationwide survey on 
maternal mortality (DoSH, 2001) revealed that maternal mortality is higher in one of these two 
regions (LRD), and is second only to CRD in the whole of The Gambia. Furthermore, according 
to the National Household Poverty Survey Report (CSD, 1998), LRD and CRD are ranked as 
the poorest regions in the country. 
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Therefore, conducting such a study in this area can provide information on the underlying 
factors contributing to low antenatal attendance and high levels of infant and maternal mortality 
in the area. 
North Bank Division hosts the British Medical Research Council's Reproductive Health 
Research Programme. In this area, people had previously participated in trials, which may have 
resulted in them being more receptive to researchers, with a resultant positive influence on the 
response rate and quality of the responses compared to those living in other parts of the country 
without the same experience. It is perhaps useful to add that an IPTp trial and CEA study in this 
part of the country is long overdue, because after many trials in the area, this is the only one that 
incorporates an economic evaluation. 
The downside of the choice is that being attached to an ongoing trial means fewer options in 
terms of choosing the sample outside the trial. In the case of this study, since NBE and LRD 
were the bases for the IPTp trial, and the economic study was attached to that trial, options to 
choose other areas were not available. The opportunity to include other areas of the country into 
the trial would likely make the sample more representative. Furthermore, people being used to 
research could equally make them less receptive. From the experience of the candidate, certain 
villages have already started criticising researchers for taking endless samples without giving 
anything in return. However, it must be clarified that these criticisms are in the minority. 
4.8. SUMMARY 
The chapter has provided an overview of the study country, The Gambia. The physical 
(geographical and climatic), demographic profiles and the general economic situation were also 
described. Poverty and gender situations of the country and their impacts on women were 
assessed. The health systems of The Gambia in general, and with emphasis on the health 
delivery system including antenatal and obstetrics care and health care financing, were 
reviewed. The chapter ended with a detailed description of the IPTp trial settings of North Bank 
East and Lower River Division and advanced reasons for the choice of those sites. The key 
message of this chapter is that The Gambia is a poor country with low per capita income and 
poor health indicators coupled with inadequate health infrastructure. 
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CHAPTER 5: AIMS, OBJECTIVES, AND DATA COLLECTION METHODS 
5.1. INTRODUCTION 
This chapter describes the objectives, data collection and analysis methods of the study. Section 
5.2 describes the relationship of the cost-effectiveness study to the IPTp trial while Section 5.3 
presents the objectives of the IPTp trial. The specific objectives of the empirical part of the 
thesis are presented in Section 5.4. The conceptual framework used to analyse the costs and 
consequences is presented in Section 5.5. The challenges of moving from efficacy to 
effectiveness and how to tackle research and protocol-driven costs are the subject of Sections 
5.6 and 5.7 respectively. Section 5.8 closely looked at anaemia and the measurement of 
haemoglonin (Hb). The approaches and tools used in data collection, including piloting, 
sampling and data processing are described in Section 5.8. Summary of data collection methods 
used to estimate IPTp costs, treatment costs of LBW and anaemia are described in Section 5.10. 
Section 5.11 describes the valuation methods used to estimate indirect costs particularly unpaid 
household work. Sections 5.12 and 5.13 focus on health consequences and resource savings 
respectively. The incremental cost-effectiveness ratio (ICER) including sensitivity and data 
analyses is the subject of 5.14. The chapter ends with a summary in Section 5.15. 
5.2. THE RELEVANCE OF THE STUDY TO THE IPTp TRIAL 
There is good evidence that IPTp is an effective strategy to decrease the risk of moderate/severe 
anaemia and low birth weight in primigravidae (IPTp Study Protocol MRC, 2002), but there are 
no estimates on the impact in multigravidae. A randomised, placebo-controlled trial of 
intermittent preventive treatment with SP in Gambian multigravidae carried out to test this was 
a collaborative effort between the Medical Research Council (MRC) Laboratories, the 
Department of State for Health in The Gambia (DoSH) and the Gates Malaria Partnership at 
London School of Hygiene and Tropical Medicine (LSHTM). The trial duration was from July 
2002 to February 2004 involving 2,688 multigravidae in rural Gambia (i. e. SP 1,346 women 
and placebo 1,342 women) who received up to four doses of SP during the pregnancy period 
and were followed up until six week post-partum (Mbaye et al, 2006). The trial and the cost- 
effectiveness were approved by the Ethical Committees of The Gambia and London School of 
Hygiene and Tropical Medicine. 
5.3. OBJECTIVES AND DESCRIPTION OF IPTp TRIAL 
The main objectives of the IPTp trial included establishing the efficacy in multigravidae of SP 
as IPTp in a randomised-placebo controlled trial and assessing its cost-effectiveness against 
current treatment. 
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In the case of primigravidae, the trial aimed to assess the effect of using SP as IPTp in the dry 
season (January-June) and whether folate supplementation increased the incidence of treatment 
failure. The specific objectives were to: 
(1) Estimate the efficacy of intermittent SP in multigravidae in a randomised placebo- 
controlled trial on: 
(a) Primary endpoints: prevalence of post-partum anaemia and low birth weight; 
(b) Secondary endpoints: prevalence of placental malaria (sub-sample) and perinatal and 
neonatal mortality; 
(2) Determine whether to apply malaria prevention in pregnancy only during the rainy season; 
(3) Determine the cost-effectiveness and acceptability of IPTp and 
(4) Determine whether it would be beneficial to delay folate supplementation for two weeks 
following administration of SP in women receiving IPTp. 
From the above objectives, (1) and (3) are concerned with multigravidae while (2) and (4) with 
primigravidae. Since the focus of this thesis is on multigravidae, the rest of this section shall be 
restricted to that group of pregnant women. The study sample was originally estimated to be at 
least 2,688 multigravidae recruited from 14 clinics in the North Bank East health district on the 
east and west of Farafenni (8), and clinics in and around Soma on the South Bank (6). A 
fieldworker purposely recruited for the trial was based at each clinic to work with the Maternal 
and Child Health (MCH) team during the monthly antenatal clinic visits organised in the nearest 
health facility. In addition, the fieldworker made follow-up home visits to study subjects. In 
order to be considered for the trial, women had to meet the inclusion and exclusion criteria for 
the trial. The procedure was that women first went through routine antenatal examination and 
registration, before being directed to the unit of the clinic identified for the IPTp trial. The 
inclusion criteria were willingness to participate and to accept to be followed-up, being resident 
in the trial area and pregnant for at least 16 weeks but less than 32 weeks of gestation at first 
visit to antenatal clinic. Excluded were those with severe malaria, severe anaemia (Hb <6g/dl), 
obstetric complications that required admission and history of adverse reaction to sulpha drugs. 
5.3.1. Follow-up part of the IPTp trial 
The follow-up was not part of routine antenatal care in The Gambia and so all aspects of it were 
brought about by the trial. After the recruitment of the women, twice weekly home visits were 
scheduled to see whether they were ill. Those suspected of having severe anaemia at any point 
during the trial had their blood taken for haemoglobin and parasitaemia and were referred to 
hospital. 
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If a woman was ill and needed urgent medical attention, the Community Health Nurse (CHN) 
within the area was informed. If the CH N was not within reach, the State Registered Nurse 
Midwife (SRNM) was informed. It was the fieldworker's duty to make sure that a health worker 
saw the woman on the same day. 
If a woman was referred after taking the medication for severe anaemia or clinical malaria, she 
remained in the study and the SRNM or the Clinical Epidemiologist was informed as soon as 
possible. If a woman died at home during pregnancy, delivery or six weeks after delivery, the 
Clinical Epidemiologist or the Principal Investigator was informed immediately. If a baby born 
alive died in the first six weeks of life, the SRNM was informed, who then scheduled a date for 
verbal autopsy with the family. The verbal autopsy is attended by both the SRNM and the 
fieldworker. Clinic staff, at any time during the trial, performed a blood test for haemoglobin 
estimation on any woman suspected to be severely anaemic. Any woman who developed a 
clinical attack of malaria during the study was treated with chloroquine and with careful follow- 
up and treatment with quinine if there was no improvement within 48 hours. At each clinic visit, 
women were questioned about side-effects or complications of the study medication. Any 
woman with a possible sulpha drug reaction had her blood taken for haemoglobin and 
parasitaemia, and did not receive any further doses of SP (MRC, 2002). 
5.3.2. Objective of the economic evaluation component of the trial 
The economic evaluation component of the IPTp trial aimed to estimate the cost-effectiveness 
of adding SP as IPTp to routine antenatal care for multigravidae compared with routine 
antenatal care alone. 
5.4. SPECIFIC OBJECTIVES OF THE THESIS 
The specific objectives are: 
1. To examine the cost-effectiveness of introducing SP as IPTp for malaria into normal 
antenatal care for multigravidae women in rural Gambia; 
2. To explore various methods of valuing indirect costs and to assess the extent to which 
they affect the cost-effectiveness ratio; and 
3. To make policy recommendations on whether or not to introduce SP as IPTp on cost- 
effectiveness grounds. 
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5.5. THE CONCEPTUAL FRAMEWORK 
The framework for the analysis outlined in Figure 5.1 was adapted from Drummond et al 
(1995), and also incorporated the new framework of Drummond et al (2005) outlined in Chapter 
2. The study is conducted from societal perspective and costs divided into direct and indirect 
components. Direct costs refer to the resources used in the delivery of health care to patients 
(preventive and/or treatment). Indirect costs are the output losses due to stoppage or reduction 
of productivity due to morbidity (Clarke et al, 2000). These losses of output in rural Gambia are 
associated with unpaid work including subsistence farm work and all aspects of unpaid 
household work including childcare. This cost categorisation makes it possible to assess the 
effect of indirect costs on the incremental cost-effectiveness ratio (ICER). Furthermore, those 
interested in the various cost components could readily re-estimate the result by using the 
perspective of their choice. Figure 5.1 shows the additional costs and consequences engendered 
by the introduction of the IPTp intervention over routine antenatal care in The Gambia. In the 
recent edition of Drummond et al (2005), a new terminology, productivity losses and gains, was 
introduced. Nonetheless, as indicated in Chapter 1, the concepts in the new framework in Figure 
5.1 and the new one in Figure 2.1 are the same. For instance, direct costs and benefits denote 
resource use (costs) and/or saved (benefits) by the intervention when compared to the 
alternative. Indirect costs and benefits have been replaced by the term productivity losses and 
gains. Given the extensive use of the term `indirect costs' in the literature, this terminology is 
retained here. 
Figure 5.1 Cost-effectiveness of IPTp for multigravidae 
Costs Consequences 
I. Direct costs to provider (Cl) I. Reduction in LBW and anaemia cases and deaths 
e. g. (C1+C2+C3+ C4)-(Si+S2+S3+ S4) 
" Health sector staff's time 
" Supplies 
" Equipment II. Resource savings due to reduced treatment (E) 
" Power " Savings in use of provider resources due to less 
" Overhead costs related to IPTp and treatment 
treatment " Savings in direct resource use of patients and 
Costs to others sectors (C2) their families 
" Savings in unpaid time lost that would have 
H. Direct costs to patients and their families (C3) been used in treatment 
" User-fees 
" Travel costs 
" Out-of-pocket expenses III. Reduction in DALYs lost (E) 
" Patients and family direct inputs into 
treatment 
III. Indirect costs (productivity losses) to patients 
and their families (C4) 
" Time lost from subsistence farm work 
" Time cost from household work 
" Patients and family direct inputs into 
treatment 
r. , iaVLL LlW1L1LVllLL OL GL kzUU , iyyZ)), 
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5.5.1. Cost of IPTp intervention 
The costs of providing IPTp at the clinic level are those incurred by the provider, patients and 
their families and the society as a whole. The methodology follows an incremental cost- 
effectiveness approach of current practice (i. e. ANC), against the intervention which is - IPTp 
added to routine care with ANC being delivered through existing antenatal clinics. 
5.5.1.1 Cost to the provider 
The provider of health services is the DoSH through health facilities such as health posts, 
dispensaries, minor health centres, major health centres and hospitals. The direct cost of the 
whole intervention to the provider includes health staff time, drugs, medical supplies, 
consumables, hospitalisation costs, etc. These costs can be categorised as costs incurred during 
clinic visits for prevention or treatment. 
5.5.1.2. Cost to users5 
The users here refer to multigravidae pregnant women enrolled in the IPTp trial and those 
treated for malaria during pregnancy. The cost to users is divided into direct and indirect. 
Direct costs 
In the case of the IPTp intervention in question, direct costs include patients' travel expenses to 
clinics to obtain IPTp, other out-of-pocket costs such as user-fees as well as costs incurred by 
family members who sometimes accompany the pregnant woman to antenatal clinic sessions. 
Indirect costs 
Indirect costs of the IPTp intervention is mainly incurred by women and their caregivers. They 
are usually in the form of time loss from subsistence farmwork, time loss from household work 
and family and patient time inputs as indicated in III of the Conceptual Framework (Figure 5.1) 
and C4 in Figure 2.1. This is mainly because most of the women and their caregivers in rural 
Gambia are not engaged in any formal employment. 
Another area of time use is during the treatment of LBW and anaemia. It is anticipated that 
those not on IPTp will travel more frequently to hospitals for treatment than those on IPTp since 
the chances of treating more LBW babies and anaemic mothers are higher than when IPTp is 
introduced. 
5 Users are the women who attend antenatal clinics and those who become sick and had to seek treatment at hospital level are 
known as patients. 
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Others may use the services of local drug sellers (pharmacies) and traditional healers. In 
addition to the time incurred by patients and their caregivers, the time input of other relatives in 
the treatment process is likely to be a high proportion of their subsistence and household work 
times. Therefore, the time use and indirect costs incurred in each case may be important 
elements in determining the cost-effectiveness of the intervention. 
5.5.2 Consequences of IPTp intervention 
The consequences of IPTp are expressed in three forms, which are: 
1. Cases of LBW and anaemia averted; 
2. Deaths from LBW and anaemia averted and 
3. DALYs from LBW and anaemia averted. 
5.5.2.1. Reduction in cases of and deaths from LBW and anaemia 
The immediate health consequences of IPTp include cases of LBW and anaemia averted due to 
a lower incidence of malaria in pregnancy. In the same vein, lower incidences of LBW and 
anaemia could in turn lead to lower deaths from the two conditions than before IPTp. Hence, 
deaths from LBW and anaemia because of IPTp would be averted. 
5.5.2.2. Disability-Adjusted Life Years (DALYs) averted 
The outcomes of this study are also expressed in terms of cost per DALYs averted. It is 
anticipated that the IPTp intervention causes more DALYs to be averted than routine antenatal 
care without IPTp. DALYs averted by introducing IPTp as part of routine antenatal care in rural 
Gambia are estimated by calculating DALYs with and without the IPTp intervention. In line 
with Homedes (2000), Murray (1996), Fox-Rushby, and Hanson (2001), the process 
incorporates weighting for life expectancy, age, future time and disability. Life expectancy for 
each age was obtained from the WHO website (WHO, 2003) and the deaths from LBW and 
anaemia were estimated using case fatality rates from records and previous reports. Disability 
weights were obtained from the Global Burden of Disease Study (Murray & Lopez, 1996) and 
the duration of the episodes of anaemia and LBW were collected from both the IPTp trial data 
and additional data obtained from hospital statistics. 
5.5.3. Resource savings to providers, patients and their families 
Savings to providers, patients and their families are categorised into savings in direct costs to 
the provider and savings in both direct and indirect costs to patients and their families. 
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5.5.3.1. Reduction in direct costs to the provider 
This cost component refers to the savings in resource use to the providers resulting from fewer 
babies and mothers being treated for all types of LBW and anaemia due to the IPTp 
intervention. These savings include staff time, the use of equipment, drugs, laboratory facilities, 
beds, overheads and referral costs. Resource savings free some scarce health care resources 
(direct costs) for other uses. 
5.5.3.2. Reduction in direct and indirect costs to patients and their families 
On the side of patients, the savings brought about by less treatment due to the IPTp intervention 
can also be divided into direct and indirect costs. 
Direct costs 
The saving in direct costs means spending less in treatment costs for all types of LBW and 
anaemia by patients and their escorts. These include reduced expenditure on transport and other 
out-of-pocket expenses. The savings also affect other family members who might otherwise 
spend much of their valuable funds on treatment. In the case of admissions, it could include 
extra food and costs related to visits by close relatives. 
Indirect costs 
In addition to the direct costs savings from the 1PTp, there is potentailly a high indirect costs as 
a result of the IPTp intervention. The indirect costs savings from IPTp are likely to arise from 
the time patients and their families save due to cases of LBW and anaemia averted. These 
include the travel time from base facilities or their homes, the time spent waiting to see a health 
professional and the time spent undergoing treatment. These indirect costs are potentially of 
importance to this study because the majority of women in rural settings are themselves the 
family `breadwinners' (see Chapter 2 for details). Therefore, time lost due to treatment may be 
very valuable to them since it can affect their productivity at both farm and household levels, 
especially during the rainy season when everybody is busy working on their farms. 
The user's contribution to health care in subsistence economies is generally underestimated and 
opportunity costs are often not considered at all. According to Abel-Smith and Rawal (1992), 
even cost-free health services have opportunity costs in the form of costs of forgone wages by 
the patient and time spent on travel, waiting and treatment. It also includes time invested by the 
caregiver accompanying the patient. Therefore, opportunity costs may be an important 
determinant of health service utilisation (Details in Chapter 2). 
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5.6. EFFICACY TO EFFECTIVENESS 
An intervention is considered effective if it improves the health outcome in a typical community 
setting; and efficacious if it results in improved health under ideal conditions (Haddix et al, 
2003, Witter, 2000). It is clear from the description of the trial that, like most Randomised 
Controlled Trials (RCTs), this trial has been conducted under ideal conditions. Activities at the 
clinic, such as haemoglobin testing, counselling and all the follow-up activities up to six weeks 
after delivery, are not part of routine antenatal care in the study setting. According to Haddix et 
al (2003), since efficacy may not directly lead to effectiveness in practice, the generalisability of 
the result is questionable. Since the aim of the thesis is to assess cost-effectiveness, a 
randomised-placebo-controlled trial is considered necessary but not sufficient for the task at 
hand. Moreover, using placebo as the comparator to SP threatens the external validity of the 
economic evaluation result because placebo is not the most relevant policy question being 
addressed by the thesis. 
Therefore, comparing the intervention group to their placebo counterparts in this case does not 
lead to a true measure of cost-effectiveness. This opens the way for the selection of a new 
comparator (Byford & Palmer, 1998). The relevant comparator in the study setting is routine 
antenatal care (i. e. current practice). To help address this issue, secondary data have been 
collected outside of the trial from both published and unpublished sources. The availability of 
this information is explained in Section 5.10. Two sets of analysis are conducted (Base cases I 
and II). Base case I, according to the trial, refers to the entire multigravidae population enrolled 
in the IPTp trial and Base case II only considers those multigravidae who do not use bednets. 
Presenting the results in Base cases I and II was necessary because the trial analysis found that 
results were different between multigravidae sleeping under a bednet and multigravidae not 
sleeping under a bednet (Mbaye et al, 2006). 
5.7. TRIAL/RESEARCH AND PROTOCOL DRIVEN COSTS 
Trial costs refer to expenses incurred in carrying out research rather than the cost of treating a 
condition. They also include the cost of procedures in the trial that would definitely not be 
performed in routine practice and are therefore solely required for the purpose of the trial itself 
(Johnston et al, 1999). These events may arise due to the close monitoring of patients in the trial 
or because of the necessity to preserve blinding (Drummond and David, 1991). A problem in 
using cost estimates from a clinical trial in an economic evaluation is the extent to which the 
costs include resource use associated with the trial per se (Drummond et al 1997). The standard 
design of trials involves direct interference with the clinical management of patients, which can 
result in an atypical and ungeneralisable estimate of resource use (Coyle & Lee, 1999). 
108 
The additional costs that are incurred because of the trial design are collectively known as 
research costs. The two main types of research-driven costs identified in the literature are 
protocol-prescribed costs and protocol-derived costs. 
Protocol-prescribed costs arise from the identification of the clinical outcomes, data collection 
methods or rigid treatment schedules. Clinical trials normally require frequent monitoring of 
patients through a higher number of tests, follow-ups and health facility visits than in normal 
practice (Coyle & Lee, 1999). They can also lead to variation in the management of patients. In 
the IPTp trial, the blinding of treatment, twice weekly follow-ups to the homes of the subjects, 
and the frequent availability of tests, are a few cases in point. The frequent data collection 
schedule in trials may also lead to protocol prescribed costs because they may increase resource 
use for patients, thereby masking the potential resource difference between treatments. 
The third type of protocol-prescribed cost is related to the more rigid treatment schedule for 
patients in trials than would occur in normal practice, thereby removing a degree of autonomy 
from the patients' own health care provider. In normal practice, response to treatment may mean 
reduced dosage of medication, but that is not usually the case in a trial setting (Coyle & Lee, 
1999). 
Protocol-derived costs occur when the design of the trial leads to the identification and 
treatment of diseases, which may not have happened outside of the trial setting (Coyle & Lee, 
1999). This may take place due to increased testing, thereby resulting in more resource use than 
would occur in normal practice. The two arms of the IPTp trial, SP intervention and the placebo, 
are similar in terms of costs at the clinic or prevention stage except for the intervention drug, 
SP. Another similarity between the two arms is evident in health service use related to the 
intervention for both the provider and patients. The time for waiting and consultation at the 
clinic, and the time taken for haemoglobin tests, are also similar. The only difference between 
the arms is the potential difference in utilisation of health services when the effects of malaria 
set in before and up to six weeks after delivery. It is hypothesised that those on placebo are at 
higher risk of catching malaria than those on SP, and therefore, the effect of malaria in terms of 
pregnancy outcome affects them more. This category of women is likely to spend more time at 
the hospital and out of their usual activities. From the comparison, it is clear that the trial data in 
its original form may not lead to any difference in cost for both the health provider and the 
patients as far as the preventive aspect is concerned. 
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In the case of the IPTp trial, research costs from the perspective of the provider include all costs 
incurred at the clinic and during follow-up. Other research costs to the provider include hiring a 
clinical epidemiologist, fieldworkers, a health economist, trial vehicle, the extra office space 
provided by the MRC, computers, data entry clerks, and motorbikes. For patients, it is the 
additional time taken to participate in the trial including the time taken to complete the efficacy 
and clinic exit questionnaires at the clinics and follow-up questionnaires at their homes. The 
approaches to tackling issues related to the exclusion or inclusion of trial costs are not always 
straightforward (Johnston et al, 1999). Including trial costs in cost analysis may overstate or 
understate the time costs (Rittenhouse, 1996). According to Drummond et al (1997), when 
collecting resource use data, the resource consequences of the research protocol should be 
minimised and the delivery of care should mirror that of normal practice. In line with this view, 
only costs, which have occurred for clinical reasons, have been included in this analysis. 
5.8 ANAEMIA 
Anaemia is a health condition that involves a reduction in the volume of red blood cells (RBC), 
consequently leading to a decrease in the concentration of haemoglobin in the blood. The 
reduction in RBC volume results in a reduced ability of the blood to transfer oxygen to the 
tissues and organs (http: //encyclopedia. thefreedictionary. com; www. dcp2. com). A person with 
anaemia often appears pale, weak and may feel breathless in severe cases. The causes of 
anaemia amongst others include nutritional deficiency of iron, folate, vitamin B12 etc; 
haemorrhage, malaria during pregnancy, genetic disorder and chronic illnesses (ORC Macro, 
2005; http: //encyclopedia. thefreedictionary. com). Early detection and prompt treatment of 
anaemia among pregnant women could help prevent LBW, severe complications of pregnancy 
and delivery and even maternal deaths. Anaemia, especially the severe form requires medical 
attention but those caused by nutritional deficiency can be treated at home once the condition 
has been diagnosed (ORC Macro, 2005). 
Haemoglobin-testing is the main method of anaemia diagnosis. There are several methods of 
testing haemoglobin (Hb) including HemoCue Hb 201 + system (ORC Macro, 2005; 
http: //encyclopedia. thefreedictionary. com). The system consists of a battery-operated 
photometer and a disposable microcuvette, coated with a drug reagent that serves as a blood 
collating device (ORC Macro, 2005; http: //encyclopedia. thefreedictionary. com). The test is 
conducted using a drop of blood taken from the person's fingertip. The level of anaemia can be 
classified as severe, moderate or mild based on the Hb concentration in the blood and according 
to criteria developed by the WHO (ORC Macro, 2005; 
http: //encyclopedia. thefreedictionary. com). 
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Haemoglobin testing and its related costs are not included in the base case analysis, rather as 
part of sensitivity analysis in Chapter 9. Hb testing in principle is part of the routine antenatal 
care services in The Gambia. However, in practice, the test is conducted only in fixed health 
facilities with laboratory facilities. This means women from outreach facilities without such 
facilities are referred to undergo such tests. 
5.9. DATA COLLECTION APPROACHES AND TOOLS 
This section is a progression on the conceptual framework presented in Section 5.5. It describes 
the methods and tools used to collect data and the approaches used to analyse different data. 
Details of data processing and analysis are also presented in the section 5.9.3. Resource use is 
usually measured on a patient-specific or a non-patient-specific basis. Those costs measured on 
a patient-specific basis are said to be stochastic because they vary between patients in terms of 
frequency and number. On the other hand, events or costs that are non-patient-specific are said 
to be deterministic because they are the same for each patient (Johnston et at, 1999). The latter 
is used in this study because events such as a day in hospital may not require measurement 
directly for each patient, especially in light of the fact that such costs are unlikely to 
significantly vary between different patients (Clark et at, 1994). In this way, data collection and 
research expenditure are minimised without disturbing the accuracy of the information 
generated (Knapp and Beecham, 1993). 
Furthermore, given the difficulty involved in identifying costs of specific conditions, all costs 
expended in treating LBW, anaemia as well as other diseases are taken onboard. This is done in 
order to avoid leaving out any unexpected resource use that may be causally related to the 
intervention in question (Johnson and Weinstein, 1997). Similarly, given that LBW and anaemia 
can cause a broad range of health problems, it is believed that it would be impossible in many 
cases for either the patient or the health personnel to state that lost productivity was directly 
related to LBW and/or anaemia. Therefore, patients reported all lost productivity without 
attempting to make attribution to LBW or anaemia or other conditions. The implication is that 
this takes on board all illnesses during the trial, and may compensate for any LBW and/or 
anaemia case not reported during the same period. The data required for this study was collected 
through questionnaires, diaries, observational methods, review of existing records and 
secondary data from peer-reviewed studies and unpublished reports. 
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5.9.1. Piloting 
All the data collection tools utilised in this thesis were carefully piloted before use. This 
accorded the researcher the chance to refine the questions for better understanding by 
fieldworkers and respondents; and to have an understanding of the time required to administer 
the tools. The piloting also made it possible to test coding methods. The clinic questionnaire 
(See Section 5.10.1 and Appendix 2) was piloted on multigravidae recruited into the trial for the 
first time. The follow-up questionnaire (See Section 5.10.2 and Appendix 3) was then piloted 
four weeks later on those who returned to the clinic for the subsequent dose of IPTp. 
Each day of piloting was followed by a short meeting of the study staff to share their 
experiences in the administration of the questionnaire including duration of interviews, the 
difficulties experienced and respondent fatigue. This was done for 12 weeks until the researcher 
was satisfied with the content of the questionnaires. Completed questionnaires were handed 
over to the computer staff to test the data entry processes and run preliminary analysis. The 
problems experienced on the computing side - such as those related to coding - were 
recognised to further improve the instruments. Clinic and follow-up questionnaires (Appendices 
2 and 3 respectively) were accompanied by detailed manuals of procedures (MoP) (for example, 
Appendix 4) developed to provide hands-on assistance to fieldworkers. The manuals gave a 
detailed explanation of questions, sometimes with examples to help the fieldworkers correctly 
solicit answers and minimise errors. The Time use Diary was piloted in Farafenni and the 
surrounding villages while hospital study tools were piloted at the AFPRC hospital. 
5.9.2. Sampling 
From the main trial sample of 2,688 women attending antenatal clinics, a sub-sample of 884 
respondents was included in the study. The survey was undertaken with a variety of objectives 
in mind, including obtaining information on travel times and expenditure on treatment. In order 
to obtain the required sub-sample of the economic study, the candidate made use of Pocock 
(1983) and also received assistance from one of the statisticians at the statistics unit of LSHTM. 
Sample size (n) was calculated using the efficacy rate for IPTp with SP for pregnant women in 
Malawi and Kenya. The respective efficacy rates are 7% with IPTp and 23% without IPTp and 
the corresponding figures for Malawi are 10% and 23% respectively. The joint efficacy of the 
two leads to averages of 8.5% and 23% with and without IPTp. The formula produces the 
sample size of 254 per arm. A pragmatic approach was therefore taken to increase the sample to 
884 because samples of 600-900 are common for this type of study. Furthermore, the higher 
sample will also cater for future dropouts. The details of the sample size calculation for the IPTp 
trial and the economic component of the study can be found in Appendix 5. 
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The sample of 884 was distributed proportionately across the 14 health facilities in the trial. In 
order to have a representative sample in terms of the seasons of the year, as far as possible, the 
total number per centre was spread equally per season and month for the duration of the trial. 
Depending on the number of women that presented at each clinic, every second or third woman 
was randomly selected to take part in the economic trial. In clinics where only one woman was 
recruited for the main trial, that person was automatically selected. A sample of 662 women was 
followed-up in their homes. The difference between the clinic study sample of 884 and follow- 
up sample of 662 was accounted for by early delivery (before four weeks after first 
recruitment), travel, those who could not be traced and death. The clinic, follow-up, hospital and 
time use studies had at least 14 fieldworkers recruited mainly from the study locality. Those 
deployed at the RVTH were recruited within Banjul and the surrounding towns. All the 
fieldworkers were trained for varying lengths of time depending on the study. 
5.9.3. Data processing and analysis 
Before handing the completed questionnaires (clinic and follow-up) to the MRC Farafenni 
computing staff for data entry, each questionnaire was checked for completeness and accuracy 
as it was submitted by fieldworkers. Those found to contain errors were corrected at the office 
level in consultation with the fieldworker concerned. Those that could not be corrected at the 
office level were referred back to the field for verification. All completed questionnaires were 
coded and entered using EPI-info 6. In order to minimise error, the data were double-entered 
using two data entry clerks. The data were then verified and initially cleaned by a computing 
supervisor. The data, partly cleaned by the MRC staff, were handed over to the candidate who 
completed the cleaning. By using STAT Transfer 6, the data were easily transferred to SPSS 
12.01 for further cleaning and analysis. Both SPSS and Microsoft Excel were used run 
descriptive analysis including, where appropriate, frequency distribution, means and 
percentages. All other data were entered by the candidate himself using a combination of Excel 
and SPSS. 
5.10 SUMMARY OF DATA COLLECTION METHODS 
Cost data required for this thesis was collected in six phases. The first focussed on the 
incremental costs of the IPTp intervention to the provider, users and their families using health 
facility cost analysis, secondary data and clinic questionnaires. The second phase was a follow- 
up study that gathered information on patients and their families' resource use in treating LBW 
and anaemia, using hospital data collection forms and follow-up questionnaires. The third and 
fourth studies, which were conducted together, gathered information on provider resource use 
for treating LBW and anaemia. 
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The same studies also collected costs incurred by patients to supplement the information 
collected at the follow-up stage. The fifth study was a Time Use Survey (TUS) used to measure 
household time use by women in rural Gambia using observation and recall methods, each 
combined with a diary. As part of this process, the sixth study - an employment survey - was 
undertaken using a specially designed form (Appendix 6) to collect employment information in 
the study areas. The first and second studies were completed by the end of the year 2003 and the 
rest by June 2004. A summary of the studies undertaken is given in Table 5.1. 
Table 5.1 Summary of studies undertaken 
Study Aims Sample Data collection tools 
size 
Incremental costs of prevention 
Study I: Incremental cost To estimate the incremental cost of providing 
of introducing IPTp IPTp at the clinic level as part of routine 
antenatal clinic. 
Provider Additional resource use of IP'Fp intervention. 894 Clinic questionnaire and 
hospital observation study 
Users and families Additional direct costs and indirect costs of 884 Clinic questionnaire 
IPTp intervention. 
Cost of treating a LBW baby and an anaemic mother 
Study 2: Follow-up of To estimate the treatment cost of LBW and 662 Follow-up questionnaire 
users and their families anaemia to patients and their families 
Study 3: Cost of treating To estimate the cost of treating LBW at the Patient data collection form 
a LBW baby at hospital AFPRCH and RVTH 
Study 4: Cost of treating To obtain the resource use consequences of 94 Follow-up questionnaire 
an anaemic mother at treating a LBW baby at the hospital level. and facility data collection 
hospital forms 
To obtain the resource use consequences of 
treating anaemic mother at the hospital level. 
Provider Resource use consequences of treating a LBW 2 Hospital observation study 
baby and/or anaemic mother at the hospital hospital and secondary data 
level. s 
Patients and families Additional direct and indirect costs for treating 662 Follow-up questionnaire 
a Low Birth Weight baby and/or anaemic and hospital observation 
mother. study 
Study 5: 'l'ime use survey To obtain the average time spent in hours on 45 Time Use Diary 
(TUS) each of the activities per women per week. 
Study 6: Employment To obtain payment for work performed by rural 127 A specially designed data 
survey women and selected male work. collection form 
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5.10.1 Study One: Incremental costs of IPTp to providers, users and families 
The aim of this study was to collect incremental costs of IPTp to the provider, antenatal care 
users and their families. The clinic questionnaire was used to collect information on cost and 
resource use of the IPTp intervention. The clinic and follow-up questionnaires were based on a 
published costing tool; "an annotated cost questionnaire for completion by patients" (Thompson 
and Wordsworth, 2001). It is important to note that some of these original instruments, adapted 
for use as clinic and follow-up questionnaires, were originally designed to be self-administered 
but due to the high illiteracy level in The Gambia this was not possible. 
Therefore, under the circumstances, the study relied on the accurate administration of the 
questionnaires by fieldworkers. A copy of the clinic and follow-up questionnaires and their 
accompanying Manuals of Procedure are included in Appendices 2,3 and 4 respectively. 
5.10.1.1 Costs to the health care provider 
The costing approach used in this study was the ingredients approach (Section 2.2.4) (Green, 
2004; Kumaranayake et al, 1998). In this approach, it is important to accurately assess the major 
cost drivers of the intervention in order to avoid small inaccuracies translating into overvaluing 
or undervaluing costs (WHO, 2006). An alternative approach is approximation, which 
concentrates on categories of inputs that do not form major cost-drivers of an intervention and 
estimate their costs using past expenditures on them. Approximation is likely to yield estimates 
that are as accurate as applying a more complicated ingredients approach method and requires 
less data (WHO, 2006). However, the ingredient approach is used in this study to estimate the 
incremental costs of adding IPTp to routine antenatal care because of a lack of previous IPTp 
interventions in The Gambia for which past expenditure records could be obtained. 
The cost to the provider includes the incremental IPTp cost to the antenatal care providers in 
terms of additional use of drugs (SP); increased time for consultation and drug-taking; and an 
additional 0.6 number of visits (from 3.4 for current practice to 4 for the intervention). This is 
shown in detail in Table 5.2. Some of this information was gathered through clinic 
questionnaires and the use of secondary data. The introduction of IPTp requires the use of 
resources in addition to those required for routine ANC but excluding IPTp programme costs 
which would not be part of any `real life' IPTp intervention. It is assumed that the costs are 
uniform across facilities regardless of whether they are base or outreach. Therefore, other costs 
related to ANC especially at the base clinics, have not been included because they do not have 
any significant effect on the implementation of IPTp. This is further explored in Chapter 10 
(discussion). 
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The incremental provider costs of IPTp are divided into the time the staff at the facility spent on 
IPTp, use of capital, materials and supplies as well as the cost of in-service training for existing 
health staff and supervisors in-charge of the IPTp implementation. Other important additional 
costs include the outlay for health promotion activities and mass sensitisation at the trial 
localities. The resources required for ANC as part of the MCH clinics are indicated in column 3 
of Table 5.2. 
Table 5.2 Anticipated resource use for IPTp in addition to normal antenatal care 
COST TO PROVIDERS 
Cost components Base case Incremental 
Current Intervention Measure Unit price Source 
practice (i. e. (i. e. adding SP 
routine ANC) to ANC) 
Drugs (SP) 0 Additional drugs Number of doses Price per dose Drug price list 
WHO/CMS 
Consumables (Hb Additional Consumption MRC 
testing) consumption purchasing 
Drug taking (CHN) 0 Additional Staff time used Wage per CF & 
minutes (minutes) minute Observation 
study 
Consultation & 0 Additional Staff time used Wage per CF & 
counselling time minutes (minutes) minute Observation 
minutes minutes minute 
Number of visits 3.4 0.6 visit I Provider cost of Cost per visit Records & 
-i, itinniI visit 
I rial 
vrug taxing u Aaannonat vimuics . 1»I I'll 
minutes minute Observation 
study 
Consultation & 0 Additional Minutes Cost per CF & 
counselling time minutes minute Observation 
stud 
Waiting time 106 Minutes Minutes Cost per CF & CQ 
minute 
Number of visits 3.4 0.6 visit Patients and family Average Records & 
cost of additional cost/visit Trial 
Treatment OPD visits: 
Anaemia Fewer visits Number of visits Cost per FQ & CQ 
outpatient 
visit 
LHW Fcwcr v isity Nunihcr of v i, its Cost per FQ & CQ 
outpatient 
visit 
Admissions (Inpatient) 
Anaemia Fewer days Length of stay Cost Per FQ & CQ 
hos ital da y 
LBW Fewer days Length of stay Cost per FQ & CQ 
Kcy: (1 - Client Flow, CQ -Clinic Questionnaire, FQ - Follow-up Questionnaire, Obvs - Observation study 
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The basis of resource use in routine antenatal care includes measurement of fundal height, 
weighing, urinalysis in base facilities only, measuring of blood pressure, immunisation, 
palpation, dispensing of iron and folic acid, and other food supplements. Haemoglobin tests are 
supposed to be performed but like urinalysis, they are only conducted in major and some minor 
health facilities as the equipment needed is not available at the peripheral level. The 
performance of the above tasks requires both human and material resources. These include staff 
time, materials and supplies, the use of existing facilities such as building space, benches, 
palpation table, equipment, vehicle and driver. Resource requirements are shown in detail in 
column 1 of Table 5.3. 
The duration of IPTp was calculated by observing of women receiving care, combined with the 
results of the clinic questionnaire completed by the women when they were first recruited into 
the trial. The clinic questionnaire made no provision for collecting information on the time the 
health staff took with each woman at the various stages of delivering IPTp at the antenatal 
clinics. Therefore, observation methods were used to monitor the time spent in delivering IPTp 
at antenatal clinics. In addition to that, health providers were asked to indicate the time it 
normally took to deliver IPTp. In the case of haemoglobin tests with a hemocue machine, one of 
the MRC field station laboratory staff was asked to estimate the time taken for a haemoglobin 
test using that equipment. Due to excess capacity in most of the antenatal care facilities, the 
addition of IPTp to normal antenatal care did not lead to any significant additional resource use 
of capital items such as additional building space, use of extra equipment purposely to cater for 
the IPTp. The additional forms of resources use under IPTp are summarised in column 4 of 
Table 5.3. 
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Table 5.3 Resource use for routine ANC and IPTp Intervention 
Resources Unit of Routine ANC IPTp 
measurement 
Recurrent 
Personnel: Hours Minutes of staff time of those Additional time on IPTp by 
(I SRNM, I SEN General, staff directly involved in ANC. SRNM, I CHNM and I CNA 
I CHNM, 1 SHS, 2 CNA, 
Driver) 
Supervision Hours Time for the DIT supervisory Additional 15 minutes. 
team on ANC 
DoSH supervisory team for Hours None Quarterly DoSH supervisory 
IPT visits to health facilities 
Laboratory/ANC staff Hours lib and urinalysis Staff time for I lb test. 
Materials and supplies Physical units Consumables for ANC and Additional IPTp materials, 
shared consumables for other e. g. roll of cotton wool, spirit, 
interventions as well cuvettes, etc. 
Equipment Minutes of use Use on ANC Use of Hemocue machine 
(BP machine, timer, 
obstetrical stethoscope, 
balance, rural for measuring 
height) 
Running cost of vehicles Kilometres Proportion of kilometres, number Depreciation ofvehicle for the 
of ferry crossings where kilometres covered for the 
applicable devoted to ANC quarterly DoSH supervisory 
visits 
Utilities Quantity Water, electricity and telephone Only water used for drinking 
consumed in apportioned to ANC tablets was considered. 
appropriate units 
Capital costs 
_ Building Space occupied Space used or proportion of time None 
use per health activity including 
ANC 
Building operating & Spaced occupied Space Norne 
vehicle 
Health promotion 
In-service training 
Kilometres per Health facility vehicle 
annum(' DI IT vehicle 
Kilometres per trip 
Kilometres per Depreciation for super 
annum visits 
Kilometres per None 
annum 
Number of health Health promotion acti' 
promotion annum 
activities 
Number trained In-service training per 
This activity is carried out 
even without IPTp and so no 
values for IPT 
Supervision even without 
Cost per kilometre (CPK) a 
ferry crossing costs for the 
quarterly supervisory visits 
Only 
vity per Health promotion for IPTp 
only considered 
annum Initial training to improve 
IPT staff 
R 23% of the kilometre per annum cost represents depreciation charges. 
118 
As already mentioned, in addition to the primary data, secondary data from other sources were 
also used. The base case for the duration of time for routine antenatal care came from the client 
flow study report commissioned by the DoSH and authored by Frances Foord (DoSH, 2000). 
The report used a time flow and workload study from the Family Care Health Systems 
Assessment and Planning Manual. It contains information such as the time taken for a 
haemoglobin test, waiting, consulting etc. 
5.10.1.2 Costs to users and their families 
The randomly selected sub-sample of 884 users out of the trial sample of 2,688 was asked to 
complete interviewer-administered clinic questionnaires. This is much higher than the estimated 
sample size of 254 in Appendix 5 (see Section5.9.2 for reasons) to counter for dropouts. The 
questionnaire elicited socio-economic information including occupation and educational status. 
It also collected information on a range of areas such as time spent waiting for treatment and on 
consultation, including the time patients took to take SP at the clinic. It sought information on 
the costs of travel, the distance from the woman's home to the clinic, the time taken to reach the 
facility, the occupation of the woman and anyone accompanying her, and any other expenses 
incurred for the purpose of visiting the clinic. For those women accompanied to the clinic, all 
costs incurred by those accompanying them were also taken into account (e. g. transport costs). 
Women were also asked about their daily work routines in order to give the researcher an idea 
of the activities they forgo to attend ANC. 
5.10.2. Study Two: Follow-up on resource use of users, patients and their families 
The reason for the follow-up study was to collect the treatment cost of illnesses during 
pregnancy and up to six weeks after delivery that related to patients and their families. 
Information was collected on any health service use including hospital days, major outpatient 
visits and even treatment from local drug sellers and traditional healers. The cost information 
ranged from transport costs; opportunity costs of travel and work times; any out-of-pocket 
expenses; the place they came from (distance); time spent in the various stages of outpatient 
departments (OPD) as well as the length of stay in the case of admission. 
Opportunity cost in this case is the loss of time for attending clinics and seeking treatment 
(work and/or non-work time) by patients and their relatives. Those admitted were asked about 
the number of family visitors they had while admitted, where the visitors came from, fares paid, 
gifts brought as well as other out-of-pocket expenses. As indicated in Chapter 2, Section 2.4, the 
social capital element in developing countries means family members and friends perform most 
of the activities together including caring for the sick. 
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The visitors mentioned here are not just ordinary persons visiting the hospital, rather close 
family members who leave their daily work to visit and care for their admitted relatives. The 
resources used for such visits including time have been included because they represent 
opportunity cost. The fares and gifts brought have alternative uses and the time could be used to 
undertake other useful activities had they not been involved in the care of their relatives. 
Reasons for not seeking care were also solicited for those who were ill and yet sought no care. 
The follow-up questionnaire is attached as Appendix 3. 
5.10.3 Studies Three and Four: LBW and Anaemia treatment costs to providers, patients 
and their families 
The objectives of these studies were to obtain both the provider and user resource use 
consequences of IPTp and the cost incurred by the provider and users for the treatment of LBW 
babies and anaemic mothers at the hospital level. The figures obtained for the treatment cost per 
case of LBW and per case of anaemia were multiplied by the frequency and duration of visits 
for patients within the sample. The studies were conducted at the AFPRCH in Farafenni, North 
Bank East and RVTH in Banjul where those affected were likely to receive treatment. Given the 
nature of the conditions being studied (i. e. LBW and severe anaemia); the sufferers were likely 
to be admitted to hospital because of the difficulty of being managed at home. Furthermore, the 
lower levels of care, such as health centres, dispensary or village health services, in the Gambia 
are poorly-equipped to adequately cater for such conditions. 
The cost data were collected by using a combination of observation and patient flow analysis 
techniques at the OPD of AFPRCH and RVTH (Mugford, 1995; Mugford et al, 1998). The 
patient data collection form used for this purpose is attached as Appendix 7. Patient-flow 
analysis records the time from when the patient arrives to be seen by different health care 
workers until he/she leaves the health facility (Johnston et al, 1999). It is useful for those 
patients likely to be seen by more than one health care worker. The study observed 86 patients 
from AFPRCH and 27 from RVTH over three weeks as the basis for the patient resource use 
estimates in order to calculate the cost of treatment for LBW and anaemia. During this period, 
resource use data were collected on all patients treated for LBW and anaemia at both the 
outpatient and inpatient departments of the hospitals. However, patients were not followed up 
beyond their discharge point from hospital as this aspect of resource use was beyond the scope 
of this study. The implication for this is that informal care provided by unpaid family members 
or friends at home which are normally paid for in other places are not taken into account. 
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5.10.3.1 Study Three: Treatment costs to the provider 
The treatment costs to the provider at the outpatient department included tests, drugs and 
personnel time allocated to treatment for a LBW baby and anaemic mother. The time spent on 
each patient by health personnel at each outpatient unit was recorded for apportionment 
purposes. Recording this information was the responsibility of the researcher and the 
fieldworkers. Health workers also facilitated data collection by observing the time taken at each 
stage of care, drugs taken, tests conducted, etc. Data collection was followed by interviews with 
officers in-charge of each activity in the various departments of the hospital. The interview 
focused on time apportionment per patient, inputs used and staff emolument. A Case Report 
Form (CRF) and a set of WHO mother-baby costing forms (WHO, 1999) were specifically 
adapted for use in this study. A CRF is often used in a clinical trial to collect resource use 
(Mauskopf et at, 1999). The information obtained was used to estimate unit costs. 
Studies of health facility costings in The Gambia conducted by reputable institutions were used 
to obtain the average unit cost of resources at the health facility level. These are the Health 
Mapping Study (1999), Fabricant and Newbrander (1994) and Financial Sustainability of EPI 
Programmes (DoSH, 2003). The World Bank supported Participatory Health Population and 
Nutrition Project (PHPNP) -through Synergy International, conducted a Health Mapping Study 
by costing most health facilities in The Gambia. Fabricant and Newbrander was a World Bank 
study of all the hospitals and selected lower level health facilities (major and minor health 
centres and dispensaries) in The Gambia. The Financial Sustainability study - as the name 
implies - assessed the sustainability of EPI programmes in The Gambia. The general 
information provided was adapted to the needs of the research and saved the researcher from 
conducting further detailed hospital costings. 
AFPRCH is one of the newest hospitals in The Gambia with no record of comprehensive 
costing studies. Therefore, to fill that gap and for the purpose of this study, a bottom-up costing 
of that facility was undertaken. Some baseline data for antenatal malaria, LBW, anaemia were 
also available at the Epidemiology and Statistics Unit (ESU), DoSH. The costing information 
obtained from the AFPRCH administration was used to help estimate the outpatient and 
inpatient costs of hospital stay at AFPRCH. 
Hospital Costing AFPRCH 
The data required for the hospital cost analysis at the AFPRCH were obtained from several 
sources. Operating and capital cost information was obtained from the Administration and 
Accounts unit of the hospital. 
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The study also made use of previous costing studies and reports in the Gambia, such as Picard et 
al (1992), Aikins et al (1993), Fabricant & Newbrander (1994) and Synergy International 
(1999). Hospital statistics on the IPD admissions, OPD visits, beds per ward, and average length 
of stay (ALoS) were obtained from the Medical Records unit of the hospital. A summary of data 
sources is given in Table 5.4. 
Table 5.4 Data sources 
Source: Hospital study and published reports 
In order to estimate the treatment costs, the data obtained from the hospital administration were 
supplemented by existing data from reports. For instance, the annual depreciation cost of 
buildings, equipment and vehicles for the year 2003 were already estimated by the Synergy 
International report. The difficulty in getting drug utilisation data for AFPRCH was overcome 
by using per unit OPD and IPD (maternity ward only) drug costs at Bansang in 1995 from 
WHO/DoSH (1995) and inflating them to their 2003 values. The 2003 costs were then 
combined with the utilisation data at the AFPRCH to obtain the cost of drugs. 
Due to poor inventory management and lack of an equipment list, the equipment at the various 
wards, department and units of the AFPRCH were physically counted and priced using the 1995 
equipment prices available from WHO/DoSH (1995). Since these prices were in Pounds 
Sterling, they were inflated to their 2003 values by using the United Kingdom (UK) Consumer 
Price Index for exports. The Sterling values were eventually converted to GMD using the 
average pound to dalasis exchange rate for the year 2003, obtained from the Central Bank of 
The Gambia. The total value of equipment at the AFPRCH calculated by Synergy International 
(1999) was apportioned according to the respective values of the equipment per 
department/unit. The 2003 replacement value of the building estimated by Synergy International 
(1999) was apportioned according to the floor area of departments/units. 
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Capital items were annualised using a 3% discount rate and their useful life (i. e. 25 years for 
buildings, eight years for vehicles and five years for equipment). 
In attempting to derive the unit cost of outpatient and inpatient anaemia care at AFRPCH, and in 
order to ascertain the overhead costs that should be allocated to the anaemia care, the various 
hospital departments and units were categorised into clinical, non-clinical and support 
(common) services. The clinical departments include the outpatient department, Maternal and 
Child Health (MCH) clinic, dental and physiotherapy clinics, main operating theatre, Medical 
ward (male and female), leprosy/TB, maternity, paediatrics and surgical wards. The non-clinical 
departments include radiology, pathology/laboratory and pharmacy. The support services are 
administration, cleaning, laundry, catering, maintenance and security. The various departments 
of the hospital with their respective costs are presented in Appendix 8. 
The bulk of the staff was already posted to specific sections of the hospital and therefore their 
costs were allocated directly to those units. Common service staff members were interviewed to 
establish how they spend their time. Salaries and fringe benefits for the staff were obtained from 
the payroll provided by the hospital's Accounts unit. Through the observation study and review 
of reports, it was established that the average time spent with each patient at the outpatient 
department was 10 minutes. It was assumed that 80% of a doctor's time was devoted to service 
delivery (i. e. 80% of eight hours) and the remaining 20% on administration (Synergy 
International, 1999). It was further assumed that assessment of referral cases at the Accident and 
Emergency (A & E) department was 10% of unit outpatient costs. The step-down method was 
used to allocate overhead costs to the various clinical departments. 
Step-down analysis of hospital overheads 
Step-down costing is normally used to estimate the unit cost of treatments at health facility level 
and is used in settings where such information is not readily available. Previous guidelines in 
estimating unit costs concentrate on health care programmes (Creese and Parker, 1994; 
Drummond et al, 1998). However, in reality, costing is different between programme and health 
facilities because disease-specific interventions do not normally have joint costs due to the 
vertical nature of their implementation and the delivery of such interventions at health centres 
may not require complex setup in terms of flows of overhead costs to consider (Conteh and 
Walker, 2004; Huff-Rousselle, 2001; Shepard et al, 1998). This lack of guidelines gave rise to 
step-down costing of health facilities. 
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The process of step-down costing took seven steps. Step one identified service departments to 
be assigned unit costs. These include for instance wards such as maternity and paediatrics in this 
case. Step two asked for cost centres to be defined so as to coincide with the administrative 
structure of the health facility. These cost centres can be defined as direct, intermediate and 
indirect. Direct cost centres represent the end point of the production line (Kadama, 1990) -. 
the actual services delivered to clients or beneficiaries. Intermediate cost centres are those that 
provide diagnosis and departmental support to the final cost centre level. These include 
pharmacy, radiology and laboratory. It should however be noted that there is no hard and 
fast 
rule for the classification but mainly depends on the objective of costing. Indirect or overhead 
costs centres are the general services centres as administration, transport and maintenance, 
which are not directly related to patient care. Step three called for the identification of the full 
cost for each input by listing all individual line items resources and group them. An example is 
shown in Table 5.5. 
Table 5.5 Example of cost centre 
Cost centre GMD 
Personnel 7,000 
Administration 1,000 
Transport 200 
Laundry 2,500 
Laboratory 200 
Other supplies 800 
TOTAL 20,000 
Step four directed costs immediately to cost centres (Shepherd et al, 1998), identify cost drivers 
(transport) and spread the cost of a nurse across different wards to reflect their varied workload. 
Step five allocated all overhead costs to final cost centres. The step-down allocation values for 
most support services took two steps in accordance with Kirigia et al (1998a; 1998b), who 
apportioned 86% to inpatient wards and 14% to OPD and then further apportioned the inpatient 
component to wards using floor space. The overhead costs of common services such as 
administration, security, laundry, kitchen, cleaning and utilities were first ranked and then 
stepped-down to the various clinical and non-clinical centres starting with the highest. In the 
case of administration, it was based on the amount of staff time, the size of the wards in terms of 
the number of beds, floor space, etc. The allocation from each cost centre continued to filter 
down to the remaining centres until the direct cost of interest remained (Drummond et al, 1998). 
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Step six computed total and unit costs for each final cost centre using activity or utilisation data 
to be able to report the results in terms of visits or hospital days and costs (Shepherd, 1998; 
Hanson and Gilson, 1993). Step seven reported the findings (see Appendix 8 for details). Other 
methods of allocating overhead costs apart from the step-down method include direct allocation 
(or multistage method) and reciprocal methods. The direct method ignores the interaction 
between cost centres and the allocation of reciprocal services and allocates overhead costs such 
as administration or housekeeping directly to the final cost centres such as wards (Mogyorosy 
and Smith, 2005). Therefore, a given ward's share of the administration would be equal to the 
total cost of administration, multiplied by the ward's share of the allocation basis; say, paid 
hours for staff in the case of laboratories. The reciprocal method uses mathematical methods to 
model the interaction between cost centres and allocate costs (Mogyorosy and Smith, 2005). 
The results are more accurate than those obtained using direct or simple step-down allocation 
(Ellwood, 1996). Other methods that could be used with the reciprocal method include step- 
down with interaction, or the multiple allocation method which allows full adjustment for 
interaction of overhead costs. The reason for selecting the step-down method was to estimate 
the unit cost of outpatient and inpatient hospital services. Unit cost, which is sometimes referred 
to as average costs (Creese and Parker, 1994) refers to the cost of providing a single good or 
service. 
Costs of inpatient days in health facilities especially, hospitals, are mostly the main drivers of 
total treatment costs, and their unit cost could affect the outcome (results) of economic 
evaluation (Oostenbrink et al; 2003). A unit cost can be attached to various levels of health care 
provision such as meals, laboratory tests (intermediate) or final cost centres such as the cost of 
providing a health care service; in this case outpatient department (OPD) visit or a bed-day in 
specific wards (maternity ward or paediatrics ward). All cost data including unit costs provide 
useful resource requirement information to run a service (Kadama, 1990), help identify costs 
and cost drivers for management information, assist in budgeting, help in comparative 
efficiency of health services across settings (Barnum and Kutzin, 1993; Flassa 1998; Adam et 
al, 2003, WHO-CHOICE, 2003) and provide a guide to the introduction of user fees to ensure 
funding is available (Conteh and Walker, 2004). However, despite the importance of unit costs, 
in many countries especially Low and Middle Income countries (LMCs), the availability of unit 
cost data is limited (Conteh and Walker, 2004; Oostenbrink et al; 2003). Lack of unit cost 
information in developing country settings include incomplete or no records of resource use to 
provider services, missing activity data (number of patients and their diagnosis), often sparse or 
unreliable data and lack of trained staff required to carryout such costing exercises. 
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In order to fill the gap, unit costs are often based on data from hospitals participating in clinical 
trials (Oostenbrink et al; 2003). The lack of unit cost data for both inpatient and outpatient care 
at the AFPRCH led to the use of step-down cost analysis. As stated earlier, AFPRCH is a new 
hospital with no previous study of this kind. 
Hospital Costing: RVTH 
Unlike at the AFPRCH, it was extremely difficult to collect provider cost data from the RVTH. 
In order to overcome this problem, the 1995 WHO Health Analysis for the Health sector was 
used as the main data source for this costing (WHO, 1995). Secondary data from the WHO 
Health Facility Costing report (WHO, 1995) and from a study conducted by Fabricant & 
Newbrander (1994) were adjusted for inflation using consumer price indices for The Gambia for 
2003. Costs were standardised to the base year in order to make them comparable to cost and 
effectiveness data collected in 2003 for the main effectiveness trial (Haddix et al, 2003). This is 
usually done by using either the Consumer Price Index (CPI) or a relevant sub-index that 
directly measures movements in the weighted average of prices of goods and services in what is 
referred to as a fixed `market basket' of goods and services purchased by households over time 
(Haddix et al, 2003). In this study, the sub-component index for health care and services 
obtained from 2003 data was used (CSD, 2003). In order to obtain the cost per inpatient day, the 
total admission cost per ward was divided by the corresponding average length of stay obtained 
from the same report. 
5.10.3.2 Study Four: Treatment costs to patients and their families 
The direct treatment costs of anaemia (moderate, severe and very severe) to patients and their 
families were assessed by gathering information through the observation study conducted at 
AFPRCH and through the use of a follow-up questionnaire. These methods are discussed below. 
In the case of OPD care for anaemia at the AFPRCH, consecutive patients and their escorts 
were monitored from the very moment they entered the hospital premises until they left at the 
end of their treatment. In addition to those seeking health services through the OPD, there were 
a few pregnant women likely to deliver at the hospital itself. In order not to miss them, women 
admitted to the maternity ward were constantly followed up until delivery time to ascertain 
whether they or their babies suffered from anaemia or LBW respectively. For each of the above, 
the full support and participation of the health authorities was obtained. Those admitted were 
observed daily until discharge. 
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Anaemic mothers and LBW babies receiving treatment at the outpatient department were 
identified by the doctor or nurse in-charge. They were then discretely followed and observed by 
the researcher/fieldworker (after obtaining their consent) through all stages of outpatient care 
i. e. from the cashier, medical records, consultation, laboratory and pharmacy until those seen at 
the outpatient department received their drugs at the pharmacy and left the hospital at the end of 
their treatment. 
During the observation period, escorts were also asked to indicate the amount they had paid (i. e. 
if they travel by vehicle) to travel to the hospital, the duration of their travel and any out-of- 
pocket expenses incurred during their hospital visit. Patients who visit OPD on their own accord 
(without referral from health centres) are usually treated and released and it is only in extremely 
rare cases that such patients are admitted. The majority of those admitted were referred from 
health centres located within the catchment area of the hospital. A patient data collection form 
(Appendix 7) was used to collect this data. 
Those very severe anaemic patients admitted were observed by fieldworkers deployed (8am- 
6pm) at the maternity ward to obtain basic information about the patients, their escorts and any 
family visitors throughout the duration of the patient's hospital stay. Fieldworkers specifically 
checked for the number of visitors to a patient, noted the places the visitors came from and the 
amount and type of gifts (cash and/or in-kind) they brought. They also asked about mode of 
travel, duration of travel and fares paid, if any. Information on bed fees was obtained from the 
health staff in-charge of the ward. The data from the outpatient and inpatient care services were 
collected for 21 days. 
Those admitted were assumed to be critical cases usually referred from peripheral health 
facilities to AFPRCH. Those referred to RVTH were also followed-up by a group of 
fieldworkers stationed at that facility. Referral costs were included because, given the distance 
between AFPRCH and RVTH, the resource use consequences to the provider and even to 
patients and their families were likely to be high. 
5.10.3.3 Direct outpatient and inpatient treatment costs of anaemia to patients and 
families at AFPRCH 
The direct cost of hospital treatment to patients and their families includes any expenditure by 
or on behalf of the moderate and severe anaemia cases seen at the OPD and also for the very 
severe anaemia cases admitted to the maternity ward. 
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5.10.3.4 Direct treatment cost to patients and families at the RUTH 
The direct costs of LBW (VLBW and ELBW) and very severe anaemia treatment to patients 
and families at the RVTH were assessed using the same methodology as explained in 5.10.3.2- 
5.10.3.3). The procedure for data collection at the RVTH was the same as was the case of very 
severe anaemia cases admitted at the AFPRCH. 
5.10.3.5. Indirect costs of LBW and anaemia treatment 
In an attempt to calculate the indirect costs of treatment for LBW and anaemia at both AFPRCH 
and RVTH, it was deemed necessary to measure the time required for the patient/mother and 
their escort to travel to and from hospital and in addition, measure the contact time between 
health staff and the patient, as well as the waiting time at the hospital before the patient was 
seen. In the case of admission, the average length of stay for each condition was measured as 
well as the time spent by family members at the hospital during the admission. Time use for 
referrals from peripheral health facilities and AFPRCH, and between the two hospitals, was 
measured for the patient/mother and escort. 
The data required to arrive at the indirect costs of treatment for each condition was collected 
from the hospitals through direct observation (the time used for each), together with the hourly 
pay rate - see Sections 5.10.4 and 5.11. Data on travel time was collected through a short 
interview with the patients/mothers and their escorts. For those admitted, information was also 
collected on the number of visitors they had per day, the gender of the visitors and the duration 
of each visit plus any cash and material gifts their visitors brought. The family escorts who 
accompany women to hospital also leave households as well as subsistence work unattended. In 
an environment where women work for an average of 18 hours per day and the average number 
of hours spent working, excluding eating, leisure and dressing times, range from 6-15 hours per 
day (Chapter 2, Section 2.4), stepping in for an ill relative would mean leaving important work 
undone. Therefore, unpaid work time (farming, income or household work) lost due to 
treatment for LBW and anaemia has an opportunity cost to escorts as well as mothers because 
the time could have been spent on potential income-generating (productive), subsistence or 
household work. `Escorts' in The Gambia are usually sisters, sisters-in-law, mothers, mothers- 
in-law, and grandmothers within working age (observation study). 
Women in rural Gambia seek treatment from several sources such as health centres, community 
health nurses (CHNs), village health posts, local pharmacies, traditional healers, local shops and 
in very serious cases, hospitals. While this might be true for some conditions, the treatment for 
LBW and/or severe anaemia is mainly sought from hospitals. 
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In the case of anaemia, less severe cases could be treated at the outpatient departments but very 
low and extremely LBW babies require hospital admission. However, due to the erratic 
electricity supply at AFPRCH, coupled with a shortage of the necessary equipment such as 
incubators, all cases of LBW babies that require treatment are referred to RVTH. 
According to the safe motherhood costing manual (WHO, 1999), severe anaemia cases that do 
not require admission have to make an average of four outpatient visits (WHO, 1999), and 
results of a search of hospital records in both AFPRCH and RVTH revealed that the average 
duration of inpatient care for anaemia was seven days. For LBW, the average length of stay 
according to the data collected from RVTH was 21 days for LBW babies and 28 days for 
ELBW babies. These are against an average length of stay of 15 days for the paediatrics ward as 
a whole (LBW and other conditions). 
5.10.4 Study Five: Household time use survey 
The time use survey measured household time use by women in rural Gambia using observation 
and recall methods, each combined with a diary for the purposes of estimating the opportunity 
cost of their time. Given the similarity in household characteristics and the limited financial 
resources available for the study, a sub-sample of 5% (n = 45) of the antenatal care (ANC) user 
survey sample was used for the household time use study. The study area was divided into 14 
clusters with each being equal to a clinic in the IPTp trial. Ten clusters of nine households were 
randomly selected from the 14 clusters. By locating the centre of each of the clusters, and by 
tossing a coin, the first five households with multigravidae in the direction pointed by the `head' 
were selected. This was repeated for the nine clusters. This method is in line with the 
methodology used by Lule & Allwright (2003). However, instead of using a bottle, fieldworkers 
were comfortable using a coin in its place. 
The study was modelled on the time use survey recommended by the United Nations through 
the United Nations Statistical Division (UNSD). The survey tools contained patient 
identification and a diary to record the daily activities of the subjects in minutes, classified by 
major activities including economic activities for the market, non-market activities, domestic 
and social activities (UNSD, 2003) (see Appendix 9 for the time use diary). The `Trial 
International Classification for Time use Activities' (ICATUS), contained in Appendix 10, was 
adapted and used alongside the diary. The ICATUS was adapted according to activities usually 
performed in rural Gambian households with a view to making the time use information 
uniform and compatible across subjects. 
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Women in rural Gambia tend to be busier during the rainy than the dry season and so using only 
one of the two periods may overstate or understate the value of the time of women. In order to 
avoid bias in terms of seasonal variation of work between the two seasons, data were collected 
for both periods. As stated in Section 4.2, June-October and November-May represent the rainy 
and dry seasons respectively. The busy period in rural Gambia is synonymous with the rainy 
season when most of the rural women are busy cultivating their fields. 
Data collection during the dry season used the observation method, and seven consecutive days 
were used to collect information in order to account for the daily variation in activities and the 
corresponding times to undertake them. The data required for the observation study were 
collected through three different steps. First, a group of fleldworkers were recruited, trained on 
the administration of the diary and deployed at the various sites on daily basis for one week in 
June 2004 to observe the daily pattern of work by the study subjects. The instrument adapted 
and used for this purpose is the UN international time use study tools used in many developing 
countries (UNSD, 2003). A whole week was used for data collection in order to minimise bias 
due to disproportionate time use by day. In order to overcome problems of intrusiveness through 
long hours of observation, fieldworkers were asked to report to the households at 8 am when the 
family would have woken up and to leave by 7 pm. This period is the daytime in The Gambia. 
Second, 45 multigravidae from the study area were interviewed, 18 from LRD and 27 from 
NBE as to how they spent their day. Third, since the study was conducted in the dry season, in 
addition to the daily observation, one day of the survey week (Wednesday) was chosen for all 
fieldworkers to ask women to recall how they spent their time during the rainy season. 
During the recall session, memory-aid techniques were used to assist with the recall for the 
rainy season. Since the rainy season had already elapsed at the time of the survey (early June 
2004), women were asked to recall how they used their time during the period. As a way of 
jogging their memories, they were asked to state how they spent their time during the rainy 
season using a list that comprised common activities performed by rural women during the 
rainy season. The common household work in rural areas was reported by women at the ANC 
clinics using the clinic questionnaire is shown in Table 5.6. This gives the researcher an idea of 
the activities women forgo to attend the antenatal clinic. The recall period is not far off from 
some of the recommended periods for recall to be effective before memory evaporates [(2-3 
months, Brown & Adams (1992); 3 months, Rivicki et al (1994)); and 4 months Weissman et al 
(1996)]. 
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Table 5.6 Key activities performed by women in the study households 
As already indicated in Section 5.10.4, time use information was also collected for IPTp, 
outpatient, and inpatient treatment of LBW and anaemia at AFPRCH and RVTH, and referrals 
between all health facilities. All activities were coded and classified according to the UN 
classification system. The original UN ICATUS is a one-size-fits-all tool adapted for use in 
different parts of the world. This common classification is useful to ensure comparability 
between time use studies within a country, across countries, and to ensure correspondence with 
existing standard classification in labour and economic statistics and the integration of the time 
use studies within the field of social and economic statistics (Bittman, 2000). The categories and 
definitions of the activities in the ICATUS took into consideration the different cultural and 
geographical context in which the activities are generally carried out, thereby providing a basis 
for international comparison of time use studies (Bediako & Vanek, 1999). The ICATUS 
activities are divided into 10 categories according to the way they are treated in the System of 
National Accounts (SNA). These are: 
1. Employment for establishments; 
2. Primary production activities (not for establishments); 
3. Services for income and other production of goods (not for establishments); 
4. Household maintenance, management and shopping for own household; 
5. Care for children, the sick, elderly and disabled for own household; 
6. Community services and help to other households; 
7. Learning; 
8. Social and cultural activities; 
9. Mass media use; and 
10. Personal care and self-maintenance. 
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These categories were further grouped into three broad categories. 1-3 fall within the SNA 
production boundary and are usually included in GDP calculations; 4-6 are `work activities' but 
fall outside the SNA production boundary comprising mainly unpaid work; and the last group, 
7-10 are usually referred to as `non-productive' activities. The easy method of distinguishing 
between productive and non-productive activities is to invoke the third party criterion by 
assessing whether an activity can be performed by a third party on behalf of someone without 
the person performing it getting the benefit/enjoyment (Reid, 1934). Those activities that can be 
performed without the person doing the work taking the benefits/enjoyment are productive 
activities and the converse is true. For instance, household work is productive while eating is 
not. 
5.10.4.1 Reasons for choosing the Observation and Recall methods 
Several reasons made the use of the observation method of data collection appropriate. 
Resources, which are a common problem in such studies, were available to undertake the 
observation study. Furthermore, given the researcher's interest in the interaction between the 
women and the fact that these women do not have the literacy skills to complete a detailed 
written account, direct observation method became the feasible option. Otherwise, one would be 
obliged to conduct a detailed interview with each woman and then reconcile variations in 
memories. A clearer overview is obtained from observing them as timing is important for the 
survey, and the study population does not place the same importance on the measurement of 
time. The interest of the study is on a relatively small population that can be thoroughly 
observed, and on which a larger range of context details can be recorded from observation than 
one can collect from a fixed detailed instrument completed by the respondents. 
For a fixed instrument to work, one needs not only a clear conceptualisation of the context 
information being collected, but also to convey that context information in a way that will be 
clearly understood and reported by all respondents in a largely similar way. Given that some of 
the conceptualisations sought are outside their normal range of experiences, this information is 
more efficiently collected by observation. It was difficult to get fieldworkers in and out during 
the rainy season, and therefore, for this period it was necessary to resort to the use of the recall 
method of measuring unpaid work. 
5.10.4.2 Study Six: Employment Survey 
The aim of this survey was to collect wage information with a view to using it to value indirect 
costs of unpaid work. The reason for this survey is that unlike many countries where time use 
studies have been carried out, The Gambia has no labour force survey, and does not conduct one 
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on a regular basis. The entire fieldwork for this part of the study was conducted by full time 
fieldworkers who were trained and deployed at the study area for a period of 2-3 months. 
Women and men doing various types of work were asked about their pay and the time of work 
in terms of hours, days and months in a year. The data were collected through a survey of paid 
workers in the study site. These included maids, restaurant workers, and market cleaners. A 
random sample of restaurants (n=15), households with maids (n=15), farm workers (n=15), 
garden workers (n=15), market traders (n=20), taxi drivers (n=16), shepherds (n=6), water 
sellers (n=15) and firewood sellers (n=10) were interviewed. Where possible, equal numbers 
were chosen from each of the Health Divisions (LRD and NBE). The information obtained from 
the survey was supplemented with secondary data collected from some institutions that 
employed uneducated women and men within the study area. 
These included employment and pay records from AFPRCH in Farafenni, Soma Health Centre, 
and Department of State for Education (DoSE) School Feeding Programme. The Child Welfare 
section of the Christian Children's Fund (CCF) was also contacted for information on the 
payment and in-kind benefits to uneducated mothers employed in their various Day Care 
Centres. 
5.11. VALUATION OF UNPAID WORK 
A method was required to value time use. This was done by assigning hourly wage rates to the 
time use data collected. The wages used were taken from the employment survey conducted in 
the study area (Section 5.10.4.2). The two methods of valuing unpaid work are input and output 
methods, as stated in the literature review (Chapter 2). For this study, however, only the input- 
based approach is used despite the clear advantages of output method (Chapter 2). This is 
mainly due to a lack of adequate data to use the output method. Furthermore, since labour is one 
of the biggest inputs in seeking care, it will be necessary to use input rather than output method. 
However, due to lack of requisite data in The Gambia, a strict use of input method may not be 
possible. Instead, labour is used as a rough estimation of the value-added by household 
production. The time measured from the time use survey is converted into monetary units. 
Labour only estimates are a good start because household production is more labour intensive 
than production in most other economic sectors. 
The choice also made it possible to compare the results with other studies in the same setting 
that used different approaches (Picard et al, 1992; Aikins et al, 1998) and to test the sensitivity 
of findings to the selection method. 
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However, Brathaug (1990) and Budlender and Brathaug (2002) pointed out the possibility for 
the calculation to underestimate the full value of household production. To estimate the value of 
household work, the calculated hourly wage rates were multiplied by the time spent on unpaid 
household work. The four different methods used to value unpaid work are, the opportunity cost 
approach, replacement cost approach, human capital approach and the frictional cost approach. 
The opportunity cost approach was used as the base case while the rest of the methods were 
reserved for sensitivity analysis. 
5.11.1 Method One: Opportunity cost approach 
The opportunity cost approach, which is the most common costing approach used in The 
Gambia (Picard et al, 1992 & Aikins et al 1998), was employed in three different ways. First, by 
using an average wage rate paid to females; second, by using the average wage rate paid to 
males; and third, by using the overall average wage rate of females and males. 
5.11.2 Method Two: Replacement cost approach 
The replacement cost method used the wage of a `generalist', such as a full time paid 
household worker, as a proxy for the lost unpaid household work. This is the average wage of 
maids working on a full time basis for civil servants and in private homes in the study setting. 
The same calculation was repeated for a `specialist' by multiplying the time for each of the sub- 
components of household work by their respective wage rates. For this, the wages of those 
responsible for cooking and childcare at Christian Children's Fund (CCF) day-care centres and 
primary school cooks in the rural area were used. 
5.11.3 Method Three: Human capital approach 
The human capital approach (HCA) typically attributes economic value to unpaid household 
work, but mainly due to methodological or other difficulties involved in its measurement, it 
sometimes attaches zero values. In this case, only the subsistence component of the work 
forgone was valued, for the duration of impairment until the person is replaced. This can go 
beyond the maximum three months period stipulated in the case of the frictional cost approach 
(see below). 
5.11.4 Method Four: Frictional cost approach 
The fourth method is the frictional cost approach (FCA) that attributes a zero economic value to 
unpaid work up to the time the person can be replaced, but only for a maximum period of three 
months. 
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Therefore, a zero value was attached to the unpaid household component of the time spent 
attending the health/clinic facilities for IPTp and/or any subsequent treatments due to LBW 
and/or anaemia. 
5.12. HEALTH CONSEQUENCES 
The consequences of interest in this research are the cases and deaths from LBW and anaemia 
averted using the effectiveness information from the 2,688 women enrolled in the IPTp trial. 
Information on these health outcomes was analysed and made available by February 2005. The 
difference in the efficacy values was obtained when the trial blinding was finally broken. 
Consequences were also expressed in terms of DALYs averted by the researcher. The main trial 
did not make provision for the collection of information on case fatality rates of LBW babies 
and anaemic mothers. In order to fill this gap, case fatality estimates for LBW babies were 
obtained from the literature and those for anaemia came from the Preliminary Indicators (DoSH, 
2001) compiled by the DoSH, Epidemiology and Statistics Unit (ESU). Expert opinion was also 
sought from Dr David Osrin (Institute of Child Health, London) to shed more light on case 
fatality of VLBW and ELBW babies. 
The data on health care utilisation by LBW babies and anaemic mothers in The Gambia was 
obtained from The Gambia Public Expenditure Review report (DoSH, 2001a) and the WHO 
Safe Motherhood Costing Manual (WHO, 1999). Table 5.7 summaries the main health outcome 
measures used in the thesis. 
Table 5.7 Outcome measures 
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The outcome measures used in this study - cases of LBW/anaemia averted, deaths from 
LBW/anaemia averted and DALYs averted from LBW/anaemia - were compiled in three 
different ways. First, the cases of LBW and/or anaemia averted were obtained by multiplying 
the prevalence rates of each of these conditions by their respective sample sizes and then 
subtracting the cases for IPTp (SP) from those for routine antenatal care (placebo). Second, in 
the case of deaths averted, the number of patients who already had the condition was multiplied 
by the respective case fatality rates to obtain the expected deaths for ANC and IPTp. Third, the 
differences in number of deaths for ANC and IPTp gave the number of deaths averted because 
of IPTp. Case fatality rates of 12.5% and 100% were used for VLBW and ELBW respectively, 
and those used for very severe anaemia cases were 11.8% at AFPRCH and 2.5% at RVTH. The 
11.8% represents the LRD regional rate of anaemia case fatality and the 2.5% is the national 
case fatality rate for anaemia (DoSH7,2001). The cases and deaths averted are based on the 
cases seen at the hospital level. 
In line with current practice in The Gambia, all cases of VLBW and ELBW are referred to 
RVTH via AFPRCH for further care. According to the Safe Motherhood Costing Manual 
(WHO, 1999), 75% of all severe anaemia cases are `very severe', while the rest are classified as 
`severe'. Further, according to the Safe Motherhood manual (WHO, 1999) and the Standard 
Treatment Guidelines (STG) for The Gambia (DoSH, 2001), all mild anaemia and 30% of 
moderate cases are treated at the ANC level with adequate supply of folic acid. The remaining 
70% of moderate cases are referred to major health centres, where 90% are treated and the 
remaining 10% are referred to hospital, in this case the AFPRCH outpatient department. 
The majority of the severe anaemia cases (70%) are treated at the major health centre level, 
while the remaining 30% are referred to hospital. All very severe anaemia cases are referred to 
hospital for admission through the usual referral channel by using the health centre ambulances. 
Of those referred from health centres, 95% are admitted at the AFPRCH while the remaining 
5% are referred to the RVTH for further treatment. The final outcome measure is presented in 
the form of DALYs averted for LBW and anaemia. DALYs comprise two sub-outcomes - as 
Years of Life Lost (YLL) and Years Lived with Disability (YLD) - estimated separately. Both 
are estimated for routine ANC and then re-estimated after the introduction of the IPTp 
intervention by using the standard formula and assumptions provided by Murray (1994). The 
difference between the sum of YLL and YLD before and after IPTp gives DALYs averted. 
Preliminary Health Indicators, The Gambia. 
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DALYs averted due to the introduction of IPTp for LBW was the sum of DALYs averted for 
VLBW and ELBW. For anaemia, it was the sum of DALYs averted for those moderate, severe 
and very severe anaemia cases seen at the AFPRCH and/or RVTH. The age used to estimate 
DALYs averted for anaemia was the mean age of the women enrolled in the main effectiveness 
trial (28 years). The details of the assumptions used in estimating DALYs are indicated in Table 
5.8. 
Table 5.8 DALY assumptions 
Low Birth Weight 
Age at onset of LBW 
VLBW I day 
ELBW 1 day 
Age at death 
VLBW 7 days Hospital records 
ELBW 5 days Hospital records 
Case Fatality, Rate (CFR) 
VI-BW 12.5% DoSH 
ELBW 100% Expert opinion (Dr. Osrin) 
Period lived with disability 
VLBW 5 years Literature 
ELBW 5 years Literature 
Proportion of girls to boys 50% Central Statistic Department 
Anaemia 
Age at onset of anaemia 
Moderate/severe anaemia 30 years Clinic Questionnaire 
Very severe anaemia 30 years Clinic Questionnaire 
Age at death Clinic Questionnaire 
Moderate/severe anaemia 30 years Clinic Questionnaire 
Very severe anaemia 30 years Clinic Questionnaire 
Case Fatality Rate (CFR) 
Moderate/severe anaemia 0°/o Preliminary indicators, 2001 
Very severe anaemia 11.8% Preliminary indicators, 2001 
Period lived with disability 
Moderate/severe anaemia 4 days Assumption 
Very severe anaemia 30.4 days Assumption 
Source Literature, Clinic questionnaire and hospital records. 
As indicated in Table 5.8, onset of all types of LBW is day one of birth and those who die from 
the condition are assumed to die after seven days for VLBW and five days for ELBW. The 
proportion of those who die (CFR) was 12.5% for VLBW and 100% for ELBW. Those who 
survive the condition live with the effects up to five years and thereafter live a normal life. 
Those likely to die from severe anaemia will die at the same age as the age of onset of the 
condition, which was assumed to be the average age of women enrolled in the trial. Only very 
severe anaemia cases were expected to die which means the CFR for moderate/severe anaemia 
is zero. 
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5.13 RESOURCE SAVINGS 
The data required to estimate the treatment cost savings to the provider for both conditions 
(LBW and anaemia) are stated in Section 5.10. where outpatient, inpatient and referral costs 
have been estimated. These were combined with the outcome data estimated in Section 5.12 to 
estimate treatment cost savings to the provider, patients and their families. To estimate 
treatment cost savings to patients and their families, the direct and indirect costs generated from 
the previous sections were used. 
The cost of treating all cases (non-fatal and fatal) of LBW/anaemia were estimated for each arm 
of the trial using the costs estimated from Section 5.10. Resource savings are the difference 
between those treated for the control (ANC) and the IPTp intervention arms. For an effective 
intervention, cases and deaths from control are expected to be higher than those after the 
intervention. It is this difference in resource use that is equivalent to savings in treatment costs. 
These changes in resource use affect all those involved in the treatment and care such as the 
health care provider, patients, and their families. Resource use savings are estimated for LBW 
and anaemia for Base cases I and II; and the sum of the savings for the provider, patients and 
their families represent savings in each case. Where the intervention led to negative cases 
averted, instead of saving resources, the intervention could lead to depletion of resources by 
treating more cases of LBW and anaemia after IPTp than before. 
5.14. INCREMENTAL COSTS AND CONSEQUENCES 
Incremental costs and consequences were estimated for each condition as well as the cost per 
DALY averted for LBW and anaemia. The incremental costs and consequences were expressed 
for Base cases I& II. In addition to providing information on the incremental costs and 
consequences of the IPTp intervention, policy makers also require information on the type of 
variables likely to influence costs and consequences and the degree of influence. Therefore, 
sensitivity analysis was conducted by varying several parameters with emphasis on those that 
affect indirect costs. The parameters included various wage rates, discount rates, number of 
visits, effectiveness and case fatality rates, and DALY parameters. The effect of each of these 
on costs, consequences and incremental cost-effectiveness ratios was assessed. 
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5.15. SUMMARY 
This chapter has outlined the study objectives and highlighted the relationship between the 
study and the IPTp trial. The data collection methods and the studies required to collect the data 
were set out. Study one used a clinic questionnaire to obtain data to assess the incremental cost 
of introducing SP as part of routine antenatal care. Study two used a follow-up questionnaire to 
assess the consequences of LBW and anaemia to patients and their families. Studies three and 
four obtained the costs of treating a LBW baby and an anaemic mother in AFPRCH in 
Farafenni and of referral cases from peripheral health facilities to AFPRCH and to RVTH in 
Banjul. Where necessary, data were supplemented by unpublished sources such as reports and 
previous studies in the same setting. Study five used time use survey methods to assess how 
women in a typical rural household in The Gambia used their time to perform various tasks. 
Study six used a specially designed employment survey form to collect information on 
employment and payment for a random sample of uneducated women and men in the study 
area. All six studies provided the requisite data for the cost-effectiveness analysis. Sensitivity 
analysis was conducted to assess the effects of key variables, especially those affecting indirect 
costs. 
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CHAPTER 6: RESULTS I: HOUSEHOLD CHARACTERISTICS AND COSTS OF IPTp 
AND RELATED TREATMENT. 
6.1. INTRODUCTION 
This chapter presents the characteristics of the study subjects and their households as well as the 
costs of IPTp and related treatments in terms of IPTp intervention costs to health care providers 
and direct costs of IPTp to patients and their families. The focus is on those costs incurred in 
addition to the cost of routine antenatal care. The chapter is divided into eight sections. The first 
section contains the introduction, followed by the background characteristics of the study 
subjects including their demographic profiles in Section 6.2. The incremental cost of the IPTp 
intervention to the health provider is presented in Section 6.3, while Section 6.4 presents the 
direct costs of IPTp to patients and their families. Sections 6.5 and 6.6 calculate the incremental 
cost of IPTp and treatment costs for LBW and anaemia respectively, in order to use these later 
in the analysis of resource savings. The chapter ends with brief summaries of the results in 
Section 6.7. 
6.2. BACKGROUND CHARACTERISTICS 
This section looks at the background characteristics of the sample of 884 women recruited into 
the trial at the antenatal clinic level as well as the 662 who were later followed-up in their 
homes, Both household and individual level characteristics were examined. The background 
information of the sample was generated using a clinic questionnaire (see Section 5.10.1- 
5.10.1.1, Chapter 5). The characteristics of the women include age, number of living children, 
ethnicity, educational status, types of marriage. These characteristics were chosen on the basis 
that they are known to positively or negatively influence the use of antenatal services (Thaddeus 
and Maine, 1994; McCaw-Binns et al, 1995) and therefore by extension, the use of IPTp in The 
Gambia. The characteristics of the household heads include sex and education. The details of 
sample selection are presented in Chapter 5, Section 5.9.2 (methodology). 
6.2.1. Demographic and other profiles 
Of the 884 women recruited at the antenatal clinics, the ages ranged from 15 to 40 with a mean 
age of 26.8. Among those whose ages were reported (882), 61 had their ages estimated by the 
fieldworkers because their ages had not initially been indicated on their antenatal cards. Of the 
881 women who stated their ethnic background, more than half (56%) were Mandinka, followed 
by Fula, then Wolof, with the rest from other smaller tribes. In terms of education, most had 
Madrassa teaching (81%). 
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Madrassa, which is Islamic education, is a very common form of education in rural Gambia. 
Primary and secondary education constituted 6% and 4% of the 884 women. Approximately 
half of the women were married in monogamous relationships while the other half were 
polygamous. In terms of occupation, the results revealed that rural women tended to have more 
than one occupation. Of the 882 women who indicated their occupations, nearly all (99.8%) 
reported household work as their primary work and the bulk of these were also engaged in 
farming (64%). The rest also doubled as traders, school cooks, seamstresses etc. Details of the 
demographic profile are given in Table 6.1. The demographic profile of women in this study is 
representative of The Gambia as a whole. For instance, Mandinkas form the majority in the 
country followed by Wolofs and then Fulas and the age brackets of the women recruited for this 
study are also identical to the age distribution of the female population in the country (CSD, 
2006). 
Table 6.1 Demographic profile of the study sample 
Frequency Percentage 
SAMPLE SIZE 884 100.0 
Age (years) 
15-19 49 5.4 
20-29 542 61.3 
30-39 275 31.1 
40-59 17 1.9 
Ethnic Group 
Mandinka 496 56.1 
Fula 237 26.8 
Wolof 79 8.9 
Other 69 7.8 
Education 
No Education 68 7.7 
Madrassa 718 81.2 
Primary 56 6.3 
Secondary 36 4.1 
Tertiary 3 0.3 
Non-Formal 1 0.1 
Don't know 2 0.2 
Marital status 
Single 7 0.8 
Monogamous 442 50.0 
Polygamous 433 49.0 
Source: Compiled from Clinic & Main clTecti%eness questionnaires 
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Table 6.2 shows that the majority (66%) of women recruited in the economic study came from 
the Lower River Division and 68% of them were recruited during the dry season. In terms of 
type of facilities, approximately one-third of the women were recruited at outreach clinics 
(36%), followed by dispensaries (17%). 
Table 6.2 Characteristics of the women and the number recruited in the economic 
study per facility 
Frequency Percentage 
HEALTH DIVISION 
Lower River Division (LRD) 586 66.3 
North Bank East (NBE) 298 33.7 
Clinic 
Farafenni 103 11.7 
Iliassa 44 5.0 
Kerewan 43 4.9 
Ngeyen Sanjal 19 2.1 
Njaba Kunda 38 4.3 
No Kunda 34 3.8 
Pallen Wolof 4 0.5 
Sara Kunda 13 1.5 
Bureng & WellingaraBa 131 14.8 
DongoroBa 30 3.4 
Jalamberch 115 13.0 
Sare Musa 81 9.2 
Solna 229 25.9 
Recruitment Season 
Rainy (July - Dec) 279 31.6 
Dry (Jan - June) 605 68.4 
Type of facility 
Outreach Facility 321 36.3 
Dispensary ISO 17.0 
MCH clinic 103 11.7 
Minor I lcalth Centre 43 4.9 
Major Health Centre 229 25.9 
NGO Clinic 38 4.3 
Source: Compiled from Clinic & Main effectiveness questionnaires 
The measurement of fundal height or gestational age in the context of this study serves two 
purposes. Firstly, it indicates the duration of pregnancy at any given point in time. Secondly, it 
indicates the time at which women report to the antenatal clinic for the first time. According to 
the trial protocol, one of the main criteria for recruitment was for the women to be at a 
gestational age of at least 16 weeks of pregnancy. The gestational age of the women in the sub- 
sample of 884 women ranged from 16-40 weeks. 
142 
Table 6.3 shows that the bulk of the women recruited into the trial at 26-30 weeks (43%) were 
aged 20-29 years. The parities of the women ranged from 2-13 with almost half of them falling 
within the range of 2-4. The number of living children of the women ranged from 0-9 with 61% 
having 1-3 children living. Approximately 4% had no children. 
Table 6.3 Characteristics of the women and the number recruited per facility 
Frequency Percentage 
Sample size 884 100.0 
Gestational age (weeks) 
16-20 85 9.6 
21-25 191 21.6 
26-30 381 43.1 
31-35 170 19.2 
36-40 57 6.4 
Parity 
2--4 436 49.3 
5-7 322 36.4 
8- 10 110 12.4 
11 - 13 16 1.8 
Children alive 
0 33 3.7 
1-3 541 61.2 
4-6 276 31.2 
7--9 32 3.6 
Source: Compiled from clinic and main effectiveness questionnaires 
6.2.2. Characteristics of household heads 
Of the original 884 women who participated in the trial, 662 (75%) were followed-up in their 
houses, whilst the rest were lost along the way in the first month of recruitment due to delivery, 
transfer and travel. Of those followed-up, Table 6.4 shows that the majority lived in male- 
headed households. The number of wives in these households ranged from 1-4 with most having 
three or four wives. For the educational levels of the household heads, Madrassa education 
dominated (74%). The majority of the household heads (71%) stated farming as their main 
occupation. 
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Table 6.4 Household level characteristics of the study sample 
Source: Compiled from follow-up questionnaire. 
6.2.3. Summary 
It has been shown in this section that the ages of the multigravidae recruited for the trial ranged 
from 15-40, with the mean age being 26.8. Half of the women are Mandinka, the largest ethic 
group in The Gambia and most of them and their husbands had Madrassa education. 
6.3. INCREMENTAL IPTp IMPLEMENTATION COSTS TO THE PROVIDER 
The costs of the IPTp intervention can be generally divided into recurrent and capital costs, 
borne by the health provider and by patients and their families, as well as those borne externally 
to the wider health sector (Drummond et al, 1997). The costs of the IPTp intervention to the 
provider are presented in terms of total provider costs per health facility and average cost per 
patient per facility, and also incremental costs by inputs. Costs are presented in terms of Base 
cases I and II (see Section 6.3.1. for details on Base cases I and II). 
6.3.1. Total provider cost of IPTp by health facility 
The subject of interest in this study is multigravidae, who form a major component (75%) of 
those women who attend antenatal clinics in The Gambia (from facility records of antenatal 
attendance and the records of women who deliver at health facilities, the proportion of 
multigravidae to primigravidae was 3: 1). In order to obtain the total cost per facility, the unit 
cost per facility was multiplied by the number of multigravidae for that health facility. The sum 
of the sub-totals for the two divisions gives the total for the study site. 
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Two different samples were used for this study to obtain total costs. The sample size in the first 
case (Base case I) is the main trial data extrapolated to the total multigravidae population in the 
trial site and the second (Base case II) is the extrapolation of those multigravidae who do not 
sleep under bednets. In order to obtain the sample of multigravidae, the population of women 
within childbearing age of 15-49 years in the two study districts was projected, using the 1993- 
2003 average annual national population growth rate of 4.2%, and population figures of 68,373 
in year 2001 and 74,236 in 2003 and their corresponding antenatal care utilisation figure in 
LRD and NBE. Taking 75% of this figure, which represents the proportion of multigravidae 
among women of childbearing age, gave 55,678 (34,980 for NBE and 20,698 for LRD). This 
represents the number of multigravidae in NBE and LRD regardless of whether they took part in 
the trial or not, because any future change in policy would affect every multigravidae and not 
only those who took part in the trial. To obtain a sub-sample of non-bednet user multigravidae 
in the study site, 22% of 55,678 was taken, to give 12,249. The 22% represents the proportion 
of those multigravidae not sleeping under bednets as reported in this trial. 
From Chapter 5, Section 5.10.1.1, the two methods of observation and health provider 
estimates, plus use of secondary data, gave an approximate total time of six minutes for the 
three health staff involved in IPTp, with a mean time of two minutes per woman per staff 
member. This included the time for counselling of women about any likely side effects of taking 
drugs, time consumed in taking SP at the clinic, and all other potential time resource use 
activities associated with IPTp. For the remaining three visits to the health facilities for IPTp, it 
was assumed that half the time taken per woman (three minutes) in the first visit was needed per 
additional visit. This estimate of time for subsequent visits is consistent with the six minutes 
reported by Goodman et al (2001) in their cost-effectiveness analysis of antenatal malaria 
prevention in Sub-Saharan Africa. 
6.3.2 Results: Base case I- Recurrent and capital costs 
By multiplying the estimated unit cost per facility and the projected clinic utilisation figures, the 
total incremental recurrent cost incurred by 34,980 women in NBE was D525,845 and the 
amount for the LRD incurred by 20,698 women was D311,470. This is shown in Table 6.5. The 
corresponding amounts for capital costs were D46,670 and D26,138, for NBE and LRD 
respectively. In terms of total incremental provider costs, D572,515 and D337,607 were 
incurred in NBE and LRD respectively. In terms of cost distribution by health facility in NBE, 
Farafenni incurred the highest cost of D307,704 that comprised D284,911 and D22,793 for 
recurrent and capital costs respectively. 
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The facility with the lowest cost was Pallen Wolof with D26,532 (i. e. D24,296 for recurrent and 
D2,236 for capital). In the case of LRD, Soma had the highest cost with DI59,330 that 
comprised D147,361 and Dl 1,969 for recurrent and capital costs respectively. The facility with 
the least cost in LRD was Bureng with D22,512 (i. e. D20,654 for recurrent and D1,858 for 
capital costs). The average cost per patient ranged from D16.20-1316.74 with the lowest being 
the average cost per patient at Farafenni and the highest at Njaba Kunda. The details are as 
indicated in Table 6.5. 
Table 6.5 Incremental IPTp cost to the provider per facility (Base case 1) 
Clinic Multigravidae 
(n) 
Total recurrent 
(D) 
Total capital 
(D) 
Total cost 
(D) 
Average cost L 
per patient 
(D) 
North Bank East (NBE) 
Illiassa 1,994 30,091 2,951 33,042 16.57 
No Kunda 2,169 32,686 3,211 35,897 16.55 
Njaba Kunda 2,658 40,030 4,466 44,496 16.74 
Farafenni 18,994 284,911 22,793 307,704 16.20 
Kerewan 3,638 54,753 5,566 60,319 16.58 
Ngeyen Sanjal 2,169 32,686 3,016 35,702 16.46 
Sara Kunda 1,749 26,392 2,431 28,823 16.48 
Pallcn Wolof 1,609 24,296 2,236 26,532 16.49 
Sub-total 34,980 525,845 46,670 572,515 16.37 
Lower River Division (LRD) 
Soma 9,811 147,361 11,969 159,330 16.24 
Sare Musa 2,401 36,183 2,929 39,112 16.29 
Jalambereh 2,153 32,445 2,626 35,071 16.29 
Kureng 1,366 20,654 1,858 22,512 16.48 
DongoroBa 2,235 33,681 3,040 36,721 16.43 
WellingaraBa 2,732 41,145 3,716 44,861 16.42 
Sub-total 20,698 311.470 26,138 337 607 16.31 
TOTAL SS_67R 9117_t1G 72.808 910.122* 16.35 
Source: Health facility costing study 
' The difference between total costs in Tables 6.5 and 6.6 is due to rounding oft in excel 
6.3.2.1. Incremental cost of IPTp by input 
Table 6.6 provides the total annual recurrent and capital cost profile of IPTp to the health 
provider. The total recurrent costs were estimated at D837,315 and the total incremental cost of 
introducing IPTp at all 14 clinics in the LRD and NBE was D910,123. The drugs (SP) needed 
for IPTp comprised the largest single cost component with 73% of the total incremental cost. 
The next most costly recurrent item was antenatal personnel cost at 14%. The overall recurrent 
cost component represents 92% of the IPTp implementation cost. Specifically, recurrent cost 
comprised, firstly, drugs, which are the 12 SP tablets per woman given over four antenatal clinic 
visits. 
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Also included in drug costs was a 10% provision for freight (since the drugs are usually 
purchased outside The Gambia) and another 10% for any wastage. Recurrent costs also consist 
of small items of equipment such as buckets and disposable plastic drinking cups, utilities, DHT 
and DoSH supervision and ferry crossing. 
Table 6.6 Incremental provider cost of IPTp by input (Base case 1) 
Type of cost Cost (D) % of total 
Recurrent costs 
Drugs 668,136 73.4 
Materials and supplies 0 0.0 
Small equipment 949 0.1 
Utilities 3,341 037 
Personnel: 
Antenatal 125,277 13.8 
DHT 1,194 0.1 
DoSH 6,681 0.7 
DoSH ferry crossing 1,113 0.12 
Vehicle Operations & maintenance 30,624 3.4 
Sub-total 837,315 92.0 
Capital costs 
Building 0 0.0 
Transport 7,238 0.8 
Equipment 10,447 1.1 
Health promotion 29,512 3.2 
Training 25,611 2.8 
Sub-total 72,808 8.0 
Total cost of IPTp intervention 910,123* 100.0 
Source: Health facility costing study 
According to the Health Mapping Study (Synergy International, 1999), outreach health facilities 
in the Gambia do not have utilities such as running water, electricity and telephone because they 
are usually located in remote rural areas where such amenities are not available. For this study, 
the only cost recorded under utilities was water, which was obtained from local wells. It is also 
assumed here that the use of other utilities such as electricity and telephone in some of the base 
health facilities (where they exist) will only vary slightly with IPTp and so would not affect 
cost. Utility costs other than those for water have therefore been omitted. The final recurrent 
cost category shown in Table 6.6 is the operation of vehicles and their maintenance. The cost 
per kilometre (CPK) method is used by Riders for Health (RFH) for estimating the depreciation, 
operation and maintenance costs of the Department of State for Health (DoSH) vehicles. RFH 
are an international NGO whose services are outsourced by the DoSH to manage and replace its 
transport fleet. 
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They use the specific amount of £0.48 (GBP) which is equivalent to D25.44 for every kilometre 
covered. The CPK includes all the running costs of the vehicle such as fuel, lubricant, 
maintenance, the driver's pay and vehicle depreciation. 
The vehicle cost included at the intervention stage of IPTp considered only the additional 
kilometres and ferry crossing costs of the vehicle used by the supervisory team of the DoSH for 
their quarterly monitoring of IPTp. Although monitoring of programmes is routine in The 
Gambia, the introduction of new interventions usually means establishing special monitoring 
teams that comprise staff from the units involved in the implementation. The two units in the 
case of IPTp are Malaria Control and MCH. The use of the base facility trekking vehicle has not 
been included because regardless of whether IPTp is introduced or not, the usual monthly treks 
will continue to take place and would cover the same distances as when IPTp is introduced. 
Capital costs include the depreciated cost of the DoSH trekking vehicle, equipment, health 
promotion and initial training. The overall capital costs represent only 8% of the total 
incremental direct costs. The costs of health promotion, initial training and equipment represent 
the three highest cost items with the lowest being transport. The cost of training health staff to 
properly administer IPTp as well as the cost of sensitising the public through health promotion 
was depreciated at a conventional discount rate of 3% with their respective useful lifetimes of 
two and four years. As already mentioned, the capital cost of clinic buildings has not been 
included because the existing facilities did not require any expansion to accommodate IPTp. 
6.3.3 Results: Base case II - Recurrent and capital costs 
The incremental recurrent cost to the provider incurred by 7,696 multigravidae who do not use 
bednets in NBE was D135,382 and the corresponding amount for LRD was D80,299 by 4554 
multigravidae (details are in Table 6.7). The corresponding capital costs were D46,361 and 
D25,987, for NBE and LRD respectively. The total incremental costs for the two health 
divisions were D181,743 and DI06,287 for NBE and LRD respectively. In terms of cost 
distribution by health facility in NBE, Farafenni again incurred the highest cost of D95,575 
which comprised D72,967 for recurrent and D22,608 for capital costs. The facility with the 
lowest costs in NBE was Pallen Wolof with D8,552 (D6,329 recurrent and D2,223 capital). In 
the case of LRD, Soma had the highest cost with D49,655, comprising D37,743 recurrent and 
Dl 1,912 capital costs. The facility with the lowest costs in LRD was Bureng with D7,253 
(D5,408 recurrent and D1,845 capital). The average cost per patient ranged from D22.87- 
D25.31 with the lowest being the average cost per patient at Farafenni and the highest at Njaba 
Kunda. 
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Table 6.7 Incremental IPTp cost to the provider per facility (Base case II) 
Clinic Multigravidae 
(n) 
Total recurrent 
(D) 
Total capital 
D) 
Total cost 
(D) 
Average cost 
per patient 
D 
North Bank East (N BE) 
Illiassa 439 7,809 2,937 10,746 24.48 
No Kunda 477 8,473 3,191 11,664 24.45 
Njaba Kunda 585 10,355 4,452 14,807 25.31 
Farafcnni 4,179 72,967 22,608 95,575 22.87 
Kerewan 800 14,104 5,536 19,640 24.55 
Ngeyen Sanjal 477 8,473 2,996 11,469 24.04 
Sara Kunda 385 6,872 2,418 9,290 24.13 
Pallen Wolof 354 6,329 2,223 8,552 24.16 
Sub-total 7,696 135,382 46,361 181743 23.62 
Lower River Division (LRD) 
Soma 2,158 37,743 11,912 49,655 23.01 
Sare Musa Sig 9,362 2,914 12,276 23.25 
Jalambereh 474 8,418 2,617 11,035 23.28 
Bureng 301 5,408 1,845 7,253 24.10 
DongoroBa 492 8,738 3,015 11,753 23.89 
WellingaraBa 601 10,631 3,684 14,315 23.82 
Sub-total 4,554 80,299 25,987 106,287 23.34 
Total 12,249 215,681 72,348 288,030* 23.51 
Source: Health laciitty costing study 
* The difference between total costs in Tables 6.7 and 6.8 is due to rounding off in excel 
6.3.3.1. Incremental cost of IPTp by input 
The total recurrent and capital costs were estimated at D215,681 and D72,348 respectively. The 
highest recurrent cost items were drugs at 51% and the lowest three were utilities (0.26%), 
DoSH ferry crossing costs (0.34%) and DHT supervision cost (0.4%). The second most costly 
recurrent item was vehicle operation and maintenance 10.6%. The overall recurrent cost 
component represents 75% (74.9%) of the IPTp implementation cost. Capital costs ranged from 
2.4%-10.2% of the total IPTp costs, with the highest cost component being health promotion 
and the lowest, transport depreciation cost. The capital share of overall costs was 25% (25.1 %). 
The total incremental cost of introducing IPTp at all the 14 clinics in the LRD and NBE was 
D288,029. The details of the cost profiles are in Table 6.8. 
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Table 6.8 Incremental provider cost of IPTp by input (Base case II) 
Type of cost Cost (D) % Of total 
Recurrent costs 
Drugs 147,000 51.0 
Materials and supplies 0 0.0 
Small equipment 1,012 0.4 
Utilities 735 0.26 
Personnel: 
Antenatal 27,563 9.6 
DHT 1,274 0.4 
DoSH 6,616 2.3 
DoSH ferry crossing 979 0.34 
Vehicle Operations & maintenance 30,502 10.6 
Sub-total 215,681 74.9 
Capital costs 
Building 0 0.0 
Transport 6,982 2.4 
Equipment 10,486 3.6 
Health Promotion 29,401 10.2 
Training 25,479 8.8 
Sub-total 72,348 25.1 
Total cost of IPTp intervention 288,029* 100.0 
Source: Health facility costing study 
6.4 DIRECT COST OF IPTp IMPLEMENTATION TO PATIENTS AND FAMILIES 
As indicated earlier, IPTp was delivered through the existing antenatal clinics and so direct 
costs to women and those who accompany them to health facilities have mostly remained the 
same. However, the key difference between routine ANC and IPTp relates to the four visits 
required under IPTp compared with the average number of antenatal visits in the Gambia of 3.4 
(Chaco, 2003). Therefore, the direct cost of IPTp to women mainly comprises the additional 
fares women and their families pay to attend the health facilities and the out-of-pocket 
expenditure incurred at the facility for the extra 0.6 visit. Those who were accompanied to the 
health facility form a very small proportion of the sample size (n = 13). Therefore, the 
associated costs have minimal impact on overall direct costs. Furthermore, not all of those 
accompanied travelled by paid transport or spent money at the facilities. For these reasons, the 
costs related to those accompanied were dropped from the analysis. In the eight health facilities 
in North Bank East (Base and Outreach combined) where women were recruited into the trial, 
only six women indicated that they had incurred transport costs to attend Base facilities. The 
three base facilities were Farafenni (n = 4), Kerewan (n = 1) and Illiassa (n = 1). 
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No woman paid a fare to travel to any of the four outreach facilities in that health division. In 
the case of Lower River Division, out of two base facilities and four outreach facilities, only 10 
women from base facilities and two from outreach facilities used transport to attend clinics. The 
majority of those who used transport attended Soma Major Health Centre (n = 9). It was 
assumed that those who used transport to go to the health facility would use the same means to 
return home. 
In terms of out-of-pocket expenditure at the health facilities, 106 women spent an average of 
D336, attending base facilities in NBE. The corresponding figures for outreach facilities were 
47 women and D117. The majority of those who spent money at the base facilities in NBE 
attended Farafenni (n = 62). As for the outreach facilities, the majority of the women attended 
Njaba Kunda (n = 25). In LRD, a total of 145 women attended base facilities, expending an 
average total expenditure of D575. The corresponding numbers for outreach facilities were 113 
women and D226. The highest number of women who spent money at the facility attended 
Soma Health Centre (n = 95), with an average total expenditure of D475. For outreach facilities, 
the majority (n = 63) attended Jalambereh with an average total expenditure of D126. 
In summary, of the 884 women recruited into the trial, only 18 paid a fare to go to health 
facilities. This represents 2% of the sample, with the remaining women travelling by unpaid 
means. The highest number of those who paid for transport attended Soma Health Centre (n = 9) 
followed by Farafenni (n = 4). Similarly, of the 884 women recruited, 411 (47%) women spent 
money at the health facility. The highest individual out-of-pocket expenditure was incurred at 
Soma (D628) followed by Farafenni (D202), then Jalambereh (D 132). 
6.4.1. Results: Base Case I- Direct cost of IPTp to patients 
Using the same cost per woman, Table 6.9 shows that the total patient cost for IPTp per annum 
for NBE was D57,017 spent by 34,980 women. The corresponding figures for LRD were 
D33,738 and 20,698 women respectively. The total patient expenditure per annum was 
D90,755. Therefore, the total expenditure for a (0.6) additional visit for IPTp per annum was 
D54,453 spent by 55,678 women on fares and out-of-pocket expenses at the facilities. The 
average expenditure per woman for the extra 0.6 ANC visit was therefore D0.98. 
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Table 6.9 Total direct cost of IPTp to patients (Base case I) 
Clinic Multigravidae (n) Total 
(D) 
North Bank East (NBE) 
Illiassa 1,994 3,250 
No Kunda 2,169 3,535 
Njaba Kunda 2,658 4,333 
Farafenni 18,994 30,960 
Kerewan 3,638 5,930 
Ngyen Sanjal 2,169 3,535 
Sara Kunda 1,749 2,851 
Pallen Wolof 1,609 2,623 
Sub-total 34,980 57,017 
Lower River Division (LRD) 
Soma 9,811 15,992 
Sare Musa 2,401 3,914 
Jalamberch 2,153 3,509 
Bareng 1,366 2,2227 
DongoroBa 2,235 3,643 
WellingaraBa 2,732 4,453 
Sub-total 20,698 33,738 
TOTAL 55,678 90,755 
Total for 0.6 clinic visit 54,453 
Average per woman 0.98 
Source: Health facility costing study 
6.4.2. Results: Base Case 11 - Total direct cost of IPTp to patients 
Table 6.10 shows that the total patient cost for IPTp per annum for NBE was D12,547 spent by 
7,696 women. The corresponding figures for LRD were D7,425 and 4,554 women respectively. 
The total patient expenditure per annum was D 19,972. Therefore, the total expenditure for a 0.6 
visit for IPTp per annum was D11,982 spent by 12,249 women on fares and out-of-pocket 
expenses. 
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Table 6.10 Total direct cost of IPTp to patients (Base case II) 
Clinic Multigravidae (n) Total 
(D) 
North Bank East (NBE) 
Illiassa 439 716 
No Kunda 477 778 
Njaba Kunda 585 954 
Farafenni 4,179 6,812 
Kerewan 800 1,304 
Ngyen Sanjal 477 778 
Sara Kunda 385 628 
Pallcn Wolof 354 577 
Sub-total 7,696 12,547 
Lower River Division (LRD) 
Soma 2,158 3,518 
Sare Musa 528 861 
Jalambereh 474 773 
Bureng 301 491 
DongoroBa 492 802 
WellingaraBa 601 980 
Sub-total 4,554 7,425 
TOTAL 12,249 19,972 
Total for 0.6 clinic visit 11,982 
Average per woman 0.98 
Source: Health facility costing study 
6.5 INCREMENTAL COST OF IPTp IMPLEMENTATION 
The total incremental cost of the IPTp intervention is the sum of the costs incurred by the 
provider, patients and families. The recurrent costs as a percentage of total direct costs represent 
87% for Base case I and 72% for Base case II and the rest represent capital and direct costs to 
patients. Patient costs alone represent only 6% for Base case I and 4% for Base case II (see 
Table 6.11). 
Table 6.11 Total direct IPTp implementation cost 
Base case I costs 
(D) 
% Base case 11 costs 
D 
% 
Provider 
Recurrent 837,315 87 215,681 72 
Capital 72,808 8 72,348 24 
Sub-total 910,122 94 288,030 96 
Patients 
Direct 54,453 6 II, 983 4 
Sub-total 54,453 6 11,983 4 
TOTAL 964,576 100 300,012 100 
Sources: Tables 6.6,6.8,6.9 and 6.10 
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6.6. TREATMENT COSTS FOR LOW BIRTH WEIGHT AND ANAEMIA 
Treatment costs comprise those expenses incurred by the provider, patients and families in 
treating LBW and anaemia at the AFPRCH and RVTH, including any referral costs. 
6.6.1. Armed Forces Provisional Ruling Council Hospital (AFPRCH) 
The treatment cost of anaemia at the AFPRCH comprises not only outpatient, but also inpatient 
treatment costs of the very severe anaemia patients who are referred from peripheral health 
facilities and admitted to the maternity ward. 
6.6.1.1. Average referral cost from health centres to AFPRCH 
The average distance from the seven health facilities within the trial site to the AFPRCH was 22 
kilometres one-way, i. e. 44 kilometres for a return trip (Source: Head of Divisional Health 
Team (DHT), North Bank East and later Lower River Divisions). Given the poor road 
conditions, the average speed for health centre ambulances was a maximum of 50 kilometres 
per hour (health centre drivers), which means that a 44 kilometre referral to AFPRCH takes 0.88 
hours (53 minutes). By using the D25.44 per kilometre payment to Riders for Health (RFH) for 
the use of health vehicles including ambulances, an average referral cost per patient to AFPRCH 
from the peripheral health centres within the trial site was D1,119. The cost per referral incurred 
for the use of a referral nurse for the round trip was D9.79. This is based on the hourly wage 
rate of D11.13, an eight-hour working day and 249 working days per annum, from an average 
annual income of D22,176 per annum. 
6.6.1.2. Outpatient treatment cost of anaemia 
The average outpatient treatment cost of anaemia was obtained by dividing the total cost 
obtained from the step-down analysis by the admission and outpatient visit cases (details in 
Table 6.12). The cost of treating one anaemia patient at the OPD/Accident and Emergency (A & 
E) which are usually combined at the AFPRCH was D271 per visit (Table 6.12). Since 
outpatient anaemia treatment requires four visits according to the Standard Treatment 
Guidelines (STG) (DoSH, 2001), the average cost to the provider for the four visits was D1,084. 
6.6.1.3. Inpatient treatment cost of anaemia 
The average inpatient cost per day in the wards at the AFPRCH ranged from D94 for 
Opthalmology (including eye theatre costs) to the most costly, D492, for Leprosy/Tuberculosis 
ward. Maternity had an average inpatient day cost of D421. The costs of these and a number of 
other wards are indicated in Table 6.12. 
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6.6.1.4. Average referral cost from AFPRCH to RVTH 
The distance covered by an ambulance for a referral from AFPRCH to RVTH was 170 
kilometres each way and 340 kilometres for a return trip (Mbaye et al, 2006). The cost per 
referral using RFH charges per kilometre of D25.44 was D8,650. It is policy at the AFPRCH 
that referrals of a reproductive health nature such as LBW and anaemia are accompanied by a 
nurse midwife (Source: Acting Chief Executive of AFPRCH). The cost per escort nurse for the 
six hours referral time is D66.78 per trip. The 10% allowance for the A&E assessment cost to 
the provider for those patients referred to RVTH through AFPRCH was D27.10. 
Table 6.12 Unit cost of inpatient department and outpatient anaemia cases: AFPRCF( 
Source. Step-down costing data 
6.6.2. Royal Victoria Teaching Hospital (RVTH) 
The treatment cost of LBW and anaemia at the RVTH includes the inpatient care costs of 
VLBW, ELBW and very severe anaemia cases referred from the AFPRCH as well as the 
additional 10% allowance for the assessment cost at the A&E department. 
6.6.2.1. Results: Inpatient treatment costs of VLBW and ELBW babies at RVTH 
For the paediatrics ward, the average cost of admission, D2,364, was divided by the average 
length of stay (ALoS) of 15 days, giving the cost per patient day as D158 (Table 6.13). 
Therefore, the average inpatient day cost to the provider for VLBW treatment for the 21 days 
average length of stay was D3,318. The average inpatient day cost to the provider for an ELBW 
treatment was D4,424 for 28 days. The cost of assessment at the A&E was D35.60. 
6.6.2.2. Inpatient treatment cost of very severe anaemia 
To estimate the inpatient treatment cost of anaemia, the inflated 2003 cost of anaemia admission 
at the RVTH of D1,759 was divided by the ALoS for the maternity ward (seven days), which 
gives a cost of D251 per inpatient day, as indicated in Table 6.13. 
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Table 6.13 Unit Costs of Maternity and Paediatrics wards at the RVTH 
Source & year Ward Per OPD A&E ALoS IP Day 
admission (D) (D) (days) cost (D) 
(D) 
Fabricant & Maternity 1,132 109 22.9 7 162 
Newbrander 
(1994) 
Paediatrics 1,521 109 22.9 15 102 
2003 Maternity 1,759 169 35.6 7 251 
Paediatrics 2.364 169 35.6 15 158 
Source: WHO/DoSH Gambia study (1995). 
6.6.3. Direct outpatient and inpatient treatment costs of anaemia to patients and families 
at AFPRCH 
The direct cost of hospital treatment to patients and their families includes any expenditure by 
or on behalf of the moderate and severe anaemia cases seen at the OPD and also for the very 
severe anaemia cases admitted to the maternity ward. 
6.6.3.1. Direct outpatient treatment costs of anaemia to patients and families 
Part A of Table 6.14 shows that the average fare paid per patient for a return trip to the 
AFPRCH for an outpatient visit was D2 1. Since all the patients observed were accompanied by 
one female escort who travelled by the same mode of transport, the fare paid for a return visit 
per escort for an outpatient visit was also estimated to be 1321. In addition, a patient and escort 
paid D5 per trip on food and another D5 as user fees for the patient alone, an amount usually 
paid by every Gambian adult for an outpatient visit. The direct cost per outpatient visit to the 
patient was therefore D31. The average cost per visit including the costs incurred by both the 
patient and her escort was D52 (D31 and D21). Since the standard number of visits for the 
treatment of moderate and severe anaemia cases at the outpatient department was four (WHO, 
1999), the direct cost for the full outpatient treatment of anaemia was estimated to be D208. 
6.6.3.2. Direct inpatient treatment cost of anaemia to patients and families 
The average daily expense incurred by a family on behalf of a very severe anaemia patient 
admitted at the hospital was D28.57. In addition, a weekly hospital bed fee of D25 per adult 
patient is paid by every Gambian. Since the average ALoS for the maternity ward (including for 
anaemia patients) was seven days (Chapter 7, Section 7.6.2), the cost of admission incurred by a 
family was the sum of the daily costs for seven days plus the hospital fees which together added 
up to D200. Details of the results are presented in part B of Table 6.14. It is assumed that the 
cost of transporting those patients who died at the hospital to their homes in either NBE or LRD 
is covered by cash gifts received at the hospital. 
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Table 6.14 Direct costs to patients and families for OPD and IP treatment for anaemia: AFPRCH 
Hospital Cost determinants Fares 
(D) 
Bed 
fees/ 
user fees 
D 
Cash 
gift 
(D) 
Out of 
pocket/ 
food (D) 
Other 
(D) 
Total 
(D) 
A. AFPRCH Anaemia (Outpatient) 
Patient (n=66) 21.00 5.00 - 5.00 - 
Escort (n=66) 21.00 - - - - - 
Sub-total per trip 42.00 5.00 - 5.00 - 52.00 
Total for 4 trips 168.00 20.00 - 20.00 - 208.00 
B. AFPRCH Anaemia (Inpatient) 
Non-fatal 
Patient (n-20) - 25.00 - - - - 
Escort (n=20) - - - N/A N/A - 
Female visitor (n=63) 2.00 - 4.00 3.50 3.00 - 
Male visitor (n=40) 2.00 - 4.00 3.50 3.00 - 
Sub-total per day 4.00 3.57 8.00 7.00 6.00 28.57 
Total for 7 days 28.00 25.00 56.00 49.00 42.00 200.00 
Fatal cases 16 25.00 32 28 24 125 
Source: Hosoital o bservation study 
6.6.3.3. Direct referral cost from health centres to AFPRCH 
It was assumed that those patients referred from peripheral health centres used health facility 
ambulances at no direct cost to them or their families. It was said that health facilities staff ask 
families to contribute fuel for referrals but no such evidence was found at the AFPRCH or the 
surrounding health facilities. 
6.6.4. Direct treatment cost to patients and families at the RVTH 
The direct cost of hospital treatment to patients and their families includes any expenditure by 
or on behalf of VLBW and ELBW and very severe anaemia cases admitted at the paediatrics 
and maternity wards of the RVTH. 
6.6.4.1. Direct inpatient treatment cost of VLBW to patients and families 
The average cost incurred by family of a VLBW patient was D54 per day. This is shown in 
Section A of Table 6.15. The average inpatient treatment cost for a VLBW for the 21 days 
(ALoS) was D1,134. Since those who suffer from VLBW are usually infants of only a few days 
old, the weekly bed fees of D50 paid by anaemic mothers at the RVTH are waived for this 
category of patients. When successfully treated and then released home, the patient, his/her 
mother and the escort pay fare back to NBE or LRD. However, it was assumed that no new 
expenses were incurred for this as the amount was taken from the cash gifts received from the 
daily visitors (family and friends) at the hospital. 
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It was also assumed that the transport cost of a dead VLBW infant back to his/her home in NBE 
or LRD came from the same cash gifts. In practice, most of the infants who die at the RVTH are 
buried within the Greater Banjul Area (GBA) and in the process, save the family from costs 
related to transporting bodies to rural areas. 
Table 6.15 Direct costs of LBW and Anaemia treatment to patients and their families: RVTH 
Hospital Cost determinants Fares 
(D) 
Bed 
fees/user 
fees (D) 
Cash 
gift (D) 
Out of 
pocket/f 
ood (D) 
Others 
(D) 
Total 
(D) 
A. RVTH VLBW (Inpatient) 
Non-fatal 
Patient (n=8) - - - - - - 
Escort (n=8) - - - - - - 
Female visitor (n=50) 14.00 - 5.50 3.50 4.00 - 
Male visitor (n=21) 14.00 - 5.50 3.50 4.00 - 
Sub-total per day 28.00 - 11.00 7.00 8.00 54.00 
Total for 21 days 588.00 - 231.00 147.00 168.00 1134.00 
B. RVTH ELBW(Inpatient) 
Patient (n 4) - - - - - - 
Escort (4=4) - - - - - - 
Female visitor (n=30) 14.00 - 5.50 3.50 4.00 - 
Male visitor (n=12) 14.00 - 5.50 3.50 4.00 - 
Sub-total per day 28.00 - 11.00 7.00 8.00 54.00 
Total for 28 days 784.00 308.00 196.00 224.00 1512.00 
Fatal case 140.00 - 55.00 35.0(1 40.00 270.00 
C. RVTH Anaemia (Inpatient) 
Patient (n=15) 0.00 50.00 - - - - 
Escort (n=15) 0.00 - - - - - 
Female visitor (n=38) 14.00 - 5.50 3.50 4.00 - 
Male visitor (n= 12) 14.00 - 5.50 3.50 4.00 - 
Sub-total per day 28.00 7.14 11.00 7.00 8.00 61.14 
Total for 7 days 196.00 50.00 77.00 49.00 56.00 428.00 
Source: Hospital obsrrcation study. 
6.6.4.2. Direct inpatient treatment cost of ELBW to patients and families 
The daily cost incurred by the relatives of a patient in the case of ELBW was D54. Therefore, 
the total, including cash gifts, for the four weeks (28 days) was D1,512 (as shown in Section B 
of Table 6.15). 
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6.6.4.3. Direct inpatient treatment costs of anaemia to patients and families 
Those very severe anaemia cases admitted at the RVTH paid a weekly bed fee of D50 for the 
average seven-day stay and their families incurred daily expenses of D54, in the case of VLBW 
and ELBW. This gave a total of D428 for a seven-day stay. The details are shown in Section C 
of Table 6.15. 
6.7. SUMMARY 
The direct cost of IPTp for the year 2003 was explored in terms of costs incurred by the 
provider, patients and their families. The total incremental cost for the provider was D910,123 
and direct cost to patients was D54,453. Together, this gave a total direct cost of IPTp of 
D964,576 for Base case I (the total multigravidae population). The corresponding values for 
Base case II (the multigravidae population who do not use bednets) were D288,029, D11,983 
and D300,012. The average cost per patient ranged from D16.20-D16.74 in Base case I, with 
the lowest being the average cost per patient at Farafenni and the highest at Njaba Kunda. The 
average cost per patient in Base case 11 ranged from D22.87-D25.31 with the lowest being the 
average cost per patient at Farafenni and the highest at Njaba Kunda health facilities. Treatment 
costs to the provider of LBW and anaemia were calculated for use later in the analysis. 
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CHAPTER 7: RESULTS II: INDIRECT COSTS OF IPTp 
7.1. INTRODUCTION 
The aim of this chapter is to measure and value unpaid work by women in rural villages and 
towns in NBE and LRD. Town in this case refers to those busy commercial centres located in 
the study area such as Farafenni and Soma. The chapter deals with the use and organisation of 
time by women within the reproductive age group (15-49 years). The time use measured for 
each household activity is converted into monetary values using four different approaches. The 
values obtained using the opportunity cost approach are then used to estimate the indirect costs 
of the IPTp intervention as well as the unit indirect costs of treating LBW babies and anaemic 
mothers at the Armed Forces Provisional Ruling Council Hospital (AFPRCH) and the Royal 
Victoria Teaching Hospital (RVTH). 
This chapter is arranged into seven sections. Section 7.2 presents the results of the household 
time use survey in terms of the main (primary) activities. Section 7.3 presents the comparative 
analysis of time use results in terms of villages and towns, health divisions, season of the year 
and the day of the week. In Section 7.4, the value of time was estimated in hourly wage rate for 
women for various household tasks, and selected wage rates for men in the study setting. Four 
different approaches are then used to value time. Section 7.5 uses the wage rates calculated in 
Section 7.4 to estimate the indirect costs of IPTp intervention, and the indirect costs of treating 
LBW babies and anaemic mothers in 7.6. The treatment costs estimated were the unit indirect 
cost of treating anaemia at AFPRCH (outpatient and inpatient) and LBW and anaemia at RVTH 
(inpatient only) plus any referral costs between peripheral facilities, AFPRCH and RVTH. The 
chapter ends with a brief summary of the main findings in Section 7.7. 
7.2 TIME USE RESULTS 
This section presents the results of household time use activities in The Gambia with a view to 
contextualising the household data. This is necessary because activities that are usually included 
as part of unpaid work vary from one society to another, often depending on a country's level of 
development (Goldschmidt-Clermont, 1982,1987). 
160 
7.2.1. Time use indices 
Most time use analyses are based on the six indices shown in Table 7.1, defined according to 
their numerators and denominators (van den Broek, 2004, ESCAP, 2003). The two important 
estimates are the number of persons in the survey population and the number of survey 
participants engaged in the activity during the course of the day. The total number in the study 
population remains the same while the number of participants changes depending on which 
activity one considers. 
Measure (i) is the average duration of activity per person in the population, while (vi) refers to 
the average duration per activity per participant in that activity. The same interpretation applies 
to (ii) and (v) but using episodes instead of participants. The proportion of participants to total 
population (iii) is called the `participation rate'. The participation rate, which is a proportion, is 
the number of persons who actually spent time doing a particular activity divided by the total 
survey population comprising those who actually used time for the activity as well as those who 
used zero time (van den Broek, 2004, ESCAP, 2003). For the purpose of this work, only indices 
(i) and (iii) were used. The main reason for measuring and valuing time use in this thesis was to 
be able to value unpaid work and therefore the two indices identified, adequately serve that 
purpose. The first gives a detailed measurement of time use while the second determines the 
extent of women's participation in a particular activity. 
Table 7.1 Time use indices 
Denominator of Numerator of Index 
Index 
Total duration of Total number of episodes Total number of 
activity of activit persons doing all 
Total number of (i) Duration (ii) Episodes (iii) Participants 
_persons 
(population) 
All persons All persons All persons 
Total number of (iv) Duration (v) Episodes 
persons doing activity 
(doers/participants) 
Participants Participants 
Total number of (vi) Duration 
_episodes of activity Episodes 
Sourcc: Adaptcd from ESCAP, 2003 
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The presentation of results of the time use study takes two forms. First, the main activities were 
all ranked from the most time-consuming to the least time-consuming. According to the 
American Time Use Study (2005), it is a fact of life that people engage in more than one 
activity at a time and the major activity they perform at a specific time is known as the main or 
primary activity. In the case of this study, the main activities represent those activities the 
women were observed doing during the household survey. Those activities performed alongside 
the main activities are referred to as `parallel' or `secondary' activities (UNSD, 2005). For the 
purpose of this study, only main activities were considered. Similarly, in paid work, people 
spend part of their time multi-tasking and part in focused activity. They are normally paid for 
the main activity only. 
Second, activities were then classified using the standard United Nations classification system 
(ICATUS) as outlined in Section 5.10.4 and Appendix 10. For the purpose of this study, 
ICATUS has been adapted deliberately to reflect the types of unpaid work that are common in 
The Gambia. Instead of the 10 groups, only seven (2,3,4,6,8,9 and 10) were relevant for the 
study setting. The childcare component of Group 5 was incorporated into Group 4. The 
composition of the groups is outlined below while the adapted classification for The Gambia is 
presented in Table 7.2. 
Personal activities include bathing, seeking medical care, sleeping, eating and dressing. Mass 
media includes listening to radio, and where available, watching television. Listening to the 
radio is classified as a main activity by the UN classification scheme, but in most countries, 
listening to radio and even a good deal of television watching time is a secondary rather than 
primary activity. As the name implies, income includes any income-generating activities such as 
selling at the local markets or being engaged in some kind of paid work or schooling. Socio- 
cultural activities include receiving visitors, visiting others, parties and meals with people at 
home; making telephone calls during free time and community includes community work, 
meetings of political or religious nature and any travelling related to them. Finally, the time 
spent on main activities was compared across days of the week, villages and towns, health 
division (LRD or NBE); and season of the year. 
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7.2.2. Main activities 
The time use data obtained from the observation study are presented in Table 7.3. Column (1) 
represents the categories of main activities. Column (2) represents the non-zero respondents for 
a particular activity (i. e. those who spent any time on a particular activity). Column (3) 
, represents the zero respondents 
for an activity (i. e. those who did not spend time in a particular 
activity). Mean time use in hours is shown in column (4) (i. e. the average time use for those 
who actually undertook a particular activity during the survey week). Mean time is estimated 
using only those women who engaged in the particular activity on the week of the survey. 
Column (5) is the participation rate, which is the proportion of those who used time for an 
activity over the sample size (i. e. sum of non-zero and zero respondents). Mean time use in 
hours, shown in column (6), is the average time use for both those who actually undertake a 
particular activity and those who indicated zero time for the same activity. This is the average 
hours spent per day performing a particular activity, representing the time use by all those 
women observed during the survey week, including those who did not perform the particular 
activity (ATUS, 2005). It reflects the number of women engaged in an activity and the duration 
of time spent performing those activities. The last three columns (7,8 and 9) represent the 
minimum, maximum and the sum of time use per activity respectively. 
The mean daily time use for main activities according to the study was 12.7 hours per day 
during the dry season. The time range per activity was 0.00 1-2.8 hours with the lowest being the 
time taken to listen to radio or watch television (participation rate of 0.003) and the highest 
being the time taken to cook for the family (participation rate of 0.9). Unlike their counterparts 
in the urban areas where women normally cook twice a day, it is not uncommon for rural 
families to cook different dishes for the three meals (breakfast, lunch and dinner). The time- 
consuming nature of cooking in this setting may be a result of using firewood, which takes a 
long time to burn. This is especially true during the rainy season when the wood is often wet. 
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Table 7.3 Main household activities 
Main 
activities 
(l) 
None- zero 
respondents 
(2) 
Zero 
respondents 
(3) 
Mean 
time 
use 
( 
hours) 
(4) 
Participation 
rate 
(5) 
Mean 
time 
(hours) 
(6) 
Min. 
(hours) 
(7) 
Max. 
(hours) 
(8) 
Sum 
(hours) 
(9) 
Cooking 281 34 3.2 0.9 2.8 0.3 892 
Farming 105 210 4.6 0.3 1.5 0.2 9 487 
Resting/ 
sleeping 
247 69 1.9 0,8 1.5 0.1 7 465 
Fetching 
water 
267 48 1.2 0.8 1.0 0.1 4 319 
Laundry 120 195 1.6 0.4 (1.6 0.1 6 190 
Pounding 125 190 1.2 0.4 0.5 0.2 5 154 
Eating 280 35 0.5 0.9 0.5 0.1 2 148 
Chatting 98 217 1.5 0.3 0.5 0.1 10 146 
Meeting! 
ceremonies 
52 263 2.7 0.2 0.4 0.5 9 141 
Sweeping 231 84 0.6 0.7 0.4 0.1 4 132 
Market 
(Lumo) 
46 269 2.8 0.1 0.4 0.3 9 130 
Gardening 61 254 1.7 0.2 0.3 0.2 6 104 
Other 
household 
work 
87 228 1.1 0.3 0.3 0.1 6 100 
Visiting 
neighbours 
81 234 1.1 0.3 0.3 0.1 4 88 
Bath/dress 189 126 0.4 0.6 0.2 0.1 I 72 
Childcare 142 173 0.5 0.5 0.2 0.1 2 71 
Medical 
care 
22 293 2.8 0.1 0.2 0.6 10 61 
Fetching 
firewood 
35 280 1.5 0.1 0.2 0.1 6 51 
Travelling 9 306 5.6 0.0 0.2 2.1 11 S 
Washing 
dishes 
125 190 0.4 0.4 0.2 0.1 2 48 
Local shop/ 
Market 
46 269 0.9 0. l 0.1 0.1 3 41 
Preparing 
food 
25 290 1.2 0.1 0.1 0.2 4 29 
Plaiting 11 304 2.3 01) 0.1 1.0 6 
25 
Receiving 
guests 
24 291 0.8 0.1 0.1 0.2 3 20 
Praying 42 273 0.3 0.1 0.04 0.1 I 12 
Rest room 33 282 0.3 0.1 0.03 0.1 2 1 
Livestock 
rearing 
3 312 1.3 0.01 0.01 0.7 2 4 
Radio/TV 11 314 0.2 0.003 0.001 0.2 0.2 
0.2 
Total 44.1 12.7 
irce: I Iouschold observation study. 
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The most time-consuming work-related activities apart from cooking were farming, with 1.5 
hours per day at a participation rate of only 0.3, and fetching water, which had an average time 
use of 1.0 per day at a participation rate of 0.8. The farming sector contributes 20-25% of GDP, 
provides food, is a primary source of export earnings, provides inputs for agro-industry and has 
well-established linkages with other sectors especially tourism (CSD, 1995). Fetching water can 
be time-consuming and so occupies a big chunk of women's time. This is even more apparent in 
places where people depend on water from deep wells for their survival. The most common 
source of daily water is traditional wells that are several metres deep. More than one-third of 
Gambian women living in rural areas use wells as their main source of water (CSD, 1995). 
Laundry and pounding were next with respective times of 0.6 hours and 0.5 hours per day. 
Unlike other household work, laundry is not done on a daily basis in villages and towns but 
rather on specific days. Some communities consider it taboo to wash their clothes on certain 
days. Ironing has a direct relationship with laundry and is practised in almost all localities. 
Carrying out basic household work, including ironing, is seen as a sign of responsibility for 
women. Like any other unpaid household work, pounding occupies the time of rural women. 
Although the government and NGOs, such as the Catholic Relief Services (CRS), have made 
efforts to replace this labour intensive practice with grinding machines, pounding remains 
common in The Gambia. The remaining main activities took between 0.001 and 0.5 hours per 
day as shown in Table 7.3. 
7.2.3. Classification of main activities 
Table 7.4 and Figure 7.1 show that `household work' recorded the highest time use with an 
average time of 6.4 hours per day during the dry season. This was followed by `personal 
activities' with an average time use of 3.3 hours per day. Mass media recorded the least time 
with only 0.001 hours. Farming took up 1.8 hours per day. This comprises farming itself (1.5 
hours), gardening (0.3 hours) and livestock rearing (0.01 hours). Farming in The Gambia is 
rain-fed and therefore mostly done during the rainy season. However, the fact that the 
household time use survey was conducted very close to the rainy season could have accounted 
for the 1.5 hours farming time. Women use months close to the rainy season to prepare their 
fields in readiness for planting. Time use for income-generating activities, community activities, 
and socio-cultural activities all fell below one hour. 
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Figure 7.1 Time use by main activities in hours 
Classification of main activities 
Time in hours 
Source: Observation study. 
7.3. COMPARATIVE ANALYSIS OF TIME USE 
O Sehest 
The aim of this section is to conduct sub-group analyses of the time use data presented in 
Section 7.2.3, Table 7.4. The sub-groups analysed include time use by day of the week, by rural 
villages and towns, by health division and by season. 
7.3.1. Day of the week 
The main activities have been classified by day of the week, as illustrated in Figure 7.2. It was 
shown in Figure 7.1 and Table 7.4 that household work was the most time-consuming activity, 
with an average daily time use of 6.4 hours. This varied by day. Household time use for the 
same group of activities on Wednesday and Friday were 7.1 hours and 7.5 hours respectively, 
while farming for the same days were only 1.0 hours and 0.1 hours. 
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Figure 7.2 Time use by day of the week in the dry season in hours 
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These two days happen to be free days from farm work for most rural women. The reason for 
not working on farms on Wednesdays is that, traditionally, this day is regarded as a day of rest 
in rural communities (source: community leaders). Being a predominantly Muslim country, 
Fridays are usually set aside for prayers. However, since not all the women within the sample 
share the same culture or practise the same religion, time has been recorded for farming on these 
two days. 
The second most time-consuming activity was `personal time', at approximately three hours per 
day. One of the most important components of personal time was the time spent chatting and 
drinking `Attaya'. The most time-consuming days for farming were Saturday and Tuesday, each 
incurring 2.5 hours, followed by Sunday with 2.4 hours. The relationship between household 
work and farming on Wednesdays and Fridays is inverse. 
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While household work is highest on these two days, subsistence farm work is lowest. It is clear 
that women work a consistent amount of time on most days of the week, but the nature of the 
work shifts from farm work to household work on Wednesdays and Fridays. The reason for this 
is that women stay at home on these two days. The least time-consuming group of activities 
across all days of the week was mass media. 
7.3.2. Time use by rural villages and towns 
Figure 7.3 classifies the main unpaid activities by rural villages and towns. In the case of rural 
villages, the highest average time of 6.3 hours per day was spent on 'household work' and the 
lowest was on `Mass media' at 0.04 and then `community' activities with 0.1 hours per day. The 
corresponding times for rural towns were 7.5 hours for household and zero hours for both 
community and mass media. Across settlements, there were slight differences in the 
prioritisation of time by activity. 
Figure 7.3 Time use by rural villages and towns in hours 
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Source: Observation study. 
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7.3.3. Health Division - NBE and LRD 
Figure 7.4 shows the activities classified by Health Division; it presents the average time use 
per division. In NBE, the most time-consuming group of activities was again household work, 
with an average daily time use of 7.0 hours. The least time-consuming activity was mass media 
with an average time use of 0.04 hours per day. The corresponding figures for LRD were 5.9 
hours for household work and 0.0 hours for mass media. Looking in more detail, cooking came 
top in NBE with an average time of 2.9 hours per day at a participation rate of 0.9. At the lowest 
end was radio/television with an average time use of 0.001 hours per day at a participation rate 
of 0.01. In the case of the LRD, cooking and farming ranked first with an average time use of 
2.7 hours per day, with respective participation rates of 0.9 and 0.5. Lowest on the ranking was 
praying, with an average time use of 0.001 hours per day at a participation rate of 0.008. 
Figure 7.4 Time use by Health Division 
Time use by Health Division 
Time in hours 
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Source: Observation study. 
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7.3.4. Season 
Since the observation data were collected during the dry season, it was necessary to collect time 
use data for the rainy season as well. The method used to collect this data was explained in 
Chapter 5, Section 5.10.4. Figure 7.5 compares the average daily time use by season of the year. 
The prioritisation of time use altered between seasons. The highest-ranking group of activities 
changed from household work (6.4 hours per day) in the dry season to farming in the rainy 
season (8.7 hours per day). Household work time decreased from 6.4 hours in the dry season to 
4.0 hours per day in the wet season. The time used for personal activities also dropped from 3.3 
hours per day in the dry season to 2.8 hours per day in the rainy season. Similarly, the time 
allocated to community activities dropped from 0.2 hours to zero and that for socio-cultural 
from 0.6 hours to only 0.1 hours. All these activities were sacrificed in favour of farming during 
the rainy season. Since the two seasons are of equal duration (six months each), in terms of 
workloads, the average of the two was estimated. Farming and related activities had the highest 
average time with 5.3 hours per day, closely followed by household activities with 5.2 hours per 
day. The group with the lowest time use again was mass media with an average time use of 
0.0005 hours. All other groups fell between household (5.2 hours) and mass media (0.0005). 
Figure 7.5 Time use by dry and rainy seasons 
Average time use by season of the year (dry & rainy) 
8. 
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Time use in hours 
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Source: Household observation study. 
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7.3.5. Summary 
This section of Chapter 7 has reviewed different methods of measuring time use and uses a 
combination of methods to measure unpaid work in rural Gambia. From the results, cooking 
tends to attract more time followed by farming. The most time-consuming activity during the 
rainy season is farming. Cooking tends to be the most time-consuming pursuit in the dry season. 
In terms of time use by settlement, household work and petty trading are more common in the 
towns compared to farming in the villages. The result of the various sub-group analyses showed 
that the only comparison that produces disparity in time use was the analysis by season of the 
year. Henceforth, the combined average of the two seasons (dry and rainy) was used to estimate 
the indirect costs for IPTp intervention and any treatment of LBW babies and anaemic mothers. 
7.4. VALUATION OF UNPAID WORK 
The next sections are devoted to valuing unpaid work in monetary terms. Sections 7.4.1 and 
7.4.2 present the wage rates for women and men respectively, followed by the rates of pay for 
certain types of household work within the study setting. In Section 7.4.3, the time use data is 
used to calculate household work value using four methods. The values obtained are used to 
estimate the indirect costs of IPTp intervention and hospital treatment for LBW and anaemia. 
Details of the methods of valuation used are presented in Section 5.11, Chapter 5. 
7.4.1. Wage level for women 
Table 7.5 presents the average hourly pay rates for female workers in the study area. The table 
was generated after collecting data on monthly pay, number of days worked as well as the 
number of hours worked per day. The top four wage rates (i. e. two cash payment only and two 
cash and in-kind payments) will be further explained. In the case of market traders, the average 
number of days they work in a month is around 26 because they take only Sundays off. 
Dividing the daily income of D170 by 11 (the number of hours spent on income-generating 
activities) gives an average hourly rate of D 15.45. 
Uneducated day care workers are paid a monthly salary of D900 and in turn, they work for 16.3 
days, which gives a daily pay rate of D55.21. Based on their daily work regime of eight hours, 
their hourly pay rate was estimated at D6.90. In addition to the financial remuneration, carers 
also benefit from in-kind payment, which in this case is one meal per day. The estimated cost of 
the meal, lunch, was D12 and the hourly rate of in-kind payment alone was D1.50. 
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Therefore, the average hourly pay rate for a day carer, including in-kind payments, was D8.40. 
The monthly rate of pay for laundry was D400. Based on four different laundry days each 
lasting 12 hours (including ironing), the hourly rate of pay was estimated at D8.33. 
Another potential form of employment for women in rural Gambia is cooking at schools such as 
lower basic or basic cycles (formally primary & secondary), Madrassa and early childhood 
development schools, and health facilities. The remuneration for each category is presented in 
Table 7.5. From the survey results, it was revealed that school cooks work 196 days in a year 
and are usually paid one 50-kilogramme bag of rice per month for nine months in a year. These 
in-kind payments are usually from the school food supply normally given by the World Food 
Programme (WFP). The average length of the school term in The Gambia is 13.8 weeks, which 
translates into a total of 41.5 weeks in one academic year. 
Since there are five school days in a week, and the number of public or school holidays in the 
country is 11, it gives 196 working days in a year. Taking the market value of the nine bags of 
rice at D700 per bag and converting it to an hourly pay rate gives an average of D5.37. Since the 
cooks also benefit from free lunch at the school, the value of that in-kind benefit has also been 
taken into account for the 196 days they work and was equivalent to D2.00 per hour. Combining 
the average hourly rate of the two in-kind benefits the cooks receive gives an overall average 
hourly rate of pay of D7.37. The hourly wage rates for other less common types of work are 
also presented in Table 7.5. 
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- 170.0 Il 15.45 None - - - - 
15.45 
900 55.21 8 6.90 Meals 1 12.00 1.50 8.40 
400 100 I2 8.33 None - - - 8.33 
- None 6 0.00 50 kg bag of rice 9 6,300 32.21 
5.37 
6 Meal 1 - 12.00 2.00 
7.37 
- 6.00 None - - - - 
6.00 
- - - 5.93 None - - - 
5.93 
454 17.46 9 1.94 Meals 3 - 29 3.22 
5.16 
700 26.92 11 2.45 Meals 3 - 29 2.64 
5.09 
5.00 None - - 
5.00 
5.00 None - - - 
5.00 
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7.4.2. Wage level for men 
As is the case in Section 7.4.1 and Table 7.5, Table 7.6 presents the average hourly pay rates for 
male workers in the study area. The table was generated after collecting data on monthly pay, 
number of days worked as well as the number of hours worked per day. The top four wage rates 
(i. e. two cash payment only and two cash and in-kind payments) are further explained. 
Shepherds who look after cattle in the study area normally work for an average of 30.4 days per 
month for 12 hours per day. They in turn have the full milk product of the cattle at their disposal 
as their pay. The Shepherds realised an average of three gallons per herd of cattle and each 
gallon was sold for D35, giving an average daily total of D105. Translating that to an hourly pay 
rate gave D8.75. 
School caretakers normally work for 196 days in a year, eight hours a day with an average 
monthly pay of D653 (D550 pay and 103 allowance). In addition to their pay, they also benefit 
from one lunch every school day, worth D12. Translating this into a monetary value gave an 
average hourly pay rate of D6.51. The hourly cash pay rate for a farm labourer was D5.17 (i. e. 
D31 for six hours of work per day). 
The hourly cash pay rate for a taxi driver was D2.62 based on the monthly pay of D889 for 26.1 
days and a 13-hour work regime. In terms of in-kind payment, they benefited from three meals 
at D29 per day, which translated to D2.23 per hour. Combining the two, gave the average 
hourly rate of payment of D4.85. The average hourly pay rates for all the remaining types of 
work typically carried out by men in the study area are indicated in Table 7.6. They include 
health facility cleaners, bakers at AFPRCH, farm labourers, garden labourers, market cleaners 
and watchmen. The average hourly pay rate across all forms of work in the study area was 
D3.86. 
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day 
Hourly 
cash pay 
(D) 
Description of in- 
kind payment 
Quantity Amount 
per year 
(D) 
Amount 
per day (D) 
Hourly In- 
kind pay 
(D) 
Average pay 
per hour (D) 
- - 12 - gallons of milk 3 38,325 105 21.75 
8.75 
653 40.06 8 5.01 Lunch 1 - 12 1.50 6.51 
- 31 6 5.17 None - - - 5.17 
889 34.06 13 2.62 Meals 3 - 29 2.23 4.85 
- 28.69 8 3.59 None - - - - 3.59 
- 28.69 8 3.59 None - - - 3.59 
479 18.42 11 1.67 Meals 2 - 17 1.55 3.22 
582 22.38 8 2.80 None - - - - 2.80 
19.38 8 2.42 None 2 250 0.80 0.10 2.52 
- 19.38 8 2.42 Uniform 2 250 0.80 0.10 
2.52 
19.38 8 2.42 Uniform 2 250 0.80 0.10 2.52 
- 19.38 8 2.42 Uniform 2 250 0.80 0.10 
2.52 
19.38 12 1.62 None - - - - 
11i- 
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7.4.3. Results of valuation 
Table 7.7 shows women's time for potential wage earning activities. The average time use by a 
woman per day is 5.3 hours on subsistence work such as farming, gardening and livestock 
rearing and 0.2 hours on income-generating activities such as selling produce at the market. The 
household component is 5.2 hours. The three components together give a total time use of 10.7 
hours per day. 
Table 7.7 Daily pattern of unpaid time use 
Farming Income generating Unpaid household Total unpaid 
(hours) work (hours) work (hours) time use 
(hours) 
Total 5.3 0.2 5.2 10.7 
Source: Household observation study, Section I. 3.4 and t: igure /. ) 
As described in Section 5.11, an input-based approach was used, and the four methods for 
valuing unpaid work - opportunity cost, replacement cost, human capital, and 
fictional cost - 
applied by using the appropriate wage rates as shown in Table 7.8 to derive average hourly 
wage rates for women, men and for both men and women. These are D5.79, D3.83 and D4.77 
respectively. The time use for each component of unpaid household work is also included in 
Table 7.8. The average hourly wage rate for farming (D5.93) represents the average hourly pay 
rate for farm work and gardening (the same in this instance) and that of income-generating 
activities (D15.45) was the hourly pay rate for market trading. The cooking time (2.7 hours) 
includes the time for cooking itself (2.4 hours), preparing food (0.1 hours) and washing dishes 
(0.2 hours), which were assumed closer to cooking than any other sub-component. In the same 
vein, shopping at the local shop (0.1 hours) was categorised under any "other household work" 
(0.3 hours), giving an average of 0.3 hours. The wage rate paid for a cook (D5.51) was the 
average for a school cook (D7.37) and health facility cook (D3.65). The hourly wage rate for a 
laundress (D5.43) comprised the average of the hourly pay of a health facility laundress (D2.52) 
and a privately hired one (D8.33). The average hourly pay rate for `other household work' is 
based on the overall hourly average rate for female work (D5.75). The hourly wage rates for the 
remaining sub-components are shown in Table 7.8. The total values generated using the four 
methods are also presented in the table (Table 7.8). The highest (D62) was obtained using the 
opportunity cost approach when the average wage rate for women was used, and the 
replacement cost approach where the hourly wages of the various specialists were used. The 
lowest values were generated using the human capital approach (when household work is 
excluded) and the frictional cost method, which considers unpaid work to be zero. 
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The opportunity cost approach is used in subsequent analyses in this chapter to estimate indirect 
costs of the IPTp intervention and those for the treatment cost of LBW babies and anaemic 
mothers (Section 5.11 for details). The values obtained for the rest of the other three methods 
are used as part of the sensitivity analysis in Section 9.3 Chapter 9. 
7.5. TIME USE FOR IPTp IMPLEMENTATION 
The aim of this section is to use the results presented in Section 7.4.3 (using the opportunity cost 
approach of estimating unpaid household work) to calculate the indirect costs of the IPTp 
intervention as well as the indirect costs of outpatient and inpatient hospital treatments for LBW 
and anaemia. The indirect costs of referring LBW and anaemia cases from peripheral facilities 
to AFPRCH and then to RVTH are also estimated. 
7.5.1. Travel time and mode of travel 
From the 622 women (70.4%) who travelled to antenatal health facilities, the mean duration of 
travel one way was 0.75 hours (45 minutes), with the minimum and maximum travel times 
being 0.17 hours (10 minutes) and 4.5 hours (270 minutes) respectively. Assuming that these 
women returned home using the same mode of travel, the majority who attended antenatal 
health facilities spent one and a half hours (1.5 hours) travelling. The majority of the women 
who attended antenatal health facilities, walked (91.6 %). 
7.5.2. Waiting time 
On arrival at the health facility, women often spent a long time waiting to see health staff. In 
eliciting answers on waiting time, two approaches were used. One method asked the women to 
state their waiting time using the conventional 24-hour clock and the other approach used the 
rice cooking time as a proxy for waiting time. The latter approach was particularly useful for 
many rural women who are not literate and would therefore find it virtually impossible to state 
time in the conventional hours and minutes. As rice is the staple food in The Gambia, it is a 
matter of fact that all the women in the study area (i. e. village and town) know how to cook it. 
Of the 884 women in the sample, 69.8% (n=617) indicated their waiting time. The average time 
reported spent waiting to see a health professional was 1.78 hours (107 minutes). The minimum 
and maximum waiting times were 0.08 hours (five minutes) and six hours (360 minutes) 
respectively. By using the rice cooking approach, out of 880 women who answered the 
question, the majority (59.5%) waited at the facility for the time it takes to cook rice once, only 
1% waited for the time it takes to cook rice four times and 12% did not wait at all (Table 7.9). 
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Table 7.9 Waiting time approximated to rice cooking 
Rice cooling Frequency Percentage 
No wait 108 12.2 
Cook rice 1 526 59.5 
Cook rice 2 191 21.6 
Cook rice 3 43 4.9 
Cook rice 4 9 1.0 
Don't know 3 0.3 
Total 880 99.5 
Missing 4 0.5 
Total 884 100.0 
Source: Clinic questionnaire. 
A survey of 50 women in the study site observing their rice cooking times revealed that the 
average time per rice cooking was 1.23 hours (74 minutes), with minimum and maximum times 
being 0.88 hours (53 minutes) and 1.57 hours (94 minutes) respectively. When this was 
translated into conventional time, it gave an average waiting time of 1.51 hours (90.5 minutes) 
per woman, with the minimum and maximum waiting times being zero hours and 4.9 hours 
respectively. The difference between the conventional 24-hour clock and rice cooking methods 
of measuring waiting time at the health facility was 15.6 minutes. A paired test of the results 
showed that the difference between the two results is significant (p=0.00) at 95% confidence 
interval. However, it is not possible to tell which of the two methods is correct. In the case of 
this study, the conventional time was used in estimating IPTp intervention for easy comparison 
with other malaria studies that used the same method. However, the significant difference 
between the methods is noted. 
When women were asked to rate their waiting time, 9.4% (n = 880) rated it `very short', 38.2% 
considered it `long' and only 5.4% felt it was `very long'. On their level of satisfaction with the 
waiting time, 52.1 % said they were `satisfied', 25.4% were dissatisfied, while 9.3% were `very 
satisfied' compared to 1.9% who were `very dissatisfied'. 
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7.5.3 Opportunity cost of antenatal care time 
It was reported in Section 7.3.4 of this chapter that there are many other competing time use 
needs that have an effect on the health seeking behaviour of antenatal women. When asked what 
they could have been doing if they were not attending antenatal clinic on that day, most of the 
women indicated household work (89.9%), followed by farming (2.3%), paid work (1.8%), 
trading (1.6%) and other (0.2%). Only 0.1% said attending school and the rest indicated 
nothing. For those engaged in trading and paid work (3.4%), the average earning per day was 
D170 with the mode being D20 per day. 
In order to estimate costs related to escorts, women were asked to indicate whether they were 
accompanied to antenatal clinics or not. Out of 880 women, the majority (97.5%) were not 
accompanied. Antenatal health facilities in rural Gambia are utilised by women who often 
walked together from the same village. Therefore, except for those at the latter stages of their 
pregnancies or those who fell sick, women are unlikely to be accompanied. The very few, 1.5% 
(n=13) who were accompanied said they were new to the area and did not know the health 
facility procedure. One woman was accompanied because she had to use a horse cart, which is 
normally ridden by men. Apart from these few cases, the rest went to the health facilities in the 
company of small children or their peers. To assess how much more time women would lose for 
the rest of the clinic day, they were questioned whether they would return home immediately 
after the antenatal visit. The majority (92.9%) said they were going home straight away. 
7.5.4. Indirect cost of IPTp intervention 
As already explained in Section 6.3.1 of Chapter 6, six minutes was required for the IPTp 
contact time during the first antenatal health facility visit, and three minutes each for the 
subsequent three visits. Therefore, the total time required for IPTp contact was 0.25 hours (15 
minutes for the four visits). Travelling time for a return trip to an antenatal health facility was 
1.5 hour (90 minutes). However, the number of visits required for IPTp (n = 4) against the 
national antenatal visit rate of 3.4 visits, means an extra 0.6 visits for the IPTp alone. Therefore, 
the travelling time for IPTp was 0.75 hours (45 minutes). The average waiting time per woman 
at an antenatal health facility was 1.78 hours (107 minutes) using the conventional 24-hour 
clock method (Section 7.5.2). The total time required for IPTp was the sum of the contact time 
for IPTp (0.25 hours), the extra travelling time required (0.75 hours) and the waiting time of 
0.89 hours, giving the total time of 1.89 hours as indicated in Table 7.10. 
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Table 7.10 Time use for IPTp at the antenatal health facility 
The average hourly pay rate generated using the female wage rate (D5.79) calculated using the 
opportunity cost approach gave the unit indirect costs shown in Table 7.11. The unit cost for 
waiting was D5.15 and for contact was D1.45. The sum of these two and that for travel gave the 
total unit cost of IPTp as 1310.94. Therefore, the total indirect cost of IPTp for the 55,678 
women in the study area was D609,117 for Base case I and D 134,004 for Base case II. 
Table 7.11 Indirect cost of IPTp intervention 
Health facility Multi- 
gravidae 
Hourly pay 
rate (D) 
Travel 
cost (D) 
Waiting 
cost (D) 
Contact 
cost (D) 
IPTp cost 
(D) 
Total 
IPTp 
Base case 1 55,678 5.79 4.34 5.15 1.45 10.94 609,117 
Base case 11 12,249 5.79 4.34 5.15 1.45 10.94 134,004 
z!, ourcc: 'ourcc: Hospital observation study 
7.6. INDIRECT COSTS OF LOW BIRTH WEIGHT AND ANAEMIA TREATMENT 
The aim of this section is to present the results of the indirect costs for treating LBW babies, and 
moderately and severely anaemic mothers. It specifically takes into consideration the travel time 
to and from the hospital in the case of outpatient treatment for anaemic mothers and the waiting 
and contact time during hospital visits. Also included is the time taken by any caregiver (escort) 
accompanying the patient for the duration of care. The section also looks at the indirect costs of 
any admission for the two conditions at AFPRCH and any referral and subsequent admission at 
the RVTH. 
7.6.1. Indirect cost of outpatient treatment of anaemia at AFRPCH 
Table 7.12 presents the results of the hospital observation study of anaemia cases treated at 
AFPRCH in Farafenni and RVTH in Banjul. In the case of moderate or severe anaemia, 
treatment is possible at the outpatient department of AFPRCH in Farafenni. 
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It has been stated earlier in this chapter that a visit to antenatal health facilities takes about 1.5 
hours for a round trip (see Section 7.5.1) but the travel time to and from hospitals takes 
approximately four times more than it takes for a return trip to basic health facilities. The reason 
is that The Gambia is served by only four public hospitals (including AFPRCH and RVTH). 
This makes access to such tertiary health facilities more time consuming for patients than going 
to basic health facilities. In this study, all patients observed at the two hospitals were 
accompanied by at least one woman. 
The four hospital outpatient visits required an average of six hours of travel per trip per patient 
and 24 hours for the four trips. The average waiting time per patient per hospital visit was 1.85 
hours (111 minutes) with the lowest and highest times being 1.12 hours (67 minutes) and 2.8 
hours (168 minutes) respectively. The maximum times were attributed to periods of no 
electricity when women had to wait for a long time before getting results of blood tests. The 
average contact time with health staff was estimated at only 0.166 hours (10 minutes) per 
patient per trip with the total for the four trips being 0.66. The average time required for the four 
OPD visits was 32.06 hours (i. e. 24 hours on travel, 7.4 hours waiting and 0.66 contact times). 
Table 7.12 Time use for treating anaemia 
AFPRCH RVTH 
OUTPATIENT DEPARTMENT 
Moderate/Severe Anaemia Unit Unit 
Travelling 6 hours (2 ways) N/A 
Number of visits 4 visits 
Duration per visit 
Waiting 1.85 hours N/A 
Contact 0.166 hours N/A 
Total time use 2.01 hours None 
Number of escorts One woman N/A 
INPATIENT (ADMISSIONS) 
Very Severe Anaemia 
Average length of stay (non-fatal) 7 days 7 days 
Average length of stay (fatal) 4 days 4 days 
Number of Escorts One woman One woman 
Daily visitors: 
One woman 
n. -_ -. __ 
2 hours (4 - 6pm) 
n. c, t ----- 
2 hours (4 - 6pm) 
nice ý,... _.. 
Source: Hospital observation study and secondary data from AFPRC'II and RVTH 
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Using the hourly rate of pay of D5.79 estimated from the first valuation method of unpaid work 
(see Section 7.4.3) and multiplying it by contact, waiting and return travel times to hospital, 
gave a unit cost of D186. This represents the indirect cost for one anaemic mother treated at 
AFPRCH. Since all the patients were accompanied, the unit cost of D186 per patient was 
multiplied by two in order to accommodate the indirect cost incurred by the escort. Assuming 
the escort was a female, the same wage rate was used. As indicated in Table 7.13, the total 
indirect costs for a patient and one escort was D372. 
Table 7.13 Indirect cost of outpatient treatment for moderate/severe anaemia 
Number Travel Waiting Contact 
of visits time (hours) (hours) 
(hours) 
4 6.0 1.85 0.166 
4 6.0 1.85 0.166 
Hourly Travel Waiting Conta Total uni 
pay (D) cost (D) cost 1-4 ct cost 
cost (D) 
(I)) I (D) 
5.79 
study and secondary data from AFPRCH. 
7.6.2. Indirect cost of inpatient treatment of anaemia at AFPRCH 
In addition to outpatient treatment of anaemia, AFPRCH has the necessary facilities to treat 
some anaemic patients in-house. By using the hourly wage rate (D5.79) obtained from the 
opportunity cost approach of valuing unpaid work, the indirect cost of an anaemic mother 
admitted at AFPRCH for seven days was D434, the whole of which was incurred from the 
hospital inpatient time. The combined indirect cost per admission (including that of the escort) 
was D868. Through the observation study, it was discovered that every admitted anaemic 
mother had an escort, usually a close relative who stayed with her at the hospital for the entire 
duration of her hospital stay. 
In addition to their own time and that of their escorts, each patient had a female family visitor 
on a daily basis who stayed for an average period of two hours per day and a male visitor for 
only 0.166 hours (10 minutes) per day for the average of seven days she was admitted (hospital 
observation study). The official visiting time for all the public hospitals in The Gambia 
(AFPRCH and RVTH inclusive) is from 4-6 pm daily, except for weekends when the time is 
extended by one hour from 4-7pm. Unlike males, who rarely stay for more than an average of 
10 minutes, females tend to utilise the full visiting time each day. It is a daily occurrence for 
them to be asked to leave the hospital when the visiting hours are over. 
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The indirect cost per female visitor was Dlii and the corresponding cost for a male visitor was 
only D25. The average indirect cost per admission of an anaemic mother at AFPRCH was 
D1,004. The details of the indirect costs of patients, their escorts and visitors are given in Table 
7.14. The indirect cost for a fatal anaemia case that stayed in the hospital for four days was 
D573. All these costs are incorporated in the estimation of treatment costs for LBW and 
anaemia at the hospital. 
Table 7.14 Unit indirect costs of inpatient care for anaemia at AFPRCH 
Average 
Length of 
Stay (ALoS) 
(Days) 
Travel 
time 
(hours) 
Average time 
per day spent at 
the hospital 
(hours) 
Hourly 
pay (D) 
Travel 
cost (D) 
Inpatient 
(IP) cost 
(D) 
Total 
inpatient 
cost (D) 
Non-fatal case 
Patient 7 0.0 10.7 5.79 0.00 433.67 434 
Escort 7 0.0 10.7 5.79 0.00 433.67 434 
Female 
visitor 
7 0.75 2.0 5.79 30.40 81.06 111 
Male 
visitor 
7 0.75 0.166 3.83 20.11 4.45 25 
Total 51 953 1,004 
Fatal case 
Patient 4 0.0 10.7 5.79 0.00 247.81 248 
Escort 4 0.0 10.7 5.79 0.00 247.81 248 
Female 
visitor 
4 0.75 2.0 5.79 17.37 46.32 64 
Male 
visitor 
4 0.75 0.166 3.83 11.49 2.54 14 
m.. ý.. 7n £AA Cu 
Sourcc: Hospital observation study and secondary data from [TRCII 
7.6.3. Indirect cost of referrals of LBW babies and/or severe anaemia cases 
Referral for VLBW and ELBW is in two stages; from peripheral health facilities to AFPRCH 
and from AFPRCH to RVTH. Most of the very severe anaemia cases have one stage of referral 
(to AFPRCH only) but some rare cases have two (i. e. for those who had to be referred to 
RVTH). The main referral hospital in The Gambia is RVTH. Any illnesses that cannot be 
treated at rural hospitals, such as AFPRCH, are referred there for further investigation and 
treatment. In cases of very severe anaemia, VLBW and ELBW cases that are not usually treated 
at AFPRCH, immediate referral is made from health centres to AFPRCH and then to RVTH. 
The average time for the first referral to AFPRCH was 0.88 hours and that for a referral to 
RVTH in Banjul (including ferry crossing) was three hours. This information has been further 
verified by the candidate after following an ambulance for a single leg of a referral from 
Farafenni to Banjul. 
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Table 7.15 presents the results of the hospital observation study of LBW babies referred from 
peripheral health facilities to AFPRCH and on to RVTH. The average time use on the part of a 
patient and his/her escort for the first referral was 0.88 hours each and for the two was six hours 
(three hours each) for the second referral. Therefore, the indirect cost of the first referral of a 
VLBW and ELBW, and/or anaemic mother, are as indicated in Table 7.16; D5.10 for the patient 
alone and twice that amount (D10.20) for the patient and the escort. The corresponding amount 
for the second referral was D34.74 (i. e. D17.37 each). The indirect cost of the few minutes spent 
at the A&E departments of the hospitals during referral is considered too negligible to include. 
Table 7.15 Time use for treating low birth weight (LBW) 
AFPRCH RVTH 
OUTPATIENT DEPARTMENT 
Low Birth Weight (LBW) N/A N/A 
Referral 
First referral (LBW) 0.88 hours 3 hours 
Second referrals (LBW) 0.88 hours 3 hours 
INPATIENT (ADMISSIONS) 
Very Low Birth Weight (LBW) 
Average length of stay (non-fatal) - 21 days 
Average length of stay (fatal) - 7 days 
No. of Escorts - One woman 
Daily visitors: 
One woman - 2 hours 
One man - 0.166 hours 
Extremely LBW 
Average length of stay (non-fatal) - 28 days 
Average length of stay (fatal) - 5 days 
No. of Escorts - 1 woman 
Daily visitors: 
One woman - 2 hours 
One man - 0.166 hours 
Source: Hospital observation study and secondary data from AFPRCH and RVTH 
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Table 7.16 Unit indirect costs of referral from AFPRCH to RVTH 
Cost determinants Hourly pay Referral 
Number of 
Referrals 
Referral time 
(hours) 
(D) cost (D) 
First referral 
Patient 1 0.88 5.79 5.10 
Escort 1 0.88 5.79 5.10 
Sub-total 10.20 
Second referral 
Patient 1 3 5.79 17.37 
Escort 1 3 5.79 17.37 
Sub-total 34.74 
Source: Hospital observation study 
7.6.4. Indirect cost of inpatient treatment of VLBW and ELBW babies at RVTH 
The category of LBW babies being considered in this study (less than or equal to 1.5kg) are not 
usually cared for at the outpatient department in The Gambia for reasons already given in 
Section 5.10.3.5, Chapter 5. While the women are often advised to use the `kangaroo' method to 
care for the less severe cases (i. e. greater than 1.5kgs and less than or equal to 2.5 kgs), severe 
cases are usually admitted, mainly at the RVTH. The kangaroo method, according to WHO, is a 
non-conventional method of caring for LBW babies after initial stabilisation (WHO, 1997). It 
requires a continuous use of body heat (i. e. skin-to-skin contact) to keep the baby warm and to 
ensure exclusive breastfeeding. The method is often used as an alternative to incubator care for 
LBW babies, especially in environments where hospitals do not have such equipment or the 
apparatus are in limited supply (WHO, 1997). Although essential in overall care delivery, it was 
not within the scope of this study to investigate home care. 
The average length of stay in the paediatrics wards at the RVTH is 15 days. However, from the 
findings of the study conducted at the RVTH, complemented by the results of searching hospital 
records and interviews with key staff of the ward, it was found that non-fatal VLBW and ELBW 
babies admitted stayed for an average of 21 and 28 days respectively. It was also observed that, 
in addition to the mother of the child, an escort per patient stayed for the entire duration of the 
admission of the baby. The number and types of visitors, as well as the duration of visits, were 
not different from those recorded at AFPRCH in the case of hospitalisation of anaemic mothers, 
i. e. two hours per day for women and 0.166 hours for men (see Section 7.6.2). The details of 
indirect costs for VLBW and ELBW are presented in Table 7.17. The unit indirect cost for 
VLBW was D1,301 and for ELBW was D1,735. 
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By including the costs incurred by the escorts and daily female and male family visitors, the 
total costs for VLBW and ELBW rose to D3,011 and D4,013 respectively. The corresponding 
indirect costs for fatal cases at the hospital were D1,004 for seven days and 13717 for five days. 
Table 7.17 Unit indirect costs of inpatient care for LBW and ELBW at the RVTH 
Average Travel Average time per Hourly Travel Inpatient Total 
length of stay time day spent at the pay cost cost inpatient 
(days) (hours) hospital (hours) (D) (D) (D) cost 
D 
A. Non-fatal cases 
LBW 
Patient 21 0.0 10.7 5.79 0.00 1,301.01 1,301 
Escort 21 0.0 10.7 5.79 0.00 1,301.01 1,301 
Female 21 0.75 2.0 5.79 91.19 243.18 334 
Male 21 0.75 0.166 3.83 60.32 13.35 74 
Total 
VLBW 
152 2859 3,011 
ELBW 
Patient 28 0.0 10.7 5.79 0.00 1,722.46 1,735 
Escort 28 0.0 10.7 5.79 0.00 1,722.46 1,735 
Female 28 0.75 2.0 5.79 121.59 321.96 446 
Male 28 0.75 0.166 3.83 80.43 17.93 98 
Total 202 3785 4,013 
B. Fatal cases 
LBW 
Escort 7 0.0 10.7 5.79 0.00 430.61 434 
Female 7 0.75 2.0 5.79 30.40 80.49 111 
Male 7 0.75 0.166 3.83 20.11 4.48 25 
Total 
VLBW 
51 946 1,004 
ELBW 
Patient 5 0.0 10.7 5.79 0.00 307.58 310 
Escort 5 0.0 10.7 5.79 0.00 307.58 310 
Female 5 0.75 2.0 5.79 21.71 57.49 80 
Male 5 0.75 0.166 3.83 14.36 3.20 18 
Total 
UK our 
36 681 717 
Source: Hospital observation study and sccondarN data from RVTII 
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7.6.5. Indirect cost of inpatient treatment of anaemia at the RVTH 
The average length of stay for an anaemia patient as well as the number and types of visitors to 
these patients admitted at RVTH were the same as those reported for AFPRCH (Tables 7.14), 
i. e. an average of two hours per female and 0.166 hours (10 minutes) per male for seven days. 
Therefore, the total indirect cost for a non-fatal patient, her escort and daily visitors was also 
D1,004. The corresponding cost for a fatal case was D573 as shown in Table 7.18. 
Table 7.18 Unit indirect costs of inpatient (IP) care for anaemia at the RVTH 
Average length 
of stay (Days) 
Travel 
time 
(hours) 
Lost time 
per day 
(hours) 
Hourly 
pay (D) 
Travel 
cost (D) 
Inpatient 
cost (D) 
Total 
Inpatient 
cost D) 
A. Non-Fatal case 
Patient 7 0.0 10.7 5.79 0.00 433.67 434 
Escort 7 0.0 10.7 5.79 0.00 433.67 434 
Female visitor 7 0.75 2.0 5.79 30.40 81.06 111 
Male visitor 7 0.75 0.166 3.83 20.11 4.45 25 
Total 51 953 1,004 
B. Fatal case 
Patient 4 0.0 10.7 5.79 0.00 247.81 248 
Escort 4 0.0 10.7 5.79 0.00 247.81 249 
Female visitor 4 0.75 2.0 5.79 17.37 46.32 ' 64 
Male visitor 4 0.75 0.166 3.83 11.37 2.54 14 
Total 29 544 573 
Sourcc: Hospital observation study and secondary data from RVTH. 
7.7. SUMMARY 
The data presented in this chapter revealed that household work in rural Gambia varies only 
slightly by location and health division. However, the differences became more apparent when 
the same data were analysed by day of the week or season of the year. It was revealed that 
farming is predominantly practised in rural villages, while women in the rural towns spent more 
time on household work. In terms of days of the week, religion and culture play important roles 
in work patterns. For example, because of Friday prayers, women do not normally undertake 
farm work on that day, and for cultural reasons, Wednesdays are regarded as rest days from 
farm work by most communities. The results also reveal that women spent significant amounts 
of time waiting before accessing care, especially in hospitals. In terms of indirect costs, it was 
shown that LBW and anaemia could cost a lot of resources not only to those affected but also to 
their escorts and relatives as well. The indirect unit costs of treatment for LBW and anaemia 
were found to be far more than that of the IPTp intervention. 
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Specifically, the indirect unit cost of IPTp was D10.94, while indirect unit costs of treatment 
were D372 for outpatient treatment of anaemia, D1,004 for inpatient treatment of anaemia at 
AFPRCH, and D34.74 for referral of LBW/anaemia cases from AFPRCH to RVTH. The 
respective indirect costs of inpatient care for non-fatal VLBW and ELBW at RVTH were 
D3,011 and D4,013, with corresponding costs for fatal cases being D 1,004 and D717. Finally, 
D1,004 was the inpatient care cost of non-fatal anaemia cases admitted at the RVTH and the 
corresponding cost for a fatal case was D573. The variation in average hourly wage rate 
dependent on the method of valuation used is likely to mean that the size of indirect costs will 
depend greatly on the estimation method used. The influence of the method of valuing indirect 
costs on incremental cost-effectiveness ratios is explored in the sensitivity analysis (Chapter 9). 
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CHAPTER 8: RESULTS III: EFFECTIVENESS AND CONSEQUENCES OF IPTp 
8.1 INTRODUCTION 
This chapter presents the effectiveness of the IPTp intervention in terms of cases of Low birth 
weight (LBW) ((Very Low birth weigh (VLBW) and Extremely Low birth weight (ELBW)) and 
anaemia (moderate, severe and very severe) averted, deaths from LBW and anaemia averted, 
and DALYs averted. The resource use consequences of IPTp in savings to the health care 
provider as well as to patients and their families are also estimated. With the introduction of 
IPTp in The Gambia, it is hoped that, if effective, it will prevent LBW in newborn babies and 
anaemia in mothers. A lower incidence of LBW and anaemia and of care-seeking for these 
conditions will free up scarce provider and patient resources for other urgent needs. 
There are two main sections to this chapter; health consequences and resource-savings. Section 
8.2 presents the effectiveness results of the IPTp in terns of cases averted, deaths averted and 
DALYs averted of LBW and the three types of anaemia. This was done in two phases, Base 
cases I and II. Base case I uses the multigravidae population in the study site and Base case II 
uses the multigravidae population in the study site who do not sleep under bednets (either 
insecticide-treated or untreated). The resource use consequences of the IPTp intervention for 
Base cases I and II are the subject of Section 8.3. Finally, Section 8.4 summarises the key 
findings of the chapter. 
8.2 HEALTH CONSEQUENCES OF THE INTERVENTION 
The purpose of the IPTp trial was to curb the morbidity and mortality effects of LBW for infants 
of multigravidae and/or anaemia for mothers in rural Gambia. Therefore, the results were 
reported in relation to the prevalence of peripheral parasitaemia, birth weight and anaemia. 
Although all these three have been considered by the trial, the focus of the study reported here is 
on those resource-consuming conditions such as VLBW, ELBW, moderate and severe anaemia. 
This is because prevalence of parasitaemia may not necessarily lead to illnesses that require 
resource use (Amadou Mbaye, personal communication). The effectiveness data came from 
results of the trial itself. These data were extrapolated using the updated version of the 2001 
multigravidae figure reported in Chapter 6, Section 6.3.1. 
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8.2.1. Trial results 
The IPTp effectiveness results are presented in terms of cases of and deaths from LBW and 
anaemia averted due to the trial. Issues around confounding factors are outlined in the same 
section. 
8.2.1.1. Effectiveness of IPTp on LBW 
The effectiveness results of IPTp on LBW were presented in the form of mean birth weight for 
IPTp and control groups (Table 8.1). Further analysis of the data was conducted in order to 
adjust it into the three types of LBW required for this study. The proportion of LBW babies 
(<2500 g) for the main trial sample as a whole was 5.4% for IPTp and 7.1 % for control. There 
was no statistically significant difference between the IPTp and control in terms of mean birth 
weight (p=0.16) (Table 8.1). For women who slept under a bednet `always' and `sometimes', no 
significant difference between mean birth weights for the IPTp and control groups was found at 
the 95% confidence interval (p=0.87). However, there was a statistically significant difference 
in mean birth weight for those women who did not use bednets for IPTp and control (p-value 
=0.002) (Mbaye et a! 2006). 
A sub-group analysis conducted on the non-bednet user multigravidae (22%) in the study area 
produced prevalence rates of 4.3% LBW (<2500g) for IPTp and 7.4% for control (see Table 8.3 
later). The distribution of birth weights into various categories were, for IPTp, 4.3% LBW, 
0.5% VLBW and 0% ELBW, and the corresponding values for control were 7.4%, 0.3% and 
0%. 
Table 8.1 Mean birth weight (and prevalence of LBW) by bednet use and number of bednet 
treatments 
All Women 55,678 
(100% 
3103g 
(5.4%) 
30758 
(7.1 "%) 
28g 0.156 
Bednet Usage 
Always 40,840 (73%) 3091g 3088g 3g 0.872 
Sometimes 2,980 (5%) 3136g 3123g 13g 0.874 
Ne%cr 11,858 (22%) 3147g 
(4.3%) 
3004g (7.4`0 143g 0.002 
Number of treatments 
One 8,890 (16°) 3078g 3079g Ig 0.977 
Two 13,111 (24%) 3093g 3036g 57g 0.167 
Three 16,768 (30%) 3138g 3115g 23g 0.512 
Source: Extrapolated from the main effectiveness trial data. 
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8.2.1.2. Effectiveness of IPTp on anaemia 
The prevalence rate for anaemia as a whole was 11% for IPTp and 9% for control, as indicated 
in Table 8.2. These results showed that there was no statistically significant difference between 
IPTp and control at 95% confidence interval (p-value of 0.17). 
Table 8.2 Prevalence of anaemia by bednet use and number of treatment (percentage with anaemia 
in parenthesis) 
All Women 55,678 2,968/28,011 
l 1% 
2,412/27,401 
9% 
0.17 
Bednet Usage 
Always 40,391(73°) 1,829/19,080(10%) 1,325/18,312(7'/0) 0.11 
Sometimes 2,891(5%) 212/1,431 (15%) 27/1,246 (2%) NA 
Never 12,395 (22%) 742/5,645 (13%) 928/5,804 (16%) 0.40 
Number of treatments 
One 9,667(17%) 636/5,168 (12%) 451/4,426 (10%, ) 0.52 
Three 16,236 (29%) 795/7,553 (I I "o) 928/8,560 (11 %) 0.90 
Four 16,370 (29%) 769/8,136 (9%) 477/8,109 (6%) 0.10 
Source: Extrapolated from the mill) e uticone irial data 
A sub-group analysis of non-bednet users produced an anaemia prevalence rate of 13% for IPTp 
and 16% for control (Table 8.3). However the result was found to be less significant at 95% 
confidence interval (p-value = 0.40). The distribution of haemoglobin (Hb) concentrations into 
three types - mild, moderate and severe anaemia, as presented in Table 8.3 - shows that 
mild anaemia forms the largest group with 89.4% for IPTp and 91.2% for control, and the 
smallest was severe anaemia with 1.9% and 1.2% for control. Moderate anaemia lies between 
the two with 8.7% and 7.6% for IPTp and control respectively. 
Table 8.3 Distribution of LBW and anaemia in rural Cambia 
Categories 
Full sample ELBW 
<100o g 
VI. BW 
1000 g-1499 g 
LBW 
15002-2500g 
LBW 
IPTp 4.31/ý 0" '. 0.50i, 99.5941 
Control 7.4% 0% 0.3% 99.7% 
Anaemia 
Severe, <5g/dl Moderate, 5g/dt-7g/dl Mild, 7g/dl-llg/dl 
IPTp (IPTp) 1I I. 91ß) 8.7% 89.4% 
Control 9% 1.2% 7.6% 91.2% 
Source: Main effectiveness trial result. 
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8.2.1.3. Discussion on confounding factors 
The results of the trial revealed that, overall, IPTp with SP is not effective for multigravidae in 
The Gambia. A number of possible reasons were advanced for this. A previous study in The 
Gambia (Greenwood et al, 1989) in which pregnant women were given regular 
chemoprophylaxis with Maloprim found a reduction in the prevalence of LBW and anaemia in 
primigravidae but no significant effects on birth weight or anaemia in multigravidae, despite a 
reduction in parasitaemia (Mbaye at at, 2006). With the median attendance in the trial of three 
doses of SP for IPTp and of placebo for control, the compliance rate was above the WHO- 
recommended doses of at least two (Chapter 1). This good compliance is due to high antenatal 
attendance in The Gambia. 
As at 2003, the percentage of women aged 15-49 who attended antenatal clinics at least once 
during pregnancy, and were seen by skilled health personnel (i. e. doctors, nurses or nurse 
midwives) was 91 % (WHO, 1999). High compliance is likely to benefit HIV positive women 
on IPTp more than those on control, but in the case of The Gambia where the adult HIV 
prevalence rate is comparatively low (see Chapter 4, Section 4.6), this issue is not relevant. 
One important activity likely to have an effect on the outcomes of the trial was the weekly 
follow-up by fieldworkers during the entire trial period. During such follow-ups, women 
suspected of having severe anaemia at any point during the trial had their blood taken for Hb 
and parasitaemia tests and were referred to the hospital. Those women who developed a clinical 
attack of malaria (fever accompanied with a positive parasitaemia) during the study were treated 
with chloroquine in line with Gambia Standard Drug Treatment Guidelines, with careful patient 
follow-up and treatment with quinine if there was no improvement within 48 hours 
(MRC/Gambia, 2002). 
Furthermore, at each clinic visit, women were asked about side effects or complications of the 
study medication. Those with possible sulpha drug reaction had their blood taken for Hb and 
parasitaemia tests; and were completely withdrawn from the trial and did not receive any further 
SP (MRC, 2002) medication. This eventually left the trial with women who were free from any 
illnesses. Given that the LBW and anaemia status were measured after delivery, most of those 
women who might have been affected could have been withdrawn from the trial before their 
delivery time. The main difference between the trial and routine antenatal care in The Gambia is 
that the rigid follow-up, which was an integral part of the trial, is non-existent in practice. The 
implication of this is that the number of LBW and anaemia cases will be understated. 
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8.2.2. Health outcome measures 
The health consequences of the IPTp intervention are presented using the health outcomes of 
the trial under two scenarios or base cases. The first, Base case I, uses the effectiveness rates 
presented for the main trial, and the second, Base case II, uses the effectiveness rates for those 
not sleeping under bednets. This is because the effectiveness rate of IPTp for those women who 
use bednets and those who do not is different. The outcome measures in each case are presented 
in terms of cases and deaths averted from LBW, and anaemia, and in terms of DALYs averted 
for the two conditions. The details of these outcome measures are shown in Table 8.4. 
Contrasting effectiveness data from sources outside the trial are tested in sensitivity analysis 
(Section 9.3). 
8.2.3. Results: Base case I 
This sub-section presents the results of IPTp for Base case I in terms of cases of and deaths 
averted for both LBW and anaemia. In addition, DALYs averted were estimated and presented 
for the same Base case. 
8.2.3.1. Low Birth Weight 
The number of LBW cases was 3,953 in the control arm and 3,007 in the IPTp arm, leading to 
946 cases averted. The cases of VLBW for the control were 12, compared to 15 for IPTp. Of 
these, 10 and 13 cases, respectively, were successfully treated, leading to -3 cases averted. Two 
deaths in each trial arm occurred at the AFPRCH, leading to zero deaths averted. There were no 
cases of ELBW in either arm of the trial, which means the cases averted of ELBW were 
automatically equivalent to zero (see Table 8.4). 
Table 8.4 Effectiveness of IPTp on LBW for all multigravidae: Base case I 
Base case 1: Multigravidae population Frequency 
Control (PTp Cases/ 
Deaths 
averted 
Prevalence of LBW (all types) 3,953 3,007 946 
Low birth weight 3,941 2,992 949 
Very low birth weight 12 15 -3 
Extremely low birth weight 0 0 0 
Royal Victoria Teaching Hospital (RVTH) 
Very low birth weight (fatal) (12.5%) 2 2 0 
Very low birth weight (non-fatal) 10 13 -3 
Extremely low birth weight (fatal) 0 0 0 
Extremely low birth weight (non-fatal) 0 0 0 
Source: Main effectiveness trial and secondary data. 
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8.2.3.2. Anaemia 
The number of anaemia cases in the control arm was 5,011, compared to 6,125 for IPTp. The 
overall number of cases of all types of anaemia averted was -1,114. The cases of very severe 
anaemia were broken down as 45 for control and 87 for IPTp, giving -42 cases of very severe 
anaemia averted. The corresponding figures for moderate and severe anaemia cases averted 
were -152 and -14 respectively. The rest of the cases averted (-906) fell into the mild anaemia 
category. The cases of moderate anaemia treated at the hospital outpatient level numbered 38 
for the control and 53 for IPTp, leading to -15 cases averted. The cases of severe anaemia 
treated at the AFPRCH outpatient department were five for the control and nine for IPTp, 
leading to -4 cases averted. Of the non-fatal very severe anaemia cases treated at the AFPRCH, 
38 were from the control and 73 from IPTp, leading to -35 cases averted. The corresponding 
cases averted from those treated at the RVTH were only two, with more cases in the 
intervention than control. Therefore, the total number of non-fatal cases averted of very severe 
anaemia, treated at hospital was -37. In terms of deaths, five occurred on the control arm and 10 
on the IPTp arm, resulting in -5 deaths averted. These details are given in Table 8.5. 
Table 8.5 Effectiveness of IPTp on anaemia for all multigravidae: Base case i 
Frequency 
Control IPTp Cases/Deaths 
averted 
Prevalence of anaemia (a0 types) 5,011 6,125 -1,114 
Mild anaemia 4,570 5,476 -906 
Moderate anaemia 381 533 -152 
Severe anaemia 15 29 -14 
Very severe anaemia 45 87 -42 
AFPRCH 
Moderate anaemia 38 53 -15 
Severe anaemia 5 9 -4 
Very severe anaemia (fatal) (11.8%) 5 10 -5 
Very severe anaemia (non-fatal) 38 73 -35 
Referrals to RVTH 
Very severe anaemia (fatal) (2.5%) 0 0 0 
Source: Main elicctivcncss trial and secondary data 
8.2.3.3. Disability-adjusted life years (DALYs) 
DALYs averted because of IPTp varied from zero to -0.69 depending on the condition. The zero 
represents DALYs averted due to ELBW and the -0.69 due to VLBW. The total DALYs averted 
from LBW alone was -0.69. The DALYs averted for moderate, severe and very severe anaemia 
ranged from zero to -125.15. 
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The lowest figure represents DALYs averted for severe anaemia and the highest represents 
DALYs averted for very severe anaemia cases seen at the AFPRCH. The total DALYs for the 
IPTp intervention was -125.8. The details of the various DALYs are given in Table 8.6. 
Table 8.6 Summary of DALY estimated values: Base case i 
YLD YLL DALI's YL1) YLL DALYs DALYs 
Averted 
Low Birth Weight 
VLBW 4.80 61.46 57.70 5.41) 61.46 58.39 -0.69 
ELBW 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Sub-total 4.80 61.46 57.70 5.49 61.46 58.39 -0.69 
Moderate anaemia 1 0.06 1 0.00 1 0.06 1 0.08 1 0.00 1 0.08 1 -0.02 1 
8.2.4. Results: Base case 11 
This sub-section presents the results of IPTp for Base case 11 in terms of cases of and deaths 
averted for both LBW and anaemia. In addition, DALYs averted were estimated for the same 
Base case. 
8.2.4.1. Low Birth Weight 
The cases of LBW in Base case II were 906 for the control and 527 for IPTp, resulting in 379 
cases averted. All cases averted represent LBW babies, as illustrated in Table 8.7. There were 
no deaths in either arm of the trial, 
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Table 8.7 Effectiveness of IPTp on LBW for non-bednet users: Base case Ti 
Control I IP7'p I Cases/ 
deaths averted 
I Extremely low birth weight (fatal) 1010101 
o1y tuw utnn wei 
Main effectiveness 
8.2.4.2. Anaemia 
The cases of anaemia recorded by each arm of the trial were 1,961 for control and 1,592 for 
IPTp, leading to 369 cases averted. Of these, very severe anaemia accounted for 18 for control 
and 22 for IPTp, resulting in -4 cases averted. Other cases averted were -2 for severe anaemia 
and 10 for moderate anaemia, with the rest (365) being mild cases averted. Out of those seen at 
the hospital, 15 non-fatal cases of very severe anaemia were successfully treated from the 
control arm and 19 from the IPTp, leading to -4 cases averted. Of the number of moderate and 
severe cases treated at the outpatient department of AFPRCH, one and zero cases, respectively, 
were averted. Of the fatal very severe anaemia cases treated at AFPRCH, two each were treated 
from the control and IPTp arms, leading to zero deaths averted. There was one non-fatal case 
successfully treated at the RVTH from each arm, leading to zero deaths averted (see Table 8.8). 
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Table 8.8 Effectiveness of IPTp on anaemia for non-bednet users: Base case 11 
Prevalence of anaemia (all types) Control IPTp Cases/Deaths 
averted 
1,961 1,592 369 
Mild anaemia 1,788 1,423 365 
Moderate anaemia 149 139 10 
Severe anaemia 6 8 -2 
Very severe anaemia 18 22 -4 
AFPRCH 
Moderate anaemia 15 14 1 
Severe anaemia 2 2 0 
Very severe anaemia (fatal) (11.8%) 2 2 0 
Very severe anaemia (non-fatal) 15 19 -4 
Referrals to RVTH 
Very severe anaemia (fatal) (2.5%) 0 0 0 
Very severe anaemia (non-fatal) I 1 0 
Source: Main effectiveness trial and secondary data 
8.2.4.3 Disability-adjusted life years (DALYs) 
The sum of the DALYs averted for LBW in Base case 11 was zero. DALYs averted for the three 
types of anaemia were -0.13 as shown in Table 8.9. The DALYs averted for moderate and 
severe anaemia was zero each. The -0.13 represents DALYs averted for very severe anaemia. 
Therefore, the total DALYs averted for Base case II was -0.13. The details of the composition 
of the DALYs averted are presented in Table 8.9. 
Table 8.9 Summary of DALY estimated values: Base case 11 
Moderate anaemia 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Severe anaemia 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Verv severe anaemia AFRPC 0.47 49.44 49.79 0.60 49.44 49.92 -0.13 
I Sub-total 1 0.50 1 49.44 1 49.82 1 0.63 1 49.44 1 49.95 1 -0.13 1 
the main 
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8.3 RESOURCE SAVINGS 
Another consequence of the IPTp intervention is the potential resource savings to the health 
care provider, patients and their families. The consequences to the provider are in the form of 
treatment cost savings from VLBW, ELBW, and the three types of anaemia (moderate, severe 
and very severe), and from deaths which would have happened without the IPTp intervention. 
The consequences to patients are savings in direct and indirect hospital treatment costs of LBW 
and anaemia not only to themselves but also to their families. Further potential resource savings 
to patients and their families could arise when the number of deaths from LBW and anaemia are 
curtailed because of the IPTp. 
8.3.1 Results: Base case I 
The resource savings realised due to the IPTp intervention for Base case I in terms of savings to 
the provider, patients, and their families are presented in this sub-section. Since health 
consequences in the IPTp arm were in general worse than in the control arm, these resource 
savings were negative, and hence are termed for simplicity `resource losses' though the negative 
signs are retained here for consistency with normal practice. 
8.3.1.1 Losses to the provider 
The resource loss to the provider for the treatment of -3 cases of VLBW averted was -D39,68 1. 
The details are given in Table 8.10. This includes the referral transport cost from the peripheral 
facilities and the cost for the first escort nurse from health centre, 10% of A&E costs at the 
AFPRCH, referral cost to RVTH for the 340 km journey and the cost for the second referral 
nurse to RVTH, 10% of A&E costs at the RVTH and 21 days in-patient costs. The 
corresponding cost to the provider for a fatal VLBW and ELBW case at the hospital within 
seven days was zero because there were no deaths from either type of LBW. The loss to the 
provider for the treatment of -15 moderate anaemia cases, -4 severe cases, -37 very severe cases 
averted and -5 deaths averted (Table 8.10) was -D201,679. The total loss to the provider 
because of IPTp, which is the sum of losses from treating LBW and anaemia, was -D241,360. 
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Table 8.10 Summary of resource losses 
A. Base case I 
Provider -39,681 -201,679 -241,360 94 -39,681 -201,679 -241,360 77 
Patient & families 0 0 
Direct -3,402 -I2,433 -15,835 6 -3,402 -12,433 -15,835 5 
Indirect 0 0 0 0 -9,168 -47,551 -56,719 18 
Sub-total -3,402 -12,433 -15,835 6 -12,570 -59,984 -72,574 23 
B. Base case 11 
Sources: Tables 6.14- 6.15 and Tables 7.13-7.18 
ote: Grand total may not add up due to rounding. 
8.3.1.2 Losses to patients and families 
The direct treatment losses to patients and families from -3 cases of VLBW averted was - 
D3,402 and the loss incurred by patients and their families for the -15 cases of moderate 
anaemia, -4 severe anaemia cases, -37 inpatient cases averted, and the -5 deaths averted, was - 
D12,433. The total direct treatment loss from the two conditions was -D15,835. The total 
treatment loss for Base case I was -D257,197. From this, provider losses represent 
94% and the 
rest is attributed to losses incurred by patients and their families. The details of these results are 
presented in Table 8.10. 
When indirect costs are taken into account, the treatment loss to patients and their families from 
-3 cases of VLBW averted was -D12,570. The loss incurred by patients and their families for 
the -15 cases of moderate anaemia, -4 severe anaemia cases, -37 inpatient cases averted, and the 
-5 deaths averted, was -D59,984. 
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The total treatment loss from the two conditions (LBW and anaemia) was -D313,914. Out of 
this, indirect costs represent 18% of this cost and are 78% of the sub-total costs for patients and 
their family losses. 
8.3.2 Results: Base case II 
The resource savings realised due to the IPTp intervention for Base case II in terms of savings 
to the provider, patients, and their families are presented in this sub-section. 
8.3.2.1 Losses to the provider 
The saving to the provider in VLBW and ELBW cases averted in Base case II was DO. This is 
because no case was averted for VLBW (Table 8.10). The losses to the provider for treating one 
OPD anaemia patient case averted and -4 very severe anaemia cases averted was -D15,328. 
Total losses to the provider because of the IPTp intervention in Base case II remained at - 
D15,328; which is the sum of the losses from treatment of LBW (i. e. VLBW, ELBW) and 
anaemia. 
8.3.2.2 Losses to patients and families 
Considering only direct costs, the losses to patients and their families from cases of VLBW and 
ELBW were DO. Since there were no cases of VLBW and ELBW averted, it therefore followed 
that resource losses from treatment were zero, The loss to patients and their families for one 
OPD anaemia case averted and -4 very severe anaemia case averted was -D592. The total 
treatment loss for the two conditions (LBW and anaemia) was -D15,920. From this total, 
provider losses represent 96% and the rest is attributed to losses incurred by patients and their 
families. 
When indirect costs are taken into account, the loss to patients and their families from cases of 
VLBW and ELBW was again DO (since there was no case of VLBW and ELBW averted) and 
the loss to patients and their families for one OPD anaemia case averted and -4 very severe 
anaemia case averted was -D4,276. Of total direct and indirect costs to patients and families, 
indirect costs represent -D3,684 (86%). The total treatment loss for the two conditions (LBW 
and anaemia) was -D19,604 and indirect costs represent 19% of this total. Table 8.10 shows the 
details of losses to patients and their families. 
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8.4 SUMMARY 
The analysis of resource consequences of IPTp showed that the provider made a total loss of - 
D241,360 for Base case I. The corresponding loss to patients and their families was -D72,574. 
Out of this, -D15,835 was direct cost and -D56,719 (18%) was indirect. The total loss incurred 
in Base case I was -D313,914. The total loss incurred from Base case II was -D19,604, which 
comprised -D15,328 to the provider and -D4,276 to patients and their families. Of this total, 
indirect costs represented -D3,684 (19%). The number of cases and deaths averted that led to 
these losses were -3 LBW and zero deaths for Base case I and the corresponding figures for 
anaemia were -19 moderate/severe anaemia, -37 very severe anaemia cases and -5 deaths. No 
cases or deaths were averted for LBW in Base case II and only -3 cases and no deaths were 
averted from anaemia. The findings of the trial have raised many issues for the CEA and these 
are discussed in Chapter 10. 
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CHAPTER 9: COSTS, RESOURCE CONSEQUENCES AND ICER OF IPTp 
9.1 INTRODUCTION 
The main purpose of this chapter is to pull together all the results from Chapters 6-8 and to 
estimate costs and resource savings and, where relevant, Incremental Cost-Effectiveness Ratio 
(ICER) for the IPTp intervention. To estimate these, the costs and effectiveness values 
estimated earlier for Base cases I and II are put together. Specifically, the cases, deaths and 
DALYs averted as well as resource savings estimated in Chapter 8 are combined with the IPTp 
and treatment costs estimated in Chapter 6, and indirect costs from Chapter 7, to calculate the 
ICERs. The second part of the chapter is devoted to a sensitivity analysis that assesses the 
robustness of the assumptions. The base discount rate of 3% was used throughout this thesis but 
the effect of changing that discount rate on costs and consequences was assessed using other 
discount rates. The various methods of measuring indirect costs were used to assess the 
susceptibility of the costs and consequences to methods of measuring indirect costs. Other 
variables tested include referral (transport) and drug costs. On the effectiveness side, sensitivity 
of the prevalence and case fatality rates for LBW from the literature and those reported in The 
Gambia (UNICEF, 2000; Okoji and Oruambo, 1992) were tested on the IPTp costs and 
consequences. The effectiveness rate for primigravidae obtained from the literature and 
effectiveness rate from the trial for multigravidae were used. These parameters were tested 
because they are likely to have an effect on the results (Briggs et al, 1994; Briggs and Sculpher, 
1995; Briggs and Gray, 1999, Briggs, 2000). 
9.2 NET IPTp IMPLEMENTATION COSTS 
Table 9.1 contains the IPTp cost for Base case I (multigravidae population), Base case II (only 
those multigravidae who do not sleep under a bednet) and treatment cost savings that arose 
because of the intervention. Treatment cost consequences, which were estimated in the latter 
part of Chapter 8, were combined with the IPTp implementation cost to obtain net costs. The 
negative signs mean that cases of, and deaths from, LBW and anaemia were more for IPTp than 
for routine antenatal care, and thus costs are incurred in treating the extra cases compared with 
the control. These negative cost savings could be regarded as `losses' in resources which would 
not have occurred without the intervention. 
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By only considering direct costs, the IPTp cost, as indicated in Table 9.1, was D964,576 for 
Base case I. The treatment cost savings from the IPTp intervention for Base case I were - 
D257,195. The difference of the treatment cost savings and IPTp implementation cost gave the 
net IPTp costs for Base case I as 131,221,771. When indirect costs are considered in Base case I, 
the IPTp costs became D1,573,693 and the treatment cost savings from the IPTp intervention 
for Base case I were -D313,914. The difference of the treatment cost savings and IPTp 
implementation costs gave the net IPTp costs for Base case I as 131,887,607. The details of the 
estimations are presented in Table 9.1 and summarised in 9.2. 
By considering only direct costs, the IPTp costs came to D300,013 for Base case II. The 
treatment cost savings from the IPTp intervention for the same base case were -Dl5,920. The 
difference of the treatment cost savings and IPTp implementation cost gave the net IPTp costs 
as D315,933. When indirect costs were considered in Base case II, the IPTp cost became 
D434,016 and the treatment cost savings from the IPTp intervention were -1319,604. The 
difference of the treatment cost savings and IPTp implementation cost gave the net IPTp costs 
as D453,620,. The details of the estimation are presented in Table 9.1 and summarised in 9.2. 
206 
Table 9.1 Costs and consequences of IPTp 
Base case I 
(D) 
Base case I 
(D) 
Base case 11 
(D) 
Base case fI 
(D) 
Direct costs Direct and 
indirect costs 
Direct costs Direct and 
indirect costs 
LBW/Anaemia LBW/Anaemia LBW/Anaemia LBW/Anaemia 
Incremental IPTp cost 
Provider 
Recurrent 837,315 837,315 215,681 215,681 
Capital 72,808 72,808 72,348 72,348 
Sub-total 910,122 910,122 288,030 288,030 
Patients 
Direct 54,453 54,453 11,983 11,983 
Indirect 0 609,117 0 134,004 
Sub-total 54,453 663,570 11,983 145,987 
Incremental IPTp cost (D) 964,576 1,573,693 300,013 434,016 
Resource savings 
Provider -241,360 -241,360 -15,328 -15,328 
Patient & families 
Direct -15,835 -15,835 -592. -592. 
Indirect 0 -56,719 0 -3,684 
Sub-total -15,835 -72,554 -592 -4,276 
Total -257,195 -313,914 -15,920 -19,604 
Net IPTp 
implementation cost (D) 
1,221,771 1,887,607 315,933 453,620 
Sourcrs: 6.11.7.9_7 18 a nd x_ 10 
9.2.1 Cost and consequences of IPTp 
The aim of this section is to compare the health outcomes presented in Chapter 8 with the net 
programme costs shown in Section 9.1. The results are shown in Table 9.2. For Base case I, it is 
clear that the control, namely routine ANC, dominates, as illustrated by the negative sign, which 
indicates that rather than reducing the cases of, and deaths from, LBW and anaemia, the IPTp 
intervention instead led to more cases and deaths. The cases and deaths averted from LBW for 
Base case I were -3 and zero respectively. The corresponding cases and death from anaemia 
were -56 and -5. The cases and deaths averted from LBW in Base case 11 were zero each and -3 
and zero respectively (details in Chapter 8). 
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Table 9.2 Summary of costs and consequences of IPTp 
Base case I 
(D 
Base case li 
Direct costs Direct and 
indirect 
costs 
Direct costs Direct and 
indirect costs 
1. IPTp implementation costs 964,576 1,573,693 300,013 434,016 
2. Resource savings -257,195 -313,914 -15,920 -19,604 
3. Net costs 1,221,771 1,887,607 315,933 453,620 
Health consequences 
Case averted 
LBW -3 -3 0 0 
Anaemia -56 -56 -3 -3 
Deaths Averted 
LBW 0 0 0 0 
Sources Tables 8.4-8.9 and 9.1 
9.3 SENSITIVITY ANALYSIS 
The cost-effectiveness results presented in the two base cases are not cast in stone because many 
assumptions (for example, ALoS, CFRs, years lived with disability, etc. ) regarding the cost and 
effectiveness were made. Furthermore, not all the data needed for the analysis were available, 
which led to the use of additional data from outside the main trial for the analysis. Therefore, 
there is the need to ascertain how the results may be affected by changes in key assumptions. To 
assess uncertainties around these assumptions, a series of one-way and some multi-way 
sensitivity analyses were conducted. One-way sensitivity analysis involves the changing of only 
one variable at a given point in time and then assessing the effect on costs and consequences 
(Drummond et al, 1997). Multi-way sensitivity analysis involves changing more than one 
variable at a time and then assessing their collective impact on the results. 
In the case of this study, the key cost variables that were varied included the discount rate, drug 
prices, introduction of Haemoglobin (Hb) test, wage rates for indirect costs, number of OPD 
visits, average length of hospital stay and referral transport costs. In the case of health 
outcomes, the effectiveness and case fatality rates for LBW and anaemia were varied for each 
condition and then varied simultaneously, and then assessed their effects. There are no known 
cases of countries where policies of giving SP as IPTp are different between primigravidae and 
multigravidae. 
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The implication of giving IPTp to all gravidae was explored in the sensitivity analysis. The 
average effectiveness rates of IPTp for primigravidae, obtained from the literature, and those 
obtained from the trial were used with a view to assessing their combined effectiveness (see 
Table 9.3.2 for details). A description of each variable tested in the sensitivity analysis and the 
justification for their inclusion are given in Tables 9.3,9.3.1 and 9.3.2. In the presentation, 
ICERs are calculated only where the health effects of IPTp are positive. 
Table 9.3 Sensitivity analysis: IPTp and treatment costs 
Variable Base case Sensitivity Justification (s) 
values analysis 
values 
One-way sensitivity anal sis 
Discount rate 3% 6%, 10°/a In order for the results of this study to be comparable to other studies in Africa and other 
and 16.4% developing countries, the discount rate was varied from the base rate of 3% to 6% and 
10%. Furthermore, since the study is in The Gambia, it is appropriate to reflect that 
country's economic situation in the results by using the real interest rate of 16.4%. 
Change in drug 100% 200% The high level of the real interest rate at 16.4% is a pointer to unfavourable economic 
price conditions in the country. Given that, and the fact that The Gambia imports all her drugs 
from third countries means that future price rise is a distinct possibility. Therefore, the cost 
of drugs (SP) has been doubled and the effect assessed on the result. 
Change in drug 100% 75% It is possible that SP could be purchased from local wholesalers rather than importing from 
prices abroad. This could lead to substantial savings by the provider. Base on this fact, drug price 
was reduced by 25% and the effect assessed. 
Change in 0% 100% Haemoglobin (Hb) tests in theory are supposed to be part of routine antenatal care. 
materials and However, in practice, Hb tests are limited to certain base health facilities only. The 
supply costs implication of introducing Hb as part of IPTp was explored in sensitivity analysis. 
Number of 4 visits 2 visits The WHO-recommended number of doses of SP as IPTp used by most studies is two. To 
ANC visits make the results comparable to those that followed the WHO guidelines, it is worthwhile to 
use the same number of visits. 
Opportunity D5.79 D3.83, The base wage rate used to estimate indirect costs was produced by using the female wage 
cost (OPA) D4.77, rates within the study site through the opportunity cost approach. In line with the objectives 
D5.14, of this study, it is necessary to use the rates reached by each of the appropriate approaches, 
D5.98, using wage rates such as that of males (D3.83), average of male and female wage rate 
D2.43 (D4.77) (opportunity cost), market replacement wage of a specialist household worker such 
DO as maid (1)5.14), market replacement wage using generalist household worker's wage 
(D5.98), human capital approach (1)2.43) and frictional cost approach (0). 
OPD visits, 7,21 and 2 visits, The average length of stay for anaemia (7 days), VLBW (21 days) and ELBW (28 days) 
average length 28 3.5,10,5 seem to be high for this category of inpatients, which could be attributed to poor medical 
of stay (ALoS) and 14 standards in The Gambia. However, with time, this could be reduced to the level of other 
countries within the sub-region. Hence the need to assess the effect of the changes on costs, 
consequences and where possible ICERs. 
Referral costs 1)1,119 & D595 & There is concern amongst the health facility heads that Riders for Health (RFH) charge too 
1)8,650 1)4,325 much for their services, to a point that a review of their contract seems very likely. This is 
necessary because a review of the contract could in turn lead to the review of the charges. 
Proportion of 22% 61.4% The latest proportion of non-bednet users in NBE and LRD was 61.4%. This proportion of 
non-bednet women not sleeping under bednets was reported in a recently published report by the 
users Malaria Control Unit (MCU) of the DoSH (DoSH, 2004) which puts the non-bednet users 
in LRD and NBE at 49.9% and 72.9% respectively. The average of these has been applied 
here to assess their impact on the results. 
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Table 9.3.1 Sensitivity analysis: effectiveness 
Variables Base case 
values 
Sensitivity 
analysis 
values 
Justification (s) 
Change in DALY parameters 
Change in discount rate 3% 6%, 10% and 
16.4% 
It is worthwhile to assess the effect of changes in discount rates on 
the DALYs averted and the ICERs as recommended in the 
literature (Fox-Rushby and Hanson, 2001). 
LBW (years lived with disability) 5 yrs 9 yrs The years lived with disability for VLBW and ELBW was 
increased from 5 to 9 years. This is useful in making the results 
comparable to other studies (Fox-Rushby and Hanson, 2001; 
Anand and Hanson, 1997). 
Age at onset of anaemia 30 yrs 26.8 yrs To assess the effect of changes in age of women at the onset of 
anaemia on DALYs and ICERs; the median age of 30 used in the 
base cases was changed to the mean age of 26.8 (Fox-Rushby and 
Hanson, 2001; Anand and Hanson, 1997). 
Multi-way sensitivity analysis 
Prevalence rates for LBW 
LBW (Base case I) 7.1% 17.4% The average prevalence rate of LBW in NBE and LRD was 17.4% 
LBW (Base case II) 7.4% 17.4% (MICS) (UNICEF, 2000). 
VLBW 0.3% 3.8% These are the distribution of VLBW and ELBW cases compiled by 
ELBW 0% 2.4% the candidate from the AFPRCH. 
Case Fatality Rate (CFR) LBW 
VLBW 12.5 53.5% It is important to compare the national case fatality rates with those 
di 
ELBW 100% 89.7% es from the literature for easy comparison with other stu 
conducted elsewhere (Okoji and Oruamabo, 1992). 
Prevalence of anaemia 
Anaemia (Base case I) 9% 83% The prevalence rate of anaemia in The Gambia was used instead of 
Anaemia (Base case II) 16% 83% the trial rate in order to assess the robustness of the trial rate 
Severe anaemia (incl. very 1.2% 6% 
(NaNA/MRC, 2001) 
Moderate anaemia 7.6% 83% 
Case Fatality Rate (CFR) 
Severe anaemia (AFPRCH) 11.8% 11.8% The Case Fatality Rate (CFR) for anaemia in NBE was used as the 
Severe anaemia (RVTH)) 2.5% 11.8% uniform rate for both hospitals instead of using different rates for 
each hospital (DoSH, 2001). 
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Table 9.3.2 Multi-way Sensitivity analysis: effectiveness 
Multi-way sensitivity analysis 
Primigravidae & 
Multigravidae: birth weight 
Base case 
values 
Sensitivity 
analysis 
values 
Justification (s) 
Base case I 
LBW (IPTp intervention) 5.4% 7.9% The average effectiveness rates from the trial and Rogerson et at (2000) for IPTp 
((5,4+10.3)/2 = 7.9%) and control ((7.1 + 23)/2 = 15.1) were used to assess the 
cost-effectiveness of IPTp for LBW for all pregnant women sleeping under 
LBW (Control) 7.1% 15.1% ITN, 
Base case 11 
LBW (IPTp) 4.3% 7.3% The average effectiveness rates from the trial and Rogerson et at (2000) for 
LBW (Control) 7.4% 15.2% IPTp ((4.3 + 10.3)/2 = 7.3%) and control ((7.4 + 23)/2 = 15.2) were used to 
assess the cost-effectiveness of IPTp for LBW for all pregnant women. 
Distribution 
VLBW (IPTp) 0.47% 2.1% The average effectiveness rates from the trial and AFPRCH for IPTp 
VLBW(Control) 0.32% 2.1% ((0.47+8.9)/2 = 2.1) and Control ((0.32+13.1)/2 = 2.1) were used to assess the 
cost-effectiveness of IPTp for LBW for all pregnant women. 
ELBW (IPTp) 0% 1.2% The average effectiveness rates from the trial and that compiled from AFPRCH 
ELBW (Control) 0% 1.2% for IPTp ((0+2.4)/2 = 1.2) and Control ((0+2.4)/2 = 1.2) was used to assess the 
cost-effectiveness of IPTp for LBW for all pregnant women. The AFPRCH data 
was used because the trial did not make provision for the collection of CFRs. 
Case Fatality Rate 
VLBW 12.5% 33% The average case fatality rates for the trial and that from Okoji & Oruamabo 
ELBW 100% 94.9% (1992) for IPTp ((12.5+53.5)12 = 33) and Control ((89.7+100)/2 = 94.9) were 
used in order to assess the cost-effectiveness of IPTp for LBW for all pregnant 
women. The main IPTp trial did not make provision for collecting case fatality 
data. Therefore, for the purpose of CEA, AFPRCH and other secondary data 
were used instead (See Section 5.11.2) for details. 
Primigravidae & 
Multi ravidae: anaemia 
Anaemia: Base case I The average prevalence rates of anaemia (75.6%) reported by Shulman et at, 
Anaemia (IPTp) 11% 43.3% (1996) and from the trial for IPTp ((11 + 75.6)/2 = 43.3) and control ((9 + 
Anaemia (Control) 9% 42.3% 75.6)/2 = 42.3) for Base cases were used to estimate the cost-effectiveness of 
ll i f or a pregnant women. anaem a 
Anaemia: Base case 11 The same was repeated for Base case II: IPTp ((13+75.6)/2 = 44.2% and 
Anaemia (IPTp) 13% 44.2% Control ((16 + 75.6/2 = 45.8%) 
Anaemia (Control) 16% 45.8% 
Severe anaemia The average prevalence rates for severe anaemia for IPTp ((1.2 + 14.5)/2 = 7.9) 
Severe anaemia (IPTp) 1.9% 7.9% and Control (1.2 + 23.7)/2 = 12.8) reported by (Shulman et at, 1999) and from f l f i Severe Anaemia (Control) 1.2% 12.8% or a anaem a l the trial were used in order to estimate the cost-effectiveness o 
pregnant women. 
Moderate anaemia ((IPTp) 8.7% 42.2% The average prevalence rates of anaemia (75.6%) reported by Shulman et at, 
(1996) and the effectiveness rates reported by the trial for IPTp ((8.7+75.6)/2 
Moderate anaemia (Control) 7.6% 41.6% 42.2) and Control ((7.6 + 75.6)12 = 41.6) 
for Base cases I and 11 were used to 
estimate the cost-effectiveness of anaemia for all pregnant women. 
Case Fatality rate 
AFPRCH 11.8% 14% The average case fatality rates of 8-20% ((8+20)/2 = 14) from Shulman et a], 
RVTH 2.5% 14% (1996) were used instead of the rates from AFPRCH (11.8%) and RVTH (2.5%) 
to estimate the cost-effectiveness of anaemia for all regnant women. 
LBW and anaemia Direct and 
D5.79 
(indirect 
costs) 
DO 
D3.83, 
D4.77, 
D5.14, 
D5.98, 
D2.43 
Sensitivity analysis was conducted by changing costs by including and 
excluding indirect costs for all pregnant women and assessed their effects on 
ICERs. Furthermore, the effects of changes in indirect costs (wage rates) were 
assessed. This will make it possible to compare this study with similar studies in 
developing countries and to assess the effects of using various wage rates of 
valuing indirect costs on ICERs. 
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9.3.1 Change in discount rate, prices of drugs, materials and supplies use, number of 
doses 
Change in discount rate has its first impact on the IPTp costs, which in turn leads to a change in 
the net IPTp cost, Changing the base discount rate from 3% to 6% led to a modest increase in 
the IPTp costs by 0.3% for Base case I as illustrated in Table 9.4, Part A. While the resource 
savings remained unchanged, these changes led to 0.2% increases in the net IPTp costs. By 
further raising the discount rate from 3% to 10%, the IPTp cost for Base case I went up by a 
mere I% and the corresponding increase in net costs was I%. The final change in the discount 
rate was to raise it from the base rate of 3% to 16.4% (real interest rate in The Gambia). The 
result of the change was an increase in IPTp intervention costs by 1% from the base case. The 
change in discount rate led to corresponding increases in net costs for Base case I. The details of 
these results and the resource savings are in Table 9.4, Part A. 
Drugs are an important component of the IPTp intervention and so any variation in price first 
affects the IPTp cost with' a ripple effect on the net costs. Drug cost represents 73% of the 
incremental IPTp cost in Base case I (Section 6.3.2.1, Chapter 6). Given the high real interest 
rate in The Gambia, which is a pointer to poor economic conditions, a future increase in drug 
prices by 100% is realistic. The effect of an upward movement of drug prices by 100% led to a 
42% increase in IPTp cost for Base case I. These changes in turn led to 35% increases in net 
IPTp costs for Base case I as indicated in Table 9.4, Part A. 
The possibility of switching suppliers from outside to local wholesalers exists. This is also 
tested in sensitivity by reducing the drug price by 25% from the trial price as there will no 
longer be the freight cost. This will likely lead to reduction in drug price. The change in drug 
price from the base price of D12 to D9 per woman led to changes in the proportion of recurrent 
cost taken up by drugs from 73% to 67% for Base case I. The new incremental IPTp cost as a 
result was 131,406,659 and D797,542 for Base case I with and without indirect costs 
respectively. The net IPTp implementation costs were D1,720,573 and D1,054,737 with and 
without indirect costs for Base case I respectively. Reduction in SP price by 25% led to 11% 
decrease in IPTp costs. With resource savings remaining the same, the net IPTp costs also 
decreased by 9%. The results of changing the SP prices by 25% are illustrated in Table 9.4, Part 
A. 
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Haemoglobin (Hb) testing is considered part of routine antenatal care (ANC) rather than IPTp 
per se. However, where it is not part of routine ANC, all the related costs of Hb testing ranging 
from materials and supplies to small equipment such as sharps and sharp boxes for disposal of 
sharps will have to be taken on board. Materials and supplies costs for Hb testing were not 
included in the cost estimation of the total IPTp costs for Base case I. Introducing the Hb test in 
IPTp led to over 500% increase in IPTp costs and the corresponding increases in the net costs 
were 434%. The details of the changes in the two variables are presented in Table 9.4, Part A. 
The WHO recommended number of doses for SP as IPTp is two. The results of changing the 
number of doses from four (in the IPTp trial) to two are indicated in Table 9.4, Part A. The 
average number of visits to ANC in The Gambia is 3.4. Therefore, reducing the number of 
doses of SP to two fits into this average. It would therefore not require the extra 0.6 visit with all 
the associated costs. Furthermore, the additional time required for IPTp from the staff and 
supervisors as well as drugs, and the waiting time at the ANC clinic, will be reduced. The effect 
of this change on IPTp cost was a 41% reduction in Base case 1. The effects of these changes on 
net IPTp costs were a 34% reduction for Base case I (Table 9.4, Part A). 
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1% in discount rate, prices of drugs, materials and supplies use, number of doses 
As illustrated in Table 9.4, Part B, the results of changing the base discount rate from 3% to 6% 
led to a modest increase in the IPTp costs of 1% for Base case II. While the resource savings 
remained unchanged, these changes led to 1% increases in the net IPTp costs. By further raising 
the discount rate from 3% to 10%, the IPTp cost for Base case II went up by 2%. The 
corresponding change in net costs was also 2%. The final variation in the discount rate was to 
raise it from the base rate of 3% to 16.4% (real interest rate in The Gambia). The result of the 
change was an increase in IPTp intervention costs by 4% in Base case II. This change in 
discount rate led to corresponding increases in net costs. The details of these results and the 
resource savings are in Table 9.4, Part B. 
Drug cost represents 51% of the incremental IPTp cost in Base case II (Section 6.3.3.1, Chapter 
6). The effect of an upward movement of drug prices by 100% led to a 34% increase in IPTp 
cost for Base case II. These changes in turn led to 32% increases in net IPTp costs for Base case 
II as indicated in Table 9.4, Part B. 
Changing the drug price by 25% from the trial price led to changes in the proportion of 
recurrent cost taken up by drugs from 51% to 44% for Base case II. The new incremental IPTp 
costs as a result, were D1,720,573 and D416,885 for Base case II with and without indirect 
costs respectively. The reduction in drug price led to 8% reduction in IPTp costs while the 
resource savings remained the same for Base case II. The effect of both these on net IPTp cost 
was an 8% decrease. 
As was the case in Base case I earlier, materials and supplies costs for Hb testing were not 
included in the estimation of the total IPTp costs for Base case II. Introducing the Hb test in 
IPTp led to over 400% increase in IPTp costs for Base cases II. The corresponding increases in 
the net costs are 398% for Base case II. The details of the changes in the two variables are 
presented in Table 9.4, Part B. The effect of changing the number of visits from four to two on 
IPTp cost was a 37% reduction in Base case 11. The effects of these changes on net IPTp costs 
were 35% decrease (Table 9.4, Part B). 
9.3.2 Changes in wage rates 
This section assesses the effects of applying the wage rates generated by using the various 
methods of measuring indirect costs, on IPTp cost, and resource consequences. These changes 
affect IPTp costs as well as resource losses with their combined effects on the net costs. These 
methods include opportunity cost (using male wage rate and average of male and female wage 
rates), market replacement, human capital and the frictional costs methods. The method used in 
the base case is the opportunity cost approach, using average female wage rate in rural Gambia. 
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When the male wage rate of D3.83 was used, it led to a 13% reduction in IPTp costs for Base 
case I. The change also led to 6% decrease in resource losses for Base case I. The combined 
reduction of the IPTp costs and resource losses was 12% reduction in net costs. Further 
changing the wage rate to the average of male and female wages (4.77) in the study site 
produced a decrease of 7% in the IPTp costs for Base case I. The effect of these changes was a 
3% decrease in resource losses. The combined effects of these changes led to a 6% decrease in 
net costs. The details are in Table 9.5, Part A. 
By changing the wage rate from D5.79 to that of a specialist wage rate (D5.14), the IPTp costs 
decreased by 4% for Base case I. The consequence of the change in wage rate on resource losses 
was a 2% decrease. The combined effect of these changes on the net cost was 4% decrease in 
Base case I as illustrated in Table 9.5, Part A. The use of a wage rate generated by using the 
average wages of several generalist household workers led to a minimal increase of the IPTp 
costs for Base case I by 1% and an increase in resource losses by 1%. The eventual change on 
net IPTp costs was also an 1% increase, as illustrated in Table 9.5, Part A. 
The estimated wage rate using the human capital approach was D2.43. A change in the base 
wage rate from D5.79 to D2.43 led to a 22% reduction in the net IPTp cost for LBW in Base 
case I. The effect of the change on resource consequences was a 9% reduction, as indicated in 
Table 9.5, Part A. The overall reduction in net costs was 20%. 
The strict use of the HCA means that the resource consequences for LBW should be 
extrapolated to 57 years (average life expectancy in The Gambia for males and females) for all 
fatal cases from age 0 for LBW. For any fatal LBW case, age 0-6 represents pre-school age and 
7-17 years is school-going age including vocational education. However, the estimation of 
school days lost is beyond the scope of this study. Therefore, the loss of productivity is 
estimated from 18 to 57 years. Since the sex ratio in The Gambia is 1: 1, equal numbers of boys 
and girls are alive at any given point in time. 
It was assumed that all fatal LBW cases lose the opportunity to earn D22,176 per annum, which 
is the annual pay for a nurse midwife in the Farafenni hospital. Therefore, the Net Present Value 
(NPV) for the deferred loss of earnings from 18 years to 57 years (i. e. over 39 years) discounted 
at 3% is D361,779 per LBW death. In the case of this study, there was no fatal LBW case and 
so using HCA affects only the wage rate D2.43 as explained earlier. 
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The modal age for females in the trial is 30 and the retirement age is 60. It is therefore assumed 
that women who died of anaemia at the modal age of 30 would, if alive, be productive up to 59 
years. To estimate the potential productivity loss, the average hourly wage rate of D2.43 was 
multiplied by 10.7 hours (i. e. average number of hours work per day) for 29 years discounted at 
a rate of 3%. The undiscounted amount for the -5 women was -D1,376,103 and the discounted 
amount was -D584,330. The resource losses and the the net costs were -D895,407 and 
D2,115,623 respectively (See Table 9.5). Applying the strict form of HCA resulted in a 185% 
increase in resource losses leading to 12% increase in net losses for Base case I. The 
corresponding changes in Base case II were 3% and 17% decreases. In the sensitivity analysis 
using the strict form of HCA, five more very severe anaemia deaths occurred due to IPTp in 
Base case I. The resource losses due to these deaths projected for 29 years and those due to 
additional cases of LBW and anaemia led to 185% increase in resource losses for Base case I 
leading to 12% increase in net costs (See Section 9.3.2 & Table 9.5). In Base case II, only one 
case of moderate anaemia was averted leading to resource saving of 3% leading to 17% 
decrease in net costs. This is what explains the movement of resource losses/savings and net 
costs of Base case I and II in different directions. 
According to the proponents of FCA, the approach does not take onboard any work outside the 
formal working environment, which means the value attached to unpaid work is zero (Section 
2.3.3, Chapter 2; Table 7.8). In effect, using the FCA is equivalent to using direct costs only. By 
excluding indirect costs therefore means the 90-day frictional period for replacing a worker does 
not arise here because there was no formal work. By varying the unpaid wage rate to zero, the 
IPTp cost and resource losses for Base case I dropped by 39% and 18% respectively. The 
combined effect of these two reductions was a 35% decrease in net cost. All these are illustrated 
in Table 9.5, Part A. 
217 
MISSING 
PRINT 
ages according to methods of estimating indirect costs 
Sensitivity analysis values 
unity cost 
roach 
ge rate ) of 
3.83 
Opportunity cost 
approach 
(average wage rate 
for male & female) 
of D4.77 
Replacement cost 
approach 
( specialist's maid 
wage rate) of D5.14 
Replacement 
cost approach 
(generalist wage 
rate) of D5.98 
Human capital 
approach 
(D2.43) 
Human capital 
approach 
(»2.43) 
(Strict form) 
Frictional Cost 
Approach (0) 
% D % D % D % D % D % D % 
5 13 1,466,792 -7 1,505,766 4 1,594,29 
4 
1 1,220,21 
6 
-22 1,220,216 -22 964,576 -39 
6 304,3 55 -3 -308,079 -2 -316,398 1 -286,643 -9 -895,407 185 -257,195 -18 
2 
12 
1,771,187 
-6 
1,813,845 
-4 1,910,69 
2 
1 1,506,85 
9 
-20 
2,115,623 
12 1,221,77 
1 
-35 
1 
10 410,498 -5 419,072 -3 438,548 1 356,252 -18 356,252 -18 300,012 -31 
-6 -18,994 -3 -19,234 -2 -19,776 1 -17,592 -10 -18,972 -3 -15,920 -19 
-10 429,492 -5 438,306 -3 458,324 1 373,844 -18 375,224 -17 315,932 -30 
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When the male wage rate of D3.83 was used, it led to 10% reduction in IPTp costs for Base case 
II. The change also led to 6% decrease in resource losses. The combined reduction of the IPTp 
cost and resource losses was a 10% reduction in net costs for Base case II. 
Further changing the wage rate to the average of male and female wages (4.77) in the study site 
produced a decrease of 5% in the IPTp costs for Base case II. The effect of these changes on net 
costs was a 3% decrease in resource losses. The combined effects of these changes led to 5% 
decrease in net costs. The details are in Table 9.5, Part B. 
By changing the wage rate from D5.79 to that of a specialist (D5.14), the IPTp costs decreased 
by 3% for Base case II. The consequence of the change in wage rate on resource losses was a 
2% decrease. The combined effect of these changes on the net cost was a 3% decrease as 
illustrated in Table 9.5, Part B. The use of a wage rate generated by using the average wage rate 
of several generalist household workers led to a minimal increase of the IPTp costs for Base 
case II by I% and an increase in resource losses by I%. The eventual change on net IPTp costs 
was also 1% increase for Base case 11 as illustrated in Table 9.5, Part B. The procedures 
followed in conducting sensitivity analysis using HCA (simple and strict) and FCA for Base 
case I are the same as was done for Base case II. The details of the results are indicated in Table 
9.5, Part B. 
9.3.3. Changes according to reductions in the number of OPD visits and ALoS for IPD, 
referral transport costs and changes in non-bednet use 
Changing OPD visits and average length of stay (ALoS) affect net costs through changes in 
resource savings. Varying the number of outpatient visits and the ALoS by 50% (i. e. from four 
to two visits for outpatient anaemia, from seven to 3.5 days for inpatient anaemia, from 21 to 
10.5 for VLBW and from 28 to 14 for ELBW cases). The resource losses to the provider and 
patients decreased by 27% for Base case I. The overall effect of the changes on the net costs 
was a 4% decrease as indicated in Table 9.6, Part A. Reducing the referral transport cost by 50% 
resulted in a 15% reduction in resource losses for Base case I, which in turn led to 2% decrease 
in net cost. Changing the proportion of non-bednet users from 22% to 61.4% in the trial site 
only affects Base case II and is discussed in the next paragraph. 
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Table 9.6 Effects on costs due to reductions in OPD visit, ALoS, referral transport costs and 
changes in non-bednet use 
Costs Base case S ensitivity analysis values 
values Reduction in OPD 
visits and ALoS by 
half 
Reduction in referral 
transport cost by half 
Change in non- 
bednet use 
(61.40/., ) 
Base case I Base case I Base case I 
D D % D % D % 
A. Base case 
IPTp cost 1,573,693 1,573,693 0 1,573,693 0 - - 
Resource 
savings/lo ses 
-313,914 -230,215 -27 -267,134 -15 
- 
Net costs 1,887,607 1,803,908 -4 1,840,827 -2 - - 
B. Base case 11 
PTp cost 434,016 434,016 0 434,016 0 1,030,315 35 
Resource 
savings/losses 
-19,604 -11,636 -41 -17,368 -11 
1,773 
101 
Net costs 453,620 445,652 -2 451,384 -0.1 1,028,542 46 
The variable changes in Base case I are the same for Base case 11. The resource losses to the 
provider and patients as a result of decreasing OPD visit and ALoS by half led to a decrease by 
41% in Base case H. The overall effect of the changes on the net costs was a 2% decrease as 
indicated in Table 9.6, Part B. Reducing the referral transport cost by 50% resulted in an I I% 
reduction in resource losses for Base case II which in turn led to 0.1 % decrease in net costs. 
Non-bednet use appears to be an important determinant of the effectiveness of the IPTp 
intervention (Mbaye et al, 2006). Changing the proportion of non-bednet users from 22% to 
61.4% in the trial site affects only Base case 11 in terms of costs, resource savings and health 
outcomes as indicated in Table 9.6, Part B. The change led to a 35% increase in IPTp cost and 
46% increase in net cost via a 101% increase in resource losses. The consequences of the 
change on all the variables are presented in Table 9.6, Part A. 
9.3.4 Changes in key DALY parameters 
The variables tested were those related to estimating DALYs. The parameters varied included 
the discount rate; years lived with disability for VLBW and ELBW, which were changed from 
five to nine years; and age at onset of anaemia from 30 to the average age of 26.8. 
15 The increases or decreases that occurred because of substituting the base case values with the new ones in the sensitivity analysis 
are indicated by the percentages in the table. 
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The effect of each of these changes on the total DALY averted for the two base cases was 
assessed (See Table 9.7, Part A for details). By changing the discount rate used to estimate 
DALYs from 3% to 6%, DALYs averted for Base case I decreased by 27%. Further changing 
the discount rate from 3% to 10% affected only DALYs averted for Base case I (48% decrease). 
Changing the discount rate again to 16.4% also affected only DALYs averted for Base case I 
(64% decrease) (See Table 9.7, Part A). 
LBW babies, especially VLBW and ELBW, were assumed to live with disability up to five 
years. This was changed to nine years and the effect assessed on DALYs. The change in years 
lived with disability led to a 1% increase in DALYs for Base case I as illustrated in Table 9.7, 
Part A. Changing the years of onset of anaemia from the modal age of those who participated in 
the trial (30 years), to the mean age of 26.8 years led to a 10% increase for Base case 1. 
Table 9.7 Effects on DALYs due to changes in discount rate, years lived with LBW disability and 
age from the onset of anaemia 
DALYs Base Sensitivity analysis values 
case 
values Change in Change in Change in Years lived Age at 
discount rate discount rate discount rate with onset of 
from 3%-6% from 3%- from 3%- disability anaemia 
10% 16.4% from 5-9 from 30- 
ears 26.8 years 
°/. % % % % 
A. Base case l 
DAM -125.8 -92.6 27 ' -66 -48 -45 -64 -127 1 -138 10 
B. Base case 11 
DALYs -0.13 -0.13 0 -0.13 0 -0.13 0 -0.13 0 -0.13 0 
By changing the discount rate or DALYs used to estimate DALYs from 3% to 6%, DALYs 
averted for Base case 11 remained unchanged. Further changing of the discount rate from 3% to 
10% and from 3% to 16.4% left DALYs averted for Base case 11 unaffected (Table 9.7, Part B). 
The changes in years lived with disability by LBW babies and years of onset of anaemia from 
the modal age of those who participated in the trial (30 years), to the mean age of 26.8 years led 
to no change in Base case 11 as illustrated in Table 9.7, Part B. 
16 The increases or decreases that occurred because of substituting the base case values with the new values in the sensitivity 
analysis are indicated by the percentages in the table, 
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9.3.5 Changes in prevalence and case fatality rates for both LBW and anaemia 
In order to re-assess effectiveness, prevalence and case fatality rates for LBW and anaemia were 
changed simultaneously. The prevalence rate of LBW was changed from the original trial rate 
of 3% to 17.4% (DoSH, 1999) and the prevalence rates for VLBW and ELBW were changed to 
3.8% and 2.4% respectively. The case fatality rates for VLBW and ELBW were also changed to 
53.5% and 89.7% respectively. The prevalence rate of anaemia as a whole was changed from 
the trial rates of 9% and 16% for Base cases I and II respectively to 83% (DoSH, 1999) and 
those for severe and very severe anaemia to 1.5% and 4.5% respectively. This is in line with the 
WHO (1999) estimate that 75% of all severe anaemia cases are very severe. The prevalence rate 
for moderate anaemia was also changed to 83% and the case fatality rates for anaemia were 
made uniform across the country using the LRD rate of 11.8% (DoSH, 1999). 
The cases of LBW averted changed from -3 to 164 and the number of deaths averted was 383 
against zero for the base value. The DALYs averted as a result of the changes were 5,770 for 
Base case I. The details of the health outcomes for the changes in prevalence and case fatality 
rates for anaemia are presented in Table 9.8. 
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Ikes in prevalence and case fatality rates 
For Base case II, the cases and deaths averted from LBW were 76 and 45 respectively. The 
DALYs averted, because of the changes, were 1,270 for Base II. The details of the health 
outcomes for the changes in prevalence and case fatality rates for anaemia are presented in 
Table 9.8. 
9.3.6 Effects on costs and DALYs of simultaneously changing the prevalence and case 
fatality rates 
The consequences of changing both the prevalence and case fatality rates are stated in Table 9.9, 
Part A. The changes were first effected for LBW only, second for anaemia only, and then 
simultaneously for LBW and anaemia. The results of the change for LBW only led to DALYs 
averted of 13,279 for Base case I. For anaemia, DALYs averted as a result of the changes was 
5,570 for Base cases 1. The third scenario was to change the prevalence and case fatality rates 
for LBW and anaemia leading to DALYs averted of 19,175. The details of these results are 
presented in Table 9.9, Part A. It should be noted that with these adjusted prevalence and case 
fatality parameters, IPTp was dominant (resource savings exceeded implementation costs). 
Table 9.9 Effects on costs and DAI. Ys of simultaneously changing the prevalence and case fatality 
rates 
Costs Base case Se nsitivity analysis value s 
values Changes in 
prevalence and 
case fatality rates 
for LBW. 
Changes in 
prevalence and 
case fatality rates 
for anaemia 
Changes in 
prevalence and 
case fatality rates 
for LBW and 
anaemia 
D D D D 
A. Base case I 
IPT cost 1,573,693 I, >73,693 1.573,693 1,573,693 
Resource 
savings/losses 
-313,914 
1,893,990 10,978 827 13 186,731 
Net costs 1,887,607 -320,297 -9,405,134 -11,613,038 
DALYs -125.8 13,279 5,570 19,175 
B. Base case 11 
IPT cost 434,016 434,016 434,016 434,016 
Resource 
savings/losses 
-19,604 
1,753,743 3,358,616 5,131,963 
Net costs 453,620 -1,319,727 -2,924,600 -4,697,947 
DALYs 0.13 672 1,270 1,942 
The results of the change for LBW only led to DALYs averted of 672 for Base case 11. For 
anaemia, DALYs averted as a result of the changes were 1,270. The third scenario was to 
change the prevalence and case fatality rates for LBW and anaemia leading to DALYs averted 
of 1942, details of which are presented in Table 9.9, Part B. IPTp again was dominant. 
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9.3.7 Prevalence and case fatality rates for primigravidae and multigravidae 
The results of changing the prevalence rates in the base case to the average rates of 
primigravidae and multigravidae on costs and health consequences are given in Tables 9.10 and 
9.12 respectively with cost calculations shown in Table 9.11 A and 9.11 B. The assumptions 
invoked in the sensitivity analysis by giving IPTp to all pregnant women were to vary the 
prevalence and case fertility rates from the base case rates (trial rates) to the average of the trial 
and those obtained from the literature or secondary data from Gambia for LBW and Anaemia. 
Specifically, the effectiveness rates for Base cases I and II for LBW for IPTp and control were 
changed from the base case rates to the average effectiveness rates from the trial and Rogerson 
et at (2000). In the case of VLBW and ELBW, the base case rates for both IPTp and control 
were changed to the average rates from the trial and AFPRCH and the care fatality rates from 
the base case rates to the average case fatality rates from the trial and Okoji and Oruamabo 
(1992). In the case of anaemia (moderate, severe and very severe), Base cases I and 11 
effectiveness rates were changed to the average prevalence rates of the trial and Shulman et al 
(1996). The base case fatality rates were also changed to the average case fatality rates of the 
trial and Shulman et at, (1996). The details of these assumptions are shown in Table 9.3.2. The 
results of the sensitivity analysis showed that 78 cases of and 99 deaths from LBW were averted 
for Base case I. The corresponding health consequences for Base case II are shown in Table 
9.10. 
Table 9.10 Summary of health consequences of giving IPTp to all pregnant women 
ase cases I& 
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With only direct costs considered, net costs were -D5,768,324 for Base case I. By considering 
indirect costs, net costs increased to -D6,330,532. The net costs generated by using the various 
wage rates in the sensitivity analysis fluctuated around the base values. The net costs were 
higher for wage rates above the base rate and the converse was true when wage rates lower than 
the base rate of D5.79 were used. The DALYs averted were 4,767. 
In Base case II, the ICERs estimated without and with indirect costs followed the same pattern 
as was the case in Base case I. The only difference was that net costs in Base case II were lower 
than those obtained for Base case I. 
Therefore, when IPTp is given to all pregnant women (primigravidae and multigravidae), it was 
found to dominate the status quo of ANC without IPTp. The DALYs averted were 1,266. The 
details are indicated in Table 9.11 Part B and calculations in Table 9.11B. 
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in Ualasis) and consequences of giving IPTp to all pregnant women (Base case 1) 
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in Dalasis) and consequences of giving IPTp to all pregnant women (Base case 11) 
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onsequences of giving IPTp to all pregnant women 
9.4 SUMMARY 
The results of the cost-effectiveness analysis using the two base cases showed that existing 
ANC dominates IPTp throughout in Base cases I and II, resulting in negative net costs that 
made it unnecessary to estimate the ICERs. The results of the sensitivity analysis revealed that 
change in discount rate from base case rate of 3% to 6%, then to 10% and finally to 16.4% leads 
to less than 5% increase in the net IPTp costs. On the other hand, changing drug price 
downwards resulted in decreases of 9% and 5% in net costs for Base cases I and II respectively. 
Changing the drug price upwards led to over 30% increase in the net costs for the two base 
cases. By reducing the number of doses from four to two, net costs decreased by over 30% for 
Base cases I and II. The introduction of Hb testing as part of the IPTp also led to over 500% 
increase in net costs for Base case I and 398% for Base case II. Changing the base wage rate 
from female wage rate to the various other methods led to mixed results. By using the 
opportunity cost approach using the average male and female wage rate, the net costs decreased 
by less than 10% for Base case I and II. On the other hand, applying the strict form of HCA 
resulted in a 185% increase in resource losses leading to 12% increase in net losses for Base 
case I. The corresponding changes in Base case II were 3% and 17% decreases. The changes are 
more pronounced in FCA (over 30% decrease) than for the rest of the methods. By reducing the 
number of OPD visits and ALoS; and referral costs by half, the net costs reduced by less than 
5% for both base cases. The increase in the proportion of non-bednet users led to 46% increase 
in net costs. Changing the DALY parameters (discount rate, years lived with disability (YLD) 
and age at onset of anaemia) for Base case I led to the following decreases in DALYs averted 
27% (3% -6%), 48% (3%-10%) and 64% (3%-16.4%) for Base case I. The change in years lived 
with disability by LBW babies and the age of onset of anaemia led to 1% and 10% increase in 
DALYs averted respectively. However, changes in DALY parameters did not affect DALYs 
averted in Base case II. Simultaneously changing prevalence and CFRs for multigravidae 
substantially increased DALYs averted (to 5,770 and 1,270 for Base cases I and II respectively). 
Finally, by assuming all pregnant women (primigravidae and multigravidae) receive IPTp 
instead of multigravidae only showed that IPTp dominates for both Base cases I and II. This 
conclusion remained the same regardless of the inclusion of indirect costs or the type of wage 
rate used. 
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CHAPTER 10: DISCUSSION 
10.1 INTRODUCTION 
This chapter discusses study results. It is divided into three main sections. Section 10.2 
discusses the methodological limitations of the study, in terms of the issues surrounding the 
collection and analysis of cost and effectiveness data. Section 10.3 summarises the findings and 
10.4 discusses them. Section 10.4 also makes comparisons between this study and other 
economic evaluations of malaria interventions in The Gambia and in other developing countries. 
10.2 METHODOLOGICAL LIMITATIONS 
The analysis of costs and effectiveness is based on the analytical framework presented in Figure 
5.1, Chapter 5. The validity of the data collected using the sub-components of the framework 
are discussed in this section. Overall, despite all the shortcomings, every effort was made to 
detect errors and to test all key uncertain variables. 
10.2.1 Costs 
The cost data collected comprises both the IPTp and the treatment costs to the provider, patients 
and their families. The IPTp cost to the provider includes the capital cost, health sector staff 
cost, initial training cost for the staff involved in IPTp, health promotion cost, drugs cost and the 
cost of other consumables used in the trial. However, it is worth noting that IPTp is an addition 
to the normal antenatal care. As a result, the additional cost of capital at the various antenatal 
health facilities was limited. The treatment of LBW and anaemia is done at the hospital level. 
The sample sizes used to collect cost data were 884 for the clinic questionnaire, 662 for the 
follow-up questionnaire, eight for the hospital observation study for VLBW, four for ELBW, 66 
for OPD anaemia at AFPRCH, 20 for IPD anaemia at AFPRCH, 15 for anaemia at RVTH, 45 
for the household time use study and 40 each for the male and female employment surveys. 
The data collection process was not without its problems. One issue that presented difficulties in 
the fieldwork was that the three fieldworkers who were originally trained to administer the 
study instruments, were transferred to another trial and this necessitated their replacement. The 
change delayed the fieldwork because the new fieldworkers had to be trained again on the 
administration of the instruments. There were also problems with follow-up into neighbouring 
Senegal for those women who were residents of that country but usually came to The Gambia 
for their antenatal care. This was mainly due to the civil war in the Southern Cassamance region 
of Senegal. 
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The solution found was to have guarantors for those whose nationalities were in doubt. A 
`guarantor' is usually a well-known woman (i. e. Traditional Birth Attendant) within the 
community who can attest to the nationality of the woman and be prepared to be held 
responsible if the woman was found to be non-Gambian. This approach helped in reducing the 
number of non-Gambian residents taking part in the trial to a manageable number. 
The data for estimating the staff cost were collected through the observation method by the 
fieldworkers and so relied on their accurate recording of time. The data required to estimate the 
capital cost items used in IPTp, such as initial training and IEC, were obtained from the existing 
prices for workshops, radio and TV announcements and therefore the costs are reliable only in 
the short term. A discount rate of 3% was used for easy comparison with the results of studies in 
other settings. The time taken to see one woman for her first visit to the antenatal clinic was 
estimated using the observation method and subsequent visit times were obtained from the 
literature (Goodman et al, 2000). The DHT and DoSH staff supervisory times were observed 
only during the first visit to the health facility and there was no assurance that the time did not 
vary between visits. With enough resources, these could have been improved by observing 
women in all four visits to the health facilities required for IPTp. 
In order to obtain the unit cost per multigravidae, the proportion of primigravidae to 
multigravidae was estimated using the antenatal statistics from the ESU, which revealed a ratio 
of 3: 1. This ratio was used to project the year 2001 multigravidae population to 2003 in the two 
study areas in order to generate up-to-date sample sizes for Base cases I and II. Furthermore, 
projecting the total population of pregnant women to 2003 took care of any potential problems 
of economies of scale. While the estimated projection is consistent with other reports (Aikins, 
1995), the proportion of those pregnant women who do not use bednets (22%) is contradicted 
by other reports in the same area, such as the Malaria control Unit (61.4%) and Meek et al 
(2001) (14%). The implication for this study is that, the result will depend on the proportion of 
non-bednet use, which in turn affects effectiveness, costs, consequences and cost-effectiveness 
of IPTp. Two studies conducted in Kenya and The Gambia showed that using different ITN 
coverage levels could lead to different cost-effectiveness levels (Goodman et al, 2000). 
The unit cost for IPTp at health facilities was assumed uniform across facilities of similar 
category, which may not reflect the reality on the ground. The client flow study has already 
revealed that some facilities have longer waiting times than others (DoSH, 2000) which have 
cost implications for both the provider and patients. Furthermore, allocating the same 
supervisory time (DHT and DoSH supervisions) to health facilities of different sizes tends to 
overstate such time for smaller facilities. 
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The direct cost of IPTp was generated using clinic and follow-up questionnaires asking women 
to state how much they had spent on transport and/or at the clinic. There were problems with 
some of the responses because some women gave higher amounts than usual. The amounts 
included money they had spent on food for the household. Since most of the antenatal clinics 
are in comparatively bigger villages than their outlier villages, it is not unusual for women to 
take the opportunity of an antenatal clinic day to buy items such as rice, onions, tomatoes and 
other household needs, which they erroneously included as part of their expenditure at the 
clinic. The remedial action taken was to follow up those women who had given unusually high 
expenditures to further question them with a view to getting the correct amounts. Through this 
follow-up verification exercise, women were asked which items they spent money on during 
their health facility visits. Those who gave items such as a bag of rice, onions, cooking oil etc, 
had the costs of those deducted from the amounts they indicated. Although those detected were 
corrected, one cannot say for sure that all such errors were detected. However, since direct costs 
to patients are just a fraction of the IPTp costs (i. e. 6% for Base case I and 4% for II), this is 
unlikely to affect the findings of the study. 
Indirect costs of IPTp - in terms of travelling, waiting and contact times at the health facilities 
- were obtained by two means. One asked the women to indicate time lost in terms of 
conventional time and the other used the rice-cooking time as a proxy. The former was obtained 
by linking the departure, travelling, and waiting times with local events such as early morning 
prayer time, breakfast, school times etc. In order to verify the results, especially given that the 
majority of the women did not have formal education (90%), rice-cooking time was used as an 
alternative measure of time. Contrary to expectations, the difference between the two methods 
(15 minutes) was significant at p-value of 0.00. The fact that the two are not the same means 
there could be an element of error. Most of the women do not normally read watches, so 
translating time into local events could minimise the error. 
The average number of visits to antenatal clinics (n=3.5 times) in The Gambia was obtained 
from a published report (Telfer et al, 2002). However, it was realised that this figure is slightly 
different from the n=3.4 visits reported by Cham (2003). Although the difference between 
these two may not affect the outcome of the study, the disparity should be noted. The indirect 
costs to families accompanying pregnant women to antenatal clinics was not included because 
only 2.5% were actually accompanied. 
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10.2.1.1 Treatment cost to the provider 
Many challenges were faced in the collection of treatment costs to the provider. One problem 
with the payroll at AFPRCH was that only names and the salaries by department/unit and 
benefits were recorded while the staff designation was left out. The inventory of equipment was 
not available and so each item had to be physically counted, which was time consuming. 
Another problem with equipment was the difficulty in obtaining prices from catalogues. Data on 
drug usage and costs were one of the most difficult to obtain and so had to be estimated based 
on the updated figures from Bansang hospital (Fabricant & Newbrander, 1994). 
Regarding outpatient care, the number of visits to hospital for anaemia treatment is based on the 
WHO and The Gambia DoSH treatment guidelines. However, the general tendency is that, as 
soon as the symptoms are cleared, most people stop visiting the health facilities and even stop 
taking their medication. Therefore, the maximum of four visits for outpatient anaemia treatment 
could be higher than what obtains in practice. Regarding inpatient care, the average length of 
stay (ALoS) for all non-fatal and fatal cases of VLBW, ELBW and anaemia were obtained from 
the hospital records corroborated by literature and expert advice. The ALoS for very severe 
anaemia at the RVTH was based on that of AFPRCH, but RVTH, being a teaching hospital, 
should have better equipment and specialist doctors, and therefore a shorter length of stay than 
AFPRCH for the same illness. A lower number of OPD visits would lead to a lower cost of an 
OPD visit to the provider, patients and families than estimated. On the other hand, assuming the 
ALoS at the AFPRCH to be the same as that of RVTH is likely to overstate the efficiency level 
and unit cost at the AFPRCH. Both cases above have ripple effects on the costs incurred by 
patients and families. 
The hospital costing data for RVTH was obtained from previous studies, such as WHO (1995) 
and Fabricant and Newbrander (1994), and was updated using the Consumer Price Index (CPI). 
There have been a lot of improvements at the RVTH over the past 10 years. The improvements 
have however not been taken into consideration. Therefore, the unit costs of A&E, paediatrics 
and maternity wards could have been under-estimated. Due to the unavailability of data, the cost 
of drugs at the AFPRCH was based on the average drug usage at Bansang hospital. However, in 
reality, the average drug usage at the two hospitals may be different (Kirigia et al, 1998a), and 
so a tendency to overstate or understate the actual drug costs may exist. Nonetheless, a 
comparison of the unit costs of OPD, paediatrics and maternity wards at AFPRCH with that of 
RVTH shows that the two sets of data were very similar. 
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The AFPRCH cost analysis was based on the actual costs incurred at the various units of the 
hospital, obtained from the records. However, the state of such records at the AFPRCH left a lot 
to be desired, especially those relating to equipment and drug use. This paucity of data may 
have affected the accuracy of the unit costs of OPD and inpatient care. Another shortcoming 
worth noting is that the hospital cost analysis took all patients as homogeneous regardless of 
their differing state of morbidity. In fact, different patients have unequal use of resources such 
as drugs, tests and even staff time. In order to obtain the actual costs, weights should ideally be 
attached to patients in line with the severity of their illnesses, which will help differentiate costs 
amongst them. It is very common for the National Water and Electricity Corporation (NAWEC) 
generator at Farafenni to break down or fuel to run out, which affects the operations of the 
AFPRCH, causing delays in getting haemoglobin test results. The constant electricity failure has 
contributed to the high cost of fuel to run the hospital generator, which also has negative effects 
on both unit outpatient and inpatient costs. 
Both the effectiveness and the treatment costs of LBW and anaemia depend on the underlying 
causes. For instance, LBW due to HIV, malnutrition or placental malaria may all differ in terms 
of treatment cost. Very severe and to some extent, severe anaemia would require blood 
transfusion as part of treatment. The real cost of treatment for anaemia depends on the 
underlying cause, severity and whether blood transfusion is needed or not. Blood transfusion 
has been recommended as the main treatment for very severe anaemia pregnant women (WHO, 
1999). In the case of this study, the cost of blood transfusion has not been separately calculated 
but incorporated as part of the hospital costs in general, through the step-down process. 
Specifically, the cost of laboratory tests was stepped-down to all the wards including maternity. 
This could have underestimated the cost of treatment for the 42 and 4 very severe anaemia cases 
in Base case I and Base case II respectively. Therefore, the study findings should be viewed in 
that context. However, it may be unlikely that any adjustment would make a big difference in 
the conclusions. 
AFPRCH has been operating at less than its full capacity, which has affected the unit OPD and 
inpatient costs. Even though it is one of the newest hospitals in the country, it lacks the basic 
staff and equipment to make it fully functional to provide quality care. The low utilisation could 
be a result of the poor quality of service at the facility, leading to high unit costs of both 
outpatient and inpatient care. Research has shown that increasing the availability of health 
services (for instance, by building more facilities or expanding health programmes) does not 
always increase the use of services (Thaddeus & Maine, 1994; p. 1093). 
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10.2.1.2 Treatment cost to the patients and families 
The information on the direct cost of treatment for anaemia and LBW to patients and their 
families was obtained from direct observation at the two hospitals (AFPRCH and RVTH). The 
accuracy of the information relied on the memory of the visitors in terms of the fares paid and 
the amount spent while at the hospital. Although the outliers were verified and where necessary 
corrected, there is no guarantee that all such errors were detected and corrected. 
The direct costs of referral to patients and their escorts were assumed to be zero but due to the 
long distance from Farafenni to Banjul, it is possible for at least an escort to buy food or water 
while waiting for the ferry. In this study, there were no additional resources to survey the 
escorts of those referred to the RVTH. 
The assumption that all the VLBW, ELBW and very severe anaemia cases seek prompt 
treatment at the hospital through peripheral health facilities may be exaggerated given that for 
many people in rural Gambia, as in most rural areas of Africa, the first-line treatment is a visit to 
traditional healers, or using drugs already at home, bought in a shop or from drug peddlers and 
pharmacies. The health facilities are usually the last resort for people to seek treatment after all 
other alternatives have failed (Ruebush et al, 1995; Ongore et al, 1989; Mensah, 2004). The 
figure for the proportion of severe anaemia cases who seek treatment at hospital level was 
obtained from the Safe Motherhood Costing Manual (WHO, 1999) which is a `one-size fits all' 
tool with all the attendant disadvantages such as lack of generalisability to other settings. This 
was remedied by adapting this generic tool to the Gambian situation by combining it with local 
epidemiological data. 
The indirect cost of treatment was estimated through the observation study at the hospitals 
(AFPRCH & RVTH) from the time women entered the hospital to the time they left. The data 
were tainted by lack of proper recording by two fieldworkers who were deliberately recording 
time without actually following the patients. This was detected after the first day and the 
fieldworkers concerned were dropped from the team and replaced by another pair. Although 
subsequent reviews and monitoring did not indicate that other fieldworkers committed the same 
error, it cannot be ruled out. The problem of electricity at AFPRCH caused serious delays in 
obtaining the results of blood tests for anaemic patients and affected the results of the time spent 
at the outpatient department. This can result in the understating or overstating of the waiting 
time. The travelling times for patients and their families for an OPD visit were obtained from 
patients and their escorts. However, the road quality varies throughout the year in both NBE and 
LRD, which could lead to travel times beyond the six-hour average reported for a round trip. 
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In terms of household time use data collection, only one week was used to collect data, so there 
is no certainty that the workload and pattern on one day, say Monday, of the surveyed week is 
the same for the rest of the other Mondays outside the survey week. By the same logic, only one 
week in a month and one season in a year were used and there is no guarantee that the week and 
the season are representative of all other periods. The study does not include the time use of 
male members of the household, which could have given insight into how household work is 
shared between couples in the study setting. 
Both recall and observation methods were used to collect time use data for rainy and dry 
seasons respectively. The recall method relies on the women to accurately remember and for the 
fieldworkers to accurately record their daily activities and their times. The observation method 
could lead to unusual activities beyond what is normal without observation. Both of these could 
understate or overstate the results. The work periods and the corresponding remuneration for 
formal work (obtained through the employment survey) were obtained from official records and 
there was little doubt as to their accuracy. However, the pay rates for informal sector workers, 
such as maids, restaurant workers, taxi drivers, shepherds, etc, were not according to any written 
contract and so the study had to rely on the information given by the employees. In order to 
verify the authenticity of the data and thereby increase its reliability, employers were 
interviewed to obtain information on the payment, rest days and in-kind gifts their employees 
normally receive. Despite that, a tendency not to mention irregular gifts such as clothing and 
money given for health care is possible. 
The estimation of indirect costs via unpaid work was based on the values of farming, income 
generating activities and unpaid household work. The household time use study clearly indicates 
that women in the study setting spent their time in a variety of ways, including productive and 
non-productive activities. A woman attending a clinic may take all the time from her social 
time, or all the time from her farming time, which have varying degrees of economic value. The 
fact is that not all of the time used at the work place is directed towards productive activities. 
Some of it is allocated to rest and other non-productive activities. Therefore, the value of the 
time used to attend health facilities for IPTp and to receive treatment could be higher or lower in 
reality. However, given the small amount of time that women spent on non-productive and 
household activities (i. e. community, socio-cultural and mass media activities together 
consumed only 0.801 minutes), this will not greatly affect the outcome of the study. In theory, 
given a well functioning labour market, women will allocate their time so that marginal benefit 
is equal to return to leisure equals return to paid employment. Due to rigidities, women may not, 
in reality, be able to allocate time in this way. 
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10.2.2 Health consequences 
The two greatest methodological challenges were associated with the effectiveness of data. 
Although the accuracy of the data was outside the control of the candidate, the data provided 
raised many unexplained issues. The prevalence rate of LBW and anaemia for multigravidae 
was different from that of other studies (Greenwood et al, 1989; Morley et al, 1964; Shulman et 
al, 1996). Furthermore, there was no follow-up in the main trial to track LBW and anaemia 
patients at the hospital. This left no other option but to take the cost of all VLBW, ELBW and 
anaemia cases who sought treatment at the two hospitals during the data collection period (i. e. 
those in and outside the trial) in order to calculate the unit cost of treatment. There is the 
unlikely possibility that differences exist between the treatment costs of the participants in the 
trial and others outside it. Furthermore, mortality data were not collected alongside the trial, 
which compelled the candidate to gather secondary case fatality rates (CFR) from hospital 
records for 2003 and from personal communications with Dr. Osrin of the Institute of Child 
Health, University of London. The implication for this study is that the rates used may depend 
on the expert asked and may vary from person to person, thereby putting the accuracy of the 
opinions into question. 
10.2.3 Costs, effectiveness and Cost-effectiveness 
There are a few issues, which may affect the findings (costs, effectiveness and cost- 
effectiveness) of this study. From the point of view of cost-effectiveness of IPTp, both costs and 
effectiveness are likely to be affected by the seasonality of malaria in The Gambia as described 
in Chapter 1. The rainy season is usually the peak period for all types of malaria including 
malaria in pregnancy. Therefore, the benefits of IPTp are likely to be higher during this period 
than during the dry season. The period before harvest marks the hungry season in all 
communities in The Gambia which has an impact on not only anaemia but LBW as well. The 
hungry season comes to a height in September, when food from the previous year's harvest runs 
out, while the new harvest will not yet be available. Other seasonal causes of anaemia include 
the hookworm described in Chapter 3. The implication of the findings of this thesis is that the 
study averages the costs and effectiveness of the trial period (July 2002-February 2004), taking 
into account two rainy and two dry seasons. Furthermore, since the two seasons in The Gambia 
(dry and rainy) are of the same duration of six months, the averaging of the costs over one year 
automatically takes into account the seasonal effects. The only likely effect of seasonality is that 
attendance to antenatal clinics, which is the medium for IPTp delivery, is likely to reduce during 
the rainy season when women are very busy cultivating their fields. A preventive intervention 
such as IPTp may not represent a priority compared to daily survival activities. 
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10.3 SUMMARY OF KEY FINDINGS OF THE STUDY 
The results of the study are summarised in Table 10.1. The total incremental IPTp 
implementation costs without indirect costs were D964,576 for Base case 1. The costs of IPTp to 
the provider alone were D910,122, which comprises 58% of the IPTp costs for Base case 1, 
while the rest was incurred by patients. The details of the composition of the costs was 
summarised in Section 6.5, Chapter 6. The main component of the recurrent cost to the provider 
was drugs (SP) (73%), followed by personnel costs (14%) for Base case 1. The direct IPTp cost 
to patients and families comprises D54,453. When indirect costs are taken into account, the 
IPTp costs increased to D1,573,693. The indirect costs component of this was D609,117. 
Table 10.1 Summary of major findings 
Base case 1 Base case Il 
Direct costs Direct and 
indirect costs 
Direct costs Direct and 
indirect 
costs 
(1) IPTp IMPLEMENTATION COST 
Provider 
Recurrent 837,315 837,315 215,681 215,681 
Capital 72,808 72,808 72,348 72,348 
Sub-total 910,122 910,122 288,030 288,030 
Patients 
Direct costs 54,453 54,453 11,983 11,983 
Indirect costs 0 609,117 (1 134,004 
Sub-total 54,453 663,570 11,983 145,987 
TOTAL IPTp IMPLEMENTATION COST 964,576 1,573,693 300,013 434,016 
(2) RESOURCE SAVINGS 
Provider -241,360 -241,360 -15,327 -15,327 
Patients & families 
Direct -15,835 -15 835 -592 -592 
Indirect 0 -56,719 0 -3,684 
Sub-total -15,835 -72,574 -592 -4,276 
TOTAL RESOURCE SAVINGS -257,195 -313,914 -15,920 -19,604 
Net IPTp implementation costs 1,221,771 1,887,607 315,933 453,620 
(3) HEALTH CONSEQUENCES OF IPTp 
(i Cases of LBW and anaemia averted 
Cases of LBW averted -3 -3 0 0 
Cases of anaemia averted (OPD) -19 -19 1 1 
Cases of anaemia averted (IPD) -37 -37 -4 -4 
(ii) Deaths from LBW and anaemia averted 
Deaths from LBW averted 0 0 0 0 
Deaths from anaemia averted -5 -5 0 0 
((iii) DALYs averted 
DALYS from LBW averted -0.69 -0.69 0 0 
DALYs from anaemia averted -125.15 -125.15 -0.13 -0.13 
TOTAL DALYS -125.84 -125.84 -0.13 -0.13 
Source: Tables 8.6-8.14; Tables 9.1-9.4 
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The total incremental IPTp implementation costs without indirect costs were D300,013 for Base 
case II. The costs of IPTp to the provider alone remained at D910,122, which comprises 66% of 
the IPTp costs for Base case II, while the rest was incurred by patients. The details of the 
composition of the costs was summarised in Section 6.5, Chapter 6. The main component of the 
recurrent cost to the provider was drugs (SP) (510/6), followed by vehicle maintenance (14%) for 
Base case II. The direct IPTp cost to patients and families came up to DI 1,983. When indirect 
costs were taken into account, the IPTp costs increased to D434,016. The indirect costs were 
D134,004. 
In terms of out-of-pocket expenditure at the health facilities in NBE, an average of D3.20 per 
woman was spent at the base facilities against D2.40 at the outreach facilities. Most of the 
expenditure in NBE was made at base facilities. In LRD, average out-of-pocket expenditure was 
D4.70 at base facilities and D2.20 at outreach clinics. In this case also, the highest expenditure 
was at base facilities. The highest number of those who paid for transport attended Soma Major 
Health Centre (n = 9) and then Farafenni MCH clinic (n = 4). Forty-seven per cent of the 
women spent money on food. 
The measurement and valuation of indirect costs were important components of the economic 
evaluation of IPTp conducted in this thesis. Special household time use and employment 
surveys were conducted to obtain information on the pattern and value of unpaid work with a 
view to coming up with the hourly wage rate for women in the study setting. The main finding 
of the time use study was that an average of 12.7 hours per day was spent by women on various 
subsistence and household activities during the dry season. Amongst the activities, household 
work took the highest proportion with 6.4 hours per day. The highest number of hours for 
household work was on Wednesdays and Fridays with 7.1 hours and 7.5 hours, respectively, 
when women did not engage in farming. The higher the time use for farming, the lower for 
household work. 
Time use also differed by settlement. Household work in the villages took 6.3 hours per day 
against 7.5 hours per day in rural towns. Household work was also the most time- consuming 
group of activities in NBE (5.9 hours per day) and LRD (seven hours per day). During the rainy 
season, household work decreased to four hours per day in favour of farming, which took 
precedence over all other activities during this period, with 8.7 hours per day. By combining the 
time for dry and rainy seasons, farming came out on top with an average time of 5.3 hours per 
day followed closely by household work with 5.2 hours per day. 
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The average wage range for women was D2.52-D15.45. The lowest represents the hourly pay 
rate for a health facility laundress/cleaner/orderly while the highest represents the rate for a 
market trader. The average pay rate for all other types of work performed by women was D5.75. 
The wage level for men varied from D1.62 - D8.75. The lowest represents the wage rate for a 
watchman and the highest is that of a shepherd. The average hourly pay rate across all forms of 
work performed by men in the study area was D3.83. The average hourly wage rates for 
women, men and for both men and women were D5.79, D3.83 and D4.77 respectively. The 
hourly wage rate for farming was D5.93, and was D15.45 for income-generating activities. In 
terms of ranking, the highest hourly wage was for the generalist in the replacement cost 
approach (RCA) (D5.98), followed by the average female wage in the opportunity cost 
approach (D5.79). Next was the specialist wage of RCA (D5.14), then average wages for males 
and females together (D4.77) and the wages of males alone (D3.83). 
The health consequences of IPTp for Base case I showed three additional cases and no change 
in deaths for LBW. The corresponding values for anaemia were 56 additional cases and five 
extra deaths. The DALYs averted for Base case I were -125.84. For Base case II, no changes in 
cases and deaths were averted for LBW, and the corresponding numbers for anaemia were three 
additional cases and no change in deaths. The DALYs averted were -0.13. 
The resource use consequences of the IPTp intervention showed that the provider, patients and 
their families incurred extra costs with IPTp. No savings were realised either by the provider or 
by patients or their families. This is because there were additional cases and deaths from both 
LBW and anaemia after the introduction of IPTp. 
These losses in Base case I without indirect costs were -D241,360 to the provider, -D15,835 in 
direct costs to patients and their families leading to resource losses of -D257,195. When indirect 
costs were taken onboard, the resource losses came to -D313,914. Out of this, indirect costs to 
patients and their families were -D56,719. When added to the direct costs, total loss of -D72,574 
to patients and their families was incurred. In Base case II, the total loss, without indirect costs, 
came to -DI 5,920, broken down into -Dl 5,327 as cost to the provider and -D592 as direct costs 
to patients and their families. The inclusion of indirect costs using the opportunity cost method 
of the female wage rate increased the losses to -D19,604. Indirect costs comprised -D4,276 and 
the rest constitute provider and direct resource losses. 
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Net implementation costs were D1,221,771 and D1,887,607 for Base case I with and without 
indirect costs respectively. The corresponding costs for Base case II were D315,933 and 
D453,620 for Base case II. These were calculated by summing the IPTp costs and resource 
losses. The inclusion of indirect costs thus increased net costs by 68% in Base case I and 44% in 
Base case II. 
Sensitivity analysis revealed that costs and DALYs were sensitive to changes in drug prices, 
introduction of haemoglobin test, number of visits, method of measuring indirect costs and 
changes in effectiveness and case fatality rates. When sensitivity analysis was conducted by 
changing the prevalence and case fatality rates to the average prevalence and case fatality rates 
for primigravidae and multigravidae taken together, the results showed that IPTp dominates - 
more effective and less costly than the control - as illustrated by the magnitude of resources 
savings and DALYs averted compared to base case values. The savings due to giving IPTp to 
all pregnant women are far greater than the IPTp implementation costs. Dominance was also 
apparent in the sensitivity analysis with effectiveness parameter changes for multigravidae alone 
as shown in Table 9.9, though these results are given less weight here since the parameters were 
not derived from the trial. 
10.4 DISCUSSIONS OF FINDINGS 
The background of study subjects showed that the largest proportion of multigravidae falls 
within the age bracket of 20-29 years. This result is similar to a recent study conducted in North 
Bank Division, which shows the higher proportion of mothers of all gravidae within the same 
age bracket (DoSH, 2004). In line with the explanation in Chapter 4, Section 4.5, factors 
contributing to being multigravidae at a young age have a lot to do with cultural and traditional 
practices such as early marriage and lack of education and other opportunities for girls. The 
general belief, especially in rural areas, is that a woman's place is in the home. This means that, 
compared to boys, girls should be exposed to limited educational opportunities up to the time 
they get married. Madrassa education, which the majority of women undertake (81.2%), only 
exposes them to the basic principles of Islam which is the religion for 95% of Gambians. The 
lack of functional literacy of the majority of the rural women was responsible for the majority of 
them being involved in only household and subsistence work rather than formal work. 
Understanding time was thought to be a major problem for rural women. To circumvent this, 
rice cooking was used as a proxy to measure time spent on major events of the day. The results 
revealed a significant difference between rice cooking as a proxy for measuring the time and 
relating conventional time to major daily activities (Section 7.5.2, Chapter 7). 
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10.4.1 Cost of IPTp 
The unit cost of IPTp to the provider was D16.35 for Base case I, which comprised D15.04 as 
the unit recurrent cost and DI. 31 as the unit capital cost. The corresponding costs for Base case 
II were D23.51, D17.61 and D5.91 respectively. The magnitude of the unit cost of IPTp was 
explained by the high recurrent costs relative to capital costs. The higher the number of women, 
the lower the cost of capital and the higher the recurrent cost. The relatively high recurrent cost- 
share stems from the use of incremental costing methodology on top of the existing ANC. 
In the sensitivity analysis, the modest increases in costs from changing the discount rate was 
because capital cost represented only 8% and 25% of the incremental costs of IPTp for Base 
cases I and II respectively. The reason is that IPTp is an additional programme on top of the 
routine ANC and therefore does not require the use of large capital items such as buildings. 
Therefore, costs do not seem to be sensitive to changes in the discount rate for both Base cases I 
and II. 
The recurrent cost component of IPTp comprised mainly drugs and personnel costs. Drug costs 
per woman were D12 and represented 73% and 51% for Base cases I and II respectively. The 
influence of changes in these costs on IPTp was shown in the sensitivity analysis. The main 
reason for the relatively high cost of drugs is because drugs such as SP in The Gambia are 
imported from developed countries and their costs are more or less dependent on the exchange 
rate of the Gambian Dalasi (money). The introduction of the haemoglobin test as part of IPTp in 
the sensitivity analysis led to a very substantial increase in IPTp costs by 520% for Base case I 
and 416% for Base case II. Haemoglobin testing is in theory part of routine antenatal care but in 
practice, it is only carried out in health facilities with laboratory services (WHO/DoSH, 2005). 
The ideal way to cut down on costs is normally through economies of scale, by increasing the 
number of women and thereby decreasing the average costs. However, given the incremental 
nature of the IPTp cost, not much can be done to cut the unit capital cost which forms only 8% 
for Base case I and 25% for Base case II. The only way of controlling recurrent costs is to 
explore ways of cutting down on recurrent costs. This can be done through efficient use of 
resources by searching for cheaper sources of local drug supply instead of using foreign ones. 
The Gambian economy has experienced problems in recent years as explained in Chapter 4, 
Section 4.3, leading to a high foreign exchange rate and import prices. Drug prices used in the 
calculation were obtained from the Medical Research Council (MRC), which purchases most of 
its supplies from the United Kingdom where the strong Pound Sterling contributes to higher 
prices (i. e. equivalent of D12 per woman). 
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However, for the purpose of this trial, SP was imported from Cosmos Pharmaceuticals in 
Nairobi, Kenya, which is expected to be cheaper than supplies from U. K. Furthermore, supplies 
from the local wholesalers could be cheaper than the Kenyan source. 
The importance of this drug cost (SP) may be because it was imported and the likelihood is that 
imported drugs are more expensive than those purchased locally. However, sensitivity analysis 
using local wholesalers as alternative sources of SP reduced the proportion of drug costs as part 
of recurrent cost only from 73% to 67% and from 51% to 44% for Base cases I and II 
respectively. 
By virtue of IPTp being externally funded, the recipient country (The Gambia) has little or no 
choice as to where it is purchased. The recent case in point is that, the bulk of the malarial drugs 
used for the Global Fund Round V malarial programme in The Gambia were imported from 
outside the country. However, it is worth acknowledging that some of the local wholesalers 
were also allowed to supply limited quantities of the same drugs. Although a small step, the use 
of local suppliers represents a paradigm shift in policy, which if continued could be useful in 
reducing costs. The recent move by the United Kingdom government to untie donor funds is 
also a step in the right direction, which gives recipient countries a free hand to utilise donor 
funds. 
On the other hand, the main catch is that, the IPTp programme in The Gambia could not 
succeed without external support because the government alone cannot shoulder the costs. 
Furthermore, with the policy of free antenatal services to all women, any attempt to introduce 
cost-recovery is likely to take a long time. Moreover, considering the very small average out-of- 
pocket expenditure (D0.98) made by women at the antenatal clinics, introduction of fees for 
IPTp could discourage usage. Previous funding studies in rural Gambia by Mills et al (1994) 
revealed that, household heads who usually bore health care bills for members of their 
households could afford a range of Dl-D5 (i. e. average of D3). However, given the large 
household sizes and the polygamous environment of the study area, the likelihood of a 
household head paying for more than one pregnant woman at a time is high. This in turns means 
high financial burden on households. 
For the drugs (SP), a combination of factors could contribute to reducing prices. The first, as 
already mentioned, is to look for cheaper suppliers, such as Egypt or the Netherlands, or 
through the WHO bulk purchase system directly from the manufacturers or to use local 
wholesalers. 
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Since the implementation is a public health concern that transcends beyond the research 
conducted by the MRC, the use of local suppliers to cut down on the high drug (SP) prices is a 
feasible option. 
The patients' share of IPTp implementation costs for Base case I was D54,453, out of which 
direct costs comprised only 3.5%. The corresponding figures for Base case II were D11,983 and 
2.8%. This shows that direct costs form a very small component of IPTp cost and are unlikely to 
adversely affect antenatal attendance in The Gambia. 
The average fare paid by the few women who used paid transport to go to an antenatal clinic 
was less than D5. It is stipulated in the health policy that 75% of the population should be 
within a maximum radius of five kilometres to the nearest health facility (DoSH, 2001). It is 
evident that the bulk of those who paid fares and spent money at the health facilities attended 
facilities in base clinics, especially those in towns such as Farafenni and Soma. The women 
could have taken `expensive trips' to seek antenatal care at this base clinic in order to use the 
opportunity to shop for the family, or it might be due to the general belief that better quality care 
was obtained at bigger health facilities rather than at the peripheral ones. Where potential 
patients have access to more than one facility, the tendency is to choose one based on their 
perception of the quality of care offered rather than distance (Iyun, 1994). The direct cost of 
IPTp at the outreach clinics is small; this could mainly be due to the short distance to travel to 
and from the clinic, which does not require payment of fares or spending money. On the other 
hand, it could be a result of lack of money to pay fares or spend at the clinic. It is also tempting 
to conclude that the majority of the women walk to the clinic because they live within a short 
distance of antenatal health facilities. However, this conclusion may not be entirely right as 
walking is not necessarily undertaken on a shorter travel distance. The low payment could be a 
result of lack of fares or means of transport within the locality. In such instances, the women 
would have no other option but to walk to health facilities. 
One way of reducing the costs for women is to cut down on the long waiting time at the 
antenatal clinics. The waiting time at Gambian health facilities is unnecessarily long regardless 
of the method used to measure it. This has been attributed, amongst other reasons, to lack of 
staff and poor organisation of work at antenatal clinics on the part of the provider (DoSH, 
2000). The Gambia enjoys a high antenatal attendance rate of 92% for the first visit only (WHO, 
2006). The reason could be, women may not have problems in making first visits to antenatal 
clinics, but their commitment for subsistence and household works could make it difficult to 
honour subsequent visits to health facilities where waiting times are unnecessarily long. 
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Despite, the long waiting time, only 38.2% of women in the clinic exit survey described waiting 
time at the clinic as `long', 52.1% were satisfied with the long wait, and only 25.4% were 
dissatisfied. The specific reasons for their satisfaction with long waiting times were not further 
explored. However, the fact that the majority of the women in the study area (90%) were 
illiterate, this could have made them shy away from criticising the waiting time in the open 
especially to those who actually administer the services. Some may feel that revealing their 
dissatisfaction with the method of delivery of antenatal services could lead to denial of such 
services in the future. 
A similar study in South Africa revealed that women are not bothered by the waiting time 
because it usually accords them the chance to conduct business, knitting, sewing, weaving 
baskets and bagging food. The products are then sold to other women waiting for their turn 
(McCray, 2004) to be attended to. What is clear in The Gambia is that women have devised 
coping strategies for the long clinic waiting time. These strategies include sending their ANC 
card to the clinic the night before; turning up very early in the morning to be seen earlier; 
sending their ANC card in advance with another woman and then turning up later; or arriving at 
the end of the morning (DoSH, 2000). 
Although childcare is an ongoing activity for women with young children, in rural communities, 
such a task is not seen as the responsibility of the mother alone but an activity happily shared by 
everyone in the household with spare time. Furthermore, childcare is seen as the main activity 
for able-bodied grandmothers and children below the marriage age. Given the high illiteracy 
rate of the girl child in rural Gambia, such people are not hard to find in the communities. In 
contrast to what obtains in The Gambia, in an environment where childcare is a problem, it 
could lead to low antenatal clinic attendance (McCray, 2004). From this study, childcare for 
mothers takes an average of 0.2 hours per day as an activity conducted on its own. This shows 
that childcare is usually shared in rural settings especially in polygamous families. 
10.4.2 Resource use consequences 
The resource-use consequences of the IPTp intervention showed that the provider made 
negative treatment cost savings. This negative savings (losses) are due to the negative 
effectiveness reported by the trial. In reality, if treatment costs are really saved, then such 
savings could be used to fund at least part of the implementation of the IPTp intervention. 
Moreover, household losses on treatment costs for Base case I were -13257,195 and -D313,914 
without, and with indirect costs respectively. The corresponding losses for Base case It were - 
D15,933 and -D19,604. 
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Based on this evidence, it is not justified to give IPTp to multigravidae alone in The Gambia, 
regardless of whether indirect costs are taken onboard or not. This shows that, when only 
multigravidae are considered, very little is achieved in terms of treatment cost savings and 
efficient utilisation of scarce resources in preventing LBW and anaemia. By using prevalence 
and case fatality rates for multigravidae and primigravidae in sensitivity analysis, IPTp is 
justified (dominates). This is due to some savings made in treatment costs of LBW and anaemia 
and also from averting deaths from the two conditions. Since the treatment resource savings are 
higher than IPTp costs, investing in the IPTp intervention for all women saves resources for 
both the government and the household in treatment costs and in the process reduces infant and 
maternal deaths. Even without including indirect costs, resource savings in base cases were 
found to be higher than the IPTp implementation costs, leading to negative net costs. Moreover, 
the resource savings were increased further with the inclusion of indirect costs. The magnitude 
of resource savings varied with the wage rate used. When the base indirect costs wage rate was 
used (i. e. female wage rate), the resource saving was 20% above the direct cost only level. By 
using other wage rates, proportions of indirect costs fluctuate around this base rate from 9%- 
20%. The lowest represents the use of simple HCA and the highest, the replacement cost wage 
rate for generalist (D5.98). The rest of the wage rates produced proportions between this two. 
The corresponding proportion for Base case II was 23% and the range was 10%-23% for HCA 
and replacement cost approach for generalist respectively. 
When IPTp was given to all pregnant women, the intervention was found to be cost saving, 
because IPTp was found to be both effective and less costly than the control. Another reason 
could be that IPTp is an incremental intervention to an already existing antenatal care, so the 
intervention cost is comparatively smaller to the likely resource savings from averting LBW and 
anaemia cases and deaths. Therefore, subtracting a larger cost-savings from smaller IPTp gives 
negative net costs. With DALYs averted being positive as indicated in Table 9.11A & B, the 
ICERs were negative. The effectiveness and case fatality rates for all types of LBW and 
anaemia from the trial were lower than those obtained from the literature. These might explain 
the high cases and deaths averted. The resultant cost savings realised outweighed the 
intervention costs, thereby leading to negative savings. In a nutshell, when IPTp was given to all 
pregnant women, it was found to dominate by being both less expensive and more effective than 
the control. Again in terms of funding therefore, it is advisable to invest in such interventions 
because they save resources which would otherwise be used for treatment of LBW and anaemia 
and avert the resources losses through deaths. The details are given in Section 9.3.7, Table 9.10. 
247 
10.4.3 Health consequences 
The trial confirmed the earlier findings that IPTp was not effective for women who have at least 
one pregnancy in The Gambia (Greenwood et al, 1989; Greenwood et al, 1994a; 1994b). One 
reason could be that the trial might not have reflected the operational setting, and as such, trial 
participants could have been more likely to show high levels of compliance than those in 
`programmatic settings' (Wiseman et al, 2003). The result could have also been different if 
LBW (1501-2449g), mild anaemia and parasitaemia cases had been considered. If ethics 
permitted, a more relaxed trial with fewer follow-ups could shed more light on effectiveness. 
The limited results of anaemia's contribution to the overall results as demonstrated in sensitivity 
analysis (Table 9.3) could be explained by two main reasons. First, the majority of those who 
suffer from anaemia fell within the mild or moderate categories. Therefore, using such 
categories to estimate DALYs led to fewer DALYs averted than it would have been with severe 
types of anaemia. This is because, the bulk of the women within the mild/moderate categories 
do not suffer from long-term disability let alone death. 
In a country like The Gambia where 83% of the women are said to suffer from anaemia 
(NaNA/MRC, 2001), mild anaemia is very much part of daily life. One of the drawbacks of 
using DALYs in economic evaluation was already highlighted in Chapter 2, and relates to 
methodological issues of the DALYs. They did not help the answer obtained for this study 
because the disability weights attached to mild/moderate anaemia are very low compared to 
severe anaemia or LBW. Evidence from the WHO website on "age-specific disability weights 
for untreated and treated forms of sequelae" included in the Global Burden of Disease study 
showed that the disability weight attached to mild anaemia was zero before and after 
intervention. It was 0.011 before and 0.011-0.012 depending on the age bracket for moderate 
anaemia. These are negligible compared to disability weights of 0.291 before and 0.256 after 
intervention for all sequences of LBW (Murray, 1996). The other reason for the result is related 
to the shortcomings of using DALYs as a unit of measurement as it places more emphasis on 
deaths than on survival with disability. Therefore, the fact that fewer women die from anaemia 
means the contribution of anaemia to the total DALYs is less compared to LBW. Larger 
disability weights for anaemia might affect the cost-effectiveness result. 
10.4.4 Incremental cost-effectiveness ratios (ICERs) 
The CERs or ICERs of health interventions are crucial in advising policy in choosing between 
competing interventions (see Chapter 2, Section 2.2.1). Including resource savings in the 
comparison of the ICERs of the intervention is necessary in order for policy makers to ascertain 
whether the difference in resource savings changes the ranking (Picard et al, 1993). 
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When two interventions have similar ICERs from comparison of implementation costs and 
effectiveness, and varying resource savings, to save costs, the one with greater resource savings 
should be implemented (Picard et al, 1993). The results of this study indicate that IPTp for 
multigravidae is more expensive and less effective than routine antenatal care in The Gambia. 
Because the effectiveness rates of IPTp were in the negative, there was no point in estimating 
ICERs for the base case scenario (multigravidae only). The cost-effectiveness conclusion for the 
study remains the same regardless of the assumptions on indirect costs. ICERs were again not 
estimated for sensitivity analysis using the prevalence and case fatality rates for both 
primigravidae and multigravidae because IPTp was found to dominate. This situation has not 
changed whether indirect costs were used or not, and according to the method of measurement 
of indirect costs. However, the resource savings were higher with indirect costs than when they 
were excluded. The proportion of resource savings above the direct costs only level was 20% 
for Base case I. It was also found that the value of resource savings varied with the wage rate 
used. The resource savings for Base case I ranged from 9%-20% with the lowest representing 
the use of the simple (non-strict) form of HCA and the highest representing the replacement cost 
wage rate for a generalist (D5.98). The rest of the wage rates produced percentage of resource 
savings between these two values. The range for Base case II was 10%-23% with the lowest 
representing savings by using non-strict HCA and the highest the base wage and replacement 
costs for a generalist. 
10.4.4.1 Methods of measuring indirect costs 
A substantial component of women's time in rural Gambia is occupied by unpaid work. Due to 
the availability of farming implements, most of the men's work in rural areas is limited to four 
hours (8.00-12.00 am) or at most six hours per day, while women spend an average of 8.7 hours 
per day working during the rainy season. This study suggests that, using different methods to 
value indirect costs, especially in rural settings where formal employment is in limited supply, 
can lead to different results only in two cases, HCA and FCA in terms of effects on net costs or 
ICER. Other methods do not make much difference. 
There is, in particular, some disparity between the values obtained using FCA and HCA. The 
values obtained in the base case analysis of multigravidae using the various methods are 
summarised in Table 10.2. While the former assigns zero value to unpaid household work, the 
estimates based on the Opportunity Cost and Replacement Cost approaches showed less 
variation in hourly rates of pay for women than both FCA and HCA. The zero value for unpaid 
work and negligible time spent on market work led to a lower value of indirect costs for FCA 
than for all other methods. 
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The straight interpretation of this is that all those who do not work in the formal sector have no 
productive value, which grossly understates the value of rural women who work for most part of 
each day. Furthermore, FCA is biased towards the skilled and well-to-do population where 
unemployment is almost non-existent, which raises equity questions (Koopmanschap, 1995). 
The inclusion of indirect costs in economic evaluation does not make it perfect, as confirmed by 
the study results. A number of methodological issues have been exposed. These include the 
various assumptions about the value attached to time by individuals not in active work, the 
choice of wage rate, and the methods used to elicit the time given up (Jacobs and Fassbender, 
1998). Contrary to suggestions that the opportunity cost method usually produces the highest 
values (Budlender, 2004), the results of this study have shown a different ranking, with the 
replacement cost method producing the highest value. The fact that the different methods have 
failed to produce the same value reinforces the view that the value obtained in measuring 
indirect costs largely depends on the method used. This implies that studies should openly state 
the method used in order to make comparison with others open and easier. As illustrated in 
Chapter 2, FCA is biased against unpaid work and biased in favour of labour in a formal work 
setting. HCA on the other hand tends to overstate indirect cost losses, which can change the 
ICERs (Koopmanshap and Rutten, 1994; Evers et at, 1997). The findings here are not different 
from those of Goeree et al (1999) who, in their valuation of productivity costs due to premature 
mortality, found that estimates from the HCA were 69% higher than when FCA was used. 
The main question that arises from this is whether FCA and HCA are useful in subsistence 
settings where no formal work exists and the bulk of the potential workforce participants are 
engaged in unpaid work. In such settings, the issue of surplus labour is not relevant because 
everybody is busy doing their own work and a day missed in rain-fed agriculture could hardly 
be replaced. Therefore, instead of relying on FCA that undervalues indirect costs or HCA that 
overvalues them, perhaps there should be a third way where unpaid work is measured and the 
number of days away from work is based on epidemiological advice for any illness. The number 
of years of productive life lost due to death and productivity lost due to bereavement should be 
based on local values of the study setting rather than on conditions in the formal market. 
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MISSING 
PRINT 
costs using various indirect cost valuation methods 
irtunity 
pproach 
sie wage 
of D5.79 
Opportunity 
cost 
approach 
(male wage 
rate) of D3.83 
Opportunity cost 
approach 
(average wage rate for 
male & female) of 
D4.77 
Replacement cost 
approach 
(specialist's maid 
wage rate) of D5,14 
Replacement cost 
approach (generalist 
wage rate) of D5.98 
Human 
capital 
approach 
(D2.43) 
Frictional cost 
approach (zero 
wage rate) 
D D D D D D 
73,693 1,367,685 1,466,792 1,505,766 1,594,294 1,220,216 964,576 
3,914 -295,117 -304,395 -308,079 -316,398 -286,643 -257,195 17,607 1,662,802 1,771,187 1,813,845 1,910,692 1,506,859 1,221,771 
4,016 388,695 410,498 419,072 438,548 356,235 300,012 
), 604 -18,390 -18,994 -19,234 -19,776 -17,488 -15,920 3,620 407,085 429,492 438,306 458,324 373,723 315,932 
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10.4.5 Comparisons with WHO threshold and other malaria intervention studies 
The findings of this study revealed that the IPTp intervention for multigravidae is more 
expensive and less effective than routine ANC. This means that there is only limited value in 
comparing it with other cost-effective interventions. Therefore, attempts were made to compare 
it with only selected studies of malaria-control interventions in The Gambia and SSA using the 
list of cost-effectiveness studies compiled by Goodman et al (2000). The disparities in data 
between this study and those reported by Goodman et al (for 1995) were maintained because 
updating them to the 2003 values would not change the ranking. However, it should be noted 
that, as rightly put by Goodman et at (2000), the cost-effectiveness of each intervention depends 
on several factors, such as drug resistance and duration of transmission, which makes simple 
comparison of results difficult. In line with that view, the comparison here is meant to give only 
a broad and rough indication of the relative cost-effectiveness of IPTp and other interventions 
studied either in The Gambia or elsewhere in the developing world. Comparison is limited to 
malaria studies only, with an emphasis on those conducted in SSA. 
10.4.5.1 Comparison with WHO threshold 
The WHO threshold states that all interventions in low and middle income countries are 
considered `very attractive' when cost per DALY averted or discounted life years gained 
(DLYG) is lower than the threshold value of $25, and `attractive' when below the upper 
threshold value of $150 per DALY averted (WHO, 1996). 
According to base case assumptions, ANC dominates. Therefore, this discussion focuses on the 
sensitivity analysis which used the average prevalence and case fatality rates for anaemia 
obtained from the trial and Shulman et al (1996; 1999) and also rates for LBW from the trial 
and Rogerson et al (2000) as proxy rates for all pregnant women (primigravidae and 
multigravidae). Since IPTp dominates the WHO threshold is irrelevant. For easy comparison 
with similar studies conducted elsewhere, findings were converted from Gambian Dalasi to a 
common denomination, the US Dollar, using the average end of year (2003) Gambian Dalasis 
(money) exchange rate of D28.7344 to 1 US Dollar. The results are indicated in Table 10.3. 
No previous studies on the cost-effectiveness of SP as IPTp have shown dominance but they 
have all shown that it was cost-effective for primigravidae and the results of the sensitivity 
analysis using primigravidae and multigravidae in this case reinforced it. Thus, using the total 
pregnant woman population, trial costs, primigravidae effectiveness from the literature and 
multigravidae effectiveness from the trial, completely transformed the results. 
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Even though giving IPTp to multigravidae confers no benefit, health benefits for primigravidae 
outweigh the costs of treating all women. The analysis is in keeping with the one made by 
Goodman et al: which concluded that if all pregnant women receive IPTp, the effectiveness of 
IPTp for primigravidae will to some degree outweigh the limited effects on multigravidae, and 
the intervention remains cost-effective (Goodman et al, 2000). As already indicated in Chapter 
8, giving IPTp to multigravidae led to more harm than good in terms of the extra number of 
deaths from and cases of both LBW and anaemia. This is true for both Base cases I and II. The 
ethical dilemma that one faces due to the trial finding is whether to give SP as IPTp to 
multigravidae in the Gambia after knowing that it confers no benefits. If anything, it carries 
some risks. 
Table 10.3 Costs and consequences of giving IPTp to all pregnant women (US$) from sensitivity 
analysis 
Without With Sensitivity Analysis by changing the wage rates 
Costs in US$ indirect costs Indirect 
costs 
Base Opportunity Opportunity Replacement Replacement Human 
case 
wage 
cost approach 
(male wage 
cost approach 
(average 
cost approach 
(Specialist's 
cost approach 
(Generalist 
capital 
approach 
rate rate) wage rate) maid wage wage rate) 
rate) 
0 D5.79 D3.83 D4.77 D5.14 5.98 D2.43 
Base case I 
(Women= 
74236) 
Incremental 
IPTp cost 
IPTpcost 44,964 71,888 62,29 66,909 6h, 71 72,616 
Resource 244,283 292,112 276,774 284,099 287,022 293,584 266,182 
savings 
Net costs -199,319 -220,224 -214,445 -217,190 -218,307 -220,768 -210,696 
DALYs 5,342 5,342 5.342 5,342 5,342 5,342 5,342 
Base case 11 
(Women=16332) 
Incremental 
IPT cost 
IPTp cost 12,763 18,981 16,878 17,886 18,283 19,185 15,373 
Resource 57,776 70,751 66.640 6t, 596 69,386 71,168 63,343 
savings 
Net costs -45,013 -51,770 -49,762 -50,710 -51,103 -51,983 -47,970 
DALYs 1,266 1,266 1,266 1,266 1,266 1,266 1,266 
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10.4.5.2 Comparison with malaria-control studies in The Gambia 
Since there has been no previous IPTp study in The Gambia, comparisons were done with 
similar cost-effectiveness studies of malaria-control interventions in The Gambia. These were to 
do with chemoprophylaxis for children (Picard et al, 1992), insecticide treatment of bednets 
(Picard et al, 1993), and modelling to estimate cost-effectiveness of net treatment (Graves, 
1998). The details of the results of these studies are in Table 10.4. No intervention was shown to 
be dominant. 
The only study that estimated the net CER was by Aikins et al (1998), which showed the net 
cost per child death averted as $494 and the cost per DALY averted as $21. In terms of cost per 
DALYs, the range was $9-$27, where the lowest represented the cost per DALY averted due to 
insecticide treatment of bednets (Picard et al, 1993) and the highest was the gross cost per 
DALY averted due to insecticide treatment of bednets (Aikins et al, 1998). As with the base 
case, the results of the sensitivity analysis using the prevalence and case fatality rates for all 
pregnant women (primigravidae and multigravidae) cannot be directly compared with those of 
previous studies in the same settings because IPTp completely dominates. 
Table 10.4 Cost-effectiveness studies in the Gambia (in 1995 US$) 
Reference Type of intervention Cost per Cost per death Cost per 
case averted DALY 
averted averted or 
DYLG 
Picard et al., 1992 (1988 data) Chemoprophyla. xis for children - $167 - 
Picard et al., 1993 (1989-90 data) Insecticide treatment of bednets - $219 9(9-$14) 
(167-$243) 
Picard et al., 1993 (1989-90 data) Insecticide treatment of bednets - $300 $13($13- 
and chemoprophylaxis ($246-$333) $20) 
Aikins et al, 1998 (1991-92 data) Insecticide treatment of bednets - Net CER $494 $21 ($14- 
($326-805) $35) 
Aikins et al, 1998 (1991-92 data) Insecticide treatment of bednets Gross cost $665 Gross $27 
Graves, 1998 Insecticide treatment of bednets - S829($447- 
2117) 
aource: uooaman et at (t vyva) 
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10.4.5.3 Comparison with IPTp in Sub-Saharan Africa (SSA) 
The results of this study were also compared to other malaria control interventions conducted in 
SSA in terms of cost per case, death or DALY averted, as illustrated in Chapter 3, Table 3.3. No 
study showed dominance. The cost per case averted ranged from $1.20-$113, where the lowest 
is the cost per compliant woman to chemoprophylaxis with coated chloroquine and old health 
education (Helitz-Allen et al, 1993) and the highest being the cost per case averted for antenatal 
treatment with chemoprophylaxis using weekly doses of chloroquine (Schultz et al, 1995). It is 
also worth mentioning here that none of the alternative studies considered indirect costs in their 
economic evaluation, and so comparing their results with those obtained from this study is not 
exactly comparing like with like. The range of cost-effectiveness ratios in terms of cost per 
death averted was $18-$542. The lowest represented the cost per death averted from antenatal 
treatment with chemoprophylaxis in Malawi (Schultz et al, 1996) and the highest, the cost per 
death averted using doses of chloroquine followed by weekly chloroquine in Malawi (Schultz et 
al, 1996). As stated in Chapter 3, Table 3.3, most of these studies considered only drug prices 
and adopted the provider perspective (Heymann et al, 1990; Helitzer-Allen et al, 1993; Schultz 
et al, 1995; Schultz et al, 1996; Goodman et al, 1999b; Wolfe et al, 2001). Similar outcomes 
were realised for cost per DALY averted. In terms of cost per DALY averted, only one estimate 
was given; $4-$29 (Goodman et al, 1999b). A recent study by Berman et al (2006) indicated 
that IPTp with SP including additional doses for HIV positive women showed the ICER at $13 
per DALY averted. The results of this study (sensitivity analysis) could not also be compared 
with the results of similar studies in SSA because in the base case, the control dominated and in 
the sensitivity analysis IPTp dominated. However, resource savings for Base cases I and II 
obtained from the sensitivity analysis using all pregnant women showed that the magnitude of 
savings was higher when indirect costs were included. The level of resource savings was also 
found to have varied depending on the wage rate used. In both Base cases, DALYs averted were 
higher in IPTp than in the control. 
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Table 10.5 Cost-effectiveness studies in Sub-Saharan Africa and selected developing countries (in 
1995 US$) 
Reference Area studied Type of intervention Cost Cost per death Cost per 
per case averted DALY 
averted averted or 
DYLG 
Sub-Saharan Africa 
Goodman et al, 1999 Sub-Saharan Chemoprophylaxis for children - - 3-41 
Africa 
Goodman et al., 1999 Sub-Saharan Insecticide treatment of bednets - - 4-10 
Africa 
Binka et al, 1997 Ghana Provision and treatment of - 2112(992- 77(37-84) 
bcdnets 2289) 
Some, 1995 Kenya Provision and treatment of - 2958(2938- - 
bednets 3120) 
Evans et al , 1997 Africa Provision and treatment of - - 
10-118 
bednets 
Goodman et al, 1999 SSA Provision and treatment of - - 19-85 
bednets 
Goodman et al, 1999 SSA Residual spraying - - 16-58 
Utzinger et al, 2001 Zambia (1929- Environmental management - 858 22-591 
1950) with DDT residual spraying in 
later years 
Sudre et al, 1992 Africa, 1991 Drug treatment for children - - - 
(drug costs only with CQ 
No resistance - 1.47 (0.21-3.36) - 
Low Resistance - 1.49 (0.22-3.36) - 
Ili gh Resistance - 2.56 (0.31-4.34) - 
Sudre et al, 1992 Drug treatment for children - - 
with AQ 
No and low resistance scenarios - 2.35 (0.34-5.40) - 
High resistance scenario - 2.89 (0.40-5.67) - 
Sudre et al, 1992 Drug treatment with SP - - 
All resistance scenarios - 1.70 (0.25-3.92) - 
Goodman et al, 1999 Sub-Saharan Improving compliance - 2-R 
Africa 
Goodman et al, 1999 Sub-Saharan Improving access to second and - 1-3 
Africa third line drugs 
Wiseman et al, 2003 Kenya Insecticide treatment ofbcdnets 38-49 1,214 Net CER* 25- 
34 
Other Developing Countries 
Akhavan ct al, 1999 Brazil Residual spraying, fogging and - 5072(785- 132 
source reduction 10,427) 
Akhavan et al, 1999 Brazil Residual spraying, fogging and - 2596(1093- 67 
source reduction, and a package 5193) 
of measures placing greater 
emphasis on early diagnosis and 
prompt treatment 
Akhavan et al, 1999 Brazil Package of measures to place 677 (271-1351 17 
greater emphasis on early 
diagnosis and prompt treatment 
Mills, 1993 1 Nepal Case detection and treatment, - Net CER* 109- Net CER* 12- 
and residual spraying 17,650 1803 
Source: Goodman et al (1999). " Net CER incorporate potential cost savings to government and household from reducing malaria 
incidence. 
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10.4.5.4 Comparison with malaria control studies in developing countries 
The final comparison was made with selected malaria control programmes conducted in other 
developing countries (Table 10.5). In this case also, no studies showed dominance, and only two 
studies are directly comparable in terms of their estimation of the net cost-effectiveness ratios. 
These are case detection, treatment and residual spraying in Nepal (Mills, 1993) and insecticide 
treatment of bednets in rural Tanzania (Wiseman et al, 2003). As indicated in Table 10.5, the 
cost per death averted was $109-$17,650 (Wiseman et al, 2003) and cost per discounted years of 
life gained (DYLG) was $12-$1,803 (Mills, 1993). The net cost per case averted was $38-$49, 
net cost per death averted was $1,214 and net cost per DYLG averted was $25-$434 (Wiseman 
et al, 2003). The results of the two base cases (I and II) reported in this study by using the 
prevalence and case fatality rates for all pregnant women (primigravidae and multigravidae), are 
more attractive than the ranges of each of these two studies in terms of cost per DALY averted. 
In terms of cost per death averted for all other studies, the range was $1.47-$2,958. The lowest 
represents the malaria treatment options with chloroquine and non-resistance in Africa (Sudre et 
al, 1992) and the highest represents the cost per death averted in Kenya through the provision 
and insecticide treatment of bednets (Some, 1995). For the rest of the other studies, the least 
attractive cost per DALY averted reported was $77 (Binka et al, 1997) for the provision and 
insecticide treatment of bednets for children in Ghana. Base cases I and II in the sensitivity 
analysis using all pregnant women (primigravidae and multigravidae) (Table 10.3) reported here 
are more attractive than the results of Binka et at. 
10.5 CONCLUSION 
In conclusion therefore, one can safely state that the control (ANC) dominates in this study if 
IPTp is provided to multigravidae only. On the other hand, the sensitivity analysis using the 
prevalence and case fatality rates of the trial for multigravidae and those reported for 
primigravidae showed that IPTp dominates compared to control. Inclusion of the resource 
savings meant that IPTp was actually cost saving because the resource savings were greater than 
the implementation costs and DALYs were averted. Therefore, giving IPTp to all pregnant 
women would save lives and productive time for the beneficiaries. 
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CHAPTER 11: CONCLUSIONS, POLICY IMPLICATIONS AND PRIORITIES FOR 
FUTURE RESEARCH 
11.1 INTRODUCTION 
The last chapter of this thesis presents the conclusions, policy recommendations of the study 
and outlines areas for future research. The chapter is arranged in three main sections. Section 
11.2 discusses how the study objectives were fulfilled and the contribution of the research to 
knowledge; Section 11.3 presents the implications of the study findings for policy; and Section 
11.4 outlines possible areas for future research. 
11.2 FULFILMENT OF STUDY OBJECTIVES AND CONTRIBUTION OF THE 
RESEARCH TO KNOWLEDGE 
11.2.1 Fulfilment of research objectives 
The study estimates the cost-effectiveness of introducing IPTp to multigravidae pregnant 
Gambian women and explores the effect of different approaches to measurement and evaluation 
of indirect costs on the ICERs. To achieve this aim, the study sets out three objectives, which 
needed to be fulfilled. Quantitative methods were used to collect the costs and effectiveness data 
to estimate the cost-effectiveness of the IPTp. The details of the research objectives and the 
methods used to achieve them, as outlined in Chapters 1 and 5, are to: 
1. Examine the cost-effectiveness of introducing SP as IPTp for malaria into normal 
antenatal care for multigravidae women in rural Gambia; 
2. Explore various methods of valuing indirect costs and assess the extent to which 
they affect the cost-effectiveness ratio and 
3. Make policy recommendations as to whether to introduce SP as IPTp on cost- 
effectiveness grounds. 
Therefore, the main purpose of this section is to assess whether the research conducted 
succeeded in achieving the objectives of the thesis. Objective three is the subject of Section 11.3 
of this Chapter 11 and it focuses on the provision of policy recommendations. Therefore, the 
focus of this section is to present answers to objectives one and two only. 
Objective one involved determining the incremental cost of IPTp at the various health facilities 
by collecting cost data for the health care provider and women enrolled in IPTp trial as well as 
the effectiveness of the IPTp. The cost to the provider presented in Chapter 6 was estimated in 
terms of the additional staff time, DHT and DoSH supervisory time and the cost of drugs (SP) 
specifically required for the IPTp. 
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Limited capital costs, which included the IEC and initial training of staff who administered 
IPTp, were included. The results have been presented in terms of recurrent and capital costs and 
by health division. 
The costs to patients included both direct and indirect costs. These were collected through clinic 
exit questionnaires. These were administered at all the antenatal clinics on the first enrolment of 
the women, complemented by the use of observational studies and estimates from health 
workers. The results for the direct cost of IPTp to patients were presented in Chapters 6 and the 
indirect costs in Chapter 7. 
The study of the treatment cost of LBW and anaemia cases treated at the hospital level was 
conducted at AFPRCH and RVTH. A hospital costing study was conducted at the former, while 
the costs for the latter were obtained from previous studies and updated to 2003 values, using 
the consumer price index. The cost of treatment to the provider included referral costs from 
peripheral health facilities to AFPRCH and where applicable, to the RVTH. It also included 
OPD and inpatient costs. The results of the provider costs of treating LBW and anaemia were 
presented in Chapter 6. 
In terms of costs to patients, observation studies were conducted at each of the hospitals with a 
view to obtaining both direct and indirect costs of treatment for LBW and anaemia incurred by 
patients, their escorts and family members. The indirect costs of treatment were presented in 
Chapter 7, while direct costs were presented in part of Chapter 6. 
The effectiveness of the IPTp intervention were estimated and presented in terms of cases of 
LBW (VLBW and ELBW) and anaemia (moderate, severe and very severe) averted, deaths 
from LBW and anaemia averted, and DALYs averted. The resource use consequences of IPTp 
in terms of savings to the health care provider as well as to patients and their families were also 
estimated in Chapter 8. To arrive at the ICERs, all the results in Chapters 6 to 8 were pulled 
together to estimate costs and resource savings and, net costs for the IPTp intervention for Base 
cases I and II. Specifically, the cases, deaths and DALYs averted as well as resource savings 
estimated in Chapter 8 were combined with the IPTp and treatment costs estimated in Chapter 
8, and indirect costs from Chapter 7, to attempt to estimate the ICERs in Chapter 9. 
To address objective two, exploring various methods of valuing indirect costs and assess the 
extent to which they affected the cost-effectiveness ratio; the study used a time use and an 
employment survey. 
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The results of these were combined to estimate the hourly wage rate for unpaid work using the 
opportunity cost approach (female wage rate) as the base case and opportunity cost approach 
(average of female and male and male wage rates), the replacement cost approach, the human 
capital approach and the frictional cost approach in sensitivity analysis. The results of the 
valuation are presented in Chapter 7. 
11.2.2 Contribution to Knowledge 
This research is designed to contribute to the long-standing problem of malaria in pregnancy 
through economic evaluation of IPTp, and to contribute to enhancing knowledge in a number of 
ways. 
Previous studies on CEA of IPTp were conducted from the perspective of the health care 
provider whereby only costs related to the health care provider were taken into account. Most of 
the other studies of malaria prevention in developing countries that estimate cost-effectiveness 
did not take into account patient and family costs. For the few that included such costs, they 
were limited to direct out-of-pocket costs while indirect costs were excluded. Moreover, where 
indirect costs were included, they traditionally emphasised losses from paid work over losses 
from household work. The emphasis of this thesis is different in that respect because it went 
beyond the usual provider to a societal perspective by also incorporating direct and indirect 
costs related to patients and their families. 
The study also contributes to knowledge in the sense that there is no known cost-effectiveness 
analysis of IPTp for multigravidae. In fact, one can safely state that this is the first study that 
estimates the cost-effectiveness of IPTp for multigravidae. The study went beyond considering 
only primigravidae, secundgravidae or all pregnant women but rather focused on multigravidae 
as a specific group. 
The study used different data collection methods and tested different approaches to valuing 
indirect costs. It provides baseline data on indirect costs in rural Gambia by using household 
time use methods through a combination of recall, observation and diary methods to measure 
time. Previous time use studies have been limited to measuring time by using either observation 
or recall methods. 
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Estimating indirect costs involved both time measurement and valuation. However, most studies 
measured time and then used secondary data in the form of wage rates to value them. For this 
study, an employment survey was used to value women's time. Furthermore, the study went 
beyond using the paid wage within the formal labour market in the form of the minimum wage 
(which does not exist in The Gambia), or the male wage rate (which happens to be lower than 
the ones estimated for women), average or constant wages. 
Empirically, there is little exploration of the implications of including indirect costs or different 
ways of measuring indirect costs in cost-effectiveness estimates of malaria prevention. This is 
one of the few studies that place emphasis on indirect costs especially unpaid household work. 
It explores not only the effects of including indirect costs but specifically uses different methods 
of measuring and valuing indirect costs, critically appraises these methods and examines their 
impact on cost-effectiveness estimates. It contributes to time costing research by highlighting 
discrepancies that could occur as a result of using different methods and therefore reaching 
different policy conclusions. However, it also showed that different approaches of the same 
method (HCA) led to minimal changes in the conclusion. 
The findings reveal a lot about conducting economic evaluation alongside a clinical trial. It is 
tempting to state that the risk of having negative results like in this study means it would be 
better for economists to wait to get efficacy results before conducting a CEA of this nature. 
However, in reality, the results of clinical trials can turn either way. Therefore, results like these 
should not deter economists from conducting CEA alongside clinical trials. It is better to accept 
that clinical and economic studies need to be done together, and that inevitably, certain 
interventions will be found not worth conducting the trial (more expensive and less effective). 
The sensitivity analysis demonstrates the value of exploring sensitiveness and an important 
finding was that, unlike the trial results for multigravidae, which showed that the control (ANC) 
dominates, giving IPTp to all pregnant women showed that IPTp dominates. 
11.3 IMPLICATIONS OF THE FINDINGS OF THE THESIS ON POLICY IN 
GAMBIA AND ELSEWHERE 
The IPTp trial did not establish that IPTp of multigravidae was cost-effective because the 
Control dominates. On the other hand, by giving IPTp to all women (e. g. primigravidae and 
multigravidae), IPTp was found to have dominated. The policy implications of these findings, 
as in the case of the main study, are not very clear. The implications of the findings of this study 
revolve around the question of whether it is managerially a good idea to target IPTp on 
primigravidae or to give it to all pregnant women, even if multigravidae do not necessarily 
benefit from it because it is cost saving. 
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The cost of treating LBW and anaemia and averting deaths from the two conditions was found 
to be far more than the IPTp intervention costs. This can be argued in two ways. The first is to 
give IPTp to all pregnant women based on managerial convenience and the real life experience 
of the researcher in the field. 
One of the difficulties that may arise in excluding multigravidae is that an ordinary rural woman 
may not understand the rationale for leaving her out from apparently benefiting from malaria 
prevention. "What about me? " was a question frequently asked during the time of the IPTp trial 
by several women wanting to be recruited. Some of those enrolled sometimes brought along 
their friends to be also considered for enrolment. This shows the difficulties involved in 
excluding women from preventive care such as IPTp. 
It will be difficult to explain to such women that their friends or relatives are not entitled to be 
on IPTp on efficacy and therefore cost-effectiveness grounds. Goodman et al (2000) argues that 
`the complexity of offering different services to different groups of women, and the political 
implications of excluding some women from valuable services like health, make it necessary to 
follow the Kenyan example and offer IPTp to all women'. The findings of the sensitivity 
analysis show that results change from positive for primigravidae (in the literature), to negative 
for multigravidae in both Base cases I and II. However, the results of the sensitivity analyses for 
all pregnant women (primigravidae and multigravidae) found IPTp to dominate. 
Another important issue to consider is that, being the only study that involves multigravidae, the 
trial was not the last word on effectiveness, as it could be flawed, in which case it would be 
sensible to conduct further studies. Since there have been no other known studies that used SP 
for multigravidae, and considering the shortcomings of this trial as explained throughout the 
thesis, further studies are worth conducting in order to establish conclusive information on the 
effectiveness of IPTp to multigravidae. On the other hand, one could conclude that 
administering IPTp to all women could be regarded as waste of scarce health resources, which 
could otherwise be used for other urgent health needs. This remains so despite the fact that SP is 
a cheap drug, which is less likely to put serious constraints on health resources. More serious 
evidence against giving SP to all pregnant women is that it causes harm to multigravidae in 
terms of additional deaths and cases of both LBW and anaemia. Therefore, in the light of the 
two opposing arguments, one tends to question whether managerial convenience or political 
correctness are more pressing than the likely harm to be caused by giving IPTp to all pregnant 
women. 
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In conclusion, based on the evidence provided in terms of efficacy, costs, and cost- 
effectiveness, it is suggested that the DoSH should limit the implementation of IPTp to 
primigravidae only until clear advice is available on its effectiveness status for multigravidae. 
It has been demonstrated in the sensitivity analysis that reducing implementation costs is 
important. A way of controlling the cost is to limit the number of SP doses per woman to only 
two, as recommended by the WHO. This ensures both the provider and patients save on the cost 
of the extra two visits. The reason for reducing the doses is that the HIV prevalence rate in The 
Gambia is 1.1% for HIV I and 0.6% for HIV 2 (DoSH Sentinel Bulletin, 2005). These rates are 
less than the 5% or 10% benchmark necessary to justify more than two doses of IPTp (Steketee 
et al, 1996a; Wolfe et al, 2001). 
The results of the study reveal that the use of bednets has a direct relationship to the 
effectiveness of IPTp. The study found protection at a significant level against LBW and 
anaemia for those women enrolled in the trial but who do not sleep under bednets at home. It 
was demonstrated that although IPTp has not been effective for the entire multigravidae 
population, it has been found to be effective for those multigravidae who do not sleep under 
bednets. In that case, the finding may be useful to The Gambia, but more so to countries where 
bednet use is very low. Given the results of the study, ITNs appear to have positive effects 
because all those women who slept under bednets are less affected by IPTp compared to those 
who do not use bednets. Therefore, ITNs appear to be a good substitute for IPTp. In the light of 
this finding, efforts need to be intensified to advocate the use of ITNs through Information, 
Education, and Communication (IEC) and provide ITNs to improve prevention, which can help 
reduce malaria in pregnancy as well as LBW and anaemia. The enthusiasm shown by UNICEF, 
WHO and other multi-lateral agencies in malaria prevention and control, could be tapped so that 
there are resources to provide IPTp to primigravidae and to fund treatment of bednets for 
multigravidae who are not on IPTp. 
The research findings on indirect costs give prominence to unpaid work largely performed by 
unskilled women. Gender inequality has been in the limelight for decades without much success 
in redressing the issue. Perhaps using health as an entry point will help address some of the 
problems women face in subsistence settings. One such problem is the exclusive responsibility 
of women for household work and taking care of the sick in such settings. By recognising and 
taking positive steps to alleviate the burden brought about by the multiple roles of women, it 
will not only have an impact on their health, but their lives as well. 
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The results in Chapter 7 show that women in rural Gambia work an average of 12.7 hours per 
day during the dry season on all activities including household work. However, household work 
tends to increase on Wednesdays and Fridays (7.1 hours and 7.5 hours respectively) when 
women do not normally work in the farms or rice fields. Household work on all other days 
accounts for 6.4 hours. The average time for farm work during the rainy season is 8.7 hours 
while the rest (4 hours) is spent on household work. 
The findings from this study underscore the fact that malaria in pregnancy is a serious burden to 
pregnant women, their families and the infants. This is indicated by the indirect costs incurred in 
its treatment, which justify efforts to combat the disease through effective prevention and 
control. Out of total treatment costs for LBW and anaemia, including those incurred by 
providers, 18% was due to indirect costs. From the total treatment costs incurred by patients and 
their families alone, indirect costs represent 78% for Base case I. In the case of Base case II, 
indirect Costs represent 19% of the total treatment costs and 86% of the treatment costs incurred 
by patients and their families. These show that indirect costs are a key component of treatment 
costs for LBW and anaemia in rural Gambia. 
Although over half of the women considered waiting times at the antenatal clinics `normal', the 
fact that they have devised coping strategies means it is indeed a problem. Efforts need to be 
made to reduce the long waiting times at health facilities especially during the rainy season 
when most women are busy at their farms. This can be done by improving the health care 
delivery at antenatal clinics thereby enhancing the quality of health services to the rural 
population. 
The study offers a good opportunity to improve certain aspects of antenatal care delivery in The 
Gambia. The relevance, as well as the significance of the measurement of indirect costs, might 
influence decisions on the expansion of health facilities by giving due consideration to more 
efficient methods of delivering health care to improve antenatal attendance. Therefore, antenatal 
clinic days at the outreach facilities in the village, especially during the rainy season, should as 
much as possible be scheduled in close consultation with the community (women). Ideal clinic 
days could be Wednesdays and Fridays when most of the rural women do not go to their farms. 
This will reduce the conflict between health seeking behaviour and unpaid work necessary for 
the survival of the rural women and their families. 
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11.4 RECOMMENDATIONS FOR FUTURE RESEARCH 
Despite the efforts to conduct cost-effectiveness analysis of IPTp for multigravidae, and to 
explore the issue of indirect costs, a few outstanding areas require future investigation. Unpaid 
work was estimated for only one person in the household, i. e. the woman. It could have been 
interesting to see how unpaid work is distributed at the household level between men, women 
and children, and its effect on health seeking behaviour. Since IPTp involves both infants and 
mothers, future research could assess the effect of LBW on schooling for children. The sample 
size for the household time use study can in future studies be increased and the data collection 
done for rainy and dry seasons through the observation method over a longer period (e. g. 2-3 
months per season) instead of one week, with a combination of observation and recall methods. 
Instead of using the hospital costing results, specific costs relating to the treatment of LBW and 
anaemia can be taken and the results contrasted with the values obtained for the general hospital 
costing. In addition, hospital cost analysis can in future be done on a larger number of patients 
conducted over a longer period, say one year, in order to factor in the outliers in terms of 
seasonal variation of malaria in pregnancy, LBW and anaemia. That, rather than the 21-day 
period used for this study, would lead to more accurate cost estimates. It will also be 
informative to policymakers when the scope of costing is expanded to include the lifetime cost 
long-term costs of both LBW and anaemia. 
The Riders for Health (RFH) contract has many positive aspects in terms of DoSH vehicle fleet 
management. It has specifically reduced the arbitrary use of health vehicles and in the process 
cut down some of the avoidable repair costs. The DoSH should find ways of improving the 
contract so that it can represent good value for money. Perhaps the starting point would be to 
conduct a study that assesses whether the extra benefits are worth the costs. It would be 
interesting to widen the scope of treatment costs to patients and families to include the cost of 
funerals and charities, and of transportation of deceased persons, and the indirect costs of 
periods away from normal work during bereavement for those in the same household and 
immediate neighbourhood. 
It is advisable to conduct further study with a view to finding out the reasons for the higher 
spending at base health facilities located in bigger rural villages and towns. In addition, steps 
should be taken to control the situation through sensitisation if the high turnout at such facilities 
is found to be based on perceived quality difference between health facilities. Cost-centre 
specific costing may be conducted and costs collected for each health facility. In the same vein, 
the corresponding effectiveness rates may also be collected for each health facility. 
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With these, the cost-effectiveness ratios can be estimated per health facility and their combined 
ICERs estimated for the entire intervention. This should give the individual weights of the 
health facilities on the cost-effectiveness of the IPTp intervention and indicate variation in 
quality. 
Finally, future research should expand the scope of this study to include all types of LBW, 
anaemia and malaria cases and can incorporate mortality and morbidity surveillance with a view 
to timely reporting any illness and deaths throughout the trial. 
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APPENDICES 
APPENDIX 1: INFORMATION EXTRACTION TOOL FOR EMPIRICAL THE 
LITERATURE REVIEW 
SUMMARY OF EMPIRICAL FINDINGS ON MEASURING INDIRECT COSTS - SHEET I 
Author (s) 
and year 
STUDY BACKGROUND 
of 
publication 
Geograp 
hical 
setting of 
the study 
Study 
populatio 
a 
Intervention 
evaluated 
Types of costs 
identified 
Type of 
forgone time 
included 
(paid/unpaid 
leisure) 
Methods 
used to 
measure 
Indirect 
costs 
SUMMARY OF EMPIRICAL FINDINGS ON MEASURING INDIRECT COSTS - SHEET 2 
COST MEASUREMENT AND VALUATION 
Approaches used to estimate Consistent use of Indirect costs The effects of Indirect costs 
indirect costs (HCA, FCA & indirect costs disaggregated on results assessed through 
WPA) from other sensitivity analysis 
costs 
Definitions: 
Paid work: Paid formal employment 
Unpaid work: Any unpaid informal work such as preparing meals, childcare, other household work, subsistence, petty trading and 
other non-formal work 
Leisure: Use of time except for paid and unpaid work i. e. sports, hobbies, socialising etc 
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APPENDIX 2: CLINIC QUESTIONNAIRE 
MALARIA IN PREGNANCY STUDY: ECONOMICS COMPONENT 
CLINIC QUESTIONNAIRE: SULFADOXINE/PYRIMET AMINE (SPI IN M LTIGRAvmAF 
Date of Interview DaYI_. I_I 
Monthlil__I 
Yearl_I_I_I, I 
Initials of fleldworker 1_1_1_1 
Identification number hIýI_I_I_I_I_I"I 
I 
MALARIA IN PREGNANCY- CLINIC QUESTIONNAIRE 
This questionnaire covers a range of areas such as the time spent in travel, waiting to receive care and the 
opportunity cost of the time of the pregnant mother accessing care at the clinic level. It also assesses the cost 
incurred in accessing care such as travel, treatment and food. It should be administered during the first visit of 
a pregnant mother attending Antenatal care. 
SECTION 1: PATIENT TRAVEL COSTS 
(1). When did you leave your home for the clinic? 
Please probe to get the approximate time of departure and tick the appropriate answer below. Please 
specify if 10. 
1.6 am (during the early morning prayers) 
[) 
2.6.30 (immediately after the early morning prayers) [] 
3.7 am (shortly before sunrise) [] 
4.7.30 (at sunrise) [) 
5.8 am (after sunrise/school going time) [ 
6.8.30 (well after sunrise) [ 
7.9 am (after breakfast) [ 
8.9.30 -10 am (Yorriyorri/Wolihha) [ 
10. Other (Spec) [] 
11. Don't know [] 
(2). How did you travel to this clinic? 
Please tick the appropriate answer and specify if 8 
1. On foot [] 
2. Bicycle [] 
3. Motorbike 
4. Public transport 
5. Donkey/Horse/Ox cart 
6. Taxi [] 
7. Private transport (including Government and NGO vehicles) [] 
8. Other (specify) [] 
(3). If you travelled by paid transport, how much did you pay as fare? 
Please write the amount in dalasis and buturs in the spaces below. 
Dalasisl, l_I Bututs I, I_I 
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(4) When did you arrive at the cWtic? Please tick the appropriate answer and specify if 10 
1.6 am (during the early morning prayers) [] 
2.6.30 (immediately after the early morning prayers) [] 
3.7 am (shortly before sunrise) [] 
4.7.30 (at sunrise) [] 
5.8 am (after sunrise/school going time) [] 
6.8.30 (well after sunrise) [] 
7.9 am (after breakfast) [] 
8.9.30 -10 am (Yorriyorri/Wolihha) [] 
10. Other (Specify) 
11. Don't know [] 
(5) How long did you wait before receiving health care at this clinic? 
Please tick the appropriate answer or write the time in hours and/or minute if possible 
1. Did not wait [] 
2. Just the time it takes to cook rice once [] 
3. The time it takes to cook rice twice [] 
4. The time it takes to cook rice three times [] 
5. The time it takes to cook rice four times [] 
6. Don't know [] 
TIME IN HOURS AND OR MINUTES 
Hours I-I_I Minutest 
(6) How do you rate the time you waited before receiving health care at this clinic? 
Please tick the appropriate answer 
1. Very short [] 
2. Short [] 
3. Neither short nor long [] 
4. Long [] 
5. Very long 
(7). Are you satisfied with the time you spent before receiving health care at this clinic? 
Please tick the appropriate answer 
1. Very satisfied [ 
2. Satisfied [] 
3. Neither satisfied nor dissatisfied [ 
4. Dissatisfied [J 
5. Very dissatisfied [] 
(8). Did you buy anvthin¢ during your visit to the clinic (for example, food, milk etc)? Please indicate 
what you bought and write the amount in dalasis and bututs in the space(s) below. Please tick 6 !f trau did 
not buy anything. 
1 ............................................... Dalasisl-I_-I BututsL_I-1 2 ............................................. Dalasis(__I_I Bututsl-l-I 3 ............................................. DalasisLj_I 
Bututslýl-I 
4 ............................................. Dalasisl_I___I Bututsl I__I 5 ............................................. Dalasisl_I-1 Bututslýl-I 6. Nothing 
(9). How much do you want to spend on food, milk etc on your way home? Please indicate what you want 
to buy in dalasis and bututs in the space(s) below. Please tick 6 if you are not going to buy anything. 
1 ............................................... Dalasisl. l_! BututsL_..! __I 2 ............................................. Dalasisl-I_I Bututsl ýl_) 3 ............................................. Dalasisl_I. _. 
I Bututsl 1-1 
4 ............................................. Dalasisl _I__I 
BututsL_ II. 
-I 5 ............................................. Dalasisl_I__I Bututsl. L__I 6. Nothing [j 
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SECTION 2: OPPORTUNITY COST OF TIME 
(10) What would you otherwise be doing had you not attend today's clinic? 
Please tick the appropriate answer(s) 
1. Household work ............................... 2. Trading .......................................... 3. Attending school (vocational) ................ 4. Farming .......................................... II 5. Paid work ....................................... 
6. Nothing .......................................... [I 7. Other (Specify) .................................. I) 
(I1) If trading (2) or paid work (5), how much do you make on average per day? 
Dalasis i_l_I Bututs 1 
_I_I 
(12) Who is doing your work while you are at the clinic? 
Please tick the appropriate answer(s) 
If n bo please skip question 13 and go to question 14 
1. Co-wife 
......................................... 
C) 
2. Daughter 
....................................... 
I] 
3. Aunt ............................................ I] 4. Mother 
........................................ 
[) 
5. Mother-in-law 
............................... 
[] 
6. Others (Specify) (] 
7. Nobody ....................................... I) 
(13) What is the normal work of the person doing your work while you are at the clinic? 
Please tick more than one answer if applicable. 
1. Household work .................................. 2. Trading .......................................... .. 
I] 
3. Attending school (vocational) ................. 4. Farming ........................................... 5. Paid work .................................... .... 6. Nothing ........................................... 7. Other (Specify) ................................... 
(14) How many days Per week do you work when you are. not sick at all? 
Please write the number of days in the space below. 
Days: 1_1 
(15). How many hours Der day do you work on average when you are not sick at all? 
Please indicate the number of hours in the space below. 
Number of hours I___I_I 
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Where auulicable, how would you divide your daily time amongst the various activities below? 
Please Probe to know whether she is not doing different work at the same time 
Activity Estimated Duration 
Household work: (in hours and/or minutes) 
(You may otherwise estimate according to 
how long it takes to cook rice) 
Cleaning/sweeping 
Fetching water 
Pounding 
Cooking 
Washing 
Childcare 
Going to the Market 
Ironing 
Attending school / university 
Trading 
Farming 
Paid work 
Leisure 
Others (Specify) 
SECTION 3: FAMILYNOLUNTEER CAREGIVER COSTS 
(17) Were you accompanied by a family member during your visit to the clinic today? (This should not 
include other women who have also come for clinic visit) 
1. Yes (please continue on to question 18) .................. 
[] 
2. No (please skip to question 20).. ................ 
(18). What is the work of the person(s) who accompanied you to the clinic? 
Please tick more than one answer if applicable. 
1. Household work ............................... 2. Trading ....................................... 
[] 
3. Attending school (vocational) ............... 
[] 
4. Farming .................. 
[] 
5. Paid work .................................... 
[] 
6. Nothing ................................. 
[] 
7. Other (Specify) .............................. 
[I 
(19) What is the reason for being accompanied by a family member to the clinic? 
(20) Will you go home straight after the clinic visit? 
Please tick the appropriate answer 
1. Yes 
2. No 
I Interviewer ...................................... 
Checked by:........................... 
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APPENDIX 3: FOLLOW-UP QUESTIONNAIRE 
FOLLOW-UP 1 OUESTIONNAIRE" SULFADOXINE/PYRIMETHAMINE (SP) IN MULTIGRAVIDAE 
Identification Number 
Follow-up date 
Dayl_I-. I 
Monthl_[-I 
Y 
Initials of Fieldworker 
1_hi-l 
MALARIA IN PREGNANCY- FOLLOW-UP OUESTIONNAIRE 
This questionnaire solicits information related to the background characteristics of the household head and the 
household assets. It further assesses whether the recruited mother got sick during her term of pregnancy until she 
gave birth to her baby. If she got sick, follow-up questions are asked to establish what sort of steps she took, the type 
of care she received, costs incurred and the opportunity cost of her time. If sick and she did not seek care, reasons for 
not seeking care should be advanced. 
SECTION 1: SOCIO DEMOGRAPHICS 
(1} What gender is your household head? 
Please tick the appropriate answer. If male, go to 2, otherwise skip to 3 
1. Male [I 
2. Female II 
(2). How many wives does the household head currently have? 
Please tick the appropriate answer. 
1. None ............................. 
[ 
2. One 
.............................. 
[ 
3. Two ............................... 
[ 
4. Three 
............................. 
[ 
5. Four ............................ 
[ 
(3 What level of education has your household head completed? 
Please tick the appropriate answer(s) 
1. None [ 
2. Primary [ 
3. Secondary [ 
4. Tertiary [ 
5. Madrassa [ 
6. Non-Formal [ 
(4) If Madrassa or Non-Formal education, how many years were spent in learning 
1. Number of years I, 1_I2. Do not know I-I 
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(5). What is the main occupation of the household head? 
1. Farmer .................................... 
[I 
2. Herdsman ................................. 
[I 
3. Shopkeeper/Retail ..................... .. 
[) 
4. Business ................................. 
[) 
5. Nurse ...................................... 
[I 
6. Domestic work ........................... 
[ 
7. Other (Please specify) .................. 
[ 
(6). Does anyone In the household own the following? If so, how many of each? 
Please write the number of assets in the boxes provided. For example, if there were two watches you would 
write: (2). If none then write zero in the box provided. 
1. Radio .................................... 
I 
__I 2. Radio cassette player .................. 
I_I 
3. Iron bed or carved wood bed......... 
4. Bicycle .................................. 5. Horse cart ............................... 
I. I 
6. Donkey cart ............................. 
I_I 
7. Ox cart .................................. 
I_I 
8. Corrugated roof ....................... 
I_I 
9. TV ....................................... 
I_I 
10. Motorbike or car .................... 
I. 
_I 11. Clock/Watch ......................... 12. Telephone/Mobile .......... 
I 
_I 
(7). Does anyone in your household own livestock? 
If so, how many of each? 
Please write the appropriate number of assets in the boxes provided. For example, if there 
were hundred cattle, please write (100) in the boxes provided. If none then write zero in the box provided. 
1. Chicken ................................... 2. Cattle ...................................... 
L-Irl_I 
3. Sheep ...................................... 
I-IýI_I 
4. Goats ...................................... 5. Horses .................................... 
I. 
_I__I ^I 6. Donkeys .................................. 
I^I-I_.. ) 
(8). What source of fuel do you use for cooking? 
Please tick the appropriate answer 
1. Collected firewood ..................... .. 
[l 
2. Purchased firewood .................. .. 3. Gas ....................................... 
I) 
4. Electricity .............................. ... 5. Crop residues .......................... 
I] 
6. Charcoal ............................... 
I) 
7. Kerosene 
.................................. 
I 
8. Other (Specify) ........................... 
[) 
SECTION 2: HEALTH AND SOCUL CARE PROFESSIONAL COSTS 
(9). During the past four weeks have you been sick? 
Please tick the appropriate answer 
1. Yes (please continue with question 10) .............. 
[) 
2. No (go to the end and sign the questionnaire).... [) 
(10) How many days in the past four weeks have you been sick? 
Please write the number of days of sickness in the space below. 
Days of sickness 1_I-I 
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(11). How severe was the sickness? 
Please tick the appropriate answer 
1. Mild (able to do normal work) ........................ [] 2. Moderate (able to do normal work with difficulty) 
3. Severe (unable to do normal work) ................ [] 
(12). Did you get better? Please tick the appropriate answer 
1. Yes ................................................... [l 2. No still moderately sick ............................ [] 3. No still seriously sick .............................. [] 
(13). For how many days during your sickness were you unable to carry on your usual activities/work? 
Please write the number of days. If none, write 0 
Days with no usual activities I-L-I 
If applicable, how many hours per day on average did you work on days of your sickness when you were able 
to do work normally? Please write the number of reduced hours. If none, write zero 
Reduced hours of work during sickness I-LýI 
(15). Did you seek care while you were sick? 
Please tick the appropriate answer 
1. Yes (please continue with question 16) .................. [] 2. No (go to question 21) .................. 
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(16). Where did you seek care? 
Please write the number of visits, the estimated duration and cost of visits in the spaces provided. Put zero if no visit 
took place in the last four weeks. 
Health provider Please tick 
Yes or No 
No. 
of 
visit 
Estimated 
duration of visit 
Cost of 
Treatment 
Cost 
of 
food 
Cost of 
Transport 
Days Hours 
Hospital/Health Centre Yes No 
Outpatient only 
Admitted/Inpatient 
Clinic/Dispensary 
Yes No 
Outpatient only 
Admitted/ Inpatient 
Yes No 
CHN 
VHW 
Pharmacy (where they 
sell drugs and related 
items) 
Shop/Kiosk (where they 
sell mainly other goods 
and some few drugs) 
- 
Traditional Healer 
Other (Specify) 
(17). How long did you wait before receiving treatment at the health facility? 
Please tick the appropriate answer 
Please write the time in hours and/or minute if possible. If you did not wait please write zero 
1. Did not wait [] 
2. The time it takes to cook rice once 
3. The time it takes to cook rice two times [] 
4. The time it takes to cook rice three times [] 
5. The time it takes to cook rice four times [] 
6. Don't know [] 
PLEASE ASK HER TO INDICATE THE TIME IN HOURS AND/OR MINUTES IF SHE CAN. 
Hours 1_I_I Minutes[ 
Please ask only those who were admitted (Questions 18-20) 
(18). While admitted, how many people on average on each day visited you? 
Please write the appropriate number of visitors in the space below: If you are not admitted, please skip to question 22 
Number of visitors per day 1 I_I 
(19). How long did your visitors stay? 
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Please write the average number of hours and/or minutes in the space below 
Average time stayed by visitor: Hours: I 1____I Minutes L___I_I 
(20). How far on average do your visitors live from your place of admission? 
Please write the appropriate distance in kilometres in the space below. 
Number of kilometres [_I_I-I 
Please ask only those who did not seek care (Questions 21-22) 
(21). Why didn't you seek treatment/care? 
Please tick the appropriate answer 
1. Illness not severe ..................... 2. Did not trust treatment ..................... 
[] 
3. Lack of money (includes lack of fare) ......... [] 
4. Facility too far away ..................... ......... 
[] 
5. Could not get transport ........................ .[] 6. Facility not open ............................... 
[] 
7. Family would not let me ..................... 
[] 
8. Busy at work ................................. 
[3 
9. Busy at home .................................. [] 
10. No permission from husband ............... 
11. Nobody to do the work ...................... 
[] 
12. Already have some drugs in the house...... [] 
13. Other (Please specify) ........................... 
(22). Please place in order the barriers to accessing care, starting with the most serious one, second most 
serious etc 
Please rank in ascending order starting with the with I as the most contributing factor for not accessing care, 
2, the second most and 3 etc 
1. Illness severe enough ..................... 
IýI_I 
2. Did not trust treatment ..................... 3. Lack of enough money (includes lack of fare) I-I_I 
4. Facility too far away .............................. 
I-ýI 
S. Could not get transport ............................ 
L_{ 
il 6. Facility not open .................................. 7. Family would not let me .......................... 8. Busy at work ....................................... 9. Busy at home ...................................... 10. No permission from husband .................. 
IýI-I 
11. Nobody to do the work ...................... 12. Already have some drugs in the house...... 
13. Other (Please specify) ........................... 
I-I-I 
SECTION 3" INFORMAL CARE/HOME HELP COSTS 
(23) In the last four weeks, have you been helped and/or cared for by a relative, friend or paid assistant either 
at home or at the hospital because of your sickness? Please tick the appropriate answer. 
1. Yes (please continue with question 2$) 
2. No (go to question 26) 1 
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(24). In the past four weeks, how many relatives or friends or paid assistants etc helped and/or 
cared for you because of your sickness? Please complete the table below by indicating the age, 
main occupation, the place the helper comes from, number of helpers and number of hours 
helped. 
Category of 
helper 
Age Occupation 
of helper 
Place the 
helper comes 
from 
No. of 
helpers 
No of 
days 
helped 
No. of hours per 
day helped 
Relatives 
Friends 
Paid assistants 
Other (specify) 
(25). Do you have any further comments or any information you would like to add about the cost to you of 
accessing care while sick? 
................................................................................................................................ . 
Interviewer ...................................... 
Checked by:........................... 
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APPENDIX 4: MANUAL OF PROCEDURE 
GENERAL INTRODUCTION OF FIELDWORKERS TO EXPECTANT MOTHERS 
I am (Name) ............................................. from 
the Medical Research Council (MRC) conducting a study on malaria in pregnancy. Through this study, 
we solicit information from selected expectant mothers to find out what costs they incur in accessing care 
during their pregnancy until they gave birth. This study is very crucial in ensuring that access to care is 
assured if we are to reduce both infant and maternal mortality in the Gambia. Therefore, your 
participation and co-operation will be highly appreciated. 
The information that you will provide will be used solely for improving the quality of care of mothers and 
children in the Gambia and will always be kept confidential. 
MALARIA IN PREGNANCY STUDY: ECONOMICS COMPONENT 
SULFADOXINE/PYRIMETHAMINE (SP) IN MULTIGRAVID-AE STUDY 
Purpose of the study 
The economic component of the Malaria in Pregnancy Trial will assess the cost, effectiveness and cost- 
effectiveness of using sulfadoxine-pyrimethamine (SP) through Intermittent Preventive Treatment (IPT) 
for multigravidae (i. e. pregnant women with more than one birth). This is in response to the need to 
gather enough evidence that will inform policy especially in light of problems encountered because of 
non-use of prophylaxis for pregnant women in The Gambia. Specific costs such as those related to 
accessing care by patients and their families at the clinic level, waiting time cost, household costs in terms 
of the opportunity cost of time, clinics and hospitals admission costs to the patients for treating and caring 
for pre-term babies and anaemic mothers will be included. Like in the effectiveness component, pregnant 
women enrolled in the economic analysis will be monitored for up to six weeks after delivery. 
This study proposes to look more deeply into the issue of what constitutes indirect costs in a rural Gambian population, and will make use of the sample of a 
randomised Controlled trial of intermittent SP for prophylaxis in pregnant women in The Gambia. It has been argued that, in order 
for intermittent treatment to be 
effective and beneficial to people, pregnant women need to take it between three and four times before delivery. Since the trial is clinic-based, pregnant women 
need to attend clinic for the same number of times before giving birth. 
Therefore, those who are worse off are those who never attend antenatal clinics and 
those who are not able to complete the treatment during their 
pregnancy. The intervention is to be assessed in terms of overall cost-effectiveness, but measuring this alone may hide possible negative effects on inequsiitios, 
with those women whose indirect costs are high, benefiting least from the intervention, and vice veT.. For the purpose of this aspect of the 
study, the following sets of instruments will be used: 
1. Clinic exit questionnaire 
2. Four weekly Follow-up questionnaire 
Some of the contents of the instruments were adapted from previous tools used in both developed and 
developing countries. They have been adapted to suit the content and logistic requirements of the trial. 
The study will help estimate both the financial and non-financial resources pregnant women and their 
families incur when accessing antenatal care in 14 clinics; eight in the North Bank and six in Lower River 
Divisions of the Gambia. Through the administration of two questionnaires, clinic exit and follow-up, the 
study will obtain firsthand information from the pregnant women on the cost they incur in accessing care 
at the clinic level. Since the study results will be aggregated, the individual information will only be an 
input into the overall framework and therefore confidentiality is automatically guaranteed. Each answer 
obtained will be combined with those of other patients involved in the study and will be reported in such a 
way that no individual will be identifiable through the report. The economic aspect of the trial is a sub- 
component of the main trial and so all the conditions that apply in the main Malaria in Pregnancy (MIP) 
trial also apply here. 
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GUIDE TO FIELDWORKERS 
The questionnaires have as far as possible been numbered chronologically. Since the clinic and follow-up 
questionnaires are to be administered separately from other instruments in the trial, identification numbers 
have been included for easy identification and assembling with other instruments especially the 
effectiveness questionnaire. The relevance of each of the questions to the study has been assessed and it 
was found out that all of them are equally relevant and so all attempts should be made to complete them 
fully. The appropriate recall period is four (4) weeks in most cases for the simple reason that the duration 
between two visits to antenatal clinic is four (4) weeks in the early stages of pregnancy in the Gambia. 
CLINIC EXIT QUESTIONNAIRE 
This questionnaire covers a range of areas such as the time spent in travel, waiting to receive care and the 
opportunity cost of the time of the pregnant woman while accessing care at the clinic level. It also 
assesses the cost incurred in accessing care such as travel, treatment and food. It should be administered 
during the first visit of a pregnant woman attending Antenatal care. This questionnaire will be 
administered to all expectant mothers within our sample. The questions included in this document are 
suitable for completion by expectant mothers themselves but the high illiteracy level in the Gambia would 
make that difficult if not impossible. Therefore, under the circumstances, the study will rely on the 
services of fieldworkers to effectively and accurately administer the questionnaire. Specific instructions 
for the fieldworkers are in italics after each question. Italics are also used to offer guidance throughout the 
questionnaire. Where it is believed that the question is not exhaustive, additional spaces have been added 
to capture all the possible answers. 
CLINIC QUESTIONNAIRE 
SECTION 1: patient travel cost 
Section 1 covers questions 1-9 that assess travelling time, mode of transport, and cost incurred. 
Q1: Given the problem in knowing time because of the high illiteracy level, the answers are related to 
things such as early morning prayers, sunrise etc. Where it is found to be possible to state the time, there 
may not be any need to ask these questions. A little bit of questioning is necessary in order to establish the 
estimated time. 
Q2: The pilot has revealed that most people walk to the clinic, which means Q3 should be skipped. For 
other modes of transport such as bicycle, motorbike, private transport etc, it might not be possible to 
indicate the fare paid. However, it might be possible to further probe to find out whether any fare has 
been paid regardless of the option chosen except on foot. 
Q3: This only gives the opportunity to indicate the fare paid if respondents use paid transport. 
Q4: When the arrival time is not known, conventional time should be linked to the common activities 
people know such as morning prayers, sunrise, school-going time etc. Like any question that requires 
time, a little bit of probing is necessary here. 
QS: Because of the difficulty it takes to understand time, one common aspect every woman knows in the 
Gambia is the time it takes to cook rice (just rice). For instances if it takes 1 hour to cook rice once, then 
cooking rice twice will be 2 hours (1 *2). If at all the time can be estimated without difficulty, it is better to 
use that option. 
Q6: This question tries to find out expectant mothers' perception regarding how long they waited before 
receiving care. 
Q7: This question tries to establish the level of satisfaction or dissatisfaction of the pregnant mothers 
concerning the time they spend before receiving care. 
Q8: Women often buy something at the clinic either through the advice of health practitioner or on their 
own volition. Whatever the reason, this should be captured. It is very common for them to buy something 
before being seen by the health provider. Any such costs should be recorded here. 
312 
Q9: It has been proven through the trial that some expectant mothers do buy things after receiving care 
on their way home. It is therefore necessary that we ask them what they intend to buy and how much they 
will spend on their way home. Any such costs should be recorded here. 
SECTION 2: OPPORTUNITY COST OF TIME 
This section covers questions 10-16 and asks how the attendance of the expectant mother at the clinic 
affected both her work (paid and unpaid). Unpaid work includes all aspects of household chores such as 
meal preparation, cleaning, taking care of children, leisure etc. These questions are asked after the woman 
has accessed the service in order for her to assess whether there is enough time left for her to do other 
work. 
Q10: Attending clinic has time cost in terms of alternative activity the person would otherwise been 
doing. The appropriate box should be ticked and if 7, specify. It is very common for people to have more 
than one profession and so only things that cannot be done at the same time are supposed to be recorded. 
Q11: For those who are trading or doing paid work, you should reflect how much they make on average 
per day. 
Q12.: This question gives the opportunity to indicate who was doing the work while the expectant mother 
was at the clinic. For most people, it is the daughter, aunt or co-wife etc. Whatever the answer, indicates 
accordingly. 
Q13: The normal work of the person doing the work while the expectant mother is at the clinic should be 
indicated here. As was the case in Q10, some people normally have more than one job and if this is the 
case, then it should be mentioned. However, for different activities done at the same time, only one 
should be recorded. 
Q14: This means the number of days worked per week For most ladies, rest days fall on Wednesdays and 
Fridays but even these two so-called rest days are used to do some other group work or 
domestic work. 
You should probe to find out what activities are carried out and record the appropriate answer. 
Q15: Please indicate here the number of hours of work the expectant mother does per day. Most people 
might not be able to say this but a little bit of probing could be helpful in getting the answer. For example, 
when do you go to the fields and when do you come back? 
Q16: This is just to help give the correct estimate for Q15. By answering this question, the study should 
be able to get a closer estimate of what has been given in Q15. Please do not spend time to 
balance the 
two. Just ask the questions and write the answers, of course with a little bit of probing. 
SECTION 3: FAMILY /VOLUNTEERS CAREGIVER COST 
Section 3 covers questions 17-20 and is not entirely different from the previous two sections except that 
they are not for the patient but for anybody who accompanies her to the clinic. It also includes the travel, 
feeding and opportunity cost of the time for that person. 
Q1 7. - This probes whether the expectant mother came to the clinic alone or with someone. This does not 
include women who came to the clinic with her to seek health care themselves. She needs to say 'Yes' or 
No'. If the answer is WO', then skip to question 20. On the other hand if it is TES, then you should 
proceed to Q19 for her to tell you the work of the person who accompanied her. 
Q18: Like in question 13, the normal work of the person accompanying the expectant mother to the clinic 
should be indicated here. As is the case, some people normally have more than one job and if this is the 
case here, then it should be mentioned. However, for different activities done at the same time, only one 
should be recorded. 
Q19: Question 19 seeks to find out the reason the expectant mother is being accompanied to the clinic. 
This is an open-ended question. 
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Q20: Question 20 seeks to find out whether the expectant mother went home straight after the clinic. 
Please Remember! Always sign the form. 
FOLLOW-UP QUESTIONNAIRE 
The follow-up questionnaire requires multiple visits, four weeks have been considered appropriate for the 
recall period. This questionnaire solicits information related to the background characteristics of the 
household head and the household assets. It further assesses whether the recruited expectant mother got 
sick during her term of pregnancy until she gave birth to her baby. If she got sick, follow-up questions are 
asked to establish what sort of steps she took, the type of care she received, costs incurred and the 
opportunity cost of her time. If she got sick and she did not seek care, reasons for not seeking care should 
be given. 
FOLLOW-UP QUESTIONNAIRE 
SECTION 1: SOCIO-DEMOGRAPHICS 
This section covers questions 1-8 which mainly asks about household head background characteristics 
and household assets. 
Q1: This asks the gender of the household head. Your work is to tick the appropriate answer. 
Q2: Question 2 only seeks information on the number of wives the household head has and you should 
just tick the correct answer. 
Q3: This one probes the level of education of the household head. Please tick the appropriate answer(s). 
Please indicate the levels that have been fully completed. 
Q4: Question 4 asks if household head has non-formal education or Madrassa and then finds out the 
number of years of schooling s/he has attended. Since this questionnaire is administered at the home of 
the expectant mother, you may seize the opportunity to ask the household head. 
Q5: Some people in the Gambia especially men, have more than one occupation. In cases where that is 
the case, only the main occupation should be selected. For example, you may ask ft MAW source of 
income, which may give an indication as to the real occupation of the household head. 
Q6: This question seeks to establish the type of assets the household has. Some of these answers are 
easily verifiable and so you should be vigilant. For example, you may find someone in the household 
listening to a radio. 
Q7: Some people normally do not want to count their living animals for various reasons and as such 
soliciting answers to this question has not been easy in the pilot. It is therefore advisable to do a lot of 
probing here. Some would say for example their chickens are more than 10 without being specific. In 
such instances, it is your role to ask whether they are up to 20. If she answers in the negative, you may 
come down to 15 until you are sure that you have a reasonable answer. 
Q8: This is the question on source of fuel used for cooking by the household. The answer here is centred 
on four items but that is not to say that other forms are not used. Please ask and accordingly tick the 
appropriate answer without pre-empting. 
SECTION 2: HEALTH AND SOCIAL CARE PROFESSIONAL COSTS 
This section covers questions Q9-22 and is mainly about any sickness during the four-week interval and 
whether any medical attention has been sought regardless of location. Please remember that cost could be 
incurred without actually going to the modern health facility, as there are many other ways to treat illness. 
There is provision for all those possibilities. 
Q9: This seeks to find out whether the person has been sick or not. If the answer is in the positive then 
you should go to the next question otherwise go to the end of the questionnaire and sign. 
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Q10: This is just to get the number of days the person has been sick. i. e. start to end dates 
Q11: This is only to know the seriousness of the sickness. Since seriousness is relative from person to 
person, it has been decided to link it to the ability to carry out normal work. 
Q12: This question tries to find out whether the person is better or not and if not what was the state of 
sickness. 
Q13: People can be sick and still be able to carry on with their normal work but in some instances, they 
may not be able to work. This question seeks to fmd out from the respondent the number of days she was 
not able to carry on with her usual activities. 
Q14: People can work on reduced hours when sick. Our interest is first to know the number of days the 
person has been sick (Q10), then the number of days she was unable to do any work whatsoever. (Q13) 
and this question (Q14) try to find out the number of days she worked on reduced hours if applicable. 
Q15: It is very common for people in this part of the world not to seek health care at all times when sick. 
They may want to get into some coping strategies in the interim. We want to know from this question 
whether the woman sought care or not. If the answer is in the positive, then go to the next question 
otherwise skip to Q21. 
Q16: The table in this question gives the expectant mother the chance to catalogue which health provider 
she visited and these could range from formal to informal care. Please note that outpatient can only be 
for hours and any period spent at the facility above 23 hours qualifies as admission. It has been assumed 
that one cannot be admitted for hours. Therefore, do not fill the black squares where they exist, as they 
are not applicable to the health facility or the provider concerned. 
Q17: This question asks the time the expectant mother waited before receiving care. It has been 
approximated to the time it takes to cook rice, which is a familiar activity to every woman in the Gambia. 
What it means here is the cooking of plain rice and not any accompanying sauce. However, if the 
expectant mother knows the time, it might not be necessary to use the rice-cooking example. In that case, 
just go straight to the conventional time 
Q18: This question refers to only those expectant mothers who have been admitted. It asks for the 
number of people that visited the expectant mother while admitted. Unless in very rare case that the 
person has no relatives in the country, visiting people at hospitals is a common phenomenon in the 
Gambia. Our interest is the average number of people (visitors) per day. 
Q19: We do not expect people to know the exact times their visitors come and go but they should be able 
to give the average time they normally stay. If they cannot not tell, the rice-cooking example can be given 
with the assumption that it takes about an hour to cook rice. You may also find out about the visiting 
hours in the health facilities concerned. 
Q20: It might be difficult for all the patients to know where their visitors come from. However, being a 
fieldworker in the area, it will be possible to tell the places they come from and you can estimate 
travelling time. If need be, write the name of the place so that you can crosscheck later, Using the 
kilometre counter on your motorbike could be a very useful tool for this purpose. 
Q21: There are several reasons why people do not seek care. The expectant mother is free to indicate 
more than one reason if applicable and so you should probe further and tick the appropriate answer(s). 
Q22: This gives the opportunity to rank the reasons in terms of the "most" to the "least" barriers to 
accessing care while sick starting with number 1, then 2 then 3,4 5 etc. Please write the appropriate 
numbers in the boxes provided. 
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SECTION 3: INFORMAL CARE/HOME HELP COSTS 
This section covers questions 23-25 and asks about any support the expectant mother may have received 
at home because of her sickness. By home-helper, we mean any person who is either employed or comes 
on voluntary basis help to carry out tasks on behalf of the expectant mother while she is sick. The work 
includes cleaning the house, ironing or gardening etc. Here the interest is only in the assistance she 
needed and was given because of her sickness and not for any other reason. 
Q23: This question asks whether the woman has been helped in any way because of the sickness she had. 
You should go to Q24 if the answer is positive otherwise you should skip to Q25. 
Q24: This question gives the expectant mother the opportunity to indicate the type of helpers; whether 
relatives, friends, paid assistants or others. The age of the helper must be recorded in order to find out 
whether s/he is a minor. The usual occupation and the place the helper comes from should also be 
recorded. You should also ask her to indicate the number of helpers, number of days helped and the 
average number of days per hour. 
Q25: Question 25 gives the expectant mother the opportunity to say anything about costs she could have 
incurred or the opportunity cost of time during her sickness not taken care of in any of the questions asked 
earlier. 
Always Remember! To thank the woman for her time and co-operation and sign the questionnaire. 
For any queries or questions, please contact: 
Pa Lamin Beyai 
MRC Filed Station 
Farafenni, North Bank Division 
Telephone: 
OR 
Telephone: 462283/4/6 
Mobile: 901686 
Email: Pa-Lamin. Beyait'a, lshtm. ac. uk 
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APPENDIX 5: SAMPLE SIZE CALCULATIONS 
Sample size calculations for Malaria In pregnancy trial 
The details of how the sample size was reached are indicated below. The primary endpoints of the trial 
are anaemia status (Hb <9g/dl) in the post partum period and low birth weight (LBW< 2500g) in 
multigravidae. To be able to observe with 80% power and 5% level of significance, a 20% reduction from 
the current estimated risk of anaemia (Hb <9 g/dl) of 30% to 24% of multigravidae during both the rainy 
and the dry season, and allowing for 20% combined refusals and loss to follow-up, a sample size of 2x 
1,115 was estimated to be sufficient (90% power 2x1478). The same estimation to observe a 75g 
difference in mean birth weight (increase from 3,000g to 3,075g; SD 500g) during both the rainy and the 
dry season would need a sample size of 2x 874 (90% power 2x 1169), while the sample size needed to 
show a reduction in proportion in LBW (<2500 g) from 16% to 12% is estimated at 2x1538. 
Sample size calculations for economic component of MIP 
In order to obtain the required sub-sample of the economic study, the researcher made use of Pocock 
(1983) and received assistance from a statistician at-the LSHTM. The size of the sample (n) was 
calculated using the efficacy rate for IPT with SP for pregnant women in Malawi and Kenya. The 
respective rates of LBW before and after taking two doses of SP as IPT at the antenatal clinic are 23% 
and 7% with IPT and the corresponding figures for Malawi are 23% and 10% respectively. The joint 
efficacy of the two leads to averages of 23% and 8.5% without and with IPT. To calculate the size of our 
sample, the following formula was used: 
n= Po* (100 - PQ) + P1 * (100 -Pf (a, ß) 
(Pi - po)2 
Where Po is the percentage of LBW babies with placebo 
Pi = percentage of LBW babies with two doses of SP 
a= the level of the significance test used for detecting treatment difference (a = 0.050 - 5%) 
1 -, 8 is the degree of certainty that Po-P1, if present would be detected (1- ý1= 0.90) @ 90% which is the 
power to detect a difference of magnitude P0-P1 
a= Type I error, represents the risk of a false positive result 
ß= Type II error, represents the risk of afalse-negative result 
The formula above produced a total sample size of 254 or 127 per arm. This was rounded up to 300 (150 
each arm in order to account for any dropouts. 
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APPENDIX 6: EMPLOYMENT SURVEY FORM 
Example of the work and pay of domestic maids 
ID Health 
District 
Duration Hours Pay in 
kind 
Composition of work 
I LRD 8am-5pm 9 200 cooking, sweeping, laundry, errands, washing 
and ironing 
2 LRD 8am-lpm 5 600 
3 LRD 
4 LRD 
5 LRD Bam-lpm 5 1,000 laundry and ironing 
6 LRD 8am-6pm 10 225 cooking, washing, sweeping, ironing 
7 LRD Sam-5pm 9 350 sweeping, laundry, fetching water, ironing, 
childcare 
8 LRD 9am-5pm 8 200 Cleaning: house, bowls, laundry, errands, 
cooking, ironing 
9 LRD 8am-7pm 11 500 laundry ironing, house fitting, cooking, sweeping 
10 LRD 8am-6pm 10 1,000 laundry, cooking, sweeping, ironing 
11 LRD 8am-6pm 10 600 laundry, ironing, sweeping, cleaning 
12 LRD 
13 LRD Bam-lpm 5 800 laundry, ironing, cleaning 
14 LRD 8-lpm 5 900 laundry, ironing, cleaning 
15 LRD 7-6pm 11 1,500 sweeping, cooking, washing, ironing 
16 LRD 8-6pm 11 300 childcare, cooking, washing, ironing, cleaning 
17 LRD 8-2pm 6 300 sweeping, ironing, laundry, errands, washing 
18 LRD 8-2pm 6 250 sweeping, washing, laundry, ironing 
19 LRD 8-7pm 11 250 laundry, ironing, cleaning, sweeping, baby caring 
20 LRD 7-6pm 11 200 cooking, laundry, sweeping 
Average 
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APPENDIX 7: FORM 1: PATIENT COST DATA COLLECTION 
OUTPATIENTS DEPARTMENT FORM FOR ALL PATIENTS 
Day of the week ................................. Date of the week: // 
Name of fleldworker :................................................. Initials of fleldworkerLj_I 
1. Arrival Time I 1_1 II 
2. Cashier: 
Time reached J_I_I_Li 
3. Medical Records: 
Time reached 1_1 
Time seen I__I_I_1 1 
Time seen I_I_1I_I 
Time left 1_1_1__1-1 
Time left L_I_I_I, I 
OUTPATIENTS DEPARTMENT FORM FOR, ANAEMIA / LOW BIRTH WEIGHT 
Day of the week ................................. 
Date of the week: 
Name of fieldworker :................................................. Initials of fleldworkerj_l_I 
1. General Consulting/Obstetrics 
I Time reached 1_I_I-1_I Time seen Time left 
2. Name of Patient ......................................... 
3. Age: 1`I_I 4. Number of children I__I___I S" 
Work 
.................................... 
5. Sex (LBW babies only) Male/Female 6. Accompanied: Yes/No 7a. Age of Escort: 
Adult/Child 
7b. Number of escorts:...... 
8. Diagnosis: LBW/Anaemia Sa. If Anaemia, Haemoglobin (HB) level dl 8b. If LBW 
weight ........ kg 
9. Pharmacy: 
Time reached I-I-I I-_I Time seen Time left ý__ _ýI 
10. Laboratory (if applicable): 
Time reached ITime seen Time left 
11. X-ray (if applicable): 
Time reached I_I_I_I_I Time seen ýI_IýLI Time left I_IýI, I_I 
12. Back to General Consulting/Obstetrics (if applicable) 
Time reached 1_1_1_1_1 Time seen Time left I, I_l, IýI 
13. End of treatment and out of the hospital LI_j_I, I 
14. Time of Admission 1__I___I_1-1 
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PLEASE ASK THIS FORM FOR THOSE ADNHTTED ONLY 
Day of the week ................................. 
Date of the week: 
Name of fieldworker :................................................. Initials of fleldworkerLj_I 
1. Name of patient admitted ........................................................ 2. Parity 
.................. 3. Haemoglobin level 
.......... 
dl 
4. While admitted, how many people visited the patient? 
Number of visitors L_1_1 
5. Length of stay of visitors? 
Arrival time of visitor: I_I_i_I_I Departure time of visitors 
II-I_LJ 
6. Where did the visitors come from? 
Origin of visitors: ......................................... 
7a. How many are adults I I_I 7b. How many are children LLI 
8a. How did the visitors travel to this clinic? .............................. 
8b. If paid Transport (fares paid) 1I_II_I 
9. Gifts brought (Please number, size and amount if money) 
1 
.................................................................................................. 2 
.................................................................................................. 3 
................................................................................................... 
4 ................................................................................................. 
5 ................................................................................................. 6 
................................................................................................. 
10. Departure time of visitors I_I_I_II 
should be 
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MISSING 
PRINT 
IN ANALYSIS OF AFPRCH COSTS (D) 
Staff 
number 
Area in 
metre 
square Beds 
Admissions/ 
contacts ALoS 
Patient 
Day 
Annultised 
equipment cost 
Annual 
gross pay 
2003 Cost Training Drugs Station 
1,857,462 2% 
(Maternity 
D9.94 
0.02 
(Paed 
D6.57 
(()PD 
D46.75 ) 
21 539 21 564 7 3,948 81,638 256,634 5,133 39,243 
8 97 15 3,079 7 21.553 118,0111 154,277 3.0N6 
14 539 26 1,040 4 4,160 70,689 175,302 3,506 
8 539 16 274 30 8,220 45,650 88,129 1,763 
21 539 30 2,228 15 33,420 65,454 282,176 5,644 332,195 
4 539 12 35 60 2100 222,687 44,817 896 
76 2,792 120 7,220 123 73,401 404.129 1001 35 0 20.028 371,438 0 
18 121 0 0 0 0 471,748 216,807 0 4,336 0 46,529 
5 45 359,685 92,971 1,859 8,294 
17 604 299 280,230 264,433 5,289 
7 25 15,414 108,932 2,179 87,087 
2 99 69,281 21,885 438 
3 16 7,894 26,102 522 
59 161 10,645 77,614 694,822 13,896 497,654 
111 1 071 0 10 944 0 0 1 281866 1 425 952 0 28 519 497 654 141 910 
66 651 121,024 897,955 17,959 34,862 
1,040,400 0 
27 539 27,975 251,737 136,440 5,035 
32 305,706 6,114 
y 36,456 114,273 2,2265 
S i 1,555 631 
139 1,190 0 0 0 0 185,455 1601 226 1,176,840 32,024 0 34,862 
0 0 0 0 0 0 0 0 0 0 0 0 
326 5,053 120 18,164 123 73,401 1,971,449 4 13 1,176, M 71 869,092 176 772 
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m Telecom 
Utilities (elec & 
water Vehicle 
Building 
maintenance Administration Fuel Domestic 
Security & 
Gardening Maintenance 
120,000 324,000 82,812 3,653,009 1,659,174 1,040,400 1,159,015 663,11-541 255,180 
260 9%. 753 3860 3,860 
7,730 34,561 8,833 389,664 134,010 84,032 192,425 92,699 35,633 
2,945 6,220 1,590 -0,1_5 51,052 32,012 74,629 16, (, 82 6,413 
5,153 34,561 8,833 389,664 89,340 56 022 192,425 92,699 35,633 
2,945 34,561 8,833 389,664 51,052 32,012 192,425 92,699 35,633 
7,730 34,561 8,833 389,664 134,010 84,032 192,425 92,699 35,633 
1,472 34,561 8,833 389,664 25,526 16.006 192,425 92.699 35,633 
1 27,975 179,025 45,755 2,018,445 484"0 304116 9%, 754 430,177 194,578 
162.262 
6,626 7,759 1,983 87,476 114,866 72,028 18,349 20,810 7999 
1,840 2,885 737 32,532 31,907 20,008 6,824 7,739 2,975 
6,258 38,729 9,899 436,655 108,484 68,026 91,595 103,878 39,930 
2,577 1,603 410 18,073 44,670 28,011 3,791 4,300 1,653 
736 6,348 1,622 71,571 12,763 6,003 15,013 17, 026 (', 545 
1,104 1,026 262 11,567 19,144 12,005 2,426 52 2.7 - 1,050 
I 21 718 10,323 2,639 116,393 376,505 236,091 24 415 27,689 10,644 
1 40,859 68,673 17,552 774,267 708,33 9 444,172 162,413 184,194 70,804 
1 24,294 41,742 10,669 470,633 
0 0 0 
9,939 34.561 8,833 389,664 172,299 
11,779 0 0 0 204,206 128,04`) 0 
3,313 0 0 0 57,433 36014 
1,840 0 0 0 31,907 20,008 0 
0 0 0 0 0 0 
51 165 76 3 19,502 860,297 465,845 9&113 0 0 0 
0 0 
0 0 0 0 0 0 0 0 0 
1 119 324 001 62 809 3 653 009 1 659174 1040 401 1 159 015 664,371 82 
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Radiology Main theatre Pharmacy Dental Physiotherapy 
Unit 
Total cost -a/admission 
Unit 
cost/patient 
day 
560,262 1,485,448 324,171 241,707 94,713 
----4"0,025 
1,277,485 
--__26,, 
841 68,712 15,228 1663 45 2 
421 
146,531 375,113 83,131 2,015,411 655 
94 
28,282 72,401 16,045 1468003 1.412 
353 
55,885 143,062 31,705 1,571,81 5 5,737 
191 
227,210 581,648 128,903 4,026,099 1.807 
120 
14,277 36,549 8,1(X) 1,032.913 29,512 
492 
499,026 1,277,485 293,112 0 0 1.962.931 7.012 
279 
81,237 207,963 
0 0 0 1,095,445 
580,262 
1,485 448 
0 0 324,171 
0 0 0 241,707 
Iý 0 U 94,711 
79,018 207 963 41,058 241,707 94,713 2,965,641 271 
91,237 207,963 41,058 241,707 94,713 6,787,387 
1,659,174 
1,040,400 
!, 159,015 
--- 
663 854 
255,180 
87,191 
0 0 0 0 0 4156 20 
13.21)/0 
0 0 0 0 0 13,200 
580 
, 263 1,485,448 324,170 241,707 94,713 12 919 838 
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APPENDIX 9: HOUSEHOLD TIME USE DIARY 
Name of HH Head .............................. Village:................................................... 
.......................................... Health District: 
Name of interviewee:......... 
Parity ......... 
Day of week: .......................................... 
Date of Interview: ........................... 
Number of people in the HH: ...................... Number of adults: .......................... Number of C\children:......... 
Health Centre use for 
ANC:........................... 
Distance: ........ .................................. 
Main Activity . Parallel Activity 
Start 
Time 
Stop 
Time 
Name Code Time 
used 
Yes =1 
No=2 
Name Code Time 
used 
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APPENDIX 10: TRIAL INTERNATIONAL CLASSIFICATION OF TIME USE 
ACTIVITIES 
Trial International Classification of Time use Activities 
1. Time use of multigravidae (15 to 49 years old) in household 
2. Questionnaire and instruction for interviewers 
The questionnaire describes a list of economic, domestic, social activities and other occupations that 
do 
not constitute activities. This list is classified according to the kind of activity, but also according to the 
logical and possible order of development of these activities during the day, from the moment a 
household member wakes up until they go to bed. These activities are classified under eight categories. 
The code of each category appears between brackets before the activity: 
(1) Economic activities for the market, 
(2) Non-market economic activities, 
(3) Domestic activities, 
(4) Social activities, 
(5) Social activities of ceremonial type, and other social activities, 
(6) Transport, travelling, 
(7) Leisure, 
(8) Studying and education, 
(9) Other activities not classified. 
1. (8) Sleeping 
2. (8) Resting, doing nothing 
3. (8) Taking bathe, dressing 
4. (8) Eating meals 
5. (3) Washing dishes 
6. (3) Upkeep of dwelling 
7. (3) Ironing 
8. (3) Washing clothes 
9. (3) Other household maintenance 
10. (3) Drying food products 
11. (2) Fetching water 
12. (2) Preparing meals for the household 
13. (2) Fetching firewood 
14. (3) Shopping 
15. (6) Travelling 
16. (3) Taking care of children 
17. (3) Taking care of elderly, sick, etc. 
18. (1) Main activity ............................... 
/ 
19. (1) Secondary activity 1 ................... 
/ 
20. (1) Secondary activity 2 ................... 
 
21. (2) Agriculture 
22. (2) Gardening 
23. (2) Livestock 
24. (2) Fishing 
25. (2) Harvesting 
26. (2) Weaving 
27. (2) Basketry 
28. (2) Crushing 
29. (2) Processing agricultural products 
30. (8) Medical care 
31. (5) Receiving guests (relatives, friends, neighbours) 
32. (8) Shopping 
33. (5) Discussing, chatting 
34. (5) Visiting relatives, friends, neighbours 
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35. (5) Attending ceremonies, baptisms, marriages, bereavements, etc. 
36. (2.5) Preparing food for ceremonies 
37. (4) Participation in social meetings (political parties, religious practices, trade unions, 
NGOs, 
community organisations) 
38. (7) Listening to Radio, Watching TV 
39. (7) Recreational activities including dancing 
40. (7) Pottery 
41. Other, specify: ...................... 
326 
